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Abstract 
 
The Application of Ru(II) Polypyridyl Complexes to Cellular Imaging 
and Sensing 
Aisling Byrne 
Fluorescent microscopy is the key bio-imaging tool that is used to study live cells. 
Luminescent transition metal complex have been explored extensively for many years 
across a range of applications from solar energy to molecular therapeutics, but it is only 
over the last decade that they have been seriously considered as  cellular imaging probes. 
Their unique photophysical properties including large Stokes shift, red emission 
wavelengths, good photostability, and sensitivity to molecular oxygen mean they are 
more than just contrast agents,  making them invaluable in diagnostics and theranostics. 
A key aim of this thesis was to drive forward the demonstrated applications of 
luminescent Ru(II) and Os(II) probes conjugated to cell penetrating peptides in cellular 
imaging and sensing using confocal microscopy, and the relatively new phenomenon of 
super resolution microscopy, specifically, STimulated Emission Depletion (STED) 
microscopy. 
Chapter 1 overviews the general photophysical and optical of ruthenium and osmium 
polypyridyl complexes, examining the current status of their application in live cellular 
imaging and sensing. Microscopy techniques such as confocal laser scanning 
microscopy, stimulated emission depletion (STED) microscopy and fluorescence 
lifetime imaging microscopy (FLIM) are discussed and how they are used alongside 
luminescent probes for cellular sensing. 
Despite its NIR emission and high photostability Os(II) complexes have not been 
reported as general imaging probes before this report. Chapter 2 describes a novel Os(II) 
complex conjugated to the octa-arginine (R8) cell-penetrating peptide sequence as a 
cellular imaging probe, and compares it to its Ru(II) analogue. The photophysical 
properties of [Os(bpy)2(pic-arg8)]
10+ and [Ru(bpy)2(pic-arg8)]
10+ are examined and 
compared, as well as its ability to be taken up by live CHO and Sp2 cells, examined by 
confocal microscopy. 
Chapter 3 outlines a novel Ru(II) oxygen sensing probe, conjugated to the mitochondrial 
localising peptide sequence FrFkFrFk, in order to direct the complex to the mitochondria 
of live HeLa cells using confocal microscopy to confirm location. Fluorescent lifetime 
imaging microscopy (FLIM) allowed [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ to measure 
oxygen concentrations and reactive oxygen species (ROS) from within the mitochondria 
of live HeLa cells. 
Chapter 4 focuses on ratiometric oxygen sensing in live cells. Here, two probes are 
examined – a ratiometric molecule and a ratiometric core-shell nanoparticle. In both 
cases, the oxygen-sensitive probe consists of a Ru(II) complex, while the oxygen-
insensitive reference probe is a BODIPY complex. 
Finally, Chapter 5 describes the application of Ru(II) probes to STimulated Emission 
Depletion (STED) microscopy. Here, signal peptides conjugated to two novel Ru(II) 
probes directs them to the endoplasmic reticulum (ER) and nucleus of HeLa cells. The 
probes performance under confocal microscopy and STED is compared in the improved 
image resolution achieved as well as their photostability under the intense STED 
xii 
 
depletion laser. High resolution images of the ER and nuclear DNA during the stages of 
mitosis are captured using STED microscopy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Chapter 1 - Introduction 
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Fluorescent probes are a crucial part of a biologists imaging toolbox which allows 
biologists to visualise subcellular components in vivo, both structurally and functionally. 
The observation of many biological processes relies on the ability to identify and locate 
subcellular contrasted against complex environments. The recent dramatic evolution of 
microscopy, in particular the development of super-resolution microscopes means that 
the demands for new imaging probes, with improved features such as photostability and 
sensitivity to the environment for multi-modal imaging has grown dramatically. 
Traditionally, all probes used for imaging and theranostic purposes haven been based on 
organic dyes. Organic fluorophores have short-lived excited state lifetimes, <10 ns, and 
susceptible to photobleaching when used under laser scanning microscopy. Their short-
lived lifetime’s means they are unable to monitor long lived bimolecular processes such 
as oxygen sensing, limiting their uses as cell imaging probes. Still today all but a few of 
the commercial probes available are based on organic molecules. 
Luminescent transition metal complexes such as those of Ru, Os and Ir are potentially 
of great interest to the area of bio photonics and theranostics, but are only starting to be 
seen as real alternatives to the organic probes. Transition metal complexes possess 
unique photophysical properties which can be exploited in the design of diagnostic and 
imaging probes.1 They have versatile chemistries which permit their optical tuning so 
that they emit in the red, away from the biological window. Their large Stokes shifts 
avoids self-quenching, and allows for such probes to be used in a variety of  sensing 
techniques, such as resonance Raman, to which organic probes are unsuited. Their long 
luminescent lifetimes makes them ideal for environmental sensing in cells, such as 
measuring oxygen concentration, making them more than just contrast agents. They can 
be highly photostable, which is an important factor for imaging in order to avoid 
photobleaching. The transition metals that have been extensively applied as luminescent 
cellular imaging probes include Ru(II), Ir(III), and less commonly Re(I). Surprisingly, 
until this report, Os(II) complexes had not been explored as general imaging probes, 
only as anti-cancer agents. The long lifetimes and environmental sensitivity of these 
complexes makes them very attractive in combining therapeutics with detection methods 
in regards to cell imaging techniques. The focus of this thesis will be to examine the 
application of novel luminescent complexes in sensing and imaging in live cells. 
 
 
3 
 
1.1 Principles of Photophysics 
 
When a molecule absorbs a photon of light, it becomes excited, typically from its ground 
state (S0) to a higher energy state. The excited molecule is generally unstable and will 
seek to relax back to its ground state through a range of deactivation pathways. Figure 
1.1 shows the Jablonski diagram which illustrates the photophysical deactivation 
processes through which the molecule can lose its excess energy when returning back to 
its ground state. Luminescence is a radiative form of emission, and occurs as either 
fluorescence or phosphorescence, depending on the excited molecule.  
 
 
 
Figure 1.1 Jablonski diagram illustrating the absorption and deactivation processes following 
excitation by a photon of light.2 
 
Fluorescence is observed when the excited photon emits from the lowest vibrational 
state of the first excited state to ground state of the same multiplicity. From Figure 1.1 
its shows the situation for most organic fluorophores wherein fluorescence occurs as the 
molecule deactivates from the first singlet excited state to the ground state, S1  S0. The 
fluorescent lifetime of this emission is very short, of the order of 10 -9 s. 
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Phosphorescence is observed when the excited molecule emits a photon emits as it 
deactivates between energy states of different multiplicities, typically from a triplet state 
T1, back to ground state, S0. When absorption occurs, the molecule becomes excited, S0 
 S1. The molecule undergoes intersystem crossing (ISC), i.e. from a singlet excited 
state to a triplet excited state, S1  T1. The deactivation process T1  S0 is called 
phosphorescence. Crossing between different multiplicities like this is, in principle, 
forbidden and typically phosphorescence can only be observed in organic fluorophores 
under conditions of very low temperature, if at all. However, spin-orbit coupling within 
molecules that contain heavy atoms can lead to lifting of the selection rule allowing 
phosphorescence to be observed at room temperature. This forbidden nature of the 
phosphorescence transition leads to slow emission decay rates, and as a result the 
molecule has a long phosphorescent lifetime, of the order of 10 -3 – 10 -1 s. This is a 
typical deactivation process of transition metal complexes who possess heavy atoms. 
 
1.1.1 Luminescent Lifetime (τ) and Quantum Yield (φ) 
The luminescent lifetime and quantum yield are two key characteristics that reflect the 
intensity of emission from a luminophore as they quantitatively assess the emission 
efficiency. Both can be affected by external factors such as the solvent, oxygen, pH and 
temperature. 
The quantum yield (φ) describes the number of photons emitted compared to the number 
of photons absorbed. Luminophores with the highest quantum yields display the 
brightest emission. The quantum yield can be determined by the emissive rate of the 
luminophore (Γ) and its rate of non-radiative decay to ground state (knr). Equation 1.1 
reflects the fraction of luminophores that decay through emission: 
 
                                                Φf   =       knr    ..……… Equation 1.1 
                                                            kr + knr 
 
Where kr is the rate of luminescence. The lifetime of the excited state of a molecule (τ) 
is defined as the average time the molecule spends in the excited state prior to relaxation 
to the ground state. It is defined as the average time taken for the luminescence intensity 
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to decay following excitation to 1/eth of its initial intensity. Equation 1.2 shows the 
luminescent lifetime of a molecule: 
 
τ =     1    ……….Equation 1.2 
                                                   kr + knr  
 
Few molecules emit their photons at precisely t = τn. The luminescent lifetime of a 
luminophore in the absence of non-radiative processes is called the natural lifetime, τn, 
which is shown in Equation 1.3: 
 
τn =     1  ………. Equation 1.3 
                                                        Γ 
 
Where Γ is the emissive decay rate of the luminophore. τn can also be calculated using 
the quantum yield, shown in Equation 1.4: 
 
τn =   τ  ………. Equation 1.4 
                                                      Φ 
 
Where the natural lifetime is a function of the measure lifetime τ and the quantum 
yield Φ. 
 
1.1.2 Properties for Ideal Imaging Probes 
Luminescent metal complexes are increasingly being used as multi-modal imaging 
probes. To date, polypyridyl complexes of transition-metals such as Ruthenium, Iridium, 
and to a lesser extent Rhenium and Osmium have been exploited for cell imaging 
applications. Their advantages include a large Stokes shift, which helps avoid self-
quenching occurring. Synthetically tuneable emission which easily enables red emission 
in the near IR region exploiting the optical window. As they are in a triplet state 
(3MLCT) they possess long phosphorescent lifetimes. This is useful as it means their 
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emission can be differentiated easily from sample auto-fluorescence on the basis of 
lifetime. Auto-fluorescence occurs from naturally fluorescent molecules in the cell, 
found in the cell medium and tissues such as nicotinamide adenine dinucleotide (NAD), 
melanin, riboflavin, and aromatic residues in proteins.3 Their emission occurs in the blue 
end of the visible spectrum, and lifetimes for such emissions, as they originate from 
fluorescence, are typically in the range of less than 10 ns. For this reason, luminescent 
complexes that possess a red to NIR emission with long lifetimes are preferable as 
biological probes. 
The photostability of a metal complex is important when they are being considered as 
an imaging probe as all fluorophores undergo photo-bleaching upon illumination, but 
extending the period for which it can be irradiated before bleaching or decomposition is 
the key. A longer emissive lifetime makes the complex more sensitive to its surrounding 
environment as it has more time for interactions to occur, such as with molecular oxygen, 
producing singlet O2, to measure O2 levels, pH, and for diffusion of analytes during the 
excited lifetime. Good cell permeabilisation is also an important feature. In recent years 
metal complexes have been made cell permeable, and have also been directed to specific 
targeted cellular locations by use of peptide, without which they could not cross the cell 
membrane, which will be discussed in section 1.5. A successful metal complex for cell 
imaging should also be bio-compatible. It should be non-toxic, quantitative, remain 
stable over long periods of time in vivo and not interfere with normal cell function.4 
 
1.2  Photophysical properties of Ruthenium (II) Polypyridyl Complexes 
 
Ruthenium is a rare transition metal and, as with all d8 transition metals, Ruthenium can 
exist in a number of oxidative states, of which only it’s oxidation state (II) forms 
luminescent complexes, making it a d6 transition metal. The photophysical properties of 
[Ru(bpy)3]
2+, the first such luminescent complex reported, has been detailed 
extensively.5-7 Figure 1.2 shows an energy level diagram of the excited state of 
[Ru(bpy)3]
2+ (A) and its photophysical properties (B). The multiplicity of the excited 
states may be singlet or triplet.  Upon excitation, the metal centre undergoes absorption, 
leading to population of the first singlet 1MLCT state. Because of the heavy metal, spin 
orbit couple enables intersystem crossing (ISC) to occur co resulting in the formation of 
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a triplet 3MLCT excited state in Ru(II) complexes from where the complex emits 
through phosphorescence, and thus, recovery of the ground state of the molecule. 
The absorbance spectrum of [Ru(bpy)3]
2+ shows a metal-to-ligand (d-π*) transition at 
451 nm. A strong absorbance at 286 nm attributed to the π-π* transitions within the bpy 
ligands, and when excited into the MLCT at 451 nm, [Ru(bpy)3]
2+  has an emission 
maxima centered around 611 nm. In aerated aqueous solution it has a quantum yield of 
0.028 and exhibits a long luminescent lifetime of 650 ns.8 
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Figure 1.2 (A) Energy level diagram for a d6 transition metal-ligand complex. Excited state 
processes: 1) absorption of light with excitation from ground state (GS) to the 1MLCT state, 2) ISC 
to the 3MLCT, 3) relaxation to GS from 3MLCT, 4) Thermal population of the 3MC state, 5) 
deactivation of the 3MC state to the ground state.5 (B) Typical spectroscopy of [Ru(bpy)3]2+ at 50 
μM  in PBS solution showing the absorbance and emission profile. 
 
Ru(II) polypyridyl complexes have been extensively examined as sensing and bio-
imaging tools in recent years due to their unique and desirable photo-physical properties. 
Its large Stokes shift avoids self-quenching, and its long phosphorescent lifetimes, in the 
100s of ns to microseconds, makes Ru(II) complexes sensitive to local environment, 
particularly to molecular oxygen. These properties can be tuned with the manipulation 
of the coordinating ligands. Figure 1.3 shows the more widely used polypyridyl ligands, 
such as 2,2’-bipyridine (bpy), 1,10-phenanthroline (phen), dipyridophenazine (dppz), 
and 2-(4-Carboxylphenyl)imidazo[4,5-f][1,10]phenanthroline) (pic).  Typically, Ru(II) 
complexes follow the configuration [Ru(L-L)2(A-A)]
2+ where LL is a polypyridyl bpy 
or phen derivative, and AA is a heteroligand. Alterations of the ligands near the 
luminescent core can selectively tune the photophysical properties. For example, to 
allow absorption over a wider range of the visible spectrum or introduce pH sensitivity 
to the photophysics. 
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Figure 1.3 Polypyridyl ligands used in designing novel metal-ligand complexes 
 
Modification of ligands coordinated to the Ru(II) centre not only alters the photophysical 
properties of the complex, but can render the complex more selective towards a specific 
target. 9 For example, the [Ru(bpy)2(dppz)]
2+ complex exhibits strong affinity for DNA. 
Crucially, it has been shown to be a ‘light-switch for DNA’, displaying virtually no 
luminescence in aqueous solution but exhibiting moderately intense, long lived 
luminescence upon intercalation between the base pairs of the duplex. The effect is 
attributed to the protection of the phenazine nitrogen on the dppz ligand from hydrogen 
bonding once the planar aromatic ligand is incorporated into the -stack of the DNA 
helix. The group of Barton et al have done extensive work demonstrating the light-
switch effect.10-12 The most studied of the molecular light switches is 
[Ru(phen)2(dppz)]
2+. As for the bpy analogue, in aqueous solution it shows no emission, 
but luminesces brightly when intercalated with DNA. This complex has been the focus 
of the work by Turro et al, where they have looked at the quenching of 
[Ru(phen)2(dppz)]
2+ when bound to DNA,13 and have used resonance Raman to show 
that DNA intercalates with the dppz ligand of the complex.14  
Ionizable ligands can also be introduced into metal complexes to induce pH sensitivity.  
For example Ru(II) complexes have been combined with ionisable ligands such as 2-(4-
Carboxylphenyl)imidazo[4,5-f][1,10]phenanthroline) (pic) ligand, where [Ru(L-
L)2(pic)].The ligand has 2 ionisable protons located on the imidazole ring, rendering it 
pH sensitive. 15 
However, even with the many alternative choices of ligands, most Ru(II) and related 
metal complexes do not readily cross the cell membrane. This has meant that in spite of 
their photophysical advantages, they had not until recently been explored widely in cell 
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imaging. Various methods have been examined for improving the uptake of metal 
complexes in cells, such as the use of PEGylation, liposomes, nanoparticles, and 
conjugation of cell penetrating peptides, which will be discussed in detail in section 1.4. 
Many have forgone attempting to make the complex permeable and have used solvents 
or detergents to permeablize the membrane. This is far from ideal as such complexes 
cannot be said to be permeable and permeabilization can irreversibly change the cell 
membrane. This thesis will focus on the application of cell-penetrating peptides as 
vectors to carry the complex across the membrane and also to target it to cellular 
organelles. 
 
1.3 Osmium (II) complexes 
 
Until recently, Ru(II), Ir(III), and to a less extent Re(I), have been the main focus as bio 
imaging luminescent complexes. However, as described in this thesis, osmium (II) 
complexes are a possible alternative, although until this report they had not been 
explored for cell imaging. Os(II) polypyridyl complexes have many of the same photo 
physical properties of the above mentioned transition metals, with some notable 
differences due to the atomic mass of the Osmium . Figure 1.4 describes the excited state 
of [Os(bpy)3]
2+
.
16 
 
Figure 1.4 Excited state of [Os(bpy)3]2+ showing the singlet (1MLCT) and triplet (3MLCT) 
transitions at a higher energy level than [Ru(bpy)3]2+.16 
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Because of its large nuclear mass, Os (II) has a stronger spin-orbit coupling than Ru(II). 
When excited into the 1MLCT between 400 and 500 nm it emits from a triplet state 
(3MLCT). Unlike ruthenium, Os(II) can be excited directly into its triplet 3MLCT 
through an absorbance at around 550 nm. However, its excited state is not generally as 
long lived as ruthenium. The main advantage of using Os(II) is that its emission maxima 
is red shifted compared to analogous Ru(II) complexes and its emission can be more 
readily tuned to the NIR region using coordinating ligands. For example, [Os(bpy)3]
2+ 
has an emission centred around 710 nm, which is well outside the auto-fluorescent 
window. A significant advantage osmium has over ruthenium is that osmium has 
outstanding photostability, as there is no possibility for thermal cross over from its triplet 
excited state to the destructive metal centred state that is much lower lying in energy for 
analogous Ruthenium complexes. Figure 1.4 compares the energy level diagrams of 
[Ru(bpy)3]
2+ and [Os(bpy)3]
2+. In ruthenium, thermally activated crossover to a metal 
centred state (3MC) leads to the destruction of the M-L bond and to a sharp decrease in 
the luminescent lifetime with increasing temperature. The 3MC state of Osmium, on the 
other hand, cannot be thermally populated as it is far better separated from the 3MLCT 
state of the complex well above kT higher energy, shown in Figure 1.4, making osmium 
more photostable than ruthenium.17 This ensures there are no changes in emission 
intensity or lifetime and no photo-bleaching during cell imaging at 37°C.18 Until now, 
there have been no reports of Os(II) complexes applied as imaging probes.  Although 
Os(II) arene complexes have be explored as anti-cancer agents. The group of Sadler et 
al have extensively studied Os(II) arene complexes.19-22 Their most recent report focuses 
on the Os(II) arene complex [Os(η6-p-cym)(NMe2-azpy)I]PF6, shown in Figure 1.5, that 
can induce ROS production in cells.23 This highly toxic, highly active complex exhibits 
higher anti-proliferative activity compared to cisplatin in ovarian cancer cells, with an 
average GI50 of 0.75 μM compared to 36.7 μM for cisplatin, where GI50 is the 
concentration of complex which inhibits the growth of 50 % of cells. 
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Figure 1.5 Chemical structure of the osmium arene complex [Os(η6-p-cym)(NMe2-azpy)I]PF6.23 
 
Chapter 2 examines a novel Os(II) complex and compares its properties and cell 
compatibility to that of an equivalent Ru(II) complex, to assess if Os(II) can be used as 
an alternative imaging probe to the much explored ruthenium. 
 
1.4 Transport across the cell membrane 
 
Transition metal complexes such as the polypyridyl complexes of Ruthenium and 
Osmium cannot pass freely across the lipid bilayer of live cells due to their polarity and 
charge. The inclusion of low concentrations (e.g. 1 to 5 % V/V)  of organic solvent such 
as DMSO or detergents like Triton X in the dye incubation medium have been used to 
increase the uptake of transition metal complexes by permeablising the membrane. 
However, the solvent or detergent affects the packing of the cell membrane, making the 
lipid bilayer more permeable. Electroporation is also method can also be used to get 
complexes to cross the cell membrane. However, none of these methods are ideal as not 
only do they damage the cell, the complexes cannot be said to be cell permeable, and 
they are therefore not extendible to tissue samples.24 In an attempt to render metal 
complexes cell permeable, cell-penetrating peptide (CPP) sequences have been used to 
exploit their cargo carrying ability,25-27 or polymers such as poly(ethylene glycol) 
(PEG),28,29 as well as structurally altering the complex using hydrophobic ligands such 
as 1, 10-phenanthroline,30 or lipophilic pendants such as estradiol.31 A balance of 
lipophilicity, charge and solubility is key to designing a successful imaging probe that 
is capable to cross the cell membrane. 
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Quantitative Structure Activity Relations (QSARs) modelling is used to try and predict 
the influences of probe chemistry on cell uptake and localisation. 31 QSARs analysis 
looks at the relevant physiochemical properties of a probe that can be modelled using 
parameters such as log P or the overall charge of the probe, and what influences such 
properties have on the cell. There are many physiochemical properties that can influence 
a probe to be taken up by the cell, such as its charge, and where it will localise, such as 
the log P value, structural ligands used in the probes design, and the use of CPPs and 
sugars to promote uptake. For example, lipophilic probes tend to localise in the 
mitochondria while cationic probes migrate towards the nuclei of live cells. 32,33 QSAR 
models were initially developed by observing a series of dyes and their interactions with 
live cells. Properties such as amphiphilicity index (AI), electric charge (Z), width and 
length (W & L), and head group size and hydrophilicity (HGH & HGS) of the dyes were 
examined in order to establish a modelling system. 34 These modelling systems were 
then used to predict the uptake and accumulating patterns of the dyes. The benefits of 
such models allows for a more critical understanding of current fluorescent probes, and 
to help in the design of novel probes and assess their behaviour with live cells. These 
methods will be discussed in this section. 35  
 
1.4.1 Mechanisms of Membrane Translocation 
In order to design new fluorescent imaging probes and direct them across the cell 
membrane, the mechanisms in which the cell allows foreign structures to cross its 
membrane must be understood. Entry into the cell can be energy-dependent uptake such 
as active transport or endocytosis, or energy-independent uptake which includes passive 
and facilitated active diffusion.36 The mechanism can direct localization of the complex, 
and can differ between varying cell lines. 
Figure 1.6 illustrates the key methods of transport across the cell membrane. Passive and 
facilitated diffusion are both energy-independent methods. Passive diffusion occurs due 
to concentration gradients which transport molecules across the lipid bilayer. Passive 
diffusion is the ideal method of uptake as it has the broadest range of applications and is 
non-selective. The pharmaceutical industry tries to exploit such mechanisms in drug 
delivery. For example, animal cell membranes have a potential of -50 to -70 mV.37 
Therefore the uptake of a complex with a positive charge can be driven by membrane 
potential, provided that the molecule is sufficiently lipophilic to enable it to migrate 
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across the hydrophobic core of the membrane. This has been explored by Barton and 
group. They demonstrate the importance of complex charge and lipophilicity to cellular 
uptake. Here they incubated HeLa cells with [Ru(DIP)2(dppz)]
2+ in either HBSS with 
valinomycin to hyperpolarize the cells, or with K+-HBSS to depolarize the cells. 
Following incubation the uptake was examined using flow cytometry, and it was found 
that hyperpolarization promoted uptake of [Ru(DIP)2(dppz)]
2+ while depolarization 
decreased the uptake.38 Facilitated diffusion involves the transport of the molecule of 
interest via membrane-bound ion channels or pores, and membrane transport proteins. 
Glucose, potassium and sodium ions all pass freely using these methods. 39  
Active transport and endocytosis are energy-dependent processes. Active transport 
involves the participation of proteins such as ATPases which act to bring the molecule 
into the cell. In order for this to occur, ATPases break down ATP to ADP, releasing a 
phosphate ion. This reaction releases energy, and this energy is used to bring molecules 
in and out of the cell, as well as for other cellular functions. Therefore, the cell uses 
energy in the form of ATP to transport molecules from the cell surface across the 
membrane upon recognition. 
 
 
Figure 1.6 Mechanisms of transport across the cell membrane. Molecules can via passive 
diffusion, or facilitated diffusion using cell surface carrier proteins. The process of active 
transport uses energy in the form of ATP to direct the molecules into the cell. Endocytosis brings 
molecules across by forming vesicles around the molecule to carry it across the membrane.39 
 
Endocytosis is a process by which the cell ingests the molecule to bring it into the cell. 
The plasma membrane is thought to engulf the molecule, forming a vesicle which is 
carried across the cell membrane and is released once inside the cell. Molecules must 
reside near the membrane, or directly interact with membrane proteins to enable 
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endocytosis to occur. Endocytosis is a method of uptake that CPPs can typically exploit 
by selectively targeting specific cell surface receptors so that molecules will only enter 
a cell of interest. This is highly advantageous in the design of therapeutic agents for 
targeting specific diseased states such as apoptosis, cell-proliferation and diabetes.40,41 
For example, the folate receptor on cancer cells is a useful target for tumor specific drug 
delivery.42 Human cancer cells show an up-regulation of folate receptors on the cell 
surface and these increased over the stages in malignancy. Therefore, conjugating 
macromolecules to folic acid enhances the delivery of the drug to folate-receptor 
expressing cancer cells rather than normal healthy cells, and enters the cells via receptor-
mediated endocytosis. 
Studying the temperature dependence of uptake can yield insight into the mechanism of 
uptake, as it reflects if uptake is energy dependent or independent. At 4 °C all metabolic 
pathways in the cell are switched off. Therefore all active endocytosis is inhibited and 
the cell cannot take up the molecule if it is transported actively. 
 
1.4.2 Lipophilicity 
Lipophilicity is a key physiochemical property that is related to the permeability to 
biological membranes. It determines absorption, distribution, and toxicity of a complex 
within a cell.43,44 The lipophilicity is determined as partition coefficients (log P), which 
describes the partition equilibrium of an un-ionized solute between water and an 
immiscible organic solvent. The larger the log P value the greater the lipophilicity. There 
have been many reports on the importance of lipophilicity in transition metal uptake in 
live cells and their toxicity.29,45-47 Lv et al reported on a series of Ru(II)-N-hetercyclic 
carbenes with different alkyl side groups, shown in Figure 1.7, 1-5. The lipophilicity of 
the 5 compounds were measured, and increased in the following order 2<1<3<4<5. They 
found that when introduced to live cells that the cytotoxicity of the compounds increased 
with increasing lipophilicity.46    
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Figure 1.7 Structure of a series of Ru(II)-N-hetercyclic carbenes and the different side alkyl groups 
1-5.46 
 
However, it could be argued that in changing the side groups the complex is becoming 
more toxic rather than the toxicity being a result of the lipophilicity. An example of this 
can be seen in a report from Lo et al. Here they looked at a series of Ir(III) cyclometalated 
complexes who differed in their ligands. In this case, the lipophilicity and toxicity were 
not linearly related shown in Figure 1.8. As the lipophilicity increased, the IC50 values 
did not change accordingly as may have been expected, suggesting that, in this case, it 
is in fact the ligands that are inducing the toxicity and not the lipophilicity.45 
 
Complex Log P IC50 
2b 1.40 1.80 ± 0.18 
2a 1.46 >230 
1b 2.30 5.87 ± 1.81 
4b 2.37 7.06 ± 1.09 
1a 2.44 1.40 ± 0.07 
4a 2.48 29.6 ± 6.94 
3b 2.53 12.0 ± 1.30c 
3a 2.56 4.00 ± 0.60c 
1c 2.59 0.10 ± 0.02 
 
Figure 1.8 Log P values and the corresponding IC50 values of a series of Ir(III) cyclometalated 
complexes. 
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1.4.3 Charge 
Healthy cells have an internal negative charge i.e. are anionic, as a result of there being 
more potassium ions inside the cell compared to sodium ions present outside the cell. 
Therefore imaging probes can be taken up via passive diffusion if they are cationic. 
Using peptide sequences rich in arginine (R) and lysine (K) give a complex an overall 
positive charge, making it more attractive for uptake. The overall final charge has been 
shown to affect where the complex localises. For example, lipophilic cations typically 
localize to the mitochondria. However, an excess of the molecular charge can hinder the 
complex from accessing the mitochondria to the due to the hydrophobicity of the 
organelle.48,49  The charge of the complex has also been shown to alter the toxicity and 
localisation of a compound within the cell as demonstrated by Dickerson et al.50,51 
Uptake studies in A549 human cells showed that Compound 1, with a charge of +2, 
entered the lysosome and mitochondria whereas compound 2, with a charge of -4 
remained in the cytosol. Viability studies shown in Figure 1.9 demonstrated that 
Compound 1, with a log P value of 1.8 ± 0.02 μM was highly toxic towards the cells 
inducing toxicity after 72 h exposure in the dark. In contrast, Compound 2 with a log P 
value of -2.2 ± 0.12 induced no toxic effects on the cells, shown in Figure 1.9. 
 
  
Figure 1.9 Uptake and viability studies of two analogous ruthenium complexes with differing charge 
and log P values in A549 human cells. Confocal microscopy showed Compound 1 entered the 
mitochondria and lysosomes, and was highly toxic towards the cells (top), while Compound 2 
remained in the cytosol having no toxic effects on the cells (bottom).50 
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Gupta and co-workers have reported on a series of cyclometalated iridium (III) 
complexes for cellular imaging where they demonstrated that the cationic nature and 
hydrogen bonding interactions of Ir (III) contributed to the specific localisation and 
emission intensity in the endoplasmic reticulum (ER) of MCF7 breast cancer cells, 
shown in Figure 1.10. 52 Using confocal microscopy they demonstrated that cells treated 
with complex 1 and 3, which contained –OH groups in position 4’ and at 2’ and 3’ of 
the appended phenolic ring, localised within the cytoplasm and low fluorescence in the 
nuclei. In contrast, complex 2, with an –OH group at position 2 of the phenolic ring, 
showed intense fluorescence in the ER. Under irradiation with 405 nm laser the complex 
caused extensive photo induced cell death, whereas no toxicity towards cells were 
observed in the dark. Although highly phototoxic towards cells, they are a useful 
example of directing imaging probes to specific organelles by means of probe design. 
 
 
Figure 1.10 Molecular structures of C1–C11 showing the cyclometalated core and the ancillary 
ligands. C1–C9 have [Ir(ppy)2]+ as the cyclometalated core whereas C11 contains [Re(CO)3Cl] as 
the metal core.53 
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1.4.4 PEGylation 
Poly(ethylene glycol) (PEG) is a polymer chain that can be both covalent attached to 
transition metal complexes to increase their hydrophobicity and improving their 
solubility. PEG linkers are an attractive means of cell targeting as they have low toxicity 
towards cells. The reduced toxicity is attributed to the reduced non-selective interaction 
with DNA, proteins, and organelles.27 PEG has been both covalently and non-covalently 
linked to transition metal complexes to increase their hydrophilicity and improving their 
solubility, water solubility and cell permeability.54-56 Lo et al have done extensive work 
with PEGylated metal complexes and have examined their effects on cell uptake and 
imaging.55,56 Recently they presented a water soluble cyclometaled Ir(III) PEG 
complex.57 Uptake studies using confocal microscopy showed the complexes 
successfully entered HeLa cells and localised in the mitochondrial region of the cell.  
The complex showed no toxicity towards the cells in the dark but interestingly, exhibited 
high phototoxicity towards the cells, indicating significant potential as a therapeutic 
photosensitizer. 
 
1.4.5 Sugar Conjugates 
Carbohydrate-modified complexes are increasingly being used in cell imaging due to 
their good biocompatibility, and can serve as new imaging reagents as well as glucose-
uptake indicators in live cells. A series of rhenium (I) polypyridine complexes bearing 
an α-D-glucose have been reported by Lo et al, shown in Figure 1.11.58 Upon incubation 
with HeLa cells, complex 3 accumulates in the mitochondria. The complexes also 
exhibited lower toxicity towards the cells than the unconjugated analogues. It is thought 
that glucose transporters (GLUTs) play an important role in the cellular uptake of these 
complexes. 
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Figure 1.11 Structure of Re(I) polypyridyl series conjugated to α-D-glucose.58 
 
In another report from Lo et al they recently demonstrated the effects of lipophilicity on 
cell uptake and toxicity of a series of phosphorescent iridium (III) complexes.45 Here 
they use D-glucose and D-galactose sugar residues to promote cell uptake, where the log 
P values of the complexes range from 1.4 – 2.59. Complexes 1a-1c, 3a and 3b, and 4a 
and 4b have significantly higher log P values compared to complexes 2a and 2b, the 
difference being an extra hydrophobic phenyl ring in the cyclometalating ligands, shown 
in Figure 1.12. It is noted that the polar sugar entity slightly reduces the log P values 
compared to the sugar-free complexes. They also demonstrate a difference in cell uptake 
between the two sugar residues. Focusing on complex 1a, which has a log P value of 
2.44, they demonstrate its localisation within the mitochondria of HeLa cells which is a 
result of its cationic and lipophilic nature. Based on the knowledge that cancerous cells 
catabolise glucose at a higher rate, these complexes pose as potential cancer imaging 
agents. 
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Figure 1.12 Molecular structure of a series of Ir(III) complexes with D-glucose (1a-4a) and D-
galactose sugar residues (1b-4b).45 
 
1.5 Cell-Penetrating Peptides 
Cell-penetrating peptides (CPPs) are short peptide sequences, less than 40 amino acids 
in length.  They function to promote and facilitate cellular uptake of molecules, and can 
do so at low concentrations. Their primary applications to date has been to transport 
therapeutic agents across the cell membrane in clinical applications as well as for 
imaging probes.41,59 
CPPs are positively charged, with sequences usually containing high loadings of lysine 
(K) and arginine (R) residues.35 The first and most widely studied CPP is that of the 
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human immunodeficiency virus type-1 (HIV-1) TAT peptide. Its high lysine/arginine 
content renders it successful in permeablizing the cell membrane, and it is this that many 
CPPs are based on.60 To date, there has not been many reports using CPPs to direct metal 
complexes. However within the few reports, CPPs have successfully been shown to be 
directed and accumulate within the mitochondria61-63 and nucleus.64,65 which will be 
discussed in more detail later on in section 1.6. 
Polyarginines are CPPs that are useful carriers of membrane impermeable molecules. 
Positively charged arginine sequences, Argn, where n ranges from 5-11 residues in 
length have been examined.66,67 The polyarginine sequence binds strongly to the 
phosphate groups on the phospholipid bilayer of the cell membrane. This interaction 
forms a pore in the membrane which allows the peptide to cross the cell membrane.  
Once they enter the cell they exhibit non-specific binding, and have been shown to enter 
the lysosomes and endosomes.68 Octa-arginine (Arg8) peptide sequences have been 
found to have optimum penetration abilities whereas sequences below Arg6 are 
relatively ineffective.67,69 For example, Neugebauer et al compared uptake of two novel 
polyarginine complexes Ru-Ahx-R5 and Ru-Ahx-R8 to assess if the number of arginine 
residues would affect cell uptake. Figure 1.13 describes the structure of the 
[Ru(bpy)2pic-Argn]
2+ complex, where n=5 or 8 arginine residues. 
 
 
 
Figure 1.13 Structure of Ru-Ahx complex with Argn = to 5 or 8 
 
Using confocal microscopy, no luminescence was seen from the platelets incubated with 
Ru-Ahx-R5 (Figure 1.14b). However a strong luminescence was seen from the cells 
incubated with Ru-Ahx-R8 (Figure 1.14d). Thus, it was concluded that Arg5 has poor 
cell penetrating abilities, and that it is a chain-length dependent process. 
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Figure 1.14 Confocal imaging of the complex in platelet cells. Uptake of Ru-Ahx-R5 (a and b) and 
Ru-Ahx-R8 (c and d) by human platelet cells67 
 
From this work it is evident that polyarginine CPPs, in particular Arg8 chains, are useful 
in directing metal complexes across a cell membrane. This thesis will use the Arg8 
sequence to direct transition metal complexes across the cell membrane. For more 
precise focusing to target a cell region, a range of peptide sequences have been 
successful. 
 
1.6 Signal peptides 
 
As described, CPPs are used to carry complexes across the cell membrane. Targeting 
specific cell organelles is challenging but potentially very important in sensing, for 
example monitoring mitochondrial function. It is has been demonstrated that signal 
peptides can be exploited for more precise targeting. Signal peptides are based on 
sequences found in proteins in organelle membranes, for example transcription factors 
such as NF-κβ. Their recognition within the cells and consequent targeting makes it 
possible to study and monitor sub-cellular events, and to deliver therapeutics to specific 
sites. To date, signal peptides have successfully been shown to be directed and 
accumulate within the mitochondria62,70 and nucleus.64,65  
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1.6.1 Nuclear Localising Signal (NLS) peptides 
Many metal complexes are targeted to DNA, for example, [Ru(dppz)3] and related 
analogues have been widely explored as DNA binders for cell therapy. Therefore 
gaining entry through the highly restricted nuclear envelope must be achieved for in-cel 
application of these materials. Nuclear localising signal (NLS) peptides are typically 
derived from transcription factors and are less than 12 residues in length. They have the 
ability to cross the cell membrane and enter the nuclear envelope. To date, NLS 
sequences that have been successfully derived from transcription factors include NF-κB, 
TCF1-α, TFIIC-β, TFIIE-β, Oct-6 and SV4071,72, of which NF-κB and SV40 have shown 
to enter the nucleus selectively.64,65 
The group of Ragin et al have investigated a series of NLS sequence peptides in their 
abilities to be directed across the cell membrane to the nucleus.71 Here they examined 
fluorescently labelled sequences which were derived from various transcription factors. 
Live uptake studies in MCF-7 breast carcinoma cells showed uptake of all NLS 
sequences. Confocal microscopy demonstrated that NF-κB peptide sequence localized 
in the cytoplasm and nuclear regions of the cells (Figure 1.15). 
 
 
Figure 1.15 Confocal microscopy of fluorescently labeled NF-κβ in MCF-7 cells showing (A) 
transmitted light image, and (B) fluorescent light image 71 
 
However, it was found that TFIIE-β and Oct-6 localized in the cytoplasm only, possibly 
due to their highly positive charge, showing similar results to that of an Arg8 peptide 
sequence. This highlights the importance of sequence charge in directing the complex 
once inside the cell. The mechanism of uptake was evaluated by examining the impact 
of temperature on uptake. At 4°C, the uptake of NLS sequences NF-κB, TFIIE-β and 
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HATF-3 were greatly reduced, whereas Oct-6, TCFI-α, SV40 and C.elegans SDC3 were 
unaffected. This demonstrates that the choice of peptide sequence can have significant 
effects on how a complex crosses the cell membrane as discussed previously. 
Of all the NLS sequences investigated by Ragin et al, NF-κB was the most effective in 
promoting transport across nuclear envelope to the nucleus and nucleoli. Following from 
this result, our group has also successfully demonstrated directing ruthenium complexes 
conjugated to NF-κβ sequence to the nucleus of CHO cells.64 It was found that by 
increasing the lipophilicity of the metal complex by replacing bipyridyl counter ligands 
with lipophilic diphenylphenanthroline ligands, the complex could be directed to the 
nucleolus. These results are significant in demonstrating the power of using NLS 
peptides in directing metal complexes not only through the cell membrane, but through 
the nuclear envelope too. They open the way to focusing ruthenium complexes directly 
to nuclear DNA for imaging and therapy, as discussed in Chapter 5. 
 
1.6.2 Mitochondria Penetrating Peptides (MPPs) 
Mitochondrial penetrating peptides (MPPs) typically consist of 4-8 positively-charged 
hydrophobic residues.73 Targeting the mitochondria is of huge importance in imaging 
and pharmaceutical research, as mitochondria are the engine of the cell. The 
mitochondria are responsible for the cells energy via ATP synthesis, supplying oxygen 
to the cell, and regulating apoptosis. Many disease states have been found to involve 
mitochondrial dysfunction. Therefore, mitochondria targeting peptide sequences are 
being examined as a means of carrying drugs directly to dysfunctional mitochondria. 
They are also being conjugated to fluorescent imaging probes in order to monitor and 
further understand how the mitochondria work in a given disease state.74 For example, 
measuring oxygen levels via oxygen probes75 and ROS production, as discussed in 
section 1.8.76 To date there has been success in localising molecules within the 
mitochondria using MPPs.62,74,77-80 For example, Horton et al have looked at various 
MPP sequences to evaluate the optimal sequence for mitochondria localization.62 They 
demonstrated that a sequence of 8-amino acids was most successful in localising in the 
mitochondria compared to chain lengths with fewer residues. Their optimal sequence 
also included d-arginine residues (r) to promote cellular stability; FrFKFrFK. 
Chapter 3 will focus on the MPP sequence FrFKFrFK in directing a Ru(II) oxygen 
measuring probe to the mitochondria in order to assess oxygen levels there.  
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1.7 BODIPY-based Fluorescent dyes 
The main focus of this work is the d6 transition polypyridyl luminophores. However, in 
Chapter 4 we exploit BODIPYs as a reference probe. Boron dipyrromethane (BODIPY) 
compounds are highly fluorescent dyes that are exploited in cell imaging in their own 
right. The BODIPY dyes comprise of the 4,4-dyfluoro-4-bora-3a,4a-diaza-s-indacene 
core structure, seen in Figure 1.16. The BODIPY core is the prototype luminophore, 
from this it exhibits good thermal, chemical and photostability. BODIPY absorbs and 
emits in the visible region with a narrow absorbance band, shown in Figure 1.17. The 
advantage of using BODIPY though is their high quantum yield, usually around Φ = 
0.60, but can be as high as 0.90. They have relatively short fluorescent lifetimes, ranging 
from 0.8-3.5 ns. The disadvantage is that the small Stokes shift and high quantum yield 
makes the complex prone to self-quenching.  
 
  
Figure 1.16 Structure of the BODIPY core.81 
 
 
Figure 1.17 Absorbance and emission spectra of BODIPY parent complex at 15μM in methanol 
solution, demonstrating the small Stokes shift between the excitation and emission maxima. Slit 
width = 5 nm. 
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The spectroscopic properties of BODIPYs can be altered by changing the substituents 
around the BODIPY core to shift the λmax or introduce charge transfer to absorbance, 
though this can reduce the quantum yield. Emission ranges of 480-700nm have been 
reported.81 Vicente et al reported on a group of long wavelength red fluorescent 3, 5-
diiodo-BODIPY complexes.82 Their emission maxima’s ranged from 576 to 686 nm, 
with the largest Stokes shift measured to be 23 nm. Uptake and co-localisation studies 
found that the complexes successfully entered Hep2 cells and located within the 
endoplasmic reticulum (ER). Our group have successfully developed a mega-Stokes 
shift BODIPY complex, with a shift of 185 nm and emission maximum of 740 nm.83 
These properties made these BODIPY compounds potentially very attractive as imaging 
dyes. As described, BODIPYs are widely used as fluorescent labels in bio imaging as 
their high lipophilicity facilitates them to accumulate in subcellular compartments.84,85  
BODIPY derivatives have been applied as intracellular sensors. Intracellular pH is an 
important factor in many physiological processes.86,87 BODIPY-based dyes have been 
shown to be useful pH indicators, activating in response to protonation.88-90 The acidic 
pH sensitivity is achieved by incorporating a p-(N,N-dialkyl)aniline moiety at the meso-
position of the core structure.91 Here, fluorescence is quenched at a neutral or basic pH, 
and upon protonation, fluorescence increases significantly. For example, the group of 
Kobayashi et al have demonstrated a pH sensitive BODIPY imaging probe in Her2 
positive cells.88,91 Using confocal microscopy they showed that no fluorescence was 
seen in the plasma membrane, which is at pH 7.4. Following further incubation with the 
complex, it localised in the lysosomes. The complex emission intensity had increased 
significantly in the lysosomes as they have an acidic pH of ~ pH 3.8. Co-localisation 
studies with LysoTracker dyes confirmed that the BODIPY complex was in the 
lysosomes (Figure 1.18).  
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Figure 1.18 pH-activation of a BODIPY-based imaging probe in Her2 positive cells. The first row 
shows control cells where the BODIPY is not sensitive to pH, where a solution of Ph-BDP–
conjugated trastuzumab (green) was added to the cells. The second row demonstrates the activation 
of the BODIPY fluorescence once it has entered the lysosomes (pH 4.5), where a solution of DiEtN-
BDP–trastuzumab (green) was added to the cells. After incubation for 24 h, localisation was 
confirmed using LysoTracker red DND-99 (red) co-localizing dye.88 
 
The results in Figure 1.17  showed the pH-activation of a BODIPY fluorescent probe at 
acidic pH in Her2 positive cells, which can be used as a clinical tool for cancer detection 
and real-time monitoring of therapy. BODIPY complexes have also been applied to 
measuring viscosity. For example, the group of Suhling et al employed a group of 
BODIPY fluorophores to measure the viscosity of live SK-OV-3 cells using FLIM 
imaging. They were able to determine the local microviscosity of the cellular 
environment based on fluorescent lifetime.92 
In addition, BODIPY chromophores have been coupled to polypyridyl complexes such 
as ruthenium to be used as a reference dye as they can be quite insensitive to the 
environment due to their short fluorescent lifetimes.93 For example, ruthenium shows 
excellent sensitivity to oxygen. However, BODIPY have much shorter lifetimes, and are 
less likely to interact with oxygen. By coupling the two complexes, oxygen can be 
measured using the O2 independent BODIPY as a reference. BODIPY has also been 
applied as a detector probe to detect ROS as it is quenched when it comes into contact 
with ROS radicals.94 Yamada et al reported on a BODIPY complex (Figure 1.19) 
capable of detecting ROS. They incubated their complex with HeLa cells, and 
introduced hydrogen peroxide, H2O2, to the cells. H2O2 is a non-radical ROS. As a result, 
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the BODIPY fluorescence was quenched, increasing the fluorescence emission intensity 
in the HeLa cells.95 
 
 
Figure 1.19 Structure of a ROS sensing BODIPY complex.95 
 
 
1.8 Oxygen Sensing Probes 
 
In recent years, there has been significant progress made in the sensing and imaging of 
intracellular oxygen of live cells and tissue. Intracellular dioxygen (icO2) is central to 
cellular functions such as respiration and energy production. It has been shown to be a 
critical marker of cell viability, and can be used to indicate disease, for example cancer 
cells are known to be of a hypoxic nature.96 The ability to measure oxygen concentration 
in the cell, and more specifically in the various sub-cellular locations, is critical in 
understanding diseased states and the molecular mechanisms of redox-driven cellular 
activity. One of the valuable characteristics of metal polypyridyl complexes such as 
Ru(II) and Ir(III) is their long luminescent triplet excited state. This can be exploited to 
measure lifetime or emission intensity changes in a cell in response to the oxygen 
environment. In an oxygenated environment, excited states of metal complexes such as 
Ru(II) are quenched by oxygen which exists is a triplet, ground state, deactivating the 
complex triplet excited state through energy transfer. This in turn generates singlet 
oxygen itself, an active ROS species.97 As a result, the luminescent lifetime and emission 
intensity decreases. Lifetime-based sensing relies on the photo luminescent quenching 
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of metal complexes, and is valuable as it is independent of probe concentration, making 
it a useful quantitative method. 
Fluorescence quenching quantitatively diminishes both fluorophore emission intensity 
and lifetime. Typical quenching reactions include photo-induced electron transfer, or 
energy transfer. Collisional quenching occurs when the excited fluorophore comes in to 
contact through mutual diffusion of the fluorophore and the quencher. The quencher 
must have the appropriate thermodynamic properties to react with the excited state 
molecule. Quenching competes with fluorescence from the fluorophore, returning to its 
ground state, or a new state that does not emit a photon. For a diffusion quencher like 
oxygen, the linear dependence of intensity on oxygen concentration [O2] can be 
described using the Stern-Volmer equation (1.5). 
 
 I0   =   τ0   = 1 + Ksv • [O2] …. Equation 1.5 
                                     I         τ 
 
Where τ0 and τ are the luminescence decay times in the presence and absence of oxygen 
and I0 and I are the respective intensities. [O2] is the oxygen concentration and KSV is 
the Stern Volmer constant that quantifies the quenching efficiency of the probe where: 
 
KSV   =   kq • τ0 …. Equation 1.6 
 
Where kq is the rate of quenching and τ0 is the luminescent lifetime in the absence of 
oxygen. 
Measuring the effects of oxygen concentrations in cells may give a better understanding 
of the role of hypoxia in tumor cells. Luminescent O2 probes are ideal as they are non-
invasive. Techniques such as Confocal Microscopy can measure changes in fluorescence 
intensity, and Fluorescence Lifetime Imaging Microscopy (FLIM) for fluorescent 
lifetime. Until recently, the only way oxygen was measured in living cells or organelles 
was invasively using electrodes, such as Clark-type electrodes. Fluorescent lifetime is 
the optimal method of choice as it is independent of probe concentration, which will 
affect intensity. 
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One of the earliest examples of oxygen sensing using metal complexes by means of 
fluorescence lifetime imaging microscopy (FLIM) was reported by Mycek et al who 
demonstrated the oxygen dependent response of tris(2,2 -bipyridyl)dichloro-
ruthenium(II) hexahydrate in human bronchial epithelial cell lines.98  The complex was 
taken up by the cells after 4 to 6 hours incubation. The oxygen concentration was 
modulated in the cytoplasm by bubbling nitrogen into the contacting medium, and was 
imaged by measuring the changes in the Ru complex luminescent decay time. Although 
they showed that the luminescent lifetime changed with changing oxygen concentrations 
in solution, they did not report on a calibration curve, meaning no quantitative data could 
be retrieved from the FLIM data of the cells. Interestingly, our group have carried 
extensive uptake studies on Ru[bpy3]
2+ in numerous cell lines including CHO, Sp2, and 
HeLa cells and have not seen any uptake of this complex without the use of DMSO or 
conjugating cell-penetrating peptides.   
Another popular oxygen sensing agent are the phosphorescent porphyrins which are 
based on platinum(II) and palladium(II) transitions metals. Pt(II)- and Pd(II)-porphyrins 
possess long lived phosphorescent states in the range of 4-100 μs for Pt(II) and 400-
1000 μs for Pd(II) probes rendering them suitable for oxygen quenching.99 Pt(II)-
porphyrin complexes possess ~2-3 times higher emission quantum yields than the Pd(II) 
derivatives.100 The group of Papkovsky et al have carried out extensive work on Pt(II)- 
and Pd(II)-porphyrins.101-105 Recently they reported on a group of phosphorescent 
tetracarbocylic Pt(II)-coproporphyrin dyes (PtCP) for intracellular oxygen sensing.106 
The complexes were taken up slowly by mouse embryonic fibroblast (MEF) cells via 
endocytosis, and localised in the cytoplasm. To monitor icO2 in dPC12 cells, the cells 
were stimulated with the mitochondrial uncoupler FCCP to alter the concentration of 
oxygen in the cell. Using luminescent lifetime and emission calibration plot they were 
able to determine that the icO2 decreased dramatically to 4 μM after 20 minutes exposure 
to FCCP. Free metallo-porphyrins tended to aggregate in aqueous solutions as a result 
of their hydrophobic nature. Therefore, the dyes are normally conjugated to polypeptides 
or synthetic polymers. Lebedev et al reported on a group of Pd-porphyrins encapsulated 
into poly(arylglycine) dendrimers in order to protect the chromophore from biological 
activities that may interfere with the oxygen sensing.107 They introduced the probes to a 
mouse brain and were able to measure intravascular pO2 using wide-field microscopy. 
A change in phosphorescence intensity was observed in response to changing oxygen 
levels.   
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1.9 Reactive Oxygen Species (ROS) 
 
Reactive oxygen species (ROS) are chemically reactive oxygen metabolites. They are 
highly reactive as they have one or more unpaired electrons in their outer shells. They 
can be produced by exogenous factors such as UV or heat exposure, or can be generated 
endogenously in the body in the mitochondria.108 ROS has been shown to play a role in 
diseases such as Parkinson’s disease and Huntington’s disease, as well as 
neurodegenerative diseases like multiple sclerosis.109 Polymorphisms in mitochondrial 
DNA (mtDNA) has also been shown to lead to cancers such as breast and prostate 
cancers as a result of the overproduction of ROS.110,111  Cells have developed methods 
of protecting themselves from ROS by producing antioxidants and degradation 
pathways.112 However, increased ROS production in the cell can cause irreversible 
damage to DNA, cellular functions, and can contribute to disease progression.113,114 The 
types of ROS include singlet oxygen (1O2), superoxide anion, and hydroxyl radical. 
Collectively, ROS is known as oxidative stress. 115  
Oxidative stress is caused by an imbalance in the cell where the production of ROS is 
greater than the cell’s ability to remove it and repair the damage. The main ROS 
produced by the mitochondria is singlet oxygen, 1O2. Oxygen has a triplet ground state. 
If O2 reduction in the cell is incomplete, it forms an activated form of O2, 
1O2, and is a 
highly reactive species. It can induce mitochondria permeability and can promote cell 
death.116 When 1O2 is generated, it can either lose its energy in the form of heat, or it can 
react with a substrate causing oxidative damage. If 1O2 reacts with an organic molecule, 
peroxides can form. The O-O bond is cleaved, generating further O2 radicals such as 
hydroperoxide.OH (O2.
-).97,117As oxidative stress has been shown to play a role in many 
cellular dysfunctions,118-120 further understanding of the underlying mechanisms 
involved in the process is essential. Fluorescent probes are highly sensitive and selective, 
which makes them ideal as sensors for ROS.108,113,121 ROS is very difficult to measure 
as a result of its high reactivity and short lived lifetimes. There are very few reports 
regarding transition metal complexes for ROS sensing. One example is that if an Ir(III) 
phosphorescent ROS sensor.122 Zhao et al found that the emission of their probe was 
greatly enhanced when it came in contact with hyperchlorite, ClO-, a reactive oxygen 
species. Hypochlorite plays an important role in the immune system as a signal molecule 
and it is mainly produced by active phagocytes. All of the studies by Zhao et  al were 
carried out in vitro and were not examined in live cells. Currently, most of the ROS 
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sensors that are reported are based on organic probes.123 For example, the group of 
Nagano et al reported on a ROS sensor which was based on rhodamine.124 They 
successfully targeted the complex to the mitochondria of HeLa cells. They stimulated 
ROS production by adding H2O2 to the cells, and recorded an enhancement in confocal 
fluorescence intensity as a result of ROS production. 
Dihydroanalogues of fluorescent dyes are commonly used probes for ROS production. 
Examples of which include 2’,7’-dichlorofluorescin (DCFH), dihydrorhodamine 123, 
and Amplex Red. Commercially available imaging probes to allow ROS to be detected 
using confocal microscopy include Amplex Red and MitoSOX Red. 
For example, MitoSOX Red is a fluoro-probe that detects superoxide in mitochondria 
of live cells.125 Figure 1.20 shows the generation of superoxide using the mitochondrial 
uncoupler Antimycin A in myocytes, and detected using MitoSOX Red. Antimycin A is 
an inhibitor of electron transfer at complex III in mitochondria. It blocks the 
mitochondria from consuming oxygen in the cell. Therefore, there is a build up of 
oxygen in the cell, altering the natural concentration.126 The change in the cellular 
environment causes the cell to undergo oxidative stress, producing ROS.127 
 
Figure 1.20 Confocal microscopy detecting the production of superoxide in live myocytes using 
MitoSOX Red.125  
 
By comparing the control cells in PBS to those treated with Antimycin A, it is evident 
that MitoSOX Red is a highly fluorescent and selective probe for the detection of ROS 
production in mitochondria.  
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1.10 Ratiometric Oxygen Sensing 
As discussed in section 1.8, luminescent lifetime is the most reliable approach to sensing 
intracellular oxygen concentrations as it is independent of probe concentration. 
However, lifetime imaging microscopy is a relatively unconventional method and not 
widely available. On the other hand, emission intensity-based sensing using 
fluorescence microscopy is possible on more conventional instruments. As emission 
intensity is influenced by probe concentration, a ratiometric approach is required for 
oxygen sensing.  
Ratiometric sensing has emerged in recent years as another method to measure oxygen 
in vivo. However, it is not an established method, and there are still many issues to be 
addressed. Ratiometric oxygen sensing allows for oxygen to be measured using optical 
methods such as confocal microscopy, which can allow for rapid real-time cell imaging 
of intracellular oxygen.128 Ratiometric oxygen probes are typically made up of a dual-
emitting system that consists of an oxygen-insensitive fluorescent reference, and an 
oxygen-quenchable phosphorescent sensor.129 Therefore, the intensity or decay lifetime 
ratio of fluorescence and phosphorescence can be used to quantify oxygen 
concentration. Ideally, both the sensor and reference of the dual probe need to be co-
excited at a single wavelength while possessing different emission maxima’s to avoid 
any cross talk. Figure 1.21 shows an example of the emission spectra of a ruthenium-
coumarin ratiometric probe.130 In this case, when excited at 405 nm, coumarin exhibits 
an emission maximum at 467 nm, and Ru(II) at 611 nm. The coumarin emission remains 
constant while the Ru(II) emission changes over a range of oxygen concentrations, 
increasing with decreasing oxygen. 
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Figure 1.21 Emission spectra of Ruthenium-coumarin ratiometric oxygen probe (20 μM) in 
Dulbecco’s phosphate buffered saline (DPBS) under different oxygen concentrations (0% O2: red 
line, 2% O2: orange line, 20% O2: green line, 50% O2: blue line, 100% O2: purple line) (A) and the 
corresponding Stern-volmer plot of phosphorescence to fluorescence. The spectra were measured 
with excitation at 405 nm.130 
 
From Figure 1.21, the probe shows excellent linearity in response to oxygen. From the 
slope of the plot it was determined that the Ruthenium-coumarin probe has a KSV value 
of 7.531 x 103 M-1, which is a relatively slow quenching rate. However, more 
measurements over the range of oxygen concentrations could have been included for a 
more accurate calibration curve.  Single molecule system for self-referenced sensing are 
difficult to make, because it is difficult to avoid cross-talk between the two probes, such 
as self-quenching. Therefore most reports of ratiometric probes are particle based. 
Ratiometric oxygen sensors are most commonly prepared by mixing different dyes to 
create a dual-emissive particle.130,131 Recently, ratiometric probes have been 
encapsulated in nanoparticles,132-134 PEBBLEs,135,136 and dendrimers.137  Their 
encapsulation helps avoid quenching and interference from biological materials other 
than oxygen in live cells.138  
PEBBLEs (Probes Encapsulated By Biologically Localized Embedding) are optical 
sensors which are designed for minimal invasive monitoring in live cells. PEBBLEs are 
typically based on hydrogel matrices such as polyacrylamide hydrogel, sol gel silica, 
and cross-linked decyl methacrylate, and can be between 20 and 100 nm in size.139 Wang 
et al reported on a RGB PEBBLE for intracellular oxygen sensing.140 Their ratiometric 
probe consisted of a Pt(II) oxygen sensor and the fluorophore N-(5-carboxypentyl)-4-
piperidino-1,8-naphthalimide butyl ester as the reference dye. Both dyes were 
encapsulated in hydrophobic polystyrene beads which protected the probes from direct 
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contact with cellular components. The porosity of the hydrogel materials allow for 
oxygen to diffuse and come in contact with the oxygen sensitive dye. Figure 1.22 shows 
the PEBBLEs in NRK cells. At oxygen saturation, the RGB PEBBLEs display a green 
fluorescence from the reference probe (A). Upon uptake by the cells, the PEBBLEs turn 
from green to red as a result of the limited oxygen supply in the cells (B-D). 
 
 
Figure 1.22 Imaging intracellular oxygen in NRK cells. (A) In the oxygen saturated cell culture 
medium, RGB PEBBLEs display green fluorescence. (B) After endocytosis (24 h), the colour of 
RGB PEBBLEs turns from green to red due to the limited oxygen supply in intracellular 
compartments. The inset shows an enlarged section of a single cell. (C) After 48 h, large amounts of 
the RGB PEBBLEs have been internalised by the cells. (D) Partial membrane rupture by 2% Triton 
X-100 releases some RGB PEBBLEs into the cell culture medium where their colour turns from red 
to green.140 
 
The group of Tobita et al reported on an Ir(III)-coumarin ratiometric oxygen probe.141 
This is one of the few examples to date of a molecular system where the small-molecule 
probe was not encapsulated. It showed excellent ratiometric properties in solution, where 
the emission intensity was shown to have a linear response to oxygen quenching, which 
resulted in a linear Stern-Volmer plot indicating dynamic quenching. The complex was 
introduced to HeLa and they were incubated at 20 % oxygen and 2.5 % oxygen to induce 
hypoxic conditions. Figure 1.23 shows that under saturated oxygen condition’s (20 %), 
the coumarin displays intense emission from with the cells while there is no contribution 
from the phosphorescent Ir(III) component. However, under hypoxic conditions (2.5 %), 
the Ir(III) luminescent emission switches on. Although these results demonstrate good 
ratiometric properties for the mapping of intracellular oxygen, the group did not  
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quantitatively measure oxygen in the cell, nor did they measure luminescence over a 
range of oxygen concentrations from within the cell, and therefore did not explore the 
full potential of this probe. 
 
 
 
Figure 1.23 Structure of Ir(III)-coumarin ratiometric oxygen probe (A). Luminescence images 
(λexc=400–410 nm) of Ir(III)-coumarin ratiometric oxygen probe in HeLa cells incubated under 20% 
and 2.5% O2 conditions (B) observed at emission wavelengths of a) 460–510 nm and b) above 610 
nm.141 
 
1.11 Confocal Laser Scanning Microscopy 
 
Cell imaging using fluorescence microscopy has become an essential tool in biology and 
life sciences. It provides an insight into how cells function and cell signalling at a 
subcellular level which has been achieved by labelling the samples with luminophores 
and using confocal microscopy to acquire an image. Before the development of confocal 
microscopy, there was wide field microscopy. Here, the sample is illuminated using an 
A 
B 
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arc or filament lamp, and the entire sample is uniformly exposed to the light source as 
shown in Figure 1.24a. However, very little detail of cellular structures can be observed 
this way without labelling. On the other hand, confocal microscopy uses lasers to excite 
fluorescently labelled samples, where only a specific, focused area of the sample is 
scanned by the light source (Figure 1.24b). This greatly improves image quality and 
resolution, as well as resulting in more detailed images. 
 
Figure 1.24 Schematics of (a) widefield and (b) confocal fluorescence microscopes, showing their 
main components. The illumination path is shown in yellow and/or blue (excitation at 395 nm) and 
the image-forming path in green (emission at 509 nm). 142 
 
Confocal laser scanning microscopy (CLSM) is a non-invasive technique used to obtain 
high-resolution 3D images with little background interference. It has the power to 
resolve and detect structures at a sub-cellular level, which has led to the requirement of 
much improved multi-modal imaging probes. The drawbacks of continued laser 
scanning include photo-bleaching, and general damage to the cell membrane through 
thermal activation by continuous exposure to the laser. To overcome over-exposure to 
high-intensity laser beams, other confocal microscopy techniques are available. For 
example, Spinning Disk Confocal Laser Microscopy (SDCLM). Here, an expanded laser 
beam scans over an array of micro lenses which are arranged on disk. These micro lenses 
align with a second disk which contains the pinholes for each micro lens. To acquire an 
image, the disks are rotated at speeds between 1800-5000 rpm. An array of focused laser 
beams scan the specimen, unlike the single laser beam of CLSM. 143,144 As multiple 
pinholes scan the area in parallel, less energy is required to excite the sample. Therefore, 
there is a reduction in fluorescence bleaching and less damage to the sample. During the 
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high-speed spinning, stable focus is maintained using an auto-focus system, allowing 
for rapid, long-term imaging of live cells. 145,146 The imaging technique in which this 
thesis uses, however, is CLSM. In order to overcome the disadvantages of the high-laser 
intensities used, new imaging complexes can be designed to ensure these problems are 
limited. 
 
1.11.1 Principle of Confocal Microscopy 
The principle distinction between wide-field microscopy and CLSM is the use of 
pinholes which work to reject light outside of the focal plane for much improved focus 
and resolution.142  By passing the exciting and detected light through pinholes, only light 
directly focused on the pinhole passes through and out of focus light is eliminated. There 
are 2 pinholes – one before the sample at the excitation line, and one for after the sample 
for the detection. The fluorescence from the sample is collected at a photomultiplier tube 
(PMT). To collect an image, the sample is scanned by the laser in the X-Y plane to build 
up the image on a per-pixel basis. CLSM is much preferred over the conventional wide-
field fluorescence microscope as it  allows for a much more detailed three dimensional 
observation in cell imaging. The principle of a confocal microscope is illustrated in 
Figure 1.25. 
 
Figure 1.25 Diagram demonstrating the optical set up of a confocal microscope 147 
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The smaller the pinhole, the higher the resolution achieved as there is less out of plane 
light and noise being let in to the PMTs. However, the disadvantages of restricting the 
region of observation using a pinhole hole is that the entire field of view is not visible, 
and there is a decrease in the luminescent intensity. The high-spatial resolution of 
confocal microscopy has provided power to investigate and detect at a sub-cellular level. 
CLSM has several other advantages over wide field microscopy; the depth of field can 
be controlled, background interferences can be eliminated from the focus, and images 
can be be acquired from different z positions or slices through a sample.148 A huge 
advantage of using CLSM is its high z-resolution. Scanning in the z direction allows for 
a Z-stack to be collected to achieve a 3D image of a sample. In order to do this the 
sample is moved on a motorised stage to collect images at different depths through the 
sample.  
To overcome the disadvantages associated with CLSM, new imaging probes can be 
designed to ensure these problems are limited. With the advancements made in CLSM 
imaging techniques in the past 10 years, there is a requirement for much improved 
imaging probes to keep up with the ever changing technology. Imaging probes have been 
designed and developed to coincide with the needs of CLSM. For example, choosing a 
complex that has a large Stokes shift will avoid self-quenching, while a long lived 
excited state avoids photo bleaching. Commercial probes for cell staining such as Atto 
and AlexFluors are widely available, but typical of organic probes, show limited 
sensitivity to the environment. However, new multimodal imaging probes that can be 
used to measure oxygen and pH are being designed so that they can be easily monitored 
in cells using CLSM. 
Transition metal complexes have all the necessary characteristics to overcome many of 
the present issues with organic probes such as photostability and self-quenching. Ru(II) 
67,149,150, Ir(III)151-153, and Re(I)52,154,155 have been widely explored as general imaging 
probes in live cell imaging. Their large Stokes shift avoids self-quenching, while their 
long lived excited state helps to eliminate the short-lived auto fluorescence found in 
biological samples. They are highly photo stable which allows for continuous 
monitoring of biological samples. Ru(II) complexes will be the focus of this thesis for 
CLSM. 
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1.12 STimulated Emission Depletion (STED) microscopy 
 
As discussed in section 1.11, confocal microscopy is currently the key bio imaging tool 
used to study live cells, tissues, and other biological structures. However, the spatial 
resolution that can be achieved in conventional optical methods is restricted by the light 
diffraction limit. The resolution limit of a microscope is defined by Abbe’s principle. 
This states that light with wavelength λ, travelling in a medium with a refractive index 
n, that converges with the angle θ will make a spot the size of d. This relationship is 
described by Equation 1.5: 
 
d =   λ     =      λ   …….. Equation 1.7 
                                              2nsinθ    2NA 
 
Where NA is numerical aperture (sinθn). Thus a microscope cannot resolve two features 
that lie located closer to each other than /2NA. 
However, the development of a number of significant advances in microscopy in recent 
years has  allowed the diffraction limit to be effectively bypassed. The first of the super 
resolution techniques to emerge was stimulated emission depletion microscopy, 
STED.156 This improvement in resolution of fluorescent microscopy led to the award of 
the Nobel Prize in chemistry for the creators Stefan W. Hell, William E. Moerner, and 
Eric Betzig in 2014.  
In 2006, a new type of super resolution technique emerged known as single-molecule 
super resolution imaging, which includes Stochastic Optical Reconstruction Microscopy 
(STORM) and Photo-Activated Localisation Microscopy (PALM). 157 The principle 
behind these techniques is that they use photo-switchable fluorophores to obtain high 
resolution images. The laser activates some of the fluorophores, while other 
fluorophores remain in a non-emissive, dark state. The difference between STORM and 
PALM is that STORM uses switchable organic fluorophores in specific reducing 
buffers, while PALM uses fluorescent proteins. 158 In both cases, however, sufficient 
photons need to be switched on so that its precise localisation can be determined before 
the fluorophore switches off. The images of the emitted photons are captured using low-
power readout lasers until they reach a dark state or photo-bleach. This process is 
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repeated to build up an image of the precise location of the single molecule photons in 
a sample. 158 High number of photons need to be collected compared to the background 
in order to achieve the highest resolution possible. Background signal can come from 
auto-fluorescence of the sample or from residual fluorescence from non-activated 
probes. Dyes such as Cy3 and Cy5 have been used for STORM to reduce background 
as they produce high photon counts for imaging, where resolutions of 20 nm have been 
achieved. 159,160 However the focus of this thesis is the application of inorganic probes 
for STED microscopy. 
Figure 1.26 illustrates the principle of STED excitation. The improved resolution is 
achieved through double excitation of the fluorophore. A focused laser pulse excites the 
fluorophore, and immediately after the excitation, a red-shifted high-intensity donut-
shaped STED beam is applied which overlaps with the excited region. It depletes the 
fluorescence of the excited fluorophore on the periphery of the excitation spot by 
stimulated emission, effectively switching the fluorophore to a temporary dark state, for 
example S1-S0.161  
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Figure 1.26 The principles of STED. (a) A laser light is used to excite (blue) fluorescence emission 
(green) in the area of focus. The STED laser (red) is used to selectively turn off emission in the outer 
periphery, allowing for better separation of fluorescent entities. (b) Increased depletion power (red) 
reduces the common area of emission, generating a sharper effective focus with nanoscale resolution 
power. (c) Following absorption of excitation light (blue photon), fluorescent molecule (black) 
spontaneously emits fluorescence (green photon) after a short time ‘t’ to return to its ground state. 
The addition of STED light (red photon) can rapidly stimulate the excited molecule to emit the 
absorbed energy (additional red photon) and return to the ground state, thus turning off fluorescence 
(green). (d) Schematic diagram of an optical STED microscope with a phase plate sculpturing the 
depletion beam (red) into a ‘doughnut-shape’ in the focal plane, overlapped with the excitation beam 
(blue), and the resulting effective detected fluorescence emission (green).162 
 
STED de-excitation is stimulated using  which coincides with the red tail of the emission 
of the fluorophore so as to avoid re-excitation of the fluorophore. This reduces the spot 
size of the incident laser to below the diffraction limit. The improved optical resolution 
obtained using STED is defined by Equation 1.8 
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d =            λ           ……… Equation 1.8 
                                            2NA√1+ Imax/Isat 
 
Where λ is the emission wavelength, NA is the numerical aperture of the objective lens, 
Imax is the peak intensity of the STED laser within the depletion zone, and Isat is the 
applied STED laser threshold intensity, in other words the intensity that depletes 50 % 
of the probes emission intensity.163 Equation 1.8 indicates that the more efficient the 
depletion process, the greater the achievable resolution. 164 Since the more intense the 
STED laser, the greater the depletion. However, the huge intensities required for STED 
makes significanr demands on the probe regarding stability. In order to achieve STED, 
a depletion laser is typically between 0.1 – 1 GW cm-2, meaning the fluorophore must 
be highly photostable with the maintenance of a high fluorescent quantum yield. 
Therefore, the choice of fluorescent probes is important in STED microscopy. 
 
 
 
1.12.1 Choosing the correct STED probe 
Most luminescent probes applied in microscopy are organic dye complexes. The 
commercially available complexes that are recommended for STED imaging such as 
Alexa Fluor,165,166 Atto,161,166,167 and Chromeo163,167 are exclusively organic but are used 
because of their high photostability. However, a key drawback is that organic probes 
have small Stokes shifts. This makes it harder to apply a STED depletion laser without 
causing re-excitation of the probe as the laser line may overlap with its absorption 
spectrum. Thus STED depletes wavelengths at the far red edge of the emission. 
Choosing the correct dye complex for STED is crucial to achieving optimum resolution. 
1) An ideal STED probe should have a large Stokes shift which has many benefits to the 
imaging process such as avoiding re-excitation by the depletion laser. Re-excitation 
leads to a prolonged dark state which results in photo bleaching.168  A large Stokes shift 
also allows for multi-labelling. Multicolour imaging is fast becoming a method of 
interest in order to image two or more complexes at the one time.167 The spectral 
separation of different labels into two or more excitation/detection channels is required, 
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and therefore fluorophores with large Stokes shifts enable the number of detection 
channels required to be reduced and avoid cross talk between the probes. 
2) Photostability is essential in STED microscopy as the probe will be exposed to high 
laser intensities during the depletion process.   
3) The emission profile of the probe must be well matched to the chosen STED depletion 
laser as the greater the overlap with the emission, the greater the extent of stimulated 
depletion.   
4) A long lived emissive state means there is a better probability for stimulated emission 
to be achieved.   
Current commercial organic probes address only the photostability and high quantum 
yield necessary for STED. Therefore, there is much work to be done on the development 
of probes to improve the performance of STED microscopy. 
 
1.12.2 Applications of STED microscopy 
STED was first experimentally demonstrated by Hell et al in 1999, whereby they imaged 
nanocrystals using standard UV-confocal, then applied a STED laser to disable the 
fluorescence from the outer part of the focal spot.169 Figure 1.27 shows the improvement 
in spatial resolution of nanocrystals achieved after using STED. A full width half 
maximum (FWHM) of the X-Y profile across the nanocrystals was measured to be 150 
± 8 nm in the standard confocal image, which improved to 106 ± 8 nm when STED was 
used. The STED image was also able to resolve two nanocrystals in the focal plane, 
whereas it appears that there is only one when confocal was used. 
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Figure 1.27 Images of adjacent nanocrystals in (a) the standard UV-confocal and (b) the STED-
confocal microscopes. Comparison of the images and the profiles reveals significantly improved 
spatial resolution in the far field. Excitation 388 nm, STED depletion laser 766 nm.169 
 
The first application of STED to live cell imaging was reported by Hell et al in 2000.168 
They labelled the membrane of live E.coli and applied STED microscopy. Figure 1.28 
demonstrates the improved resolution of the membrane compared to the confocal image 
(b). Here they have ‘broken the diffraction barrier’ by up to a factor of 2 in the lateral 
and 6 in the axial direction.  
 
Figure 1.28 Resolution improvement of labelled E.coli membrane. A 3-fold improvement was 
demonstrated using STED (b) compared to the simultaneously recorded confocal image (a).168 
 
Many improvements in STED imaging techniques have been made since this early work. 
In 2009, reports from the same group demonstrated sub-diffraction STED nanoscopy 
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images of mitochondrial cristae structure inside a cell.170 Here they were able to non-
invasively image the arrangements of the translocase of the outer membrane (TOM) of 
the mitochondria, shown in Figure 1.29. Figure 1.29a demonstrates the complexity of 
the mitochondria in the cell. The sketch described in (b) illustrates that the size of the 
mitochondrial tubule is beyond the diffraction limit of a general confocal microscope. 
Upon scanning of the mitochondrial tubules, the confocal image gives no structural 
detail of the antibody-labelled mitochondria. However, the STED images reveal 
individual TOM complexes on the mitochondria membrane, demonstrating 30 nm 
resolution for the first time using optical methods. 
 
 
Figure 1.29 STED nanoscopy of mitochondrial cristae. (a) The mitochondrial network of a PtK2 
(kangaroo rat) cell. The mitochondria were labelled with antibodies against the TOM-complex 
(green) and the microtubule cytoskeleton with antibodies against -tubulin (red). The nucleus was 
labelled with DAPI (blue). (b) Sketch comparing the dimensions of a mitochondrial tubule (left) with 
the confocal (middle) and the STED focal volume (right), drawn to scale. (c) Mitochondria labelled 
with antibodies specific for the TOM complex comparing the confocal image (left) with the STED 
image (right). Scale bars: 10 µm (a) and 500 nm (c). 170 
 
Time-lapse STED, a newer extension of STED, was employed by the group of Nägerl 
et al to image changes in synapse functions in live brain tissue.171 Figure 1.30 
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demonstrates a resolution of 60 – 80 nm of actin present at depths of 120 μM in brain 
slices. They established an average resolution of 190 nm for confocal microscopy and 
60 nm for STED microscopy at depths up to 90 μm in brain slices. Such penetrating 
depths and improved resolutions highlights the diversity of STED applications, which 
will be increasingly be applied to the biomedical imaging of normal and abnormal 
functions. 
 
 
Figure 1.30 Live STED images of dendrites of hippocampal neurons recorded at various depths 10, 
35, 63, and 78 μm below the tissue surface. Samples were labelled with pSCA-Lifeact-EYFP vector. 
They were excited at 490 nm, and the 595 nm STED depletion laser.171 
 
Long-term changes to synapse function is a central challenge for neurobiological 
research. Imaging of the synapse in Figure 1.30 is one of the few examples where STED 
has been used to study biological functions. To date STED reports have focused on 
method development with improved resolutions and the development of imaging dyes, 
rather than the discovery of new biological functions.  
Nuclear pores located on the nuclear surface of a cell are typically 80 nm long and 145 
nm in diameter.172 The nuclear pore prevents the passage of non-specific molecules to 
enter the nuclear envelope while still allowing the diffusion of water, sugars and ions. It 
also plays a key role in cellular processes such as gene activation. Imaging such 
structures using conventional confocal cannot be achieved because of the diffraction 
limit. However, Hell et al were able to achieve high resolution images of nuclear pores 
using single-colour STED nanoscopy.165  Figure 1.31 demonstrates the confocal versus 
STED images acquired of the nuclear pore complex in a fixed HeLa cell. Atto 647N was 
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used to stain the nuclear pore for imaging. A high contrast image was achieved, and the 
background noise has been significantly reduced, along with the improved resolution 
following STED. However, this report only focuses on the development of new imaging 
dyes and achieving improved spatial resolutions, using the nuclear pore to do so. There 
have been no dynamic biological studies carried out on the nuclear pore using STED 
microscopy. 
 
Figure 1.31 Nuclear pore complex stain with Atto647N in a fixed HeLa cell. The detailed structure 
can be clearly resolved compare to the confocal equivalent. 165 
 
To date, the greatest improvement in resolution was reported by Hell et al in 2013 where 
they demonstrated resolutions as low as 20 nm in unprocessed data images.173 Figure 
1.32 describes dual-stained protein complexes of the nuclear pore complex (NPC) with 
immuno-labelled homodimers. Upon applying STED, the detail of the NPCs structure 
could be clearly resolved from the dual-labelling, with the diameter of an NPC was 
found to be around 160 nm in diameter. The STED image of a single NPC revealed that 
it consists of 8 subunits, each with a size of between 20-40 nm, surrounding an 80 nm 
sized centre. 
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Figure 1.32 Fluorescence nanoscopy of protein complexes with a compact near-infrared 
nanosecond-pulsed STED microscope. (A) STED reveals immuno-labelled subunits in the nuclear 
pore complex. The diameter of the ring was established as ∼160 nm. Scale bar, 500 nm. (B) An 
individual nuclear pore complex image showing eight antibody-labelled gp210 homodimers as 20–
40 nm in diameter, with an 80 nm-sized centre. 173 
 
The abilities to dual-stain protein structures allows for in-depth imaging at sub-
diffraction resolution using STED. Up until now, all of the reports of STED microscopy 
have been based on organic probes. To date, there have been no reports of transition 
metal complexes applied to STED. Transition metal complexes possess all the 
previously described attributes of a good STED probe such as large Stokes shifts, long 
lived emissive states, red emission and photostability. Chapter 5 will look at the 
application of two Ru(II) complexes as a novel STED imaging probes. 
 
 
1.13 Fluorescence Lifetime Microscopy (FLIM) 
 
Fluorescence lifetime microscopy (FLIM), or in the context of metal complex 
luminophores are sometimes referred to as phosphorescence lifetime imaging (PLIM), 
is a quantitative microscopy technique which maps the spatially resolved average 
luminescence lifetime of a probe across a sample.  The application of fluorescence 
lifetime imaging to live cells was first reported in 1992.174 and, although it is not yet 
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widely adopted in cell biology laboratories its use is growing.  FLIM systems are 
typically used in tandem set-ups implemented in conventional confocal and multi-
photon microscopes.175,176 The biggest advantage of FLIM is that the lifetime of a 
luminophore is independent of its concentration, making FLIM is the most reliable way 
of assessing the probe environment without need for ratiometric signal. In other words 
changes to lifetime can be attributed to changes in the local environment and not probe 
loading. 
FLIM can be used as a Time domain (TD) or Frequency domain (FD) system. In FD 
FLIM, the light source is pulsed at a high frequency and modulates the fluorescence. 
The delay in the fluorescence between the pulses causes a phase shift. The lifetime can 
be determined from the shift or decrease in the phase.177    TD FLIM typically employs 
time correlated single-photon counting (TCSPC), where short pulses of light excite the 
sample and the fluorescence decay is directly measured with a time gated system. This 
is the principle behind TCSPC.178 This is the system used throughout this thesis. In 
TCSPC, the sample is excited using a pulsed-laser diode (LDs) to create short pulses of 
light. The time between the excitation pulse and the emission of a fluorescent photon is 
recorded. The data is collected by detecting single photons of the fluorescent  and 
marking their arrival times at the detector with respect to the laser pulse.177,179 The time-
dependent intensity is measured between the excitation pulse and the photon.17 Each 
detected photon creates a histogram or decay curve which builds up over time to give 
the lifetime decay, shown in Figure 1.33. Typically, the detection rate is 1 photon per 
100 excitation pulses. The decay time τ is calculated from the slope of the plot log (I) t 
versus t. Or, more commonly by non-linear least squares fitting of the decay curve. 
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Figure 1.33 Lifetime measurement using Time-domain system. Single photons are detected based 
on their arrival times (middle image) and collected to create a histogram decay curve 17 
 
In imaging mode, the detected photons are sorted into time bins according to their arrival 
time, resulting in a lifetime decay plot of photon distribution and arrival time after each 
laser pulse and in the resulting FLIM image, each pixel is made up of the detected 
photons in that region, making up a false-colour image.180 The advantage of this method 
over time domain and gated systems as that it counts all the photons that reach the 
detector, giving much higher efficiency, and typically requires low excitation intensity 
compared to conventional fluorescence imaging. It is useful for photosensitive samples 
as photo-bleaching or sample damage during longer acquisition times is avoided.17 
TCSPC FLIM delivers the highest time resolution with the best lifetime accuracy  of the 
time resolved fluorescence imaging methods.181 Because of the high resolution of the 
the lifetime data it can resolve complex decay profiles from a sample and it is compatible 
with confocal laser scanning microscope systems.182 However acquisition times can be 
long, particularly for long lived probes because the cycle time depends on average 
wavelength lifetime, and this can limit the dynamic range of TCSPC systems. 183  
The acquired FLIM image is a contrast image where each pixel contains a fluorescent 
decay lifetime, not intensity. The data is analysed by fitting to fluorescence decay 
models, and can be mono- or bi-exponential.184 Mono-exponential (single-exponential) 
is used when there is only one expected fluorophore present in the complex, for example 
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Ru(bpy)3
2+. A bi-exponential decay is used for a complex with two fluorophores with a 
single emitting state but can be de-convoluted based on their lifetimes. For example, 
Ru(BODIPY) complexes are bi-exponential. The shorter component BODIPY has a 
lifetime of around 3-4 ns and can be separated from the Ru component whose lifetime 
is around 500 ns. The lifetime of a fluorphore can change, and can be fitted to a bi- or 
multi-exponentail decay when exposed to different environments. For example, 
dipyridophenazine (dppz) complexes in organic solevents generally have a mono-
exponential luminescent lifetime, or no luminescent lifetime when in aqueous solution, 
as described preveiously in section 1.2. However, when bound to DNA, the lifetime can 
significantly increases, or can be fitted to a bi-exponentail decay. Barton et al showed 
that [Ru(phen)2dppz](PF6)2] comlex exhibited no luminecsnet lifetime in water. 
However, upon binding to DNA, it could be fir to a bi-exponential decay, resulting in 
two luminescent lifetimes of 120 ns and 750 ns, with the shorter lifetime being the more 
dominant of the two.178 
 
1.13.1 Applications of Metal Complexes Luminophores in FLIM 
In contrast to organic dyes whose lifetimes are relatively short, typically between 1 and 
5 ns, the long luminescent lifetime of transition metals such as Ru, Ir, and Re, typically 
on the scale of hundreds of nanoseconds, is well outside the auto-fluorescence of 
biomaterials. This offers the opportunity to time-gate out such contributions to the 
decay. In addition, metal complexes frequently show better photostability than organic 
luminophores which is a particular advantage in lifetime imaging where in order to 
collect a representative lifetime image, several images need to be collected to reduce 
noise, correct for background fluorescence, and auto-fluorescence from the cell.  This 
can lead to long acquisition times and photobleaching leading to artefacts in the lifetime 
data if the probe is photo-unstable.175 
Environmental sensing in cell biology using luminescent lifetime is highly advantageous 
as it is a non-invasive method of monitoring oxygen,185 pH,186,187 and ion 
concentration188 where the right probes are available, based on the changes of a 
fluorophore’s lifetime. Many fluorophores used in microscopy show lifetime variations 
upon binding to different targets. This can be exploited to study binding with cellular 
proteins such as DNA. Recently, Baggalely et al reported on a [Ru(tpphz)] complex that 
entered the nucleus of HeLa cells.189 They used phosphorescent lifetime imaging 
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microscopy (PLIM) to determine if the probe had bound to chromosomal DNA. Figure 
1.34 shows that the probe has a luminescent lifetime of 124 ± 13 ns in the cytoplasm, 
which increased to 200 ± 12 ns upon binding to DNA, where binding was confirmed by 
confocal microscopy. The probe also had no toxic effects towards the cells, and ideal 
attribute for a cell sensing probe. Given the biological significance of DNA and its role 
in genetic diseases, such probes can potentially be used to specifically target and report 
on the micro-environment of DNA. 
 
 
Figure 1.34 PLIM (left) and confocal (right) comparison of fixed, permeabilized MCF7 cells treated 
with complex 1 (100 mm, 45 min, PBS buffer). 189 
 
Protein-protein interactions can be studied using Förster resonance energy transfer 
(FRET). FRET occurs when two fluorophores, a donor and acceptor, are in close 
proximity to each other (<10nm) and their emission spectra overlap. FRET is detected 
when the donor and acceptor come into contact and the excited energy from the donor 
is transferred non-radiactively to the acceptor who is in its ground state190, for example 
when two tagged proteins interact. This gives conformational changes of lifetime 
quenching detected using FLIM. It has also been used to monitor post-translational 
modifications (PTMs) such as phosphorylation.191 PTMs are of huge interest at the 
moment as it is believed that certain PTMs are the molecular beginning of certain cancer 
states. 
As discussed previously, oxygen is the key metabolite in cellular functions. O2 sensors 
are based on fluorescent quenchers. Quenching reduces the fluorescent lifetime, which 
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can be detected accurately using FLIM techniques.192 This has been discussed in more 
detail in section 1.8. 
The luminescent lifetime of transition metal complexes is sensitive to its environment, 
including viscosity, whereby the complex is polarized. Changes in the viscosity within 
the cell membrane have been linked to various diseases such as Alzheimer’s, cystic 
fibrosis, and diabetes.94 FLIM imaging can therefore be used to accurately monitor and 
study the local viscosity, cell membrane fluidity, and lipid packing in cells using suitable 
polypyridyl complexes.193,194 
 
1.14 Resonance Raman Spectroscopy 
 
Resonance Raman spectroscopy is a form of vibrational spectroscopy where, rather than 
absorbing light, light is scattered by a vibrating molecule creating vibrational transition 
frequency bands that are characteristic of the structure of the compound. This analytical 
method can be employed to determine the chemical structure of molecules, and examine 
their interactions at a molecular level. 
 
Figure 1.35 shows a simplified energy level diagram which illustrates the vibrational 
and electronic energy levels of a molecule and the origin of a Raman transition. In 
conventional Raman, vibrational transitions occur when there is an energy exchange 
between the photon and the scattering molecule. The exciting laser, which is too low in 
energy to stimulate an electronic transition, stimulates the molecule to transit to a short-
lived virtual state. The molecule relaxs from this state, exchanges energy with the 
incident photon, and returns to a different vibrational state. It is the difference in this 
energy shift from the absorbed and emitted photon that gives rise to Raman scattering. 
If the molecule gains energy and returns to a higher stat, the emitted photon will shift to 
a lower frequency, resulting in Stokes scattering. If the molecule returns to a lower state, 
it will shift to a higher frequency, known as an anti-Stokes shift. If there is no scattering 
of light and the molecule returns to the same vibrational state, then Raleigh scattering 
will occur. The vibrational information is analogous to IR spectroscopy. However, as 
Raman is a scattering phenomenon, unlike IR spectroscopy which is an absorbance 
spectroscopy, the incident light does not have to match the energy of the vibrational 
56 
 
transition it is instigating. In conventional Raman, a laser, often visible light which is at 
a frequency outside of the absorbance spectrum, is used. 195  
 
 
Figure 1.35 Jablonski diagram showing the typical vibrational and electronic energy levels of a 
molecule. The upward arrows depict excitation by a light source, and the downward arrows depict 
the resulting emitted photon detected.196 
 
1.14.1 Resonance Raman Spectroscopy 
Resonance Raman spectroscopy, which is used in this thesis, is a special case of Raman 
spectroscopy which occurs when the exciting laser matches an electronic transition of a 
molecule, leading to the population of an electronically excited state. The principle of 
resonance Raman spectroscopy is illustrated above in Figure 1.34. Because the exciting 
laser excites the sample to a vibronic state, vibrational modes associated with that 
transition are greatly enhanced. This enhancement of the scattering gives higher 
frequency signals than traditional Raman, with intensities up to 6 orders of magnitudes 
higher, which allows for components at low concentrations to be detected.197 Only the 
parts of the molecule involved in the transition are enhanced. Therefore, the resonance 
Raman spectra associated with this absorption region of the molecule will be enhanced 
and distinguished. This yields much simpler Raman spectra, which reveal the molecular 
origin of the optical transition. Figure 1.36 shows the resonance Raman spectra of the 
complex [(bpy)2Ru(MQ’)2]2+ in 0.1 M CH3CN solution when excited into the different 
wavelengths 363 nm, 457 nm, and 568 nm. This demonstrates an example where 
exciting into the different optical transitions of the complex results in resonance spectra 
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with different absorbances. For example, when excited at 363 nm, there is a peak centred 
on 800 cm-1, which does not appear when excited at the other wavelengths. The 
vibrational band 920 cm-1 is used as the non-resonant marker as this peak was unaffected 
at the different wavelengths.198 
 
 
 
 
 
 
Figure 1.36 Resonance Raman spectra of [(bpy)2Ru(MQ')2]2+ complex in 0.1 m CH3CN solution 
excited at different wavelengths.198 
 
Using resonance Raman makes it possible to identify optical transitions, and because of 
increased sensitivity over conventional Raman, to directly probe and monitor molecule 
interactions within cellular proteins and membranes.  In the visible range, resonance 
Raman is used to probe biological samples such as carotenoids. In the UV range, 
aromatic molecules and functional groups are specifically detected.199  
Resonance Raman of live cells has the ability to provide detailed information on cellular 
biochemical and in analysing the compositions of the different cell compartments within 
the cell label free, although the cell components such as proteins tend to require UV 
excitation for resonance enhancement. 
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Label free resonance Raman of live cells has the ability to provide detailed information 
on cellular biochemicals and in analysing the compositions of the different cell 
compartments within the cell. The dye distribution and structure can be tracked and 
probed from within the cell with great sensitivity.149, 200 Raman is not influenced by 
oxygen concentration or other environmental factors. Figure 1.37 shows a Raman map 
of a CHO cell and the corresponding spectra from the nucleus, cytoplasm and 
membrane.201 here they have calibrated specific peaks associated with the DNA, 
proteins, and lipids in the different regions. This information can be used to track 
changes to specific peaks when monitoring interactions or the effects of changes to the 
cells environment.   
 
 
Figure 1.37 Raman map of a CHO cell (a) and the corresponding spectra of the nucleus (1), 
cytoplasm (2), and membrane (3) respectively (b).149  
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Labels can be introduced to a sample to map distributions and interactions within a 
sample. Ideal labels possess strong Raman signals with specific unique marker bands to 
track in the sample. For example, introducing a C=C (≤ 1800 cm-1) or C≡C (≥ 2900 cm-
1) stretching modes are very useful as they are seen at very isolated spectral regions that 
do not interfere with the sample.199 
The MLCT transitions of polypyridyl complexes such as Ruthenium and Osmium give 
strong resonance Raman signals and, due to their large Stokes shift, there is very little 
fluorescence interference, making them ideal labels for Raman mapping. Ligands such 
as bipyridine exhibit strong Raman signals at specific peak positions when resonant with 
the MLCT such as 1603, 1560, 1480, 1315 1270, 1025, and 665 cm-1. These signature 
peaks are useful in tacking the complex in the cell.  
Labelling probes have been used to monitor the cellular environment in response to 
changes in oxygen and pH. Our group have shown that the resonance Raman spectra of 
Ru(bpy)2(pic-arg8)]
2+ complex was pH dependent in the cell, but was insensitive to 
oxygen.  By working out a ratio of a pH dependent marker peak and pH independent 
peak and calibration plot of Raman spectra varying pH was developed. Therefore, the 
pH of the different cellular components can be probed and measured without directly 
compromising with the cell.149  
 
1.15 Conclusions 
 
Luminescent transition metal complexes are finding increasing application across cell 
imaging and sensing.  This is driven by their very attractive photophysical properties 
and growing understanding regarding their permeability and targeting within cells.  As 
shown in this review, the theory behind transition metal complex photophysics has 
highlighted their valuable characteristics as applied to cell imaging. Their long 
luminescent lifetimes, large Stokes shifts, good photostability and sensitivity to the 
environment make attractive candidates in the field of bio-imaging and diagnostics. 
There has been extensive literature reports on transition metal complexes, in particular 
Ru(II) polypyridyl complexes, as novel probes cell imaging and sensing. The ability to 
target such complexes to cross the cell membrane, localise in specific organelles, and 
sense from within has been improved dramatically in the past decade, by using ancillary 
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ligands for lipophilicity, sugar conjugates, PEGylation, and cell penetrating peptide 
sequences. The future of transition metal fluorescent probes lies in the development of 
such probes to be applied to new emerging imaging techniques such as super-resolution 
microscopy, for example STED, to allow for live cell imaging while obtaining high 
contrast images with little background noise. To date, there has been little application of 
STED to studying biological activities. Most of the reported work is on the improved 
spatial resolution over general confocal, and the development of STED probes in live 
cells. But these probes have not shown any sensing abilities in vivo. Therefore, future 
work will have to focus on developing STED-suitable fluorescent probes with high 
quantum yields and photostability that can also be utilised as environmental sensors in 
live cells and tissues. 
The aim of this thesis is to apply novel luminescent metal-ligand complexes to cell use. 
To carry out our optical/photophysical characterization of complexes, novel 
[Os(bpy)2(pic-arg8)]
10+ complex will be assessed as a multimodal imaging tool and 
compared to the widely used Ru(II) equivalent, demonstrated in Chapter 2. 
Chapter 3 will highlight the characteristics of oxygen sensor probe Ru(bpy)2phen-
COOH and its peptide conjugate Ru(bpy)2phen-FrFKFrFK. The aim of this chapter is to 
direct the complex across the cell membrane and to the mitochondria to measure O2 
concentration from within the cell.  
Chapter 4 will focus on a ratio-metric, core shell nano particle probe to measure oxygen 
concentration in cells. It consists of BODIPY complex as a reference probe located in 
the core of the sturcture, and an oxygen-sensitive Ru(II) complex on the outside. Based 
on the ratiometric emission intensites of the two probes, oxygen concentration can be 
measured using confocal microscopy. 
Finally, Chapter 5 will explore the application of Ru(II) polypyridyl complexes for 
STimulated Emission Depletion microscopy. The Ru(II) probes are conjugated to CPPs, 
for precise targeting of the endoplasmic reticulum and the nucleus, which allows 
excellent high resolultion images to be acquired by discriminating against any 
background noise in the cell. 
 
 
 
61 
 
References 
1. Gill MR, Thomas JA. Ruthenium(II) polypyridyl complexes and DNA—from structural 
probes to cellular imaging and therapeutics. Chemical Society Reviews. 2012;41:3179. 
2. Ebrecht R, Paul CD, Wouters FS. Fluorescence lifetime imaging microscopy in the medical 
sciences. Protoplasma. 2014;251:293-305. 
3. Juris A, Balzani V, Barigelletti F, Campagna S, Belser P, von Zelewsky A. Ru(II) 
polypyridine complexes: Photophysics, photochemistry, eletrochemistry, and 
chemiluminescence. Coord Chem Rev. 1988;84(0):85-277.  
4. Caspar JV, Meyer TJ. Photochemistry of ru(bpy)32+. solvent effects. J Am Chem Soc. 
1983;105:5583-5590. 
 
the bologna group. from early studies to recent developments. Coord Chem Rev. 
2001;211(1):97-115.  
6. Nakamaru K. Synthesis, luminescence quantum yields, and lifetimes of trischelated ruthenium 
(II) mixed-ligand complexes including 3,3'-dimethyl-2,2'-bipyridyl. Bull Chem Soc Jpn. 
1982;55:2697. 
7. Ma D, He H, Leung K, Chan DS, Leung C. Bioactive luminescent transition-metal complexes 
for biomedical applications. Angew Chem Int Ed. 2013;52:7666-7682. 
8. Delaney S, Pascaly M, Bhattacharya PK, Han K, Barton JK. Oxidative damage by ruthenium 
complexes containing the dipyridophenazine ligand or its derivatives: A focus on intercalation. 
Inorganic Chemistry. 2002;41:1966-1974. 
9. Friedman AE, Chambron J, Sauvage J, Turro NJ, Barton JK. Molecular ‘‘Light switch” for 
DNA: Ru(bpy)2(dppz)2+. J Am Chem Soc. 1990;112:4960-4962. 
10. McConnell AJ, Song H, Barton JK. Luminescence of [ru(bpy)2(dppz)]2+ bound to RNA 
mismatches. Inorg Chem. 2013;52:10131-10136. 
11. Ferna´ndez-Moreira V, Thorp-Greenwood FL, Coogan MP. Application of d6 transition 
metal complexes in ﬂuorescence cell imaging. Chem. Commun. 2010;46:186. 
12. Turro C, Bossmann SH, Jenkins Y, Barton JK, Turro NJ. Proton transfer quenching of the 
MLCT excited state of ru(phen)2dppz2+ in homogeneous solution and bound to DNA. J Am 
Chem Soc. 1995;117:9026-9032. 
13. Chen W, Turro C, Friedman LA, Barton JK, Turro NJ. Resonance raman investigation of 
ru(phen)2(dppz)2+ and related complexes in water and in the presence of DNA. J Phys Chem 
B. 1997;101:6995-7000. 
62 
 
14. Pellegrin Y, Forster RJ, Keyes TE. pH dependent photophysics and role of medium on 
photoinduced electron transfer between ruthenium polypyridyl complex and anthraquinone. 
Inorg Chim Acta. 2009;362(6):1715-1722.  
15. Shaw GB, Styers-Barnett DJ, Gannon EZ, Granger JC, Papanikolas JM. Interligand electron 
transfer dynamics in [os(bpy)3]2+: Exploring the excited state potential surfaces with 
femtosecond spectroscopy. J Phys Chem A,. 2004;108:4998-5006. 
16. Moucheron C, Kirsch-De Mesmaeker A, Kelly JM. Photoreactions of ruthenium (II) and 
osmium (II) complexes with deoxyribonucleic acid (DNA). Journal of Photochemistry and 
Photobiology B: Biology. 1997;40(2):91-106 
17. Lakowicz JR. Principles of fluorescence spectroscopy. Vol Third Edition. Springer; 
2006:954. 
18. van Rijt SH, Kostrhunova H, Brabec V, Sadler PJ. Functionalization of osmium arene 
anticancer complexes with (poly)arginine: Effect on cellular uptake, internalization, and 
cytotoxicity. Bioconjugate Chem. 2011;22:218-226. 
19. van Rijt SH, Mukherjee A, Pizarro AM, Sadler PJ. Cytotoxicity, hydrophobicity, uptake, 
and distribution of osmium(II) anticancer complexes in ovarian cancer cells. J Med Chem. 
2010;53:840-849. 
20. Kostrhunova H, Florian J, Novakova O, Peacock AFA, Sadler PJ, Brabec V. DNA 
interactions of monofunctional organometallic osmium(II) antitumor complexes in cell-free 
media. J Med Chem 2008, 51, 3635–3643. 2008;51:3635-3643. 
21. van Rijt SH, Romero-Canelón I, Fu Y, Shnyder SD, Sadler PJ. Potent organometallic 
osmium compounds induce mitochondria-mediated apoptosis and S-phase cell cycle arrest in 
A549 non-small cell lung cancer cells. Metallomics. 2014;6:1014-1022. 
22. Hearn JM, Romero-Canelón I, Munro AF, et al. Potent organo-osmium compound shifts 
metabolism in epithelial ovarian cancer cells.  Proc Natl Acad Sci U S A. 2015;112:3800-3805. 
23. Dobrucki JW. Interaction of oxygen-sensitive luminescent probes ru(phen) and 3 21 ru(bipy) 
with animal and plant cells in vitro 3 mechanism of phototoxicity and conditions for non-
invasive oxygen measurements. Journal of Photochemistry and Photobiology B: Biology. 
2001;65:136-144. 
24. Peacock AFA, Habtemariam A, Ferna´ndez R, et al. Tuning the reactivity of osmium(II) and 
ruthenium(II) arene complexes under physiological conditions. J. Am. Chem. Soc. 
2006;128:1739. 
25. Fuchs SM, Rainesa RT. Internalization of cationic peptides: The road less (or more?) 
travelled. Cell Mol Life Sci. 2006;63:1819-1822. 
26. Jones SW, Christison R, Bundell K, et al. Characterisation of cell-penetrating peptide-
mediated peptide delivery. British Journal of Pharmacology. 2005;145:1093-1102. 
63 
 
27. Li SP, Lau CT, Louie M, Lam Y, Cheng SH, Lo KK. Mitochondria-targeting cyclometalated 
iridium(III)–PEG complexes with tunable photodynamic activity. Biomaterials. 2013;34:7519-
7532. 
28. Marin V, Holder E, Hoogenbooma R, Schubert US. Functional ruthenium(II)- and 
iridium(III)-containing polymers for potential electro-optical applications. Chem Soc Rev. 
2007;36:618-635. 
29. Komatsu H, Yoshihara K, Yamada H, et al. Ruthenium complexes with hydrophobic ligands 
that are key factors for the optical imaging of physiological hypoxia. Chem Eur J. 2013;19:1971-
1977. 
30. Lo KK, Hui W. Design of rhenium(I) polypyridine biotin complexes as a new class of 
luminescent probes for avidin. Inorg Chem. 2005;44:1992-2002. 
31. Horobin RW, Rashid-Doubell F, Pediani JD, Milligan G. Predicting small molecule 
fluorescent probe localization in living cells using QSAR modeling. 1. overview and models for 
probes of structure, properties and function in single cells. Biotechnic & Histochemistry,. 
2013;88:440-460. 
32. Horobin RW, Stockert JC, Rashid-Doubell F. Fluorescent cationic probes for nuclei of living 
cells: Why are they selective? A quantitative structure–activity relations analysis. Histochem 
Cell Biol. 2006;126:165-175. 
33. Horobin RW, Stockert JC, Rashid-Doubell F. Uptake and localisation of small-molecule 
fluorescent probes in living cells: A critical appraisal of QSAR models and a case study 
concerning probes for DNA and RNA. Histochem Cell Biol. 2013;139:623-637. 
34. Horobin RW, Rashid-Doubel F. Predicting small molecule fl uorescent probe localization in 
living cells using QSAR modeling. 2. specifying probe, protocol and cell factors; selecting 
QSAR models; predicting entry and localization. Biotechnic & Histochemistry. 2013;88:461-
476. 
35. Madani F, Lindberg S, Langel U, Futaki S, Graslund A. Mechanisms of cellular uptake of 
cell-penetrating peptides. J Biophys. 2011;2011:414729. 
36. Komor AC, Barton JK. The path for metal complexes to a DNA target. Chemical 
Communications. 2013;49(35):3617. 
37. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell JE, eds. Molecular cell 
biology. 2000. W.H. Freeman New York, ed. ; No. 4th ed. 
38. Puckett CA, Barton JK. Mechanism of cellular uptake of a ruthenium polypyridyl complex. 
Biochemistry. 2008;47:11711-11716. 
39. Puckett CA, Ernst RJ, Barton. J.K. Exploring the cellular accumulation of metal complexes. 
Dalton Trans. 2010;39:1159-1170. 
64 
 
40. Heitz F, Morris MC, Divita G. Twenty years of cell-penetrating peptides: From molecular 
mechanisms to therapeutics. British Journal of Pharmacology. 2009;157:195-206. 
41. Deshayes S, Morris MC, Divita G, Heitz F. Cell-penetrating peptides: Tools for intracellular 
delivery  of therapeutics. Cell Mol Life Sci. 62;2005:1839-1849. 
42. Lu Y, Low PS.  Folate-mediated delivery of macromolecular anticancer therapeutic agents. 
Advanced Drug Delivery Reviews. 2002;54:675-693. 
43. Arnott JA, Planey SL. The influence of lipophilicity in drug discovery and design. Expert 
Opin Drug Discov. 2012;7:863-875. 
44. Tang TS, Yip AM, Zhang KY, et al. Bioorthogonal labeling, bioimaging, and 
PhotocytotoxicityStudies of phosphorescent ruthenium(II) PolypyridineDibenzocyclooctyne 
complexes. Chem Eur J. 2015;21:1-13. 
45. Law WH, Lee LC, Louie M, Liu H, Ang TW, Lo KK. Phosphorescent cellular probes and 
uptake indicators derived from cyclometalated iridium(III) bipyridine complexes appended with 
a glucose or galactose entity. Inorg Chem. 2013;52:13029-13041. 
46. Lv G, Guo L, Qiu L, et al. Lipophilicity-dependent ruthenium N-heterocyclic carbene 
complexes as potential anticancer agents. Dalton Trans. 2015;44:7324. 
47. Mazuryk O, Magiera K, Rys B, Suzenet F, Kieda C, Brindell M. Multifaceted interplay 
between lipophilicity, protein interaction and luminescence parameters of non-intercalative 
ruthenium(II) polypyridyl complexes controlling cellular imaging and cytotoxic properties. J 
Biol Inorg Chem. 2014;19:1305-1316. 
48. Ross MF, Filipovska A, Smith RA, Gait MJ, Murphy MP. Cell-penetrating peptides do not 
cross mitochondrial membranes even when conjugated to a lipophilic cation: Evidence against 
direct passage through phospholipid bilayers. Biochem J. 2004;383:457-468. 
49. Mahon KP, Potocky TB, Blair D, et al. Deconvolution of the cellular oxidative stress 
response with organelle-specific peptide conjugates. Chemistry & Biology. 2007;14:923-930. 
50. Dickerson M, Sun Y, Howerton B, and Glazer EC. Modifying charge and hydrophilicity of 
simple ru(II) polypyridyl complexes radically alters biological activities: Old complexes, 
surprising new tricks. Inorg Chem. 2014;53:10370-10377. 
51. Svensson FR, Matson M, Li M, Lincoln P. Lipophilic ruthenium complexes with tuned cell 
membrane affinity and photoactivated uptake. Biophys Chem. 2010;149(3):102-106. 
52. Mandal S, Poria DK, Ghosh R, Ray PS, Gupta P. Development of a cyclometalated iridium 
complex with specific intramolecular hydrogen-bonding that acts as a fluorescent marker for the 
endoplasmic reticulum and causes photoinduced cell death. Dalton Trans. 2014;43:17463. 
53. Mandal S, Poria DK, Ghosh R, Ray PS, Gupta P. Development of a cyclometalated iridium 
complex with specific intramolecular hydrogen-bonding that acts as a fluorescent marker for the 
endoplasmic reticulum and causes photoinduced cell death. Dalton Trans. 2014;43:17463. 
65 
 
54. Samanta D, Kratz K, Zhang X, Emrick T. A synthesis of PEG- and phosphorylcholine-
substituted pyridines to afford water-soluble ruthenium benzylidene metathesis catalysts. 
Macromolecules. 2008;41:530-532. 
55. Lo KK. Luminescent rhenium(I) and iridium(III) polypyridine complexes as biological 
probes, imaging reagents, and photocytotoxic agents. Acc Chem Res. 2015;48:2985-2995. 
56. Li SPY, Liu HW, Zhang KY, Lo KK. Modification of luminescent iridium(III) polypyridine 
complexes with discrete poly(ethylene glycol) (PEG) pendants: Synthesis, emissive behavior, 
intracellular uptake, and PEGylation properties. Chem Eur J. 2010;16:8329-8339. 
57. Li PY, Lau CTS, Louie MW, Lam YW, Cheng SH, Lo KKW. Mitochondria-targeting 
cyclometalated iridium(III)-PEG complexes with tunable photodynamic activity. Biomaterials. 
2013;34:7519-7532. 
58. Louie M, Liu H, Lam MH, Lam Y, Lo KK. Luminescent rhenium(I) polypyridine complexes 
appended withan a-d-glucose moiety as novel biomolecular and cellular Probes. Chem Eur J. 
2011;17:8304-8308. 
59. Ndinguri MW, Solipuram R, Gambrell RP, Aggarwal S, Hammer RP. Peptide targeting of 
platinum anti-cancer drugs. Bioconjugate Chem. 2009;20:1869-1878. 
60. Brooks H, Lebleu B, Vivès E. Tat peptide-mediated cellular delivery: Back to basics. Adv 
Drug Deliv Rev. 2005;57(4):559-577.  
61. Yousif LF, Stewart KM, O. Kelley S. Targeting mitochondria with organelle-specific 
compounds: Strategies and applications. ChemBioChem. 2009;10:1939-1950. 
62. Horton KL, Stewart KM, Fonseca SB, Guo G, O. Kelley S. Mitochondria-penetrating 
peptides  . Chemistry & Biology. 2008;15:375-382. 
63. Jean SR, Tulumello DV, Wisnovsky SP, Lei EK, Pereira MP, O. Kelley S. Molecular 
vehicles for mitochondrial chemical biology and drug delivery. ACS Chem Biol. 2014;9:323-
333. 
64. Blackmore L, Moriarty R, Dolan C, et al. Peptide directed transmembrane transport and 
nuclear localization of ru(II) polypyridyl complexes in mammalian cells. Chem Commun. 
2013;49:2658. 
65. Boulikas T. Putative nuclear localization signals (NLS) in protein  T ran scr i pt io n factor. 
Journal of Cellular Biochemistry. 1994;55:32-58. 
66. Fuchs SM, Raines RT. Pathway for polyarginine entry into mammalian cells. Biochemistry. 
2004;43:2438-2444. 
67. Neugebauer U, Pellegrin Y, Devocelle M, et al. Ruthenium polypyridyl peptide conjugates: 
Membrane permeable probes for cellular imaging. Chem Commun. 2008;42:5307-5309. 
66 
 
68. Al-Taei S, Penning NA, Simpson JC, et al. Intracellular traffic and fate of protein 
transduction domains HIV-1 TAT peptide and octaarginine. implications for their utilization as 
drug delivery vectors. Bioconjugate Chem. 2006;17:90-100. 
69. Kloß A, Henklein P, Siele D, et al. The cell-penetrating peptide octa-arginine is a potent 
inhibitor of proteasome activities. European Journal of Pharmaceutics and Biopharmaceutics. 
2009;72(1):219-225.  
70. Pisani MJ, Weber DK, Heimann K, Collins JG, Keene RF. Selective mitochondrial 
accumulation of cytotoxic dinuclear polypyridyl ruthenium(II) complexes. Metallomics. 
2010;2:393-396. 
71. Ragin AD, Morgan RA, Chmielewski J. Cellular import mediated by nuclear localization 
signal peptide sequences. Chem Biol. 2002;9(8):943-948.  
72. Brandén LJ, Mohamed AJ, Smith CIE. A peptide nucleic acid–nuclear localization signal 
fusion that mediates nuclear transport of DNA. Nature Biotechnology. 1999;17:784-787. 
73. Heller A, Brockhoff G, Goepferich A. Targeting drugs to mitochondria. European Journal 
of Pharmaceutics and Biopharmaceutics. 2012;82(1):1-18 
74. Pisani MJ, Weber DK, Heimann K, Collins JG, Keene FR. Selective mitochondrial 
accumulation of cytotoxic dinuclear polypyridyl ruthenium(II) complexes. Metallomics. 
2010;2:393-396. 
75. Kondrashina AV, Dmitriev RI, Borisov SM, et al. A phosphorescent nanoparticle-based 
probe for sensing and imaging of (intra)cellular oxygen in multiple detection modalities. Adv 
Funct Mater. 2012;22:4931-4939. 
76. Frantz M, Wipf P. Mitochondria as a target in treatment  . Environmental and Molecular 
Mutagenesis. 2010;51:462-475. 
77. Ferna´ndez-Carneado J, Van Gool M, Martos V, et al. Highly efficient, nonpeptidic 
oligoguanidinium vectors that selectively internalize into mitochondria  . J Am Chem Soc. 
2005;127:869. 
78. Malhi SS, Murthy RSR. Delivery to mitochondria: A narrower approach for broader 
therapeutics. Expert Opin Drug Deliv. 2012;9:909. 
79. Yousif LF, Stewart KM, Horton KL, O. Kelley S. Mitochondria-penetrating peptides: 
Sequence effects and model cargo transport. ChemBioChem. 2009;10:2081-2088. 
80. Tan C, Wu S, Lai S, et al. Synthesis, structures, cellular uptake and apoptosis-inducing 
properties of highly cytotoxic ruthenium-norharman complexes. Dalton Trans. 2011;40:8611. 
81. Nepomnyashchii AB, Cho S, Rossky PJ, Bard AJ. Dependence of electrochemical and 
electrogenerated chemiluminescence properties on the structure of BODIPY dyes. unusually 
large separation between sequential electron transfers  . J Am Chem Soc. 2010;132:17550-
17559. 
67 
 
82. Jiao L, Yu C, Uppal T, et al. Long wavelength red fluorescent dyes from 3,5-diiodo-
BODIPYs. Org Biomol Chem. 2010;8:2517-2519. 
83. Martin A, Long C, Forster RJ, Keyes TE. Near IR emitting BODIPY ﬂuorophores with 
mega-stokes shiftsw  . Chem Commun. 2012;48:5617-5619. 
84. Kowada T, Maedab H, Kikuch K. BODIPY-based probes for the fluorescence imaging of 
biomolecules in living cells. Chem Soc Rev. 2015;44:4953. 
85. Zheng Q, Xu G, Prasad PN. Conformationally restricted dipyrromethene boron difluoride 
(BODIPY) dyes: Highly fluorescent, multicolored probes for cellular imaging. Chem Eur J. 
2008;14:5812-5819. 
86. Izumi H, Torigoe T, Ishiguchi H, et al. Cellular pH regulators: Potentially promising 
molecular targets for cancer chemotherapy. Cancer Treat Rev. 2003;29(6):541-549. 
87. Schindler M, Grabski S, Hoff E, Simon SM. Defective pH regulation of acidic compartments 
in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr)†  . 
Biochemistry. 1996;35:2812-2817. 
88. Urano Y, Asanuma D, Hama Y, et al. Selective molecular imaging of viable cancer cells 
with pH-activatable fluorescence probes  . Nature Medicine. 2009;15:104-109. 
89. Boens N, Leen V, Dehaen W. Fluorescent indicators based on BODIPY. Chem Soc Rev. 
2012;41:1130-1172. 
90. Boens N, Qin W, Baruah M, et al. Rational design, synthesis, and spectroscopic and 
photophysical properties of a visible-light-excitable, ratiometric, fluorescent near-neutral pH 
indicator based on BODIPY  . Chem Eur J. 2011;17:10924-10934. 
91. Hoogendoorn S, Blom AEM, Willems LI, van der Marel GA, Overkleeft HS. Synthesis of 
pH-activatable red fluorescent BODIPY dyes with distinct functionalities. Organic Letters. 
2011;13:5656-5659. 
92. Kuimova MK, Yahioglu G, Levitt JA, Suhling K. Molecular rotor measures viscosity of live 
cells via fluorescence lifetime imaging. J Am Chem Soc. 2008;130:6672-6673. 
93. Zhou Q, Lei W, Hou Y, et al. BODIPY-modified ru(II) arene complex—a new ligand 
dissociation mechanism and a novel strategy to red shift the photoactivation wavelength of 
anticancer metallodrugs†. Dalton Trans. 2013;42:2786. 
94. Benniston AC, Copley G. Lighting the way ahead with boron dipyrromethene (bodipy) 
dyes  . Phys Chem Chem Phys. 2009;21:4124-4131. 
95. Yamada Y, Tomiyama Y, Morita A, Ikekita M, Aoki S. BODIPY-based fluorescent redox 
potential sensors that utilize reversible redox properties of flavin. ChemBioChem. 2008;9:853. 
96. Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev 
Cancer. 8;2008:967-975. 
68 
 
97. Ruggi A, van Leeuwen FWB, Velders AH. Interaction of dioxygen with the electronic 
excited state of ir(III) and ru(II) complexes: Principles and biomedical applications. Coord Chem 
Rev. 2011;255(21–22):2542-2554.  
98. Zhong W, Urayama P, Mycek M. Imaging fluorescence lifetime modulation of a ruthenium-
based dye in living cells: The potential for oxygen sensing. J Phys D: Appl Phys. 
2003;1689:1695. 
99. Papkovsky DB, O’Riordan TC. Emerging applications of phosphorescent 
metalloporphyrins. Journal of Fluorescence,. 2005;15:569-584. 
100. Borisov SM, Nuss G, Klimant I. Red light-excitable oxygen sensing materials based on 
platinum(II) and palladium(II) benzoporphyrins. Anal Chem. 2008;80:9435-9442. 
101. O’Mahony FC, O’Riordan TC, Papkovskaia N, Kerry JP, Papkovsky DB. Non-destructive 
assessment of oxygen levels in industrial modified atmosphere packaged cheddar cheese. Food 
Control. 2006;17(4):286-292.  
102. Papkovsky DD, Ponomarev GV. Spectral-luminescent study of the porphyrin-diketones 
and their complexes. Spectrochim Acta A. 2001;57:1897-1905. 
103. Dmitriev RI, Papkovsky DB. Optical probes and techniques for O2 measurement in live 
cells and tissue  . Cell Mol Life Sci. 2012;69:2025-2039. 
104. Dmitriev RI, Zhdanov AV, Jasionek G, Papkovsky DB. Assessment of cellular oxygen 
gradients with a panel of phosphorescent oxygen-sensitive probes. Anal Chem. 2012;84:2930-
2938. 
105. Fercher A, Borisov SM, Zhdanov AV, Klimant I, Papkovsky DB. Intracellular O2 sensing 
probe based on cell-penetrating phosphorescent nanoparticles. ACS Nano. 2011;5:5499-5508. 
106. Dmitriev RI, Ropiak HM, Ponomarev GV, Yashunsky DV, Papkovsky DB. Cell-
penetrating conjugates of coproporphyrins with oligoarginine peptides: Rational design and 
application for sensing intracellular O2. Bioconj Chem. 2011;22:2507-2518. 
107. Lebedev AY, Cheprakov AV, Sakadzˇic´ S, Boas DA, Wilson DF, Vinogradov SA. 
Dendritic phosphorescent probes for oxygen imaging in biological systems. Appl Mater 
Interfaces. 2009;1:1292-1304. 
108. Gomes A, Fernandes E, Lima JLFC. Fluorescence probes used for detection of reactive 
oxygen species. J Biochem Biophys Methods. 2005;65(2–3):45-80.  
109. Tiede LM, Cook EA, Morsey B, Fox HS. Oxygen matters: Tissue culture oxygen levels 
affect mitochondrial function and structure as well as responses to HIV viroproteins. Cell Death 
Dis. 2012;3:274. 
110. Petros JA, Baumann AK, Ruiz-Pesini E, et al. mtDNA mutations increase tumorigenicity 
in prostate cancer. Proc Natl Acad Sci USA. 2005;102:719-724. 
69 
 
111. Penta JS, Johnson FM, Wachsman JT, Copeland WC. Mitochondrial DNA in human 
malignancy. Mutation Research/Reviews in Mutation Research. 2001;488(2):119-133.  
112. Nagano T. Bioimaging probes for reactive oxygen species and reactive nitrogen species. J 
Clin Biochem Nutr. 2009;45:111-124. 
113. Dickinson BC, Srikun D, Chang CJ. Mitochondrial-targeted fluorescent probes for reactive 
oxygen species. Current Opinion in Chemical Biology. 2010;14:50-56. 
114. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417:1-
13. 
115. Apel K, Hirt H. Reactive Oxygen Species: Metabolism, oxidative stress, and signal 
transduction  . Annu Rev Plant Biol. 2004;55:373-399. 
116. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. Mitochondria and reactive 
oxygen species. Free Radical Biology and Medicine. 2009;47(4):333-343. 
117. Gerritsen HG, Sanders R, Draaijer A, Ince C, Levine YK. Fluorescence lifetime imaging 
of oxygen in living cells. Journal of Fluorescence. 1997;7(1):11. 
118. Jacobson MD. Reactive oxygen species and programmed cell death. TIBS. 1996:83-86. 
119. Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. 
Nature Reviews Drug Discovery. 2004;3:205-214. 
120. Jenner P. Oxidative stress in parkinson’s disease. Annals of Neurology. 2003;53:26-38. 
121. Kalyanaraman B, Darley-Usmar V, Davies KJA, et al. Measuring reactive oxygen and 
nitrogen species with fluorescent probes: Challenges and limitations. Free Radical Biology and 
Medicine. 2012;52(1):1-6. 
122. Zhao N, Wu Y, Wang R, Shia L, Chen Z. An iridium(III) complex of oximated 2,20 -
bipyridine as a sensitive phosphorescent sensor for hypochlorite. Analyst. 2011;136:2277-2282. 
123. Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T. Development of novel 
fluorescence probes that can reliably detect reactive oxygen species and distinguish specific 
species. The Journal of Biological Chemistry. 2003;278:3170-3175. 
124. Koide Y, Urano Y, Kenmoku S, Kojima H, Nagano T. Design and synthesis of fluorescent 
probes for selective detection of highly reactive oxygen species in mitochondria of living cells. 
J Am Chem Soc. 2007;129:10324-10325. 
125. Mukhopadhyay P, Rajesh M, Yoshihiro K, Haskó G, Pacher P. Simple quantitative 
detection of mitochondrial superoxide production in live cells. Biochem Biophys Res Commun. 
2007;358(1):203-208.  
126. Park W, Han Y, Kim S, Kim S. J Cellular BioChem. 2007;102:98-109. 
70 
 
127. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell. 2005;120:483-
495. 
128. Dmitriev RI, and Papkovsky DB. Optical probes and techniques for O2 measurement in 
live cells and tissue. Cell Mol Life Sci. 2012;69(12):2025-2039. 
129. Feng Y, Cheng J, Zhou L, Zhou X, and Xiang H. Ratiometric optical oxygen sensing: A 
review in respect of material design. Analyst. 2012;137:4885. 
130. Hara D, Komatsu H, Son A, Nishimoto S, Tanabe K. Water-soluble phosphorescent 
ruthenium complex with a fluorescent coumarin unit for ratiometric sensing of oxygen levels in 
living cells. Bioconjugate Chem. 2015;26:645-649. 
131. Yoshihara T, Murayama S, Tobita S. Ratiometric molecular probes based on dual emission 
of a blue fluorescent coumarin and a red phosphorescent cationic iridium(III) complex for 
intracellular oxygen sensing. Sensors 2015. 2015;15:13503-13521. 
132. Zhang G, Palmer GM, Dewhirst MW, Fraser CL. A dual-emissive-materials design concept 
enables tumour hypoxia imaging. Nat Mat. 2009;8:747-751. 
133. Wu C, Bull B, Christensen K, McNeill J. Ratiometric single-nanoparticle oxygen sensors 
for biological imaging. Angew Chem. 2009,;121:2779-2783. 
134. Doussineau T, Schulz A, Lapresta-Fernandez A, et al. On the design of fluorescent 
ratiometric nanosensors authors. Chem –Eur J. 2010;16:10290. 
135. Koo YL, Cao Y, Kopelman R, Koo SM, Brasuel M, Philbert MA. Real-time measurements 
of dissolved oxygen inside live cells by organically modified silicate fluorescent nanosensors. 
Anal Chem. 2004;76:2498-2505. 
136. Xu H, Aylott JW, Kopelman R, Miller TJ, Philbert MA. A real-time ratiometric method for 
the determination of molecular oxygen inside living cells using Sol−Gel-based spherical optical 
nanosensors with applications to rat C6 glioma. Anal Chem. 2001;73:4124-4133. 
137. Lee YK, Ulbrich EE, Kim G, et al. Near infrared luminescent oxygen nanosensors with 
nanoparticle matrix tailored sensitivity. Anal Chem. 2010;82:8446-8455. 
138. Choi NW, Verbridge SS, Williams RM, et al. Phosphorescent nanoparticles for quantitative 
measurements of oxygen profiles in vitro and in vivo. Biomaterials. 2012;33(9):2710-2722 
139. Buck SM, Koo YL, Park E, et al. Optochemical nanosensor PEBBLEs: Photonic explorers 
for bioanalysis with biologically localized embedding. Curr Opin Chem Biol. 2004;8(5):540-
546.  
140. Wang X, Gorris HH, Stolwijk JA, et al. Self-referenced RGB colour imaging of 
intracellular oxygen. Chem. Sci. 2011(2):901. 
141. Yoshihara T, Yamaguchi Y, Hosaka M, Takeuchi T, Tobita S. Ratiometric molecular 
sensor for monitoring oxygen levels in living cells. Angew Chem Int Ed. 2012;51:4148-4151. 
71 
 
142. Vonesch C, Aguet F, Vonesch J, Unser M. An introducction into fluorescence microscopy: 
The colored revolution of bioimaging. IEEE Signal Processing Magazine. 2006:20-31. 
143. Nakano A. Spinning-disk confocal microscopy - a cutting-edge tool for imaging of 
membrane traffic. Cell Struct Funct. 2002;5:349-355. 
144. Wang E, Babbey CM, Dunn KW. Performance comparison between the high-speed 
yokogawa spinning disc confocal system and single-point scanning confocal systems. Journal 
of Microscopy. 2005;218:148-159. 
145. Sakurai T, Lanahan A, Woolls MJ, Li N, Tirziu D, Murakami M. Live cell imaging of 
primary rat neonatal cardiomyocytes following adenoviral and lentiviral transduction using 
confocal spinning disk microscopy. J Vis Exp. 2014;88:51666. 
146. Egeblad M, Ewald AJ, Askautrud HA, et al. Visualizing stromal cell dynamics in different 
tumor microenvironments by spinning disk confocal microscopy. Dis Model Mech. 2008;2-
3:155-167. 
147. Forster RJ, Keyes TE, Vos In JG, eds. Interfacial supermolecular assemblies, wiley:  . 
Wiley; 2003. 
148. Paddock SW. Principles and practices of laser scanning confocal microscopy. Molecular 
Biotechnology. 16;2000:127-149. 
149. Neugebauer U, Cosgrave L, Pellegrin Y, Devocelle M, forster RJ, Keyes TE. Mulitmodal, 
muliparameter cell imaging using ruthenium polypyridyl peptide conjugates. Proc SPIE. 
2012;8427:84270C. 
150. Xu W, Zuo J, Wang L, Ji L, Chao H. Dinuclear ruthenium(II) polypyridyl complexes as 
single and two-photon luminescence cellular imaging probes. Chem Commun. 2014;50:2123. 
151. Zhao Q, Yu M, Shi L, et al. Cationic iridium(III) complexes with tunable emission color as 
phosphorescent dyes for live cell imaging. Organometallics. 2010;29:1085-1091. 
152. Xiong L, Zhao Q, Chen H, et al. Phosphorescence imaging of homocysteine and cysteine 
in living cells based on a cationic iridium(III) complex. Inorg Chem. 2010;49:6402-6408. 
153. Dolan C, Moriarty RD, Lestini E, Devocelle M, Forster RJ, Keyes TE. Cell uptake and 
cytotoxicity of a novel cyclometalated iridium(III) complex and its octaarginine peptide 
conjugate. J Inorg Biochem. 2013;119:65-74. 
154. Balasingham RG, Coogan MP, Thorp-Greenwood FL. Complexes in context: Attempting 
to control the cellular uptake and localisation of rhenium fac-tricarbonyl polypyridyl complexes. 
Dalton Trans. 2011;40:11663. 
155. Choi AW, Liu H, Lo KK. Rhenium(I) polypyridine dibenzocyclooctyne complexes as 
phosphorescent bioorthogonal probes: Synthesis, characterization, emissive behavior, and 
biolabeling properties. J Inorg Biochem. 2015;148(0):2-10 
72 
 
156. Hell SW, Wichmann J. Breaking the diffraction resolution limit by stimulated emission: 
Stimulated-emission-depletion fluorescence microscopy. Opt Let. 1994;19:780-782. 
157. Hess ST, Girirajan TPK, Mason MD. Ultra-high resolution imaging by fluorescence 
photoactivation localization microscopy. Biophys J. 2006;91(11):4258-4272 
158. Godin A, Lounis B, Cognet L. Super-resolution microscopy approaches for live cell 
imaging. Biophys J. 2014;107(8):1777-1784.  
159. Heilemann M, Margeat E, Kasper R, Sauer M, Tinnefeld P. Carbocyanine dyes as efficient 
reversible single-molecule optical switch. J Am Chem Soc 2005 Mar 23;127(11):3801-6. 
2005;127:3801-3806. 
160. Rust MJ, Bates M, Zhuang X. Stochastic optical reconstruction microscopy (STORM) 
provides sub-diffraction-limit image resolution. Nat Methods 2006 Oct; 3(10): 793–795. 
2006;3:793-795. 
161. Kasper R, Harke B, Forthmann C, Tinnefeld P, Hell SW, Sauer M. Single-molecule STED 
microscopy with photostable organic fluorophores. Small. 2010;6:1379-1384. 
162. Blom H, Brismar H. STED microscopy: Increased resolution for medical research? Journal 
of Internal Medicine. 2014;276:560-578. 
163. Moneron G, Medda R, Hein B, Giske A, Westphal V, Hell SW. Fast STED microscopy 
with continuous wave fiber lasers. Optics Express. 2010;18:1302-1309. 
164. Fernández-Suárez M, Ting AY. Fluorescent probes for superresolution imaging in living 
cell. Nature Reviews Molecular Cell Biology. 2008;9:929. 
165. Kolmakov K, Wurm CA, Meineke DNH, et al. Polar red-emitting rhodamine dyes with 
reactive groups:Synthesis, photophysical properties, and two-color STED Nanoscopy 
applications. Chem Eur J. 2014;20:146-157. 
166. Wildanger D, Medda R, Kastrup K, Hell SW. A compact STED microscope providing 3D 
nanoscale resolution. Journal of Microscopy. 2009;236:35-43. 
167. Meyer L, Wildanger D, Medda R, et al. Dual-color STED microscopy at 30-nm focal-plane 
resolution. Small. 2008;4:1095-1100. 
168. Klar TA, Jakobs S, Dyba M, Egner A, Hell SW. Fluorescence microscopy with diffraction 
resolution barrier broken by stimulated emission. Proc Natl Acad Sci USA. 2000;97:8206-8210. 
169. Klar TA, Hell SW. Subdiffraction resolution in far-field fluorescence microscopy. Optics 
Letters. 1999;24:954-956. 
170. Schmidt R, Wurm CA, Punge A, Egner A, Jakobs S, Hell SW. Mitochondrial cristae 
revealed with focused light. Nano Lett. 2009;9:2508-2510. 
73 
 
171. Urban N, Willig K, Hell S, Nägerl U . STED nanoscopy of actin dynamics in synapses deep 
inside living brain slices. Biophys J. 2011;101(5):1277-1284 
172. Adam SA. The nuclear pore complex. Genome Biol. 2001;2:1-6. 
173. Göttfert F, Wurm C, Mueller V, et al. Coaligned dual-channel STED nanoscopy and 
molecular diffusion analysis at 20 nm resolution. Biophys J. 2013;105(1):L01-L03 
174. Lakowicz JR, Szmacinski H, Nowaczyk K, Johnson ML. Fluorescence lifetime imaging of 
calcium using quin-2. Cell Calcium. 1992;3:131-147. 
175. Levitt JA, Kuimova MK, Yahioglu G, Chung P, Suhling K, Phillips D. Membrane-bound 
molecular rotors measure viscosity in live cells via fluorescence lifetime imaging. J Phys Chem 
C,. 2009, 113 (27);113:11634-11642. 
176. Ryder AG, Glynn TJ, Przyjalgowski M, Szczupak B. A compact violet diode laser-based 
fluorescence lifetime microscope. Journal of Fluorescence. 2002;12:177-180. 
177. Borst JW, Visser AJWG. Fluorescence lifetime imaging microscopy in life sciences. Meas 
Sci Technol 2010;21:1-21. 
178. Suhling K, French PMW, Phillips D. Time-resolved ﬂuorescence microscopy. Photochem 
Photobiol Sci. 2005;4:13-22. 
179. Becker W. Fluorescence lifetime imaging – techniques and applications. Journal of 
Microscopy. 2012;247:119-136. 
180. Becker W, ed. Advanced time-correlated single-photon counting techniques. 
Berlin/Heidelberg/New York: Springer; 2005. 
181. Ballew RM, Demas JN. An error analysis of the rapid lifetime determination method for 
the evaluation of single exponential decays. Anal Chem. 1989;61:30-33. 
182. Pawley J, ed. Handbook of biological confocal microscopy. Springer; 2006; No. 3rd edt. 
183. Becker W. Fluorescence lifetime imaging – techniques and applications. Journal of 
Microscopy. 2012;247:119-136. 
184. Festy F, Ameer-Beg SM, Ngab T, Suhling K. Imaging proteins in vivo using fluorescence 
lifetime microscopy. Mol BioSyst. 2007;3:381-391. 
185. Dmitriev R, Kondrashina A, Foley T, Papkovsk DB. Imaging of molecular oxygen at 
subcellular resolution in mammalian cell culture: From 2D to 3D models (764.1). The FASEB 
Journal. 2014;28. 
186. Sanders R, Draaijer A, Gerritsen HC, Houpt PM, Levine YK. Quantitative pH imaging in 
cells using confocal fluorescence lifetime imaging microscopy. Anal Biochem. 
1995;227(2):302-308.  
74 
 
187. Hanson KM, Behne MJ, Barry NP, Mauro TM, Gratton E, Clegg RM. Two-photon 
fluorescence lifetime imaging of the skin stratum corneum pH gradient. Biophys J. 
2002;83(3):1682-1690.  
188. Gilbert D, Franjic-Würtz C, Funk K, Gensch T, Frings S, Möhrlen F. Differential 
maturation of chloride homeostasis in primary afferent neurons of the somatosensory system. 
International Journal of Developmental Neuroscience. 2007;25(7):479-489 
189. Baggaley E, Gill MR, Green NH, et al. Dinuclear ruthenium(II) complexes as two-photon, 
time-resolved emission microscopy probes for cellular DNA. Angew Chem Int Ed. 
2014;53:3367-3371. 
190. Valeur B. Molecular fluorescence: Principles and applications. Wiley-VCH; 2001:399. 
191. Stubbs CD, Botchway SW, Slater SJ, Parker AW. The use of time-resolved fluorescence 
imaging in the study of protein kinase C localisation in cells. BMC Cell Biol. 2005;6:1-12. 
192. Dmitriev RI, Papkovsk DB. Optical probes and techniques for O2 measurement in live cells 
and tissue. Cell Mol Life Sci. 2012;69:2025-2039. 
193. Suhling K, Cade NI, Levitt JA, et al. Fluorescence lifetime imaging applied to 
microviscosity mapping and fluorescence modiﬁcation studies in cells  . Biomedical Imaging : 
The Chemistry of Labels, Probes and Contrast Agents. 2012:371-390. 
194. Stöckl MT, Herrmann A. Detection of lipid domains in model and cell membranes by 
fluorescence lifetime imaging microscopy. Biochimica et Biophysica Acta (BBA) - 
Biomembranes.2010;1798(7):1444-1456. 
195. Robert B. Resonance raman spectroscopy. Photosynth Res. 2009;101:147-155. 
196. Hooijschuura JH, Verkaaika MFC, Davies GR, Ariese F. Will raman meet bacteria on 
mars? an overview of the optimal raman spectroscopic techniques for carotenoid biomarkers 
detection on mineral backgrounds. Netherlands Journal of Geosciences. 2016;95:141-151. 
197. Hong Z, Asher SA. Dependence of raman and resonance raman intensities on sample self-
absorption. App Spec. 2015;69:75-83. 
198. Bates WD, Chen P, Bignozzi CA, Schoonover JR, Meyer TJ. Resonance raman 
spectroscopy of ruthenium(II)  and osmium(I1) polypyridyl complexes  containing the N-
methyl-4,4'-bipyridinium  radical (MQ) as a ligand: Evidence for a  M(dn) - MQ(R*) methl-to-
ligand charge  transfer (MLCT) transition   . Inorg Chem 1995,34, 6215-6217. 1995;34:6215-
6217. 
199. Opilik L, Schmid T, Zenobi R. Modern raman imaging: Vibrational spectroscopy on the 
micrometer and nanometer scales  . Annu Rev Anal Chem. 2013;6:379-398. 
200. Cosgrave L, Devocelle M, Forster RJ, Keyes TE. Multimodal cell imaging by ruthenium 
polypyridyl labelled cellpenetrating peptides. Chem Commun. 2010;46:103-105. 
75 
 
201. Zhang X, Yin H, Cooper JM, Haswell SJ. Characterization of cellular chemical dynamics 
using combined microfluidic and raman techniques. Anal Bioanal Chem. 2008;390:833. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Chapter Two: A Comparison of Ruthenium (II) and Osmium 
(II) Polypyridyl complex as a Luminophore for Cellular 
Imaging 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
77 
 
2.1 Introduction  
 
The demand for well-designed luminescent probes for live cell imaging and sensing is 
growing due to the improvements of luminescent-based imaging technologies available. 
Traditionally, organic fluorophores are the primary materials used as probes in 
fluorescence microscopy. However, such probes suffer drawbacks such as poor 
photostability, small Stokes shifts, poor solubility in aqueous solutions, and short lived 
emissive states. Inorganic probes based on transition metal complexes overcome these 
limitations, making them potentially very valuable as alternative probes for imaging 
purposes. To date, luminescent inorganic probes have focused on platinum group metals 
such as ruthenium and iridium complexes, which have been fairly widely studied in this 
context.1-6 Osmium (II) polypyridyl complexes share many properties with the widely 
studied Ru(II) complexes, making them, in theory, useful imaging probes.  In fact, some 
of their properties are superior to that of Ru(II). While Ru(II) polypyridyl complexes 
emit in the spectral range 600 to 700 nm, Os(II) complexes emit in the NIR region, well 
outside the auto fluorescence window, with an emission maximum typically between 
700 and 850 nm. This strongly coincides with the biological window, ideal for imaging. 
They, like Ru(II) polypyridyl complexes, have a large Stokes shift which reduces self-
quenching. Although they tend to have relatively short-lived emission lifetimes, Os(II) 
complexes are less likely to be quenched by oxygen. This can be an advantage in a cell 
imaging probe as quenching by oxygen in a cell can lead to the production of singlet 
oxygen, causing phototoxicity during the imaging process. Another advantage of Os(II) 
complexes is that their d-d states cannot be accessed by thermal cross-over from its 
excited triplet state, making Os(II) complexes more photostable than Ru(II) complexes. 
This also renders their photophysics temperature independent, ideal for studies which 
require incubating cells at 37 °C.6, 7  
Until now, reports of osmium complexes in a biological context have been largely based 
on Os(II) as potential chemotherapeutic agents, and there have been no reports regarding 
Os(II) as an imaging agent. For example, the group of Sadler et al have extensively 
studied a group of Os(II) arene complexes as an anti-cancer agents.8, 9 One of which they 
reported on was an Os(II) arene complex that was conjugated to an octa-arginine peptide 
sequence.10 They demonstrated increased uptake and binding to nuclear DNA as a result 
of using the cell penetrating peptide (CPP) sequence octa-arginine (Arg8). As discussed 
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in Chapter 1, cell penetrating peptides such as octa-arginine are widely used to  carry 
molecular cargo across the cell membrane. With the appropriate modification to use 
ligands that are less labile, high toxicity can be avoided to generate a general probe suited 
to cell imaging rather than anti-cancer purposes. 
The aim of this chapter was to evaluate a new NIR emitting Os(II) complex as a potential 
probe for cell imaging and sensing.  The [Os(bpy)2(picCOOH)]
2+ parent complex and its 
peptide conjugate [Os(bpy)2(pic-arg8)]
10+ were assessed as luminescent imaging probes,  
and compared to the ruthenium equivalent [Ru(bpy)2(pic-arg8)]
10+ which had been 
previously studied by Neugebauer et al.11 The photophysical properties of 
[Os(bpy)2(pic-arg8)]
10+ were examined, and its ability to penetrate the cell membrane 
was assessed by means of confocal microscopy and using high through put analysing 
techniques. Its sensitivity to cellular environments was explored by fluorescence lifetime 
imaging microscopy (FLIM) techniques, as well as using Raman spectroscopy to 
examine the complex interactions inside the cell to assess, overall, its suitability as an 
imaging probe. 
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2.2 Materials and Methods 
2.2.1 Materials 
The [Os(bpy)2(picCOOH)]
2+ parent complex was synthesized and characterized by Dr 
Ciaran Dolan (DCU).12 The conjugation to the octa-arginine peptide was carried out by 
Dr Aaron Martin (DCU). Chemicals and solvents used in experimental procedures were 
all purchased from Sigma Aldrich (Ireland) unless otherwise stated. All solutions were 
made using deionised water, which was purified by a Milli-Q plus 18.5 Millipore 
purifying system. 
Sp2/0-Ag 14 murine myeloma spleen cells (ATCC no. CRL-1518) and Chinese Hamster 
Ovarian (CHO) (CHO-K1 ATCC no. CCL-61) were purchased from ATCC Cell 
Biology Collection (UK). Resazurin reagents were acquired from Promokine. Cell 
culture media, serum and penicillin/streptomycin were purchased from Sigma. Cell 
culture flasks were purchased from Corning Incorporated.  
 
2.2.2 Spectroscopic Measurements 
The UV/Vis spectra were recorded on a Jasco V-679 UV/Vis/NIR spectrophotometer. 
Fluorescence emission and excitation were measured using a Cary Eclipse Fluorescence 
Spectrometer, both at a slit width of 5 nm. Solution measurements were carried out in 
1% DMSO with PBS for the parent complex, and PBS only for the conjugate in a Hellma 
quartz cuvette of 1 cm optical path length.  
 
2.2.3 Quantum Yield 
The phosphorescent quantum yields of [Os(bpy)2(picCOOH)]
2+ and [Os(bpy)2(pic-
arg8)]
10+ were estimated by matching the MLCT absorbance transition with a standard 
[Ru(bpy)3]
2+ in PBS solution [ΦP = 0.028 in PBS].13 Both solutions were excited into 
the MLCT region of matched absorbance and the corresponding emission was recorded. 
The luminescent quantum yield was calculated by using the following formula in 
Equation 2.1: 
 
ΦP(x) = (Ax/As) (Fs/Fx) (nx/ns)2 ΦPs  …… (Equation 2.1) 
 
80 
 
Where ΦP is the phosphorescent quantum yield, A is the absorbance at the excitation 
wavelength, F is the area under the corrected emission spectrum, and n is the refractive 
index of the solvent used. The subscripts s and x refer to the standard and unknown 
respectively. The quantum yield experiment was carried out three times and the average 
quantum yield is the reported value 
       
2.2.4 Luminescent Lifetimes 
The lifetimes were collected using a FluoTime 100 Time-Correlated Single Photon 
Counting (TCSPC) instrument. The 370 nm laser line was used to excite both the 
osmium and ruthenium complexes, provided from a Picoquant ‘PDL 800-jB’ pulsed 
diode laser. 10,000 counts were collected for each lifetime measurement. The 
measurements were carried out using either Picoquant Nanoharp software for ruthenium, 
or Picoquant Timeharp software for osmium. The luminescent lifetimes were calculated 
using the PicoQuant FluoFit software by fitting an exponential decay function to each 
decay plot. The data was then fit to a mono-exponential decay curve. The goodness of 
fit was evaluated by visual inspection of the residuals and by confirming the fit had a χ2 
value between 0.9-1.1. 
 
2.2.5 Cell Culture 
The SP2 Myeloma suspension cell line were grown in Dulbecco’s modified Eagle’s 
medium (DMEM) with stable L-glutamine and the CHO cells in DMEM/Hams F-12, 
both supplemented with 10 % foetal calf serum and 1 % penicillin/streptomycin. Cells 
were kept at 37 °C with 5 % CO2, and harvested when they 90 % confluency for CHO, 
and 1 x 106 cells/mL for SP2 cells. CHO cells were harvested using 0.25 % trypsin for 
5 minutes at 37 °C. CHO cells were seeded at 2.5 x 105 cells in 2 mL media and SP2 
cells were seeded at 2.5 x 105 cells in 1.5 mL media on 35 mm glass bottom culture 
dishes and grown for 24 h. The media was removed and cells were washed with PBS 
solution supplemented with 1.1 mM MgCl2 and 0.9 mM CaCl2. 
 
2.2.6 Real time confocal imaging 
CHO and SP2 cells were seeded at 2.5 x 105 cells in 1.5 mL Lebovitz on poly-L-lysine coated, 
16 mm coverslips in a 12-well plate or 35 mm glass bottom culture dishes and left for 24 h at 37 
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ºC with 5 % CO2. Either [Os(bpy)2(picCOOH)]2+ or [Ru(bpy)2(picCOOH)]2+ parent complexes 
(0.05 % v/v DMSO in PBS) or the octa-arginine conjugates (in aqueous PBS alone) were added 
to the cells to achieve a final concentration of 40 µM, and were left to incubate for various time 
intervals. The cells were washed with PBS (supplemented with 1.1 mM MgCl2 and 0.9 mM 
CaCl2) and imaged immediately, using a Zeiss LSM510 Meta Confocal microscope with a 63x 
oil immersion objective lens on a temperature-controlled stage at 37 °C. To assess temperature 
dependence of uptake, cells were prepared as described above, and incubated with the complex 
at 4 ºC. The cells were excited at 488 nm by an Argon ion laser and emission was collected using 
the long pass 650 nm filter set. For real-time imaging, 70 µM dye was added and cells were 
imaged immediately using the Time Series mode to capture images every 10 minutes over 120 
minute period. 
 
2.2.7 High-throughput Uptake Studies 
Live high throughput (HTP) uptake study was carried out to monitor uptake over 2 
hours. CHO cells were seeded at 2 x 104 cells per well in a 96-well plate, and incubated 
overnight at 37 °C with 5 % CO2.  Nuclei were stained using Hoescht (200 µg/ml) which 
was added 20 minutes before measurements. The media was removed and the cells were 
washed once with PBS (supplemented with 1.1 mM MgCl2 and 0.9 mM CaCl2). The dye 
uptake rate was measured by reading five random fields of view per well, using an 
Insight Cell Analyzer 1000 by GE, with a 20x objective. The data was analysed using 
In Cell Analyzer 1000 Investigator program by measuring the intensity of the complex 
within the cell and taking away any background noise. 
 
2.2.8 Cytotoxicity Studies 
Both cell lines were seeded in a 96-well plate at 1 x 104 in 100 µL of media, and left to 
incubate at 37 ° C at 5 % CO2 for 24 hours. The compounds were added to the wells to 
give final concentrations of 200, 150, 100, 40, 10, 1 and 0.1 µM. The cells were 
incubated over night with the dyes. 10 µL Resazurin reagent (PromoKine) was added to 
each well, and incubated for 7 h in the dark at 37 °C. Absorbance readings were recorded 
using a Tecan 96-well plate reader at 570 nm and 600 nm for background subtraction. 
All cytotoxicity experiments are reported in terms of % viability, where 100% viability 
= 100% of viable cells in the well. Each experiment was carried out in triplicate (n=3 ± 
SD). 
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2.2.9 Phototoxicity Study 
CHO cells were seeded at 2 x 105 in 2 mL media on a 35 mm glass-bottom dish and 
grown for 24 h at 37 °C with 5 % CO2. 500 µL media was removed and 70 µM of the 
parent and conjugate was added and left for a further 24 h. Images were recorded using 
a Zeiss LSM 510 Meta Confocal microscope with a 63x oil immersion objective lens 
and the heated stage was set up to 37 °C. DRAQ 7, a nuclear staining dye, was added to 
the culture dish (1:100 dilution). The 633 nm HeNe laser and 488 nm Argon laser were 
used to excite DRAQ 7 and osmium respectively. Emission was collected using the long 
pass 650 nm filter set for both dyes. An initial image was taken at t = 0 using the multi-
track feature to show the loading of the osmium and that the cells were viable. The light 
was set to 1.36 x 10-15 mJ and the cells were left exposed for 3 h. Control cells were set 
up in the same manner, but without the addition of the osmium complex. DRAQ 7 
nuclear stain was added and was exposed to 1.36 x 10-15 mJ light until DRAQ 7 had 
entered the cells. 
 
2.2.10 Phosphorescent Lifetime Imaging Microscopy (PLIM) 
For PLIM studies cell lines were seeded on 35 mm glass bottom culture dishes at 
densities stated in section 2.2.5. PLIM images were acquired using a Microtime 200 
instrument by PicoQuant, with a 63x oil immersion objective lens with 256 x 256 
resolution. The sample was imaged for 20 minutes to ensure high counts were obtained. 
The sample was excited using the 405 nm laser line, and the emission was collected 
using the filter suited for the complex. Data was analysed using PicoQuant Symphotime 
software to extract the lifetimes in different areas of the cell. An exponential decay 
function was fitted against the sample decay plot to get a tail fit with a χ2 between 0.9-
1.1 for each location. 
 
 
2.2.11 Resonance Raman spectroscopy and cell mapping 
To acquire  a resonance Raman spectra of [Os(bpy)2(picCOOH)]
2+ and 
[Ru(bpy)2(picCOOH)]
2+ parent and peptide conjugates, 70 µM solutions in 1 % ACN 
and PBS for parent complex, and PBS only for peptide conjugates, were pipetted on to 
16x16 mm cover slips. Three separate locations of the solution on the slide were 
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measured to obtain an average spectrum of the complexes. For cell mapping, CHO cells 
were seeded on 35 mm glass bottom culture dishes and incubated with [Os(bpy)2(pic-
arg8)]
10+ (70 μM) for 24 h. Raman spectra within different regions of live CHO was 
collected using a 50x Olympus objective coupled to a 488nm Argon laser. The Raman 
spectrometer was calibrated using the centre frequency of a silicon band at 520 cm-1 
from a silicon sample and the Rayleigh line. Three locations per cellular region were 
measured to obtain an average spectrum of each compound at that location. The spectra 
were baseline corrected and analysed using NSG LabSpec 5.0 software. 
 
 
2.3 Photophysics 
 
Scheme 2.1 illustrates the structures of [Os(bpy)2(picCOOH)]
2+ (A), [Os(bpy)2(pic-
arg8)]
10+ (B) and [Ru(bpy)2(pic-arg8)]
10+ (C) which are the focus of this study. The 
complexes are structurally analogous but for the identity of the coordinated metal. Both 
complexes belong to the d block of transition metals on the periodic table and have 
isoelectronic configurations, i.e. d6 in their M(II) states. However ruthenium is a second 
and osmium a third row metal., the nuclear mass of osmium is therefore greater. 
The parent complexes are conjugated to an octa-arginine (Arg8) peptide sequence, via 
an amide bond, which renders the complexes cationic with an overall charge of 10+. 
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Scheme 2.1 Chemical structures of [Os(bpy)2(picCOOH)]2+  parent complex (A), [Os(bpy)2(pic-
arg8)]10+ (B), and [Ru(bpy)2(pic-arg8)]10+ (C). 
 
Figure 2.1 shows representative optical spectroscopy of [Os(bpy)2(pic-arg8)]
10+ and 
[Ru(bpy)2(pic-arg8)]
10+ in PBS solution. [Os(bpy)2(pic-arg8)]
10+ complex exhibits a 
strong absorbance band at 486 nm (ε ~ 4.7 x 103 L mol-1 cm-1) attributed to the 1MLCT 
transition. When excited into this 1MLCT absorbance, [Os(bpy)2(pic-arg8)]
10+ exhibits 
an emission maxima centred at 720 nm which is outside the auto-fluorescence window. 
The emission was shown to be unaffected by the conjugation of the Arg8 peptide (Table 
2.1). Both [Os(bpy)2(pic-arg8)]
10+ and [Ru(bpy)2(pic-arg8)]
10+ also have a strong 
absorbance band at approximately 285 nm, which may be assigned to the π-π* 
transitions within the bipyridine ligand, while a shoulder at approximately 330 nm is 
attributed to the pic ligand. As expected, the parent complexes exhibit large Stokes shifts 
in 1% DMSO and PBS. [Os(bpy)2(pic-arg8)]
10+ exhibited slightly red-shifted emission 
in PBS centered at 726 nm on conjugation. [Ru(bpy)2(pic-arg8)]
10+ exhibited an emission 
maximum centered at 610 nm. The luminescence from [Os(bpy)2(pic-arg8)]
10+ is at a 
lower energy than that from [Ru(bpy)2(pic-arg8)]
10+ due to the smaller gap between the 
Os(II) metal centre and the bpy ligand, and therefore the emission of [Os(bpy)2(pic-
arg8)]
10+ is significantly lower in Figure 2.1 compared to  [Ru(bpy)2(pic-arg8)]
10+ at the 
same concentration. 
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Figure 2.1 Absorbance and emission spectra of [Os(bpy)2(pic-arg8)]10+(—) and [Ru(bpy)2(pic-
arg8)]10+ (—) in aerated PBS solution (30 μM). [Os(bpy)2(pic-arg8)]10+ was excited into the MLCT 
at 488 nm and the emission was collected between 500 – 900 nm. [Ru(bpy)2(pic-arg8)]10+ was excited 
at 458 nm and the emission was collected between 520 – 750 nm, both at a slit width = 5nm. 
 
Table 2.1 compares the spectroscopic properties of the complexes. The emission 
lifetimes were measured using Time Correlated Single Photon Counting (TCSPC). 
Figure 2.2 shows representative TCSPC emission lifetime decay traces of 
[Os(bpy)2(picCOOH)]
2+ (A) and [Os(bpy)2(pic-arg8)]
10+ (B) in PBS solution at room 
temperature. A background measurement, an IRF, which is shown in red, was recorded 
using Ludox solution. This is deconvoluted from the Osmium decay to eliminate any 
contribution from the laser or electronics of the optical system. The lifetimes were 
obtained by iterative deconvolution so that the fit conformed to a χ2 value as close to 1 
as possible. [Os(bpy)2(picCOOH)]
2+ has a luminescent lifetime of 33 ± 0.1 ns (A). Upon 
conjugation, [Os(bpy)2(pic-arg8)]
10+ emission lifetime decreased slightly to 31 ± 0.2 ns, 
indicating that the peptide conjugation had a slight effect on the  complex photophysical 
properties (B).The emission lifetime traces were fit to give a χ2 value between 0.9 and 
1.1, and fit was also evaluated by visual inspection of the residuals of the fit. 
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Figure 2.2 TCSPC emission lifetime traces of [Os(bpy)2(picCOOH)]2+ (A) and [Os(bpy)2(pic-
arg8)]10+ (B) in PBS solution at room temperature. The complexes were excited using the 370 nm 
laser, and the data was acquired using the PicoQuant Time Harp system. The IRF was measured 
using Ludox solution (___). The lifetime traces (___) (•) were fit to give a χ2 value between 0.9 and 
1.3, and residuals showed no structure, indicating an excellent fit. 
 
On the other hand, [Ru(bpy)2(picCOOH)]
2+ has a considerably longer lifetime than the 
[Os(bpy)2(picCOOH)]
2+ complex of 540 ns which did not change with peptide 
conjugation. The shorter lifetime of [Os(bpy)2(pic-arg8)]
10+ is due to the strong spin orbit 
coupling of the osmium centre. To investigate sensitivity to oxygen, samples were 
purged with nitrogen for 20 minutes and the emission lifetimes were measured again. 
Neither the lifetime nor emission of [Os(bpy)2(picCOOH)]
2+ and peptide conjugate were 
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affected by the absence of oxygen (Figure 2.3). In contrast, [Ru(bpy)2(picCOOH)]
2+ 
emission lifetime increased from 540 ns to 872 ns under de-aerated conditions, which is 
typical behaviour of ruthenium complexes. The quantum yield (φf) of 
[Os(bpy)2(picCOOH)]
2+ and its peptide conjugate was found to be 0.002 ± 0.0007 in 
aerated PBS solution. Consistent with the emission lifetime, the quantum yield was 
found to be independent of oxygen concentration. This was obtained using [Ru(bpy)3]
2+ 
as a standard solution.13   
 
 
Figure 2.3 Emission intensity of Os(II) complex independent to oxygen concentrations. 
[Os(bpy)2(pic-arg8)]10+ (40 μM in PBS solution) was depleted of oxygen using nitrogen gas for 20 
minutes. Oxygen concentrations were measured using a micro needle fiber-optic probe (Presens) 
before and after emission intensity was read (using a Varian Fluorimeter, slit width 5 nm). 
 
Although [Os(bpy)2(pic-arg8)]
10+ has a short lifetime, rendering it oxygen-independent, 
its photophysical properties such as its large Stokes shift and NIR emission, suggest that 
osmium may be a suitable imaging probe. If designed correctly, Os(II) complexes may 
be used for other sensing applications, such as pH, without the interference of oxygen 
concentration. 
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Table 2.1 Spectroscopic and photophysical data for Os(bpy)2(pic-COOH)]2+ and Ru(bpy)2(pic-
COOH)]2+ complexes in aqueous PBS solution. Lifetimes were measured at (a) room temperature, 
(b) 20 °C, and (c) 37 °C for the peptide conjugates. 
*From Neugebauer et al 11   In de-aerated acetonitrile ¶ Quantum yields measured in aerated PBS 
solution. Φf values measured using Ru(bpy3)2+ = 0.028 as standard solution.19 
 
Compound λ
abs
/λ
ex 
(nm) λ
em
/nm Φ
f
 
(quantum yeild)
 
τ
f
/ns
a
 
[Os(bpy)
2
(pic)]2
+
 
 
 
 
[Os(bpy)
2
(pic)]2+ 
484 
 
 
 
488 
720 
 
 
 
726 
0.0022 ± 
0.0007¶ 
 
 
0.01 ± 
0.02 
33 ± 0.1 a 
33 ± 1.1 b 
31 ± 1.9 c 
 
57 ± 0.4 
 
 
 
[Os(bpy)
2
(pic-arg8)]
10+ 
 486 726 0.0025 ± 
0.0008¶ 
31 ± 0.2 a 
33 ±  2.47 b 
29 ± 2.05 c 
 
[Ru(bpy)
2
(pic)]
2+ *  458 608 0.067 540 
a 
570 ± 74.8 b 
624 ± 70.2 c 
[Ru(bpy)
2
(pic-arg8)]
10+
*
 470 610 0.06 478 a 
536 b 
514 ± 4.9 c 
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2.4 Cell Uptake Studies of Os(II) versus Ru(II) using Confocal Microscopy 
 
In order to investigate the application of Os(II) as an imaging probe compared to Ru(II), 
real time uptake studies were carried out. Two cell lines were used; Chinese hamster 
ovary (CHO) cells and Sp2/0 mouse myeloma cell. Mammalian cell lines such as CHO 
and murine myelomas generate proteins that closely resemble that of humans.14 
Therefore the uptake and interactions of Os(bpy)2(pic-arg8)]
10+ complex can be explored 
and compared across the two cell types. Cells were seeded at 2 x 105 cells on a 35 mm 
glass bottom culture dish and left to incubate at 37 °C with 5 % CO2 for 24 h. 
[Os(bpy)2(pic-COOH)]
10+ (0.05 % DMSO and PBS) or [Os(bpy)2(pic-arg8)]
10+ (PBS) 
were added to the cells in Lebovitz media. Confocal images were obtained using a 488 
nm laser to excite the complex, and emission was collected using long pass 650 nm filter 
set. 
To evaluate the optimum working concentrations, a range of concentrations between 20 
and 100 μM of both the parent and peptide complexes were incubated with CHO and 
Sp2 cells for varying time periods. The [Os(bpy)2(picCOOH)]
2+ parent complex did not 
permeate the cell membrane. Uptake of the parent complex was only observed when 
cells were exposed to a 0.1 % Trition/PBS solution which permeabilises the cell 
membrane. Similar observations were reported for the [Ru(bpy)2(pic-arg8)]
10+ analogue 
by Neugebauer et al.11 It was found that 70 µM for 2 h were the optimum conditions for 
imaging [Os(bpy)2(pic-arg8)]
10+. 
Live cell uptake studies were carried out to assess how efficiently the compound is taken 
up by CHO and Sp2 cells. For both cell lines, entry into the cell was observed within 
minutes of addition, as described in Figure 2.4. 
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Figure 2.4 Live uptake of [Os(bpy)2(pic-arg8)]10+ by CHO and Sp2 cells. 70 µM complex in phenol 
red-free media was added, and cells imaged continuously using Time Series mode. Uptake was 
instantaneous for both cell lines. The initial uptake was seen after 2 minutes exposure (A), with 
further uptake seen after 10 minutes (B), and at 17 minutes (C) of continuous confocal scanning. 
Cells were excited with a 488 nm argon laser and the emission was collected using a long pass 650 
nm filter set. Fluorescent images and background overlay images are presented. 
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Uptake was broadly similar in both cell lines, however [Os(bpy)2(pic-arg8)]
10+ appeared 
to cross the CHO membrane more rapidly. After 2 minutes of exposure to [Os(bpy)2(pic-
arg8)]
10+ the complex appeared to concentrate in the cytoplasm (Figure 2.4a), 
distributing throughout different cellular components, such as the nucleolus (Figure 
2.4b). The same uptake was observed for the equivalent [Ru(bpy)2(pic-arg8)]
10+ complex 
in Sp2 myeloma cells.11 Neugebauer et al reported uptake after 2 minutes of exposure 
to [Ru(bpy)2(pic-arg8)]
10+ , and it distributed throughout the cytoplasm, however with 
one distinction, it did not penetrate the nuclear envelope. 
After 2 h incubation with 70 µM [Os(bpy)2(pic-arg8)]
10+, the complex was readily taken 
up by both Sp2 and CHO the cells. Figure 2.5 (A and B) focuses on a group of Sp2 cells 
which is representative of the sample, illustrating the uptake of [Os(bpy)2(pic-arg8)]
10+. 
The complex appears to penetrate the membrane and localize within different cellular 
compartments of the cytoplasm.  However, it was found that nuclear penetration was 
light or heat activated by the laser as in the absence of light it did not enter the nuclear 
envelope as demonstrated previously during real-time uptake in Figure 2.4. Similar 
distribution was observed in CHO cells (Figure 2.5 E and F), however the complex 
emission is much brighter in CHO cells compared to Sp2 under the same imaging 
conditions. A possible suggestion for this is that [Os(bpy)2(pic-arg8)]
10+ is being 
quenched from within the Sp2 cells, for example, by the pH of the cell. Sp2 cells are a 
cancer cell line. Cancer cells tend to have a slightly more acidic pH as they produce 
more lactic acid as a result of their increased metabolism, which could be quenching the 
emission.15 A single Sp2 cell (C and D) and a single CHO cell (G and H), which are 
representative of the broader behaviour in the sample, show a more punctate distribution 
in both cell lines, with no entry into the nucleolus. This shows that entry into the nuclear 
envelope was photo-activated as localization within the nucleolus was observed only 
upon continuous irradiation with the confocal laser during the live uptake measurements.  
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Figure 2.5 Confocal imaging of [Os(bpy)2(pic-arg8)]10+ in Sp2 and CHO cells, incubated with 70 
µM for 2 h at 37 °C in the absence of light. The distribution of [Os(bpy)2(pic-arg8)]10+ in a group of 
Sp2 cells (A and B), and the localisation within a single Sp2 cell (C and D). The distribution of 
[Os(bpy)2(pic-arg8)]10+ in a group of CHO cells (E and F), and the localisation within a single CHO 
cell (G and H), both representative of the population of cells in the sample. [Os(bpy)2(pic-arg8)]10+ 
was excited using a 488 nm argon laser, and the emission was collected using a 650 nm long pass 
filter. 
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Temperature studies were carried out to investigate the mechanism of uptake as 
described in Chapter 1. Cells were prepared as described in section 2.2.5, but were 
incubated at 4 °C for 2 h instead of 37 °C. Under these conditions it was found that the 
cells did not take up [Os(bpy)2(pic-arg8)]
10+, indicating strongly that the complex is 
taken up by active transport.16 Furthermore, the punctate distribution of the complex 
implies it is taken up by endocytosis, where the cell membrane forms a vesicle around 
the molecule to carry into the cell. This correlates well with the temperature study 
results, as endocytosis is a form of active transport.17 However this would need to be 
looked at it in greater detail to irrevocably confirm endocytosis as the mode of uptake.  
 
2.4.1 Co-localisation studies of [Os(bpy)2(pic-arg8)]10+ in CHO cells 
As discussed in Chapter 1, polyarginines do not generally localize in specific organelles 
but tend to distribute throughout the cytoplasm. In order to address if and where 
[Os(bpy)2(pic-arg8)]
10+ was localising in the cell, co-localisation studies were carried out 
using commercial organelle-specific dyes. CHO cells were incubated with 70 μM 
[Os(bpy)2(pic-arg8)]
10+ for 2 h before the commercial dyes were introduced. The 
smallest working concentration of the commercial dyes was used to ensure they did not 
stain other organelles. LysoTracker Green™ (50 nM) was used to stain the lysosomes, 
and MitoTracker Deep Red™ (150 nM) was used to stain mitochondria. Figure 2.6 
demonstrates the co-localisation of [Os(bpy)2(pic-arg8)]
10+ in live CHO cells. It appears 
to have entered some mitochondria and lysosomes, but not all of them according to the 
staining of the commercial dyes.  
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Figure 2.6 Co-localising studies of [Os(bpy)2(pic-arg8)]2+ with MitoTracker Deep Red (150 nM) (A 
and B) and LysoTracker Green (50 nM) (C and D) in PBS solution. Column (i) exhibits both the 
Osmium channel, localising dye channel and background channel; column (ii) osmium channel only; 
column (iii) localising dye channel only; column (iv) overlap of osmium with localising dye 
excluding background channel. [Os(bpy)2(pic-arg8)]10+ was excited using a 488 nm argon laser and 
the emission was collected using a long pass 650 nm filter. LysoTracker Green was excited using a 
488 nm argon laser and the emission was collected using a band pass 505 – 530 nm filter. 
MitoTracker Deep Red was excited using a 633 nm HeNe laser and the emission was collected using 
a long pass 650 nm laser. 
 
95 
 
Os(II) arene anticancer complexes have been found to target DNA, accumulating in 
DNA rich areas such the nuclear membrane, nucleolus, and mitochondria. For example, 
Sadler and group have reported on an Os(II) arene complex, [(biphenyl -arene)Os(4-
methyl-picolinate)Cl], and introduced it to A2780 ovarian cancer cells. 9 Figure 2.7 
compares the structures of [(biphenyl -arene)Os(4-methyl-picolinate)Cl] (A) with 
[Os(bpy)2(pic-arg8)]
10+ (B). [(biphenyl -arene)Os(4-methyl-picolinate)Cl] has a free –Cl 
group, which is one possible route for this complexes in vivo activation, where –Cl can 
be replaced by H2O making the complex more reactive.  
 
Figure 2.7 Chemical structures comparing [(biphenyl -arene)Os(4-methyl-picolinate)Cl] arene 
complex (A), taken from Sadler et al, 9 with [Os(bpy)2(pic-arg8)]10+ complex (A). 
 
Although the two complexes are very different in structure, Sadler et al demonstrated 
that [(biphenyl-arene)Os(4-methyl-picolinate)Cl] complex accumulated within the 
nucleolus and mitochondria after exposure for 12 h (Figure 2.8).   
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Figure 2.8 TEM image of Os(II) arene biphenyl complex (20 μM) localising within the nucleolus 
and mitochondria of an A2780 ovarian carcinoma cell, incubated for 12 h.9  
 
The mitochondria accumulation shown in Figure 2.8 is common to the localisation of 
[Os(bpy)2(pic-arg8)]
10+ in CHO cells investigated in this chapter. This could suggest that 
osmium has an affinity for mitochondria once it crosses the cell membrane. However, 
upon incubation with [Os(bpy)2(pic-arg8)]
10+ in the absence of light, no localisation was 
found in the nucleolus. This could reflect on the lipophilicity of the two complexes. This 
is something that would have to be in investigated further. 
 
2.4.2 HTP Uptake Studies 
As the complexes appeared to penetrate the nuclear envelope under direct and 
continuous exposure to the confocal laser, live high throughput (HTP) uptake study was 
carried out to obtain a  more detailed insight into the dynamics of uptake over 2 h. The 
advantage of using HTP is it allows for the monitoring of cell uptake without long 
exposure times to laser scanning. Therefore, uptake can be studied without the impact 
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of light seen, which was observed previously in Figure 2.4, under continuous scanning 
during confocal microscopy. The experiment was carried out at the School of Medicine, 
CRANN and AMBER Centres as part of Trinity College Dublin with the help of Dr. 
Anthony Davies. CHO cells were prepared in a 96-well plate as described in section 
2.2.6. [Os(bpy)2(pic-arg8)]
10+ and [Ru(bpy)2(pic-arg8)]
10+ were added separately to the 
cells, and the uptake was measured using an Insight Cell Analyser 1000 (GE 
Healthcare). The complex solutions were present for the duration of the experiment. 
Uptake was recorded via fluorescence intensity from 5 random fields of view per well 
at 37 °C. The results are presented in Figure 2.9. Initially, both complexes were taken 
up quickly, and the emission intensity continuously increased over time.  Interestingly, 
[Ru(bpy)2(pic-arg8)]
10+ appears to be taken up in two steps, whereas [Os(bpy)2(pic-
arg8)]
10+ uptake appears to be more continuous. The difference in emission intensities 
between the complexes is a reflectance of their quantum yields (Φ) within the cells. The 
continuous increase in intensities indicates no self-quenching occurred. Over the course 
of the experiment, both complexes accumulate within the cells. After 2 h, it was found 
that uptake plateaued for [Ru(bpy)2(pic-arg8)]
10+ but [Os(bpy)2(pic-arg8)]
10+ continued 
to enter the cells. 
The rate of uptake (k) for each complex was determined by finding the slope of the plot 
Ln (I) v t, where I is the emission intensity and t is the time in seconds. From the uptake 
plot in Figure 2.7, there appears to be a lead in time as there is no uptake of 
[Ru(bpy)2(pic-arg8)]
10+ in the first 30 minutes of incubation. However, this is not the 
case for [Os(bpy)2(pic-arg8)]
10+ which is taken up instantaneously once introduced to the 
cells. As everything in the experiment is equal; i.e. the concentration of the complexes, 
the number of cells seeded in the wells, and the time when the complexes are added to 
the cells, this interesting effect must be due to the lipophilicity of the complexes. The 
heavy osmium is likely to be more lipophilic than ruthenium, due to nuclear shielding. 
The rate of uptake was determined for both complexes. As [Ru(bpy)2(pic-arg8)]
10+ 
appears to not enter the cells in the first 30 minutes of addition, the uptake rates for both 
[Ru(bpy)2(pic-arg8)]
10+ and [Os(bpy)2(pic-arg8)]
10+ were determined between 40 
minutes and 120 minutes. The rate of uptake for [Ru(bpy)2(pic-arg8)]
10+ was found to be 
0.57 s-1. On the other hand, [Os(bpy)2(pic-arg8)]
10+ has a slower uptake rate of 0.21 s-1, 
which can appears to be more linear and steady, which can be seen from the plots in 
Figure 2.7. 
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Figure 2.9 Cellular uptake of [Os(bpy)2(pic-arg8)]10+ (—) and [Ru(bpy)2(pic-arg8)]10+ (—) in live 
CHO cells using the InCell Analyzer High Throughput method at 37 °C. The complexes were excited 
using a 480 nm laser at 5 random fields of view of each sample, and the emission was collected using 
a long pass 620 nm filter. (Data normalised to no dye) 
 
Methods such as HTP can allow us to see the cell-complex uptake rate more efficiently 
than confocal microscopy as the cells are scanned for 20 seconds and at multiple fields 
of view to record the average emission at each time point with little laser exposure. Photo 
bleaching and photo toxicity can be avoided as the compound is not being continuously 
exposed to laser scanning. Cells are less likely to be damaged by the laser, which can 
force them to take up the compound or redistribute it over time through thermal damage 
from direct light exposure, or through the generation of singlet oxygen by the complex. 
 
2.5 Cytotoxicity 
 
From the uptake studies described previously in section 2.4, neither [Os(bpy)2(pic-
arg8)]
10+ nor [Ru(bpy)2(pic-arg8)]
10+   appear to be toxic towards the cells at short 
exposure times. The cytotoxicity of [Os(bpy)2(pic-arg8)]
10+ and [Ru(bpy)2(pic-arg8)]
10+ 
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was then examined and compared in CHO and Sp2 cells using the Resazurin (Alamar 
Blue) assay. Resazurin (7-hydroxy-3H-phenoxazin-3-one-10-oxide) is a non-
fluorescent dye that is used as an oxidation-reduction indicator in cells. It measures the 
metabolic activity of the cells. Viable cells reduce the non-fluorescent resazurin to the 
highly fluorescent resorufin and dihydroresorufin. Therefore, it is a method of measuring 
cellular ATP. The extent of reduction, and therefore the fluorescent intensity, is directly 
proportional to the number of viable cells over time.  
Cells were prepared in 96-well plates as described in section 2.2.7, and was carried out 
in the absence of light. Figure 2.10 illustrates a plot of absorbance versus metal complex 
concentration (µM) in Sp2 (A) and CHO (B) cells. [Os(bpy)2(picCOOH)]
2+ and 
[Ru(bpy)2(picCOOH)]
2+ parent complex’s (0.1 % vol. DMSO) did not induce toxicity 
towards the cells, even up to concentrations as high as 200 μM over 16 h. Similarly, the 
octa-arginine conjugates induced little toxicity towards the cells, with cells remaining 
viable at concentrations as high as 150 µM in CHO cells (B). Interestingly, 
[Os(bpy)2(pic-arg8)]
10+ did have a cytotoxic effect on Sp2 cells at concentrations greater 
than 100 µM (A). In comparison, the assay indicated that [Ru(bpy)2(pic-arg8)]
10+ was 
slightly more toxic towards the CHO cells, showing a 10 % decrease in cell viability 
compared to cells treated with [Os(bpy)2(pic-arg8)]
10+. Nonetheless, the low cytotoxicity 
of the [Os(bpy)2(pic-arg8)]
10+ conjugate further indicates that this compound is a 
valuable molecular probe for multimodal imaging. 
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Figure 2.10 Cell viability in Sp2 (A) and CHO cells (B). Live cells were treated with [Os(bpy)2(pic-
COOH)]10+ (Osmium), [Os(bpy)2(pic-arg8)]10+ (Osmium-R8), [Ru(bpy)2(pic-COOH)]10+ 
(Ruthenium) and [Ru(bpy)2(pic-arg8)]10+ (Ruthenium-R8) for 16 h followed by addition of resazurin 
reagent for a further 6 h. Absorbance was read at 570 nm with background at 600 nm subtracted, n=3 
in triplicate 
 
The group of Sadler et al compared Ru(II) and Os(II) arene complexes that were 
structurally analogous except for the metal centre, shown in Figure 2.11.18 They 
demonstrated that the Ru(II) arene complex exhibited toxicity towards cancer cells while 
the Os(II) arene complex did not.  
A 
B 
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Figure 2.11 Structure of a Ru(II) arene complex and the analogous Os(II) arene complex. 18 
 
Although arene complexes are designed to be highly toxic towards cells, and they are 
structurally very different to the complexes studies in this chapter, the results show the 
same trend seen here, indicating very interestingly, that the heavier third-row transition 
metal ion Os(II) is less toxic than Ru(II). The lack of biological activity is possibly due 
to it being relatively more inert compared to Ru(II). However, in a separate report of an 
Os(II)-arene-arg8 complex, it showed significant cytotoxicity towards CHO cells.
10 The 
Arg8 conjugate demonstrated higher toxicity than Arg5 and the parent complex as it 
increased the cell uptake abilities of the complex. By comparing these very different 
complexes and their effects on cells, it shows that the ligands play an important role in 
the cytotoxic effects of different Os(II) complexes, as well as between Os(II) and Ru(II) 
analogue complexes.  
 
2.6 Phototoxicity 
 
As the application of [Os(bpy)2(pic-arg8)]
10+ in the context of this thesis is in 
luminescence imaging, the complex stability and particularly its cellular toxicity under 
exposure to light is an important factor. As demonstrated previously in section 2.5, 
[Os(bpy)2(pic-arg8)]
10+ showed no significant toxicity towards both cells lines when 
incubated in the absence of light. Therefore the phototoxicity of [Os(bpy)2(pic-arg8)]
10+ 
was investigated in CHO cells. The cells were prepared as described in section 2.2.8. 
CHO cells were exposed to a white light source at 1.36 x 10-15 mJ intensity, using the 
confocal microscope white light.  Control CHO cells were examined with DRAQ 7 in 
PBS (1:100 dilution) in the absence of [Os(bpy)2(pic-arg8)]
10+. After 3 h, no DRAQ 7 
had entered the cells indicating they were still viable. Next, in a separate glass-bottom 
culture dish, [Os(bpy)2(pic-arg8)]
10+ (70 μM in phenol-red free media) was added to 
 
102 
 
CHO cells and left to incubate for 24 h (37 °C with 5 % CO2) to ensure maximum uptake. 
Prior to imaging, DRAQ 7 was added to the cells. The cells were exposed to the white 
light source (1.36 x 10-15 mJ) for 3 h. No change in the location of [Os(bpy)2(pic-arg8)]
10+ 
in the cells was observed, and the cells remained viable. Similar results were observed 
in section 2.5, where CHO cells were still viable after being exposed to 70 μM 
[Os(bpy)2(pic-arg8)]
10+ for 24 h in the absence of light. There was no change in cell 
morphology associated with toxicity, such as surface blebbing, which is a sign of photo 
toxic effects19 indicating that [Os(bpy)2(pic-arg8)]
10+ is not phototoxic to the cells under 
the conditions described here.  
 
2.7 Photostability 
Good photostability of a fluorophore is a desired characteristic of an imaging probe. This 
ensures it will not photo bleach under continuous excitation over long imaging times, 
for example in dynamic studies. One of the key disadvantages of organic chromophores 
for live cell imaging is that they are frequently prone to photo bleach over extended 
periods of light exposure. The photostability of [Os(bpy)2(picCOOH)]
2+ in solution was 
explored and compared to [Ru(bpy)2(picCOOH)]
2+ as this complex had been shown 
previously under imaging conditions to exhibit significantly superior performance in 
terms of photostability compared to fluorescein.11 
To explore photostability under imaging conditions, solutions of each complex in PBS 
(70 μM) were pipetted onto a cover slip. The samples were excited using a 488 nm argon 
laser at 0.24 μW/cm2 laser power. The samples were then continuously irradiated for 10 
minute intervals in one area at 7.2 μW/cm2 laser power. Figure 2.9 illustrates the results 
after 20 minutes of continuous excitation. 
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Figure 2.12 Photostability of [Os(bpy)2(picCOOH)]2+ and [Ru(bpy)2(picCOOH)]2+ in PBS solution 
was assessed using confocal microscopy laser scanning. Bleaching was performed by exciting 
[Os(bpy)2(picCOOH)]2+ with 488 nm laser and 458 nm laser for [Ru(bpy)2(picCOOH)]2+. Both 
complexes were scanned using 30 % laser power at 10 minute intervals. The complexes were imaged 
at the lowest laser power of 1 % before scanning (A and D), after 10 minutes (B and E), and 20 
minutes scanning (C and F). 
 
Remarkably, it was found that [Os(bpy)2(picCOOH)]
2+ did not bleach at all after 20 
minutes of continuous high intensity laser scanning, seen in Figure 2.12 A-C, whereas 
[Ru(bpy)2(picCOOH)]
2+ underwent significant bleaching after 10 minutes of scanning 
(E), and further bleaching after a final exposure time of 20 minutes (F). Neugebauer et 
al reported that [Ru(bpy)2(pic-arg8)]
10+ retained more than 50 % of its initial 
luminescence after 20 minutes of continuous irradiation from within a platelet, and that 
this probe is significantly more stable than the commonly used imaging probe 
fluorescein.11 The photostability of the Os complex, is therefore outstanding.  The origin 
of this photostability is the large ligand field splitting of the dd levels of Os(II) 
complexes.  Unlike Ru(II) complexes its 3MC state cannot be thermally populated from 
its lowest excited state making them more photostable than Ru(II) complexes.20 
These results suggest  Os(II) polypyridyl complexes like [Os(bpy)2(pic-arg8)]
10+ may be 
valuable imaging probes particularly for dynamic or imaging studies over extended 
periods due to low toxicity towards cells and extreme photostability.   
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2.8 Phosphorescent Lifetime Imaging Microscopy (PLIM)  
 
Phosphorescent lifetime imaging microscopy (PLIM) is a useful method for measuring 
the emission lifetime of a probe from within the cell. The advantage of using Ru(II) and 
Os(II) metal complexes for lifetime applications is that their emission lifetimes are 
environmentally sensitive. Cellular environments, such as oxygen concentration and pH, 
can be monitored using changes in the luminescent lifetimes as the lifetime is 
independent of probe concentration. Luminescent lifetime measurements in solution 
showed that [Ru(bpy)2(pic-arg8)]
10+   has a lifetime of 540 ns, while [Os(bpy)2(pic-
arg8)]
10+ has a lifetime of 33 ns (Table 2.1). PLIM was carried out to investigate the 
variation of the lifetime of each complex within a cell. CHO and Sp2 cells were prepared 
as described in section 2.2.9, particularly given that [Os(bpy)2(pic-arg8)]
10+ is not 
sensitive to O2.The PLIM images were acquired using a Microtime 200 instrument. The 
samples were excited with a 405 nm laser line and emission was collected using a long 
pass 530 filter set. Each cell image was exposed to scanning for 20 minutes to ensure a 
high number counts were collected for accurate decay statistics. Even though the sample 
is scanned for long periods of time to generate the lifetime data, the laser power is low, 
at 0.7 μW/cm2 compared to 7 μW/cm2 for confocal imaging. Therefore, the cell is not 
compromised by thermal damage from the laser or by the generation of free radicals 
such as singlet oxygen by the metal complex. [Os(bpy)2(pic-arg8)]
10+ and [Ru(bpy)2(pic-
arg8)]
10+  lifetimes were compared in Sp2 cells, while [Os(bpy)2(pic-arg8)]
10+  lifetimes 
were measured in Sp2 and CHO cells to assess any differences between cell lines. 
Figure 2.13 shows the false-colour lifetime distributions of [Os(bpy)2(pic-arg8)]
10+ (A) 
and [Ru(bpy)2(pic-arg8)]
10+ (B) measured separately in a live single Sp2 cell. The 
lifetime distribution in this cell is representative of the cells throughout the sample. The 
overall average lifetimes in the cells were analysed using SymPhoTime software, where 
each pixel represents the average lifetime at that point in the cell. This creates the false 
colour images of the cell. 
Table 2.2 summarises the average luminescent lifetimes of [Os(bpy)2(pic-arg8)]
10+ and 
[Ru (bpy)2(pic-arg8)]
10+ in the membrane and cytoplasm of the cells. The average 
lifetime of [Os(bpy)2(pic-arg8)]
10+ in the cell was found to be 20 ± 0.9 ns, which is 
slightly shorter than in aqueous PBS solution at 29 ± 2.05 at 37 °C. The lifetime within 
the membrane was measured to be 18.8 ± 0.6 ns and 14.5 ± 1.5 ns in the cytoplasm.  As 
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[Os(bpy)2(pic-arg8)]
10+ lifetime was shown to be unaffected by oxygen, it is an 
alternative environmental parameter, such as local viscosity at the membrane that is 
causing the increase in lifetime there compared to the cytoplasm.20 [Ru(bpy)2(pic-
arg8)]
10+ demonstrated different lifetime distributions to the osmium complex, with the 
lifetime decreasing from 540 ± 12 ns in the cytoplasm to 453 ± 25 ns in the membrane.11 
In this case, as [Ru(bpy)2(pic-arg8)]
10+ is sensitive to oxygen concentrations, therefore 
this is likely to play a role in the varying lifetimes between the cell regions. For example, 
a higher oxygen concentration would be expected in the lipophilic membrane, quenching 
the luminescent lifetime there. 
 
 
 
Figure 2.13 False-colour luminescent lifetime images of [Os(bpy)2(pic-arg8)]10+ (A) and 
[Ru(bpy)2(pic-arg8)]10+ (B) (taken from Neugebauer et al 11) and the corresponding intensity images 
in Sp2 cells. Prior to imaging, Sp2 cells were incubated with 70 μM complex for 24 h and images 
were acquired using a Microtime 200 system by PicoQuant for 20 minutes on a temperature 
controlled stage set to 37 °C. The samples were excited with a 405 nm laser line and the emission 
was collected using a long pass 530 nm filter. (Image zoom=10) 
106 
 
The luminescent lifetime of images [Os(bpy)2(pic-arg8)]
10+ were acquired in live CHO 
cells and compared to the lifetime distributions in Sp2 cells. Figure 2.14 shows the 
acquired PLIM false-colour images of [Os(bpy)2(pic-arg8)]
10+ in a single CHO cell (A) 
and Sp2 cell (B) with their corresponding lifetime distribution charts. These cells are 
representative of the samples. The lifetime profiles of [Os(bpy)2(pic-arg8)]
10+ between 
the cell lines is surprisingly different, summarised in Table 2.2. The average lifetime 
was obtained using SymPho Time Analysis software, and provides the average lifetime 
of all the pixels of the selected cell area. Interestingly, the overall average lifetime in 
Sp2 cells was found to be longer than that in the CHO cell, which is reflected in the 
differences in the lifetime distribution throughout each cell type, shown in Figure 2.11. 
The lifetime in the membrane is from 18.8 ± 0.6 ns in the Sp2 cell, compared to 13 ± 1.5 
ns in the CHO cell. The lifetime in the cytoplasm was found to be 14.5 ± 1.5 ns in the 
Sp2 cell, and 11.6 ± 0.4 ns in the CHO cell. This is a significant difference between the 
two cell lines, although the trends in lifetime distribution are the same for each cell line, 
i.e. the lifetime increases in the cell membrane, relative to the lifetime of the cytoplasm. 
This is attributed to tight lipid packing in the plasma membrane which prevents 
[Os(bpy)2(pic-arg8)]
10+  from relaxing to ground state as fast as it does in the cytoplasm. 
21  
 
 
Figure 2.14 Luminescent lifetime imaging of [Os(bpy)2(pic-arg8)]10+ in a live CHO (A) and a live 
Sp2 cell (B). Prior to imaging, Sp2 cells were incubated with 70 μM [Os(bpy)2(pic-arg8)]10+ complex 
for 24 h in cell culture media, and images were acquired using a Microtime 200 system by PicoQuant 
for 20 minutes on a temperature controlled stage set to 37 °C. The samples were excited with a 405 
nm laser line and the emission was collected using a long pass 530 nm filter. (Image zoom=10) 
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Table 2.2 Average luminescent lifetimes (ns) of [Os(bpy)2(pic-arg8)]10+ in CHO and Sp2 cells, and 
[Ru(bpy)2(pic-arg8)]10+ in Sp2 cells. Each value represents the mean ± SD for 3 separate experiments.  
*Values taken from Neugebauer et al for comparison 11  
 
Average τ (ns) 
[Os(bpy)2(pic-arg8)]10+ 
(ns) 
[Ru(bpy)2(pic-
arg8)]10+ 
(ns) 
CHO Sp2 Sp2 
Overall Cell 10.7 ± 0.7 20 ± 0.9 479 
Membrane 13 ± 1.5 18.8 ± 0.6 453 ± 25* 
Cytoplasm 11.6 ± 0.4 14.5 ± 1.5 540 ± 12* 
TCSPC τ in solution 
(at 37 °C in PBS solution) 
 
29 ± 2.05 
 
514 ± 4.9 
 
 
The variations in the luminescent lifetimes of [Os(bpy)2(pic-arg8)]
10+ within the two cell 
lines suggests that osmium is influenced by its local environment. These changes are not 
influenced by oxygen as it was demonstrated previously in section 2.3 that 
[Os(bpy)2(pic-arg8)]
10+ shows no sensitivity to oxygen concentrations. During PLIM, 
images were acquired at 37 °C using a heated stage to keep the temperature constant 
throughout the process. Ruling out the possibilities of temperature and oxygen, it 
suggests that the emission lifetime differences may be attributed to the local 
environments and cell structure between the two cell lines; CHO, a mammalian cell line, 
and Sp2, a cancerous cell line. Lipid modifications in the cell membrane, such as 
accumulation of cholesterol, are associated with cancer cells due to the increased 
proliferation rates.22 The over-expression of fatty acids, which make up the 
phospholipids in the cell membrane, is also found in cancer cells, such as prostate cancer. 
It is tempting to speculate that these structural differences might be affecting the changes 
in lifetime of [Os(bpy)2(pic-arg8)]
10+ in the two cell lines.23  
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2.9 Resonance Raman Spectroscopy 
 
As demonstrated in section 2.3, [Os(bpy)2(pic-arg8)]
10+ exhibits a broad visible 
absorbance and a large Stokes shift. These properties make Os(II) highly suitable for 
resonance Raman. The advantage of using resonance Raman is its ability to selectively 
monitor a probe against a complex background, for example, against a background of 
lipid, carbohydrate and protein in cells. Resonance Raman in CHO cells was conducted 
and compared with a drop cast solution of the complex on a glass slide.  The resonance 
Raman spectra of [Os(bpy)2(pic-COOH)]
2+ and [Os(bpy)2(pic-arg8)]
10+ are presented in 
Figure 2.15. For comparison, solutions of both complexes in PBS in solution were 
pipetted on to a glass slide, and excited with a 488 nm argon laser into the 1MLCT 
absorbance band. The spectra were normalized to the 1317 cm-1 bipyridine (bpy) peak 
as it exhibits little dependence on the environment.24 
 
 
Figure 2.15 Raman spectra of [Os(bpy)2(pic-COOH)]2+ (—) and [Os(bpy)2(pic-arg8)]10+ (—) in PBS 
solution (70 µM) excited using a 488 nm laser. Data was normalised to the 1317 cm-1 bpy peak and 
offset for clarity. (n=3) 
 
 
109 
 
As demonstrated in Figure 2.15, [Os(bpy)2(pic-arg8)]
10+ exhibits a remarkably strong 
resonance Raman signal when excited at 488 nm in PBS solution. Signature vibrational 
modes for the bipyridine (bpy) ligand appear at 1603, 1552, 1482, 1317, 1269, 1173, 
1024 and 670 cm-1. Interestingly, unlike the analogous [Ru(bpy)2(pic-arg8)]
10+ complex 
where the pic moiety was weaker at this excitation, vibrational modes for the pic moiety 
are equally as intense, seen at 1556, 1506 cm-1, and a 1458, 1422, 1248, 1198 and 829 
cm-1. This suggests Os(dπ) to bpy π* transition and Os(dπ) to pic π* MLCT transition 
are both resonant at 488 nm. The spectra of [Os(bpy)2(pic-COOH)]
2+ and its peptide 
conjugate do not show any significant changes as expected, as the peptide does not 
contribute to the visible optical transition.  
Resonance Raman mapping of [Os(bpy)2(pic-arg8)]
10+ in a CHO cell was then examined. 
Figure 2.16 shows representative Raman mapping of [Os(bpy)2(pic-arg8)]
10+ in a single 
CHO cell. The CHO cells were prepared as described in section 2.2.10 with 70 µM 
[Os(bpy)2(pic-arg8)]
10+. Point spectra were acquired at the cell membrane, cytoplasm, 
and nucleus, and compared to [Os(bpy)2(pic-arg8)]
10+ spectrum in solution. The sample 
was excited using a 488 nm laser line, as this is coincident with the 1MLCT absorbance, 
and the spectra were acquired for 64 seconds. Spectra were normalized to 1317 cm-1 
peak.  
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Figure 2.16 Raman spectra of [Os(bpy)2(pic-arg8)]10+ accumulation in a CHO cell. Cells were 
incubated with 70 μM complex for 24 h (37 °C with 5 % CO2). Media was removed and cells were 
washed twice with PBS buffer supplemented with 1.1 mM MgCl2 and 0.9 mM CaCl2. Spectra 
compared to [Os(bpy)2(pic-arg8)]10+ solution in PBS. (n = 3). 
 
Consistent with emission confocal images, the resonance Raman confirms that 
[Os(bpy)2(pic-arg8)]
10+ accumulates within the cell and distributes widely. Interestingly, 
the 1459 cm-1 pic vibrational band shows a 2-3 fold relative increase in intensity in the 
cell compared to the bpy reference at 1482 cm-1 in the cell compared to when in solution. 
The 1267 cm-1 bpy vibrational band broadens as [Os(bpy)2(pic-arg8)]
10+ enters the cell. 
The peak broadens and the intensity decreases as the complex is internalized and enters 
the cell organelles. Broadening of Raman peaks is often associated with a heterogeneous 
environment. The aromatic ring stretch coupled CH mode at 1552 cm-1 exhibits a 
shoulder at 1559 cm-1 in PBS solution, which disappears upon entering the cell. Instead, 
a shoulder at 1549 cm-1 appears.25 This may be as a result of changes to the pH of the 
environment. Similar effects were noted for the Ru(II) analogue but were not as strong 
as [Os(bpy)2(pic-arg8)]
10+.24  
[Os(bpy)2(pic-arg8)]
10+ has demonstrated excellent Raman signal from within the cell. 
The changes in which [Os(bpy)2(pic-arg8)]
10+ undergoes once inside the cell makes it a 
useful Raman probe for tracking cellular functions at the various organelles via cell 
mapping.  
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2.10 Conclusions 
 
Chapter 2 explored, for the first time, Os(II) complexes as multimodal imaging probes, 
and compared the complex [Os(bpy)2(pic-arg8)]
10+ to its Ru(II) analogue [Ru(bpy)2(pic-
arg8)]
10+. 
The photophysical, cell uptake, and in-cell optical properties of a novel [Os(bpy)2(pic-
COOH)]2+ and conjugate [Os(bpy)2(pic-arg8)]
10+ were investigated. Like ruthenium, 
osmium has a large Stokes shift, but it emits outside the biological window at λmax 720 
nm. This is an ideal characteristic of an imaging probe as it avoids the auto-fluorescence 
of a cell and self-quenching. It was found to have a much lower lifetime of 33 ns, and to 
be oxygen independent, unlike its ruthenium analogue that possesses a much longer 
lifetime of 560 ns and is sensitive to O2 concentrations. A disadvantage is the relatively 
low quantum yield, nonetheless, good quality images were acquired without self-
quenching occurring. 
Confocal microscopy demonstrated that [Os(bpy)2(pic-arg8)]
10+ was easily taken up by 
cells, internalized in the first 2 minutes of exposure. Similar results were shown by 
Neugebauer et al of [Ru(bpy)2(pic-arg8)]
10+.11 Both complexes accumulated in the 
cytoplasm, and distributed throughout the cell with no specificity for particular 
organelles. Co-localization studies confirmed that [Os(bpy)2(pic-arg8)]
10+ had entered 
some lysosomes and mitochondria of the cell, but not all, which is consistent with octa-
arginine as a general cytoplasmic targeting peptide. Nuclear penetration by 
[Os(bpy)2(pic-arg8)]
10+ was observed during live uptake studies, possibly as a result of 
photo activation, and increased lipophilicity. The lipophilicity is something that needs 
to be explored further in [Os(bpy)2(pic-arg8)]
10+ uptake, localisation, and toxicity 
towards cells. 
Although it has a much shorter lifetime than that of [Ru(bpy)2(pic-arg8)]
10+ at 33 ns in 
solution, the lifetime is still considerably long compared to organic dyes. [Os(bpy)2(pic-
arg8)]
10+ lifetime in CHO cells was examined using PLIM imaging. Both [Os(bpy)2(pic-
arg8)]
10+ and [Ru(bpy)2(pic-arg8)]
10+ showed changes in their lifetimes when 
internalized. A lower lifetime was seen in the cytoplasm compared to the membrane for 
both complexes, which could be a result of tight lipid packing in the plasma membrane. 
As [Os(bpy)2(pic-arg8)]
10+  is insensitive to oxygen concentrations, the significant 
changes in [Os(bpy)2(pic-arg8)]
10+ luminescent lifetime that were observed in the cell are 
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attributed to other environmental factors in the cell, such as pH. This is something that 
will have to be explored further. This suggests that [Os(bpy)2(pic-arg8)]
10+ may be useful 
as an environmental sensing probe without the interference of oxygen. 
Finally, the large large Stokes shift allowed for the resonance Raman of [Os(bpy)2(pic-
arg8)]
10+ to be explored. Useful confirmation of probe structure can be obtained using 
resonance Raman. In aqueous solution it exhibited a strong resonance Raman spectrum, 
with no interference from the peptide conjugate. Raman mapping of [Os(bpy)2(pic-
arg8)]
10+ in a CHO cell demonstrated clear spectra from the membrane, cytoplasm, and 
nucleus. The bpy moiety showed to be affected by internalization, with clear changes to 
its vibrational bands compared to when in solution. The changes may also be a result of 
the changing pH of the cell environment. This is something to be looked at in greater 
detail in the future. 
The [Os(bpy)2(pic-arg8)]
10+ peptide conjugate shows promise as a multi-modal imaging 
probe, and proved to be as effective as its Ru(II) equivalent. In terms of its ease of uptake 
and lack of phototoxicity and cytotoxicity towards cells, this will allow for long term 
confocal scanning to be carried out without compromising the state of the cell. Although 
it is oxygen independent, [Os(bpy)2(pic-arg8)]
10+ shows promise as a successful probe 
in studying the local viscosity, cell membrane fluidity, and lipid membranes in the cell 
using FLIM imaging techniques. This will have to be explored in greater detail. Overall, 
its NIR emission and excellent photostability have shown Os(II) complexes to be a 
suitable metal complex in cell imaging over its Ru(II) equivalent. 
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Chapter Three: Ru (II) polypyridyl complex conjugated to a 
mitochondria penetrating peptide (MPP) as an oxygen sensor 
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3.1 Introduction 
 
Intracellular oxygen is the key metabolite in energy generation in mammalian cells. It is 
also a substrate of numerous enzymatic reactions within the cell which are vital for 
normal cell function. Therefore, monitoring oxygen concentrations within living cells is 
a valuable way of assessing cellular respiration and metabolism. 
Oxygen can be detected in luminescence imaging through its ability to quench the 
excited state of the given luminophore, and thus reducing emission intensity and 
lifetime. However, the emission intensity is also affected by probe concentration, 
making emission intensity via imaging an unreliable quantitative method. Whereas, the 
luminescent lifetime of a luminophore is independent of probe concentration and 
therefore is a more suitable measurement parameter.1-3 Platinum group metal complexes, 
such as ruthenium and osmium, emit from a triplet excited state which can interact with 
a triplet acceptor, in this case oxygen allowing for quenching via energy transfer. 
There have been relatively few oxygen probes reported that are capable of crossing the 
cell membrane without the need for permeabilisation using solvents, for example DMSO 
or detergents such as Triton X. These complexes can be rendered water soluble by 
incorporating conjugation peptides, PEG groups and other bio-compatible functional 
groups, as discussed previously in Chapter 1. This chapter will focus on using signal 
peptide sequences to promote water solubility and enhance cell uptake whilst targeting 
the probe specifically to the mitochondria. 
As discussed earlier, the advantages of using transition metals such as ruthenium are 
their photostability, high quantum yield, and oxygen sensitivity. In order to selectively 
target specific cellular organelles, in this case, the mitochondria, a specific mitochondria 
penetrating peptide (MPP) sequence will be used in order to measure oxygen from 
within the mitochondria.4 The mitochondria are the energy centres of the cell. All of the 
ATP required for cellular functions is formed there. In order to produce ATP, the 
mitochondria consumes ~90 % of the cells oxygen. 5 Thus O2 concentrations in the 
mitochondria directly reflect the health of the cell. Mitochondrial dysfunctions have 
been found to play a part in a range of debilitating diseases including Alzheimer’s, 
Parkinson’s, and Multiple Sclerosis, typically as a result of abnormal O2 metabolism in 
the mitochondria. 6, 7 The coupling of a Ru(II), O2 probe with an MPP would be 
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advantageous in directing the complex across the cell membrane without compromising 
the cell. It would provide real-time information on oxygen concentrations in the 
mitochondria monitored by methods such as phosphorescent lifetime imaging 
microscopy (PLIM).  This would make imaging of cellular O2 useful in the biochemical 
toxicity of diseases caused by the dysfunction in the mitochondria. 
Due to the relatively low lipophilicity and the cationic charge of metal based probes, 
difficulties arise in successfully directing a metal-based probe to the mitochondria and 
penetrating the organelle. 8 To date, there have been a number of examples of 
luminophores reported to reach the mitochondria.9-11 For example, Lo et al recently 
described a family of PEGylated cyclometalated iridium complexes which reached the 
mitochondria and exhibited strong phototoxicity.12 Keene et al reported on di-nuclear 
ruthenium complexes that showed to selectively locate in the mitochondria of L1210 
murine leukaemia cells.11 But in all of these studies, the complexes were not specifically 
designed to target the mitochondria. The nature of their designs allowed serendipity to 
play a role as they localised within the mitochondria. Recently, Chao et al synthesised 
a series of Ru(II) complexes designed to target the mitochondria by possessing a 2-
phenylimidazo[4, 5–f][1, 10]phenanthroline (PIP) ligand.13 However, their aim was to 
induce apoptosis from within the mitochondria as an anti-cancer agent rather than as an 
imaging sensor probe. 
The aim of this chapter was to evaluate a Ru(II) complex as an oxygen sensing probe 
and to generate a calibration plot reflecting its response to oxygen concentrations. The 
Ru(II) complex conjugated to peptide sequence FrFKFrFK (r = D-arginine) where 
previously shown to be investigated as a mitochondrial targeting probe, as a means to 
report on oxygen levels from within the mitochondria. 
This chapter details the [Ru(bpy)2phen-Ar-COOH]
2+ complex, conjugated to two 
peptide sequences for in-cell sensing. The probe’s luminescent emission intensity and 
lifetime was measured in response to oxygen concentrations to generate calibration 
curves which could then be applied to cells. Detailed cell studies were carried out, 
looking at the general uptake of the complexes by cells, and the co-localistaion within 
the mitochondria. Oxygen concentrations from within the mitochondria were measured 
using PLIM, and the oxygen concentrations were modulated using the antibiotic 
Antimycin A. Antimycin A is an inhibitor of electron transfer at complex III in 
mitochondria. It blocks the mitochondria from consuming oxygen in the cell. Therefore, 
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there is a build up of oxygen in the cell, increasing the natural concentration. This was 
used in order to test the probes ability to respond dynamically to the changing 
environments from within the mitochondria. 
 
3.2 Materials and Methods 
3.2.1 Materials 
 
[Ru(bpy)2phen-Ar-COOH]
2+ parent complex and the peptide conjugate were 
synthesised by Dr. Aaron Martin (DCU). All chemicals and solvents used in 
experimental procedures were purchased from Sigma Aldrich (Ireland). All solutions 
were made using deionised water, which was purified by a Milli-Q plus 18.5 Millipore 
purifying system. 
Resazurin reagents were acquired from Promokine. Cell culture media, serum and 
penicillin / streptomycin were purchased from Sigma Aldrich.  Cell culture flasks were 
purchased from Corning Incorporated 
 
3.2.2 Spectroscopic Measurements  
 
The UV/Vis spectra were recorded on a Jasco V-679 UV/Vis/NIR spectrometer. 
Fluorescence emission and excitation were measured using a Cary Eclipse Fluorescence 
Spectrometer, both at a slit width of 5 nm. Solution measurements were carried out in 1 
% v/v DMSO with PBS, and neat PBS in a Hellma quartz cuvette of 1 cm optical path 
length. 
       
3.2.3 Luminescent Lifetimes 
 
The lifetimes were collected using a FluoTime 100 Time-Correlated Single Photon 
Counting (TCSPC) instrument. The 405 nm laser was used to excite parent and 
conjugate complexes, provided from a Picoquant ‘PDL 800B’ pulsed diode laser. 10,000 
counts were collected for each lifetime measurement. Analysis of measurements was 
carried out using either Nanoharp or Timeharp software. The luminescent lifetimes were 
calculated using the PicoQuant FluoFit software by fitting an exponential decay function 
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to each decay plot. The data was then fitted to a mono-exponential decay to the 
background decay curve, using a tail fit with a χ2 value between 0.9-1.1. 
 
3.2.4 Real-time confocal luminescent imaging 
HeLa cells were seeded at 1.5 x 105 cells in 2 mL  media on 35 mm glass-bottom culture 
dishes. Cells were grown for 48 h at 37 ºC at 5 % CO2. The growth medium was removed 
and 75 µM of the [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ or [Ru(bpy)2-Phen-Ar-Arg8]
10+ in 
phenol red indicator-free media was added and allowed to incubate  for 2 h at 37 ºC at 5 
% CO2 in the dark. The dye/media solution was removed and cells were washed with 
PBS supplemented with 1.1 mM MgCl2 and 0.9 mM CaCl2. Cells were imaged using a 
Zeiss LSM510 Meta confocal microscope using a 63X oil immersion objective lens and 
heated stage set to 37 ºC. A  488 nm Argon ion laser was used to excite the complex, 
and emission was collected using a long pass 560 nm filter set. 
 
3.2.5 Cytotoxicity Studies 
 
HeLa cells were seeded in a 96-well plate at 1 x 104 in 100 µL of media, and left to 
incubate at 37 °C at 5 % CO2 for 24 hours. The compounds were added to the wells 
resulting in final concentrations of 200, 150, 100, 40, 10, 1 and 0.1 µM. The cells were 
incubated overnight with the dyes. 10 µL Resazurin reagent (PromoKine) was added to 
each well, and incubated for 7 h in the dark at 37 °C. Absorbance readings were recorded 
using a Tecan 96-well plate reader at 570 nm and 600 nm for background subtraction. 
All cytotoxicity experiments are reported in terms of percentage (%) viability, where 
100 % viability = 100 % of viable cells in the well. Each experiment was carried out in 
triplicate (n = 3 ± SD). 
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3.2.6 Phosphorescent Lifetime Imaging Microscopy (PLIM) 
 
HeLa cells were seeded at 1.5 x 105 on a sterile 35 mm glass bottom culture dish and 
were incubated for 48 h. 75 µM of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ in phenol red-
free media was added for 2 h incubation in the dark at 37 ºC at 5 % CO2. The media was 
removed and cells were washed with PBS (supplemented with 1.1 mM MgCl2 and 0.9 
mM CaCl2). Live PLIM images were acquired usung MicroTime 200, PicoQuant, 
attached to a Zeiss LSM510 confocal microscope using a 63 x oil immersion objective 
and heated stage set to 37ºC.  Each PLIM image was acquired for 10 minutes with 256 
x 256 resolution. 405 nm laser was used to excite the sample, and emission collected 
using a long pass 530 nm filter. The data was analysed using PicoQuant Symphotime 
software. Lifetimes were fit to a mono-exponential decay until a χ2 value of 0.9 - 1.1 
was achieved. The average lifetime was taken from 2 separate experiments (n = 2). 
 
3.2.7 Oxygen studies in HeLa cells 
HeLa cells were seeded as described previously and incubated with 75 µM complex 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ in phenol red-free media for 2 h  at 37 ºC and washed 
with PBS/MgCl2/CaCl2 solution. PLIM images were aquired immediately using 
Microtime 200, PicoQuant attached to a Zeiss LSM510 confocal microscope using 63x 
oil immersion objective, using a heated stage at 37 ºC. Each PLIM image was acquired 
for an average of 10 minutes to reach 10,000 counts, with 256 x 256 resolution. A 405 
nm laser was used to excite the sample, and emission collected using a long pass 530 
filter. 200 µg/mL Antimycin A in PBS (supplemented with 0.9 mM CaCl2 and 1.1 mM 
MgCl2) was added to live HeLa cells and left for 10 minutes at 37 ºC to accumulate, and 
the PLIM image was acquired over time.  Cells were incubated for a further 90 minutes 
with the Antimycin A, and PLIM image was acquired at a final exposure time of 100 
minutes. 
 
3.2.8 [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ phototoxicity towards HeLa cells 
 
HeLa cells were seeded at 1.5 x 105 in 2 mL cell media on 35 mm glass bottom culture 
dishes and incubated for 48 h. The media was removed and cells were washed with PBS 
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supplemented with 1.1 mM MgCl2 and 0.9 mM CaCl2 and transferred to a 37 ºC heated 
stage. 75 µM of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ in phenol red-free media and DRAQ 
7 (1:100) was added to the live cells and scanned immediately using the Time Series 
mode on a Zeiss LSM510 Meta confocal microscope. DRAQ 7, which stains the nucleus 
of dead cells, was excited using 633 nm HeNe laser 10 % transmission, and 488 nm 
Argon laser 3 % transmission for [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+. Emission was 
collected using a long pass 650 nm filter set for DRAQ 7, and long pass 560 nm filter 
for [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+. Cells were scanned continuously using the 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ settings for 5 minute intervals, imaging with the 
DRAQ 7 settings between intervals to assess viability. For the control, cells were set up 
as described above, and DRAQ 7 (1:100) in phenol red-free media was added to the live 
cells. They were scanned continuously using the ruthenium settings, and imaged after 
each interval to assess for DRAQ 7 uptake. 
 
3.3 Photo physical properties and Characterisation of [Ru(bpy)2phen-Ar-
COOH]2+ and Peptide Conjugates 
 
Figure 3.1 shows the emission and absorbance spectroscopy of [Ru(bpy)2phen-Ar-
COOH]2+ and [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+, both in PBS aqueous solution (pH 
7.4). They both exhibit an absorbance band at 460 nm, which is assigned to the 
ruthenium π to ligand π* MLCT transition. The strong absorbance band observed at 
~280 nm is attributed to the π-π* transitions of the polypyridyl ligands. The absorbance 
spectra appear to be identical, but a more intense absorbance at the same concentration 
is detected for [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+, which is attributed to the presence of 
two ruthenium centres at the peptide bridge (Scheme 3.1). When excited into the MLCT 
band at 460 nm, an intense emission band is exhibited at approximately 604 nm. 
Conjugation to the peptide appeared to have no effect on the photophysics of the dimeric 
complexcmpared to its parent. 
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Scheme 3.1 Chemical structure of dimeric [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+  mitochondrial 
localising complex. 
 
 
 
Figure 3.1 Absorbance and emission spectra of ruthenium parent complex [Ru(bpy)2phen-Ar-
COOH]2+ (—) and MPP conjugate [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ (—). Spectra were recorded 
at 50 μM in aqueous solution (PBS). Both complexes were excited into the MLCT band at 458 nm 
and the emission was collected between 500 – 750 nm, both at a slit width = 5nm. 
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The luminescent lifetimes were fit to a mono-exponential lifetime decay, signifying that 
there is only one luminescent lifetime present. The luminescent lifetime of 
[Ru(bpy)2phen-Ar-COOH]
2+ parent complex increased from 455 ± 11 ns to 689 ± 6 ns 
upon peptide conjugation which is attributed to some modest protection of the metal 
centre from diffusing oxygen by the peptide. The samples were then deaerated by 
purging with nitrogen for 20 minutes and luminescent lifetime measurements were 
recorded again. Time correlated single photon counting (TCSPC) was used to measure 
the luminescent lifetimes. Following deaeration, the lifetimes of both complexes 
increased dramatically. The luminescent lifetime of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ 
increased from 689 ± 6 ns to 1.23 μs ± 10 ns. Figure 3.2 shows the luminescent lifetime 
decays of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ when aerated (A), and de-aerated (B) 
using time correlated single photon counting (TCSPC).  
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Figure 3.2 TCSPC emission lifetime traces of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ under aerated (A) 
and de-aerated (B) condiotions. [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ was de-aerated for 20 minutes 
with nitrogen. The complexes were excited using the 450 nm laser, and the data was acquired using 
the PicoQuant Nano Harp system. The lifetime traces (___) and residuals (•) were fit to give a χ2 value 
between 0.9 and 1.1.  
 
The luminescent lifetimes were obtained by fitting the model to the curve (•) to give a χ2 
value as close to 1 as possible and goodness of fit was also assessed by visual inspection 
of the residuals (e.g. Figure 3.2 bottom). In both cases, the decays were fit to give χ2 
values of 1.089 when aerated, and 1.034 when de-aerated, indicating in agreement with 
the residuals shown above, an excellent fit. Table 3.1 summarises the photophysical 
properties of parent complex [Ru(bpy)2phen-Ar-COOH]
2+ and MPP conjugate 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+. 
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Table 3.1 Photophysical properties of the [Ru(bpy)2phen-Ar-COOH]2+ parent complex,  
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ mitochondrial complex, and [(Ru(bpy)2phen-Ar)2-AHX-
Arg8]10+ complex in PBS solution (12.5 µM) at room temperature 18 °C. 
 
Complex Φ (%) UV-Vis  
Absmax 
λmax τ 
aerated 
(18 °C) 
τ  
deaerated 
(18 °C) 
[Ru(bpy)2phen-
Ar-COOH]2+ 
0.046 ± 
0.003 
460  604 455 ns ± 11 ns 780 ns ± 9 ns 
[(Ru(bpy)2phen-
Ar)2-
FrFKFrFK]7+ 
0.053 ± 
0.002 
460  604 698 ns ± 6 ns 1.23µs ± 10 ns 
[(Ru(bpy)2phen-
Ar)2-Arg8]10+ 
0.067 ± 
0.005 
460 604 579 ns ± 11 ns 1.02 μs ± 9 ns 
 
 
3.4 Oxygen dependent studies 
 
To further investigate the oxygen sensitivity of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+, the 
emission intensity and lifetimes were recorded over a range of oxygen concentrations in 
vitro at room temperature (18 °C). The oxygen saturation concentration of 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ (50 μM in PBS) was determined to be 220 μM/L 
using a PreSense oxygen probe, and the initial emission spectra was recorded in air 
saturated solution. The solution was then fully degassed using nitrogen for 15 minutes. 
This resulted in a final oxygen concentration measured from the PreSense probe of 2 
μM/L in the solution, and the emission intensity was recorded. Oxygen was reintroduced 
slowly into the sample, recording the emission spectra at different oxygen 
concentrations. Figure 3.3A shows that the emission intensity increased dramatically by 
~50 % when fully aerated (—) to when fully deaerated (—). As oxygen was reintroduced 
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in to the sample, the emission intensity decreased linearly. The same linear decrease was 
observed for the luminescent lifetime. Such behaviour in response to oxygen is typical 
of Ru(II) complexes. 
 
 
 
 
Figure 3.3 Luminescent emission intensity measured as a function of O2 for [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ in PBS (50 μM, 18 °C). Emission intensity versus O2 from saturation to deaeration (A), 
where the legend shows concentrations of O2 in the media as measured independently by O2 sensor. 
The corresponding Stern-Volmer plot (B) of emission intensity as a function of oxygen 
concentration. The sample was de-aerated with nitrogen for 20 minutes and the emission intensities 
were measured at various oxygen concentrations. The arrow indicates the decrease in the luminescent 
emission intensity as the oxygen concentration increases.  
 
A 
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To determine the rate of quenching by oxygen, the data was fit to a Stern Volmer plot 
applying the Stern Volmer equation given in equation 3.1: 
 
I0/I = τ0/τ = 1 + KSV [O2] …. Equation 3.1 
 
Where I0 is the emission intensity in the absence of oxygen, I is the emission intensity, 
τ0 is the lifetime in the absence of oxygen, τ is the lifetime, KSV is the Stern-Volmer 
quenching constant and [O2] is the concentration of oxygen, mol/dm
3. KSV can be used 
to determine the biomolecular quenching rate using the following equation 3.2: 
 
KSV = kq.τ0 …. Equation 3.2 
 
where KSV is the slope of the Stern Volmer plot, kq is the rate of quenching and τ0 is the 
luminescent lifetime in the absence of oxygen.  
Figure 3.4 shows the corresponding Stern Volmer plot of the oxygen dependent 
luminescent emission intensity of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+. The linear plot 
indicates that there is only one type of oxygen quenching occuring. Figure 3.4 shows the 
linear relationship between [O2], and τ0/τ and I0/I for [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+. The matching plots for τ0/τ (•) and I0/I (•) shows that [(Ru(bpy)2phen-
Ar)2-FrFKFrFK]
7+ is undergoing dynamic quenching by oxygen. Dynamic quenching 
occurs when the luminophore in its excited state comes into contact with the quencher 
through diffusion, and returns to the ground state with out emitting any luminescence. 
In this case, [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ is being quenched by the oxygen present 
in the solution. 
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Figure 3.4 Stern-Volmer plot of luminescent emission intensity as a function of oxygen, I0/I (•) and 
the corresponding luminescent lifetime as a function of oxygen, τ0/τ (•), for [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ in PBS (50 μM, 18 °C). 
 
Oxygen studies were then investigated at 37 °C to mimic the probes response to 
biological conditions. Ruthenium polypyridyl complexes have been suggested to 
possess radical temperature dependence. This can affect the spectroscopic properties 
such as emission intensity and lifetime.14 At high temperature, Ru(II) lifetimes undergo 
a photochemical or photophysical deactivation as a result of thermally activated surface 
crossing from the 3MLCT to  the 3MC state.15 In this case, [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ has a luminescent lifetime of 689 ± 6 ns in aerated PBS at 18 °C which 
decreases significantly to 458 ± 7 ns in aerated PBS at 37 °C. Therefore, for a more 
realistic interpretation of the analytical response of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ 
under imaging conditions the luminescent emission and lifetimes over a range of oxygen 
concentrations were measured at 37 °C. Prior to the de-aeration process, the sample was 
incubated in a water bath so it reached 37 °C and nitrogen gas was bubbled into the 
sample for 15 minutes. During the de-aeration process and reintroduction of O2, the 
sample remained in the water bath to maintain the temperature (37 °C) throughout the 
measurements. The fluorescent lifetimes (τ) and emission spectra were recorded at a 
range of oxygen concentrations. A linear relationship was observed at 37 °C, as indicated 
by the Stern-Volmer plot of [O2] versus lifetime decay. Figure 3.5 compares the 
relationships at 18 °C and 37 °C.  
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Figure 3.5 Stern-Volmer plot of the luminescent lifetimes of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ (50 
μM) as a function of [O2] at 18 °C (•) and 37 °C (•) in PBS solution. 
 
The oxygen quenching rate constants were obtained from KSV and the lifetime values in 
the absence of oxygen (τ0), and were determined to be 2.5 x 109 M s-1 at 18 °C and 4.64 
x 109 M s-1 at 37 °C, summarised in Table 3.2. In comparison, DeGraff et al reported on 
oxygen quenching rates for [Ru(bpy)3]
2+ to be 2.97 x 109 M s-1 at 19 °C, and 4.73 x 109 
M s-1 at 39 °C in water.16 These conform well to the values found for [(Ru(bpy)2phen-
Ar)2-FrFKFrFK]
7+ but quenching rates for [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ are 
somewhat lower. This may be attributed to the large peptide conjugated to the complex, 
protecting the complex from quenching. 
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Table 3.2 Changes in the lifetime of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ in response to temperature 
and oxygen concentration, where aerated conditions have 220 µmol/L at oxygen saturation, and de-
aerated conditions have 2 µmol/L oxygen present. The Stern Volmer rate KSV and quenching rate kq 
for 18 °C and 37 °C. 
 
 18 °C       37 °C        
τ aerated (ns) 689 ± 6  458 ± 7  
τ de-aerated (ns) 1.23 µs ± 10 ns 948 ± 6 
KSV 0.0044 0.0031 
kq 2.5 x 109 M s-1 4.64 x 109 M s-1 
 
 
3.5 Cell Uptake and Mitochondria Localisation Studies 
 
In order to assess the ability of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ to cross the cell 
membrane and localise in the mitochondria, HeLa cells, an adherent cervical cancer cell 
line, were used. HeLa cells were seeded at 1.5 x 105 in 2 mL culture media and grown 
48 hours before imaging. All images were acquired using a Zeiss LSM510 confocal 
microscope with a 63 x oil immersion objective lens. Ru(II) was excited using a 488 nm 
laser line and emission was collected using a long pass 560 nm filter set. 
 
3.5.1 Cell uptake of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ 
 
In order to determine the optimum working concentration, a range of concentrations 
between 10 and 100 μM of both the parent and peptide complexes were incubated with 
HeLa cells for varying range of time periods of 1, 2, and 6 h at 37 °C and 5 % CO2 in 
the absence of light. The parent complex [Ru(bpy)2phen-Ar-COOH]
2+ showed poor cell 
penetration ability as no luminescence was observed in the HeLa cells. In comparison, 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ was readily taken up by the cells in a concentration 
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dependent manner. The optimum working conditions were found to be at a concentration 
of 75 μM in the cell media for an incubation time of 2 h.  
Live uptake studies showed that the initial uptake was rapid. Figure 3.6 shows the 
complex binding to the cell membrane after 3 minutes (A and B), and entering the cell 
after 5 minutes exposure (C and D). The likely reason for rapid membrane binding and 
uptake is the cationic charge of the peptide sequence, which promotes electrostatic 
association with the negatively charged exterior cell membrane. 
 
 
 
Figure 3.6 Live uptake of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ in HeLa cells. 70 μM [(Ru(bpy)2phen-
Ar)2-FrFKFrFK]7+ in phenol red-free media was added to HeLa cells.  The complex crosses the 
membrane after  3 minutes (A and B), and diffuses in the cells after 5 minutes (C and D) upon 
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addition. The temperature was kept at 37 °C using a heated stage. The complex was excited using a 
488 nm argon ion laser and the emission was collected using a long pass 560 nm filter. 
 
After 1 h [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ exhibited strong luminescence from within 
the cell, and appeared to concentrate within the cytoplasm, excluding the nuclear region. 
After incubating for 2 h at 37 °C in the absence of light, it strongly localised within the 
mitochondria, as illustrated in Figure 3.7 A-C, which shows a group of HeLa cells, 
illustrating the same distribution of the complex across all of the cells. This is 
representitive of the probe distribution throughout the sample. D-F looks closely at a 
single HeLa cell, where there is evidence of localization within specific cellular 
compartments in the cytoplasm. 
 
 
Figure 3.7 Confocal imaging of HeLa cells with 75 µM [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ for 2 h 
at 37 °C in the dark. A-C show representative uptake by HeLa cells (z = 1). D-F shows distribution 
within a single HeLa cell, suggesting that the complex is localising in specific cellular compartments 
(z = 3). A and D represent the bright-field confocal image of the cell. B and E represent complex 
intensity in the cell. C and F shows the overlay of the channels. The complex was excited using a 
488 nm argon ion laser and the emission was collected using a long pass 560 nm filter. 
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As discussed in Chapter 1, probes can cross the cell membrane in either an energy 
dependent or independent manner. To determine the mode of uptake, the cells were 
incubated with 75 μM [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ for 2 h at 4 °C in the dark. 
Figures 3.8 A and B show that under these conditions, [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ failed to cross the cell membrane. Upon closer inspection of the cells, C 
and D show that the complex resides solely at the membrane. Comparing this to Figure 
3.7 shows that uptake of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ is temperature dependent. 
When initially introduced to the cells, [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+  may bind 
electrostatically to the plasma membrane due to its high charge, as described earlier. 
This observation, combined with the temperature dependent studies suggests that uptake 
occurs via an activated process such as endocytosis. 
 
 
Figure 3.8 Confocal imaging of HeLa cells after incubation with 75 μM [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ at 4 °C for 2 h. A and B represent the general distribution throughout the sample. C 
and D look closely at a group of cells to show localisation. (A and C represent the ruthenium channel 
only, B and D show an overlay with the white light channel). The complex was excited using a 488 
nm argon ion laser and the emission was collected using a long pass 560 nm filter. 
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To assess the effect of different peptide sequences on uptake of the complex, 
[(Ru(bpy)2phen-Ar)2-Arg8]
10+ was introduced to HeLa cells in the same manner as 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ to compare the behaviour of a cell penetrating 
peptide (CPP) with the mitochondrial peptide sequence. As described in Chapter 1, octa-
arginine (Arg8) is a general CPP that localises within the cytoplasm and enters some, but 
not all organelles. [(Ru(bpy)2phen-Ar)2-Arg8]
10+ displayed a similar distribution in HeLa 
cells when incubated under the same conditions as [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+. 
Figure 3.9 shows a representative image of the manner in which [(Ru(bpy)2phen-Ar)2-
Arg8]
10+ appears to localize within the cytoplasm, and does not enter the nucleus. 1(A-
C) and 2(D-F) illustrate that the uptake of [(Ru(bpy)2phen-Ar)2-Arg8]
10+ and its 
distributions within the cell were the same for all cells across the sample. 
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Figure 3.9 Confocal imaging of [(Ru(bpy)2phen-Ar)2-Arg8]10+  in HeLa cells. HeLa cells were 
incubated with 75 μM [(Ru(bpy)2phen-Ar)2-Arg8]10+  in phenol red free media for 2 h in the absence 
of light. 1A-C and 2D-F focus on several cells for a representative uptake image of the complex 
across the sample. 3G-I presents a single HeLa cell and the localisation of the complex. A, D and G 
represent the bright-field confocal image of the cell. B, E and H shows the overlay of the channels. 
C, F and I represent complex intensity in the cell. The complex was excited using a 488 nm argon 
ion laser and the emission was collected using a long pass 560 nm filter. Yellow false colour used to 
distinguish [(Ru(bpy)2phen-Ar)2-Arg8]10+ from [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ in previous 
images. 
 
3(G-I) looks closely at a single HeLa cell.  The complex shows a more punctate 
distribution throughout the cytoplasm, suggesting that it has entered many cellular 
organelles, which is characteristic of the distribution of Arg8 peptide sequence, where 
similar localisation was also demonstrated in Chapter 2 for the complex [Ru(bpy)2PIC-
Arg8]
10+. 
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3.5.2 Mitochondria Localisation Studies 
 
To assess the localisation of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+, 75 μM was incubated 
with HeLa cells for 2 h at 37 °C. MitoTracker Deep Red, a commercial mitochondrial 
targeting dye, was added to the cells for the final 30 minutes of incubation for dual 
staining. Figure 3.10 shows the accumulation of both [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ and MitoTracker Deep Red (150 nM) in the mitochondria, where 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ is in green, MitoTracker in red, and their 
colocalization in yellow.  
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Figure 3.10 Confocal images showing co-localisation of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ in the 
green channel (A), MitoTracker Deep Red in the red channel (B) in HeLa cells, and the backscatter 
(C). The co-localisation represented in yellow where the two complexes co-localise in the 
mitochondria (D). Similarly, E-H is based on the distribution within a single HeLa cell. HeLa cells 
were incubated with 75 μM [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ in phenol red free indicator for 2 h 
in the absence of light. MitoTracker Deep Red (150 nM) was added to the cells for 30 minutes prior 
to imaging in PBS buffer. [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ was excited using a 488 nm laser and 
the emission was collected using a long pass 560 nm filter. MitoTracker Deep Red was excited at 
633 nm and the emission was collected using a long pass 650 nm filter. 
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To confirm that [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ and MitoTracker Deep Red are both 
coincident in the mitochondria, a profile cross section of a fluorescence image of a HeLa 
cell was examined and its corresponding fluorescent intensity profile plotted. This plot 
in Figure 3.11 confirms that they are both localising within the same cellular components 
and that both are nuclear excluding. The profile also suggests that [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ has a more selective and specific localization within the mitochondria, 
while the commercial MitoTracker appears to be more dispersed and diffused suggesting 
that it is residing in the mitochondrial membrane. 
 
 
 
Figure 3.11 Co-localization of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ in green and MitoTracker Deep 
Red in red and their co-localisation in yellow. The line profile across the cell and the corresponding 
fluorescence intensity profile demonstrate co-localisation of the two complexes HeLa cells were 
incubated with 75 μM [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ in phenol red free indicator for 2 h in the 
absence of light. MitoTracker Deep Red (150 nM) was added to the cells for 30 minutes prior to 
imaging in PBS buffer. [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ was excited using a 488 nm laser and the 
emission was collected using a long pass 560 nm filter. MitoTracker Deep Red was excited at 633 
nm and the emission was collected using a long pass 650 nm filter.  
 
Many groups have reported on metal complexes localising in the mitochondria, but the 
mitochondria were not typically the predicted target in these studies. For example, Keene 
et al demonstrated mitochondrial localisation of a dinuclear ruthenium in murine 
leukemia cells using confocal microscopy.11 However, the complex localised in the 
mitochondria by chance as they did not use any mitochondrial penetrating peptides to 
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specifically target the mitochondria. Similarly, Puckett and Barton reported on a 
[Ru(DIP)2dppz]
2+ complex, which after 2 h incubation with HeLa cells localised in the 
mitochondria without specifically targeting the mitochondria.17  
Conversely, this result indicates that this peptide sequence, FrFKFrFK, is a successful 
mitochondria penetrating peptide (MPP) for carrying metal complexes in a predictable 
way. Not only can it direct a metal complex to the mitochondria, it can also enable it to 
penetrate the mitochondrial membrane. The luminescence from within the mitochondria 
is bright and distinguishable from the background, i.e. the rest of the cell. This allows 
for a precise and localised monitoring of oxygen from the mitochondria. 
 
3.6 Oxygen dependent studies in HeLa cells using Phosphorescent Lifetime 
Imaging Microscopy 
 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ showed excellent sensitivity to oxygen in vitro, and 
as described in section 3.4, successfully localized within the mitochondria. To assess 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ as a biological O2 probe, Phosphorescent Lifetime 
Imaging Microscopy (PLIM) imaging was used to interogate its lifetime within the 
mitochondria of a HeLa cell.  
At 37 °C in aqueous solution, the luminescent lifetime of [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ was found to be 458 ns ± 6 ns, as described earlier in section 3.3. The 
luminescent lifetime was measured at 37 °C as Ru(II) spectroscopic properties are 
sensitive to temperature, and to mimic the cellular environment as imaging is frequently 
carried out at this temperature. For in vivo studies, HeLa cells were prepared on 35 mm 
glass bottom culture dishes for 48 h, and 75 μM of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ 
was added for 2 h. Live PLIM images were recorded using MicroTime 200, PicoQuant 
software, and excited with a 405 nm laser line. Figure 3.12 shows the acquired false-
colour PLIM image of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ in a single HeLa cell (A), 
which is representitve of the sample, and the corresponding luminescent lifetime decay 
plot (B). To aquire the luminescent lifetime of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ from 
within the mitochondria, only the mitochondrial regions were imaged.  
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Figure 3.12 PLIM image and distribution of lifetime of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ in HeLa 
cells. HeLa cells were incubated with 75 μM complex for 2 h and washed with PBS supplemented 
with 1.1 mM MgCl2 and 0.9 mM CaCl2. The lifetime within the mitochondria is 525 ± ns (n = 2). 
The sample was excited with a 405 nm laser and the emission was collected using a long pass 530 
nm filter. 
 
The luminescent lifetime decay distribution shows a single exponential mode, with the 
average lifetime in the mitochondria to be 525 ± 10 ns. The increase in lifetime from 
458 ns ± 6 ns when fully aerated in solution to 525 ± 10 ns in the mitochondria suggests 
that oxygen concentration in the mitochondria is slightly lower. Based on the calibration 
plot at 37 °C (Figure 3.5), the measured lifetime represents an intracellular oxygen 
concentration of ~183 μmol. The lower concentration at the mitochondria is expected 
for normal metabolizing cells as some of the oxygen taken up by the cell gets used up 
by other cellular organelles or is lost in the diffusion process to the mitochondria. 
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3.6.1 Antimycin A as an O2 inhibitor in mitochondria 
 
To further assess the ability of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ to report on the 
dynamic changes to oxygen concentration cellular respiration, the O2 concentration in 
the cell was altered using Antimycin A. Antimycin A is an inhibitor of electron transfer 
at complex III in mitochondria. It blocks the mitochondria from consuming oxygen in 
the cell. Therefore, there is a build up of oxygen in the cell, increasing the natural 
concentration.18 This change in the cellular environment causes the cell to undergo 
oxidative stress, leading to reactive oxygen species (ROS) production. As discussed in 
Chapter 1, ROS are chemically reactive oxygen metabolites. They are highly reactive as 
they have one or more unpaired electrons in their outer shells. ROS are formed as a 
natural byproduct of cellular metabolism of oxygen. However, under oxidative stress 
there is an increase in ROS production which can have a damaging effect on the cell. As 
a result in the increase of ROS, there is a decrease in ATP production.19 The most 
common ROS produced by the mitochondria under oxidative stress is singlet oxygen, 
1O2. 
HeLa cells were prepared as described in section 3.2.8. Antimycin A (200 µg/mL) was 
added to the cells in PBS solution, which were then incubated for 10 minutes. The 
lifetime of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ was then measured and mapped using 
PLIM imaging. The lifetime was measured at 10 minute intervals, to a total exposure 
time of 100 minutes. Figure 3.13 A-C shows the PLIM image of the region of 
mitochondria monitored following the addition of Antimycin A (A), after 10 minutes 
exposure (B), and 100 minutes (C). In Figure 3.11 (A), the luminescent lifetime decay 
map shows a gaussian distribtuion of lifetimes with a single maxima, with an average 
lifetime measured to be 525 ns. Antimycin A was added to the cells and after 10 minutes 
exposure, the luminescent lifetime decay changed, shown in Figure 3.13 (B). Here, the 
decay appears to be bi-modal distribution, suggesting that there are two  distributions of 
lifetimes present in the mitochondria. The two peaks represent the two median 
luminescent lifetimes of approximately 220 ns nand 423 ns. The longer luminescent 
lifetime of 423 ns can be attributed to the increase in oxygen in the mitochondria as a 
result of the Antimycin A, quenching the lifetime of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+. 
The shorter lifetime of 220 ns is as a result of the formation of ROS by the cell. After 
100 minutes exposure to Antimycin A, the luminescent lifetime decay distribution 
returns to a single peak, shown in Figure 3.13 (C), where the median luminescent 
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lifetime is 228 ns. It is highly unlikely that oxygen quenching is contributing to the 
shorter lifetime component as when [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ is  is in air 
saturated solution it has a luminescent lifetime of 458 ns. Oxygen concentration cannot 
exceed saturation. Therefore, a separate quenching pathway is causing the futher 
reduction in [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ lifetime. The shorter luminescent 
lifetime is tentatively attributed to in the presence of ROS which is quenching the 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ emission. ROS production in the mitochondria is 
likely to be occuring in response to the oxidative stress caused by the Antimycin A.  The 
superoxide anion (O2 
•-), hydrogen peroxide (H2O2), and hydroxyl radical (
•OH) have all 
been shown to be produced in response to Antimycin A in the mitochondria.19 However, 
it is the superoxide anion O2 
•- that is the most likely ROS contributor in this quenching 
process. Superoxide O2 
•- is produced when O2  becomes reduced and loses an electron, 
shown in equation 3.3. 
 
O2 + e
- = O2 
•- …. Equation 3.3 
 
It is possible than when [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ comes in contact with 
oxygen, it becomes reduced gaining anelectron from the oxygen and as a result, produces 
O2 
•-. This energy transfer is the possible cause of the quenching that is occuring to the 
luminescent lifetime. The likelyhood of this occurance is based on the redox potential 
of the compound. A similar complex [Ru(bpy)2(PIC)]
2+, where PIC = 2-(4-
Carboxylphenyl)imidazo[4,5-f][1,10]phenanthroline) was reported to have a redox 
potential of ~1.2 V.20 Assuming that [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ has a similar 
redox potential, it would suggest that [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ is easily 
oxidised, as stated in Equation 3.3. This would account for generation of ROS, and the 
further quenching of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ luminescent lifetime. 
Figure 3.13 D-F shows the luminescent lifetime of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ 
in the mitochondria of control cells, that were not exposed to Antimycin A, over the 
same time intervals. The luminescent lifetime decays are all of a single modal  
distribution with a median decay of 526 ± 21 ns. This suggests that the luminescent 
lifetime of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ does not change in the mitochondria over 
time when the cell is metabolizing normally and it can be used to measure the oxygen 
concentration there over extended periods.  
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Figure 3.13 PLIM lifetime distributions of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ in HeLa cells in 
response to the addition of Antimycin A.  HeLa cells were incubated with 75 µM of [(Ru(bpy)2phen-
Ar)2-FrFKFrFK]7+ in phenol red-free media for 2 h in the absence of light. Each PLIM image was 
acquired for 10 minutes. A 405 nm laser was used to excite the sample, and the emission was 
collected using a long pass 530 nm filter. The luminescent lifetime of [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ in HeLa cell (A) and the decrease in lifetime when Antimycin A (200 µM) is added 
after 10 min (B) and 100 min (C). Control HeLa cells, with no addition of Antimycin A, at 0 min 
(D), after 10 min (E), and 100 min (F). (z = 10)  
 
Figure 3.14 shows a plot of lifetime (τ) versus time (minutes) of the control cells and 
those exposed to Anytimycin A over the 10 minute intervals. The results displayed an 
initial decrease in the average lifetime from 525 ns to 423 ns after the first 10 minutes. 
The decrease in the average lifetime continued until it reached a plateau at 228 ns after 
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100 minutes. Similar results were reported by Fercher et al. who introduced oxygen 
sensitive nanoparticles to mouse embryonic fibroblast (MEF) cells, using Antimycin A 
to stimulate the cell metabolism. Their results showed a decrease in the fluorescent 
intensity in response to the changing oxygen concentration.3 They did report on the 
production of ROS as a result of using Antimycin A. 
 
 
Figure 3.14 Effects of Antimycin A on the lifetime of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ over 100 
min at 37ºC. PLIM images were acquired every 10 minutes to measure any changes in lifetime. The 
control sample of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ only was measured without any addition of a 
mitochondrial uncoupling reagent. 
 
ROS play crucial roles in both the physiological and pathological processes in the cell. 
For example, ROS play an important role in modulating signal transduction cascades 
and transcription factors in the mitochondria. However, overproduction of ROS leads to 
oxidative stress in the cell which has been implicated in many diseases, as discussed 
previously in Chapter 1. Therefore there is a need to develop novel probes for ROS 
sensing. However, detecting ROS in live cells is very difficult. They are highly reactive 
and short-lived, and therefore do not accumulate to high levels for accurate detection. 
There are any different types of ROS, which are produced and detoxified in subcellular 
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compartments. Their individual study would require probes that specifically target 
subcellular locations.21 To date, there have been few reports on ROS sensors capable of 
quantitatively measuring ROS in live cells. Those that have been reported are based on 
organic probes not transition metal complexes. For example, the group of Nagano et al 
reported on a ROS sensor which was based on rhodamine.22 They successfully targeted 
the complex to the mitochondria of HeLa cells. They stimulated ROS production by 
adding H2O2 to the cells, and recorded an enhancement in confocal fluorescence 
intensity as a result of ROS production. Similarly, Tang et al reported on a fluorescent 
superoxide anion O2
•- probe for live cell imaging of ROS.23 They were able to direct 
their complex, MF-DBZH, to the mitochondria of HepG2 cells, and measure O2
•- there. 
They reported low cytotoxicity of their complex, which is ideal for sensing in live cells. 
However, in both cases, using the luminescence intensity in confocal imaging to measure 
ROS production has its limitations, since, as mentioned earlier, the luminescent intensity 
in imaging is dependent on the probe concentration in the cell. Therefore, it is very 
difficult to quantitatively measure ROS production in this manner. Also, the results 
would vary across different cell types depending on the loading conditions and how 
much of the probe is taken up by the cells. For this reason, using lifetime to quantitatively 
measure ROS production using techniques like PLIM is a more reliable method as 
luminescent lifetime is independent of probe concentration. 
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Table 3.3 Luminescent lifetimes (ns) of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ at 37 °C in vitro in PBS 
solution under aerated and de-aerated conditions compared to the biological lifetimes in the 
mitochondria before and after the addition of Antimycin A. 
 
 
Compound 
τ (ns)  
@ 37 °C 
 aerated 
τ (ns)  
@ 37 °C 
deaearated 
τ (ns) 
mitochondria 
@ T0 
 
τ (ns) 
mitochondria 
@ T100 
 
[(Ru(bpy)2phen-
Ar)2-
FrFKFrFK]7+ 
 
458 ± 7 
 
948 ± 6 
 
525 ± 10 
 
228  
 
 
In order to ensure that the changes observed to [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ was 
as a result of the mitochondrial environment and not as a result of coming in contact 
with Antimycin A, the luminescent emission and lifetime of [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ with Antimycin A were measured in PBS solution (pH 7.4) at 37 °C. 
Figure 3.15 (A) shows the emission intensity of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ in 
PBS solution, and [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ mixed with 200 μg/mL Antimycin 
A.  
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Figure 3.15 Luminescent emission intensity of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ in PBS solution 
(—), and [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ mixed with 200 μM/mL Antimycin A (—), at 37 °C 
(A). Both solutions were excited into the MLCT band at 458 nm and the emission was collected 
between 500 – 750 nm, both at a slit width = 5. Luminescent lifetime decay of [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ mixed with 200 μM/mL Antimycin A (B). . The complexes were excited using the 450 
nm laser, and the data was acquired using the PicoQuant Time Harp system. The lifetime traces (___) 
and residuals (•) were fit to give a χ2 value between 0.9 and 1.1 The spectra were recorded at 15 μM 
in aqueous solution (PBS) that were heated to 37 °C using a water bath. 
 
A slight decrease in the emission intensity was observed between the two solutions. 
Although both solutions were made up to give a final concentration of 15 μM, the 
concentration may have slightly decreased upon the addition of the Antimycin A. 
However, the luminescent lifetime was, within experimental error, unaffected by the 
Antimycin A, and was measured to be 468 ns (B), compared to 458 ± 7 ns without 
Antimycin A. 
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3.7 Cytotoxicity 
 
The effect of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ on the viability of the cells was carried 
out using the Alamar Blue (Resazurin) cytotoxicity assay as explained in section 3.2.6. 
Figure 3.16 shows that the parent complex [Ru(bpy)2phen-Ar-COOH]
2+ did not induce 
cytotoxicity in HeLa cells. 75 % of cells were viable when exposed to concentrations as 
high as 200 µM for 24 h in the dark. In comparison, cell viability decreased dramatically 
to 15 % at 200 µM when exposed to [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+. 40 % viability 
was observed at the working concentration of 75 µM. The IC50 value is the minimal 
amount of a drug needed to inhibit 50 % of cells. [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ 
was found to possess an IC50 value of 47.45 µM.  This result further suggests that the 
parent complex is not internalised by the cell unlike the peptide conjugate. 
To assess if the toxicity was as a result of localising in the mitochondria, or induced by 
the complex itself, the toxicity of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ and 
[(Ru(bpy)2phen-Ar)2-Arg8]
10+ were compared. The complexes were added to HeLa cells 
for 24 h and assessed using the Resazurin assay as previously described. Figure 3.15 
shows 0 % viability of HeLa cells at concentrations of 150 and 200 µM [(Ru(bpy)2phen-
Ar)2-Arg8]
10+, with an IC50 value of 44.64 µM. 
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Figure 3.16 Cytotoxicity of [Ru(bpy)2phen-Ar-COOH]2+ and [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ 
compared to that of [(Ru(bpy)2phen-Ar)2-Arg8]10+ at varying concentrations, incubated for 24 h in 
the dark at 37ºC at 5 % CO2. HeLa viability was assessed using the Resazurin (Alamar Blue) assay 
(n=3). 
 
A time-dependent cytotoxicity study was carried out on [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ at 75 µM over 1-7 h to assess cell viability during the working incubation 
time. After 2 h incubation with [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+, which was the 
chosen working incubation time, 98 % of the cells remain viable. After 5 hours, cell 
viability decreased to 40 %, shown in Figure 3.17. 
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Figure 3.17 Time dependence toxicity of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ in HeLa cells. The cells 
were incubated with 75 μM [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ in the absence of light over 7 h. (n = 
3) 
 
As demonstrated in section 3.4, [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ localises in the 
mitochondria of cells after 2 h incubation. From the time dependence toxicity results, 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+  is a useful mitochondrial imaging and sensing probe 
up to 5 h exposure to the complex. After 5 h, cell viability decreases dramatically. This 
suggests that [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ could be a useful qualitative probe in 
imaging compromised mitochondria, and therefore be used to compare the physical 
changes of healthy and unhealthy mitochondria. Furthermore, the result of the time 
dependent viability study indicates that it is the Ru(II) parent complex that is inducing 
the toxicity of the cells, not its localisation. As described in section 1.6.1, polyarginine 
sequences deliver complexes in a non-selective manner, where binding to the 
mitochondria, lysosomes, and endosomes can occur, resulting in cell death. The wide 
permeation abilities of [(Ru(bpy)2phen-Ar)2-Arg8]
10+ are likely to be the reason for the 
higher toxicity results. Section 2.5 outlines the cytotoxicity of a [(Ru(bpy)2PIC-Arg8]
10+ 
complex, which showed a similar distribution within the cell but did not induce toxicity 
towards the cell. This is further confirmation that it is the parent complex inducing 
toxicity, not the peptide or cellular localization. The high toxicity of the 
[Ru(bpy)2phen]
2+ complex would suggest that it may possibly be a useful therapeutic 
agent when introduced to cells for longer periods of time. 
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3.8 Phototoxicity 
 
Ru(II) complexes are ideal photosensitisers due to their strong absorbance and long-
lived excited states. In section 3.6 it was described that [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ induces toxicity after 24 h incubation in the absence of light. Given the 
fact that these complexes are intended for imaging, it was important to also assess their 
photocytotoxicity. From cellular uptake studies described in 3.4.1, HeLa cells remain 
viable after 2 h incubation in the dark. Cell viability following exposure of 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ to a light source of 488 nm (0.64 µW/cm2) in live 
HeLa cells was examined. 
Figure 3.18 shows live uptake of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ by HeLa cells. 
Cells were continuously scanned at 5 minute intervals with a 488 nm laser to induce 
phototoxic effects. After the initial 5 minutes (1A-C), [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ entered the cells. After a further 15 minutes scanning (2D-F), the complex 
appeared to have permeablised all cellular compartments, including the nucleus. After 
25 minutes (3G-I), the complex induced extensive cell death, indicated by the entry of 
DRAQ 7. Photo damage can occur to labelled cells nearby due to light scatter. As a 
control, an area that was not exposed to the light was examined (4J-L). No damage to 
the cells was observed. After the constant illumination, the luminescence of 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ showed a 5-fold increase in emission upon photo 
damage compared to the intensity of the complex that was not exposed to light. This 
suggests that the immediate uptake is caused by a loss in the plasma membrane integrity 
as the complex accumulates within the cell more rapidly than shown earlier in the live 
uptake studies in section 3.4. The loss of membrane integrity is as a result of 
phototoxicity which was induced by the constant illumination.  
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Figure 3.18 Phototoxicity of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ (75 μM in phenol red-free media) 
in HeLa cells. Uptake of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ is presented in (1A-C) but no toxicity 
to cells was observed. After 20 minutes, some toxicity has ensued (2D-F), and after 25 minutes 
DRAQ 7 has entered the nucleus of all the cells indicating cell death (3G-I). After 35 minutes 
exposure to [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ complex in a new location that has not been exposed 
to the laser, there was no entry of DRAQ 7, shown in image K where no emission is detected as cells 
are still viable (4J-L). The laser power used was Ex 488 nm 0.64 µW/cm2. Emission was collected 
using a long pass 560 nm filter. Channels for [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ only, DRAQ 7 only, 
and an overlay of the channels is shown for each time point. 
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Control experiments illustrated in Figure 3.19 demonstrate that when HeLa cells were 
exposed to the same light source in the absence of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+, 
no DRAQ 7 entered the cells up to 35 minutes of scanning under the same laser power 
exciting at 488 nm (0.64 µW/cm2). 
 
 
 
Figure 3.19 Control HeLa cells for phototoxicity. Cells were scanned continuously, exciting at 488 
nm, using the same confocal settings at a laser power of 0.64 µW/cm2 at 5 min intervals, and imaged 
between each interval to assess for DRAQ 7 uptake (Ex 633 nm HeNe laser, long pass 650 nm filter 
set). (A) 0, (B) 20, (C) 25, and (D) 35 minutes of scanning. 
 
As [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ is not toxic towards the cells when incubated for 
2 h in the dark, it was necessary to assess if phototoxicity could be induced from within 
the mitochondria.  Figure 3.20 (A-C) shows HeLa cells, incubated with [(Ru(bpy)2phen-
Ar)2-FrFKFrFK]
7+ (75 µM) for 2 h in the dark. Cells were exposed to the light source 
and scanned continuously at 5 minute intervals. After 20 minutes of exposure, 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ induced cell death from within the mitochondria, 
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indicated by entry of the complex and DRAQ 7 into the nucleus (E-G). Again, 
phototoxicity was only detected in areas exposed to light. Luminescence intensity 
showed a 3-fold increase in emission after scanning (D) compared to intensity after 
incubation in the absence of light (A). 
 
 
Figure 3.20 HeLa cells were incubated with 75 µM [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ for 2 h, 
washed and DRAQ 7 added (A-C). Cells were exposed to continuous light source and DRAQ 7 
entered the nucleus after 20 min scanning (D-F). Laser power used was Ex 488 nm 0.64 µW/cm2. 
Channels for [(Ru(bpy)2phen-Ar)2-FrFKFrFK]7+ only, DRAQ 7 only, and an overlay of the channels 
is shown for each time point. 
 
One possible reason for the photo-induced damage in cells is the production of singlet 
oxygen. In order to produce singlet oxygen 1O2, there needs to be oxygen present, 
photoexcitation of a triplet photosensitizer like Ru(II) can energy transfer to oxygen 
leading to formation of its single state. Dobrucki reported on the phototoxicity of 
[Ru(phen)3]
2+ towards macrophages.24 Here, it was demonstrated that there was an 
increase in cell uptake and luminescent emission from the nucleus upon irradiation. 
Furthermore, he showed that in the presence of histidine, a singlet oxygen scavenger, 
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that the phototoxicity towards the macrophages was reduced, suggesting that singlet 
oxygen was the mechanism of phototoxicity. 
The increase in luminescent intensity on irradiation was surprising and we speculate it 
could be due to binding to DNA, RNA, or other proteins which are available after 
disruption of the cell. One possible mechanism of DNA binding might be between the 
bipyridine ligands of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ and the DNA. [Ru(bpy)3]
2+ has 
been studied in regards to binding to DNA.25 The bipyridine ligand is likely to undergo 
electrostatic binding with DNA as it has reduced hydrophobic interactions compared to 
a phenanthroline ligand.26  [Ru(phen)3]
2+ has been shown to have an affinity towards 
DNA and RNA.27,28 wherein it has been reported to bind stereoselectively to DNA 
through partial intercalation.28-30 For example, the group of Cardin et al reported on the 
intercalation of a [Ru(phen)2dppz]
2+ complex with DNA oligonucleotides.31 Here they 
showed semi-intercalation of the phenanthroline ligand into the minor groove of B-
DNA.  However, it is unlikely to be phen binding here as [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ due to steric interference by the peptide. 
As mentioned earlier, the emission intensity of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ 
increased 5-fold when the complex/media solution was added to the cells (Figure 3.18 
A-C), whereas the emission only incraesed 3-fold when the cells were incubated with 
the complex then washed (Figure 3.20 D-F). The differences in the increasing emission 
intensity suggests that the induced phototoxicity could be occuring in a concentration 
dependent manner. In the case of Figure 3.18, there is an abundence of [(Ru(bpy)2phen-
Ar)2-FrFKFrFK]
7+ present in the sample, suggesting that there is more complex present 
to bind to the DNA/RNA/proteins of the cell. On the other hand, there is a limited aount 
of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+  present in Figure 3.20, i.e. the amount that was 
taken up by the cells during incubation. The damage appears to occur throughout the 
cells in Figure 3.18 compared to Figure 3.20, suggesting that more 1O2 is being produced 
as a result of the different concentrations of [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ 
available. Also, the concentration of oxygen in the lipid membrane of a cell is  expected 
to be higher than that in the cell. As [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+  is taken up by 
the cell and is under constant illumination, it is likely that there is more 1O2 being 
produced at the cell membrane than when [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ is in the 
mitochondria, causing more damage across the whole cell as a result.  
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3.9 Conclusions 
 
Chapter 3 described the application of a novel dimeric Ru(II) probe conjugated to an 
MPP localising sequence FrFKFrFK to cell imaging, and O2 and ROS sensing. The 
ability of the conjugate to cross the cell membrane and measure oxygen in the 
mitochondria were explored. 
The photophysical properties of the parent and peptide conjugate were examined, and 
they exhibited a strong absorbance band at λmax = 460 nm, and emission maxima of 604 
nm. The peptide conjugation did not affect the properties of the complex. 
Confocal microscopy demonstrated that the parent complex was not capable of entering 
cells, whereas [(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ exhibited efficient uptake, optimised 
for imaging at 75 µM incubated for 2 h in the absence of light. Co-localisation studies 
confirmed that the MPP sequence FrFKFrFK was successful in bringing the complex 
across the cell membrane and directing it to the mitochondria. Dual-staining with 
MitoTracker Deep Red confirmed co-localisation at the mitochondria. 
PLIM studies established that the probes response to O2 could successfully be translated 
to measuring O2 in the cell. This was further investigated by using the mitochondria 
uncoupler Antimycin A to alter O2 concentration in the mitochondria. The 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ lifetime decreased from 525 ns at  0 minutes to 423 
ns after 10 minutes, and finally reached a lifetime of 228 ns after 100 minutes exposure. 
This was due to quenching by the build-up of oxygen and ROS production in the cell. 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ also displays promise as a therapeutic agent. Its 
relatively low cytotoxicity at short incubation times in the absence of light, and induced 
high phototoxic effects upon exposure to light are the ideal properties of a 
photosensitiser used in photodynamic therapy (PDT), of which [(Ru(bpy)2phen-Ar)2-
FrFKFrFK]7+ has clearly demonstrated to have. The mechanism of cell death, either 
necrosis or apoptosis, needs to be explored further. Overall, not only has 
[(Ru(bpy)2phen-Ar)2-FrFKFrFK]
7+ exhibited great promise as a probe for monitoring 
the O2 environment in the mitochondria, it has also shown to be a powerful ROS sensor 
in live cells, something that is currently very difficult to achieve.  
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4.1 Introduction 
The past decade has seen a widespread interest in optical sensing using fluorescence as 
a result of its sensitivity and ease of use. Fluorescence sensing has been employed to 
measure parameters such as temperature,1 pH,2 concentration of calcium ions,3  and O2.
4-
6 Optical sensors for oxygen have found many different applications in biological 
domains such as (a) in food technology,7,8 (b) biotechnology, 9,10 and (c) intracellular 
oxygen sensing.11,12  
This interest in optical methods of intracellular oxygen sensing and determining oxygen 
concentration has spurred on the development of oxygen sensing techniques applied to 
cells and in-vivo methods.13-15 The value of oxygen sensing in such domains has been 
discussed in the preceding chapters.  Fluorescence based methods possess key features 
that make them ideal for measuring oxygen such as (a) full reversibility, (b) lack of 
consumption during measurement, (c) allows for remote sensing, and (d) the ability to 
image oxygen.15  
Oxygen concentration can be measured from either the lifetime or emission intensity of 
the phosphor. Luminescent lifetime measurements in vivo require specialist detection 
strategies such as TCSPC or phase fluorimetery for example in fluorescence lifetime 
imaging microscopy (FLIM) as described in Chapter 1. FLIM is an ideal method for 
sensing as lifetime is independent of probe concentration and lifetime can be calibrated. 
However, intensity-based imaging probes makes sensing more widely accessible, since 
it requires conventional steady state detectors such as those used in conventional 
fluorescence microscopy rather than a specialized instrumentation. However, as 
emission intensity is influenced by probe concentration, a reference probe that is 
insensitive to oxygen must be introduced to which the intensity of the probe can be 
ratioed, to give quantitative measurements. Of course the ratio of probe and reference 
must be constant.  The combination of an oxygen-sensitive probe with an insensitive 
reference probe results in a single excited, dual-emitting probe that can potentially be 
imaged to give ratio metrically determined intracellular oxygen imaging. These 
ratiometric methods allow for fluorescence-based intensity imaging. 
As expanded below, effective molecular ratiometric probes are difficult to accomplish 
so the majority of reported ratiometric probes are particle based such as dyes encased in 
polymer structures PEBBLES,16,17 and nanoparticles.13,18-20 The ideal properties of a 
ratiometric probe include: 1) good spectral separation between the fluorescence or 
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phosphorescence of probe and reference 2) only the phosphorescent probe exhibits 
oxygen quenching; 3) reverse energy transfer does not occur from the phosphor to the 
fluorophore, avoiding cross-talk between the two complexes; 4) electron transfer 
quenching does not occur between the fluorophore and the phosphor; 5) it is taken up 
sufficiently by cells.  
Single molecule probes are rare as it is difficult to design a single-excitation, dual-
emitting probe with no cross-talk between the two. The advantages of using molecular 
systems though is that the sensitivity and detection of the sensor can be adjusted based 
on the dye concentrations and permeability/targeting within the cell is easier. Particle 
encasement though offers protection from interfering quenchers when introduced to live 
cells. The group of Papkovsky et al have carried out extensive work on oxygen sensing 
using both nanomaterials and porphyrins. They recently reported on phosphorescent Pt-
porphyrins encased in a polyacrylate nanoparticle for oxygen sensing, shown in Figure 
4.1. The particles were successfully taken up by neural cells. Upon stimulation with 
Antimycin A, they were able to measure a change in oxygen concentration using 
PLIM.21 In a similar report they demonstrated ratiometric oxygen sensing based on 
phosphorescent quenching of Pt-porphyrins in neurospheres.22 A neurosphere is a cluster 
of neural stem cells which are used to study neural precursor cells in vitro. 
 
Figure 4.1 Structure of a Pt(II)-tetrakis(pentafluorophenyl)porphyrin (PtPFPP) polyacrylate 
nanoparticle.21 
 
Ratiometric probes based in the quenching of transition metal complexes by oxygen 
have been widely explored. 16,23-26 Real time monitoring of intracellular oxygen has been 
carried out using such probes as oxygen quenching in live cells is a reversible process.14 
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The long-lived phosphorescent emission increases the quenching efficiency of the 
probes. This has been discussed in more detail in Chapter 1. 
This chapter focuses on two approaches to ratiometric optical oxygen sensing. The first 
is a ratiometric, dual emitting molecule. It consists of a ruthenium probe sensitive to 
oxygen, and a BODIPY reference which is insensitive to oxygen. The second is a core-
shell poly(styrene) nanoparticle, where the reference BODIPY complex is located in the 
core of the structure, while the ruthenium oxygen probe is conjugated to the poly(L-
lysine) surface. Ruthenium’s long luminescent lifetime renders it environmentally 
sensitive to oxygen. Its oxygen sensitivity has been explored extensively as an oxygen 
sensing probe, which was discussed in Chapter 1.6,27 This along with its photostability 
and other optical properties described, makes ruthenium an excellent choice as the 
oxygen sensitive component for these ratiometric approaches. BODIPY was chosen as 
the reference probe as its short luminescent lifetime renders it insensitive to oxygen. 
BODIPY complexes possess high quantum yields which is ideal for cell imaging.  In the 
context of ratiometric sensing the sharp emission bands of the BODIPY are also useful 
in limiting overlap between probe and reference. However, the challenge of using 
BODIPYs alongside ruthenium for a ratiometric probe lies in the concentration ratio in 
which they are combined. Efforts must be made to ensure that the BODIPY (which 
usually have far greater quantum yields than ruthenium) does not outshine the ruthenium 
emission due to the difference in their quantum yields. Another challenge will be to 
avoid any cross talk between the two components. It is anticipated that any potential 
communication between the two probes will be limited in the core-shell nanoparticles 
as the BODIPY component is located in the poly-styrene core away from the ruthenium 
which is located at the shell.  The molecular dyad was carefully designed to address both 
these issues by using a bromoBODIPY with reduced emission intensity and ensuring no 
energy or electron transfer between each moiety was thermodynamically feasible.26 Both 
probes are assessed as quantitative optical oxygen sensing probes, generating calibration 
plots which can be translated to live cell imaging. 
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4.2 Materials and Methods 
4.2.1 Materials 
[Ru-(bpy-Ar-COOH)2-phen-Ar-BODIPY-Br2] complex was synthesised by Dr. Aaron 
martin (DCU) shown in Scheme 4.1. [Ru(bpy)2-phen-COOH]
+2 and BODIPY-Br2 
complexes for the core-shell particles were synthesised by Christopher S. Burke (DCU). 
The polystyrene core-shell particles and dye loading were synthesised and carried out 
by Dr. Jaco Jacobs (DCU), shown in Figure 4.14. 
All chemicals and solvents used in experimental procedures were purchased from Sigma 
Aldrich (Ireland). All solutions were made using deionised water, which was purified 
by a Milli-Q plus 18.5 Millipore purifying system. HeLa and CHO-K1 cells (ATCC) 
were used. Resazurin reagents were acquired from Promokine. Cell culture media, 
serum and penicillin / streptomycin were purchased from Sigma Aldrich. Cell culture 
flasks were purchased from Corning Incorporated. 
 
From here on in [Ru-(bpy-Ar-COOH)2-phen-Ar-BODIPY-Br2] will be called 
[Ru(bpy)2-phen-BODIPY-Br2] complex, and the core-shell particles will be called 
RuBODIPY particles for distinction.  
 
4.2.2 Spectroscopic Measurements  
The spectroscopic properties of [Ru(bpy)2-phen-BODIPY-Br2] and the RuBODIPY 
particles were assessed in aqueous PBS solution (pH 7.4) at room temperature. The UV-
vis spectra were obtained on a Jasco V-670 spectrophotometer. The steady state dual 
emission spectra were collected on a Varian Cary Eclipse fluorescence 
spectrophotometer with an excitation and emission slit width of 10 nm. The luminescent 
lifetimes of the ruthenium and BODIPY components were obtained using a time 
correlated single photon counting (TCSPC) PicoQuant system. The exciting laser for 
both components was 405 nm. 10,000 counts were collected for each lifetime 
measurement, and performed in triplicate. Lifetime decays were analysed using 
PicoQuant Nano Harp for the long lived ruthenium component, and Time Harp for the 
short lived BODIPY component. 
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4.2.3 Oxygen Calibration Studies 
To measure the oxygen sensitivity, [Ru(bpy)2-phen-BODIPY-Br2] complex was purged 
with nitrogen for 20 minutes and RuBODIPY particle solutions in PBS were purged 
with nitrogen for 10 minutes, both at room temperature. The oxygen concentration was 
measured using a PreSense Oxygen Probe. The particles were slowly re-aerated to give 
a range of oxygen concentrations (measured in μmol/L). The emission spectra and 
lifetimes were measured to construct an oxygen calibration curve for the molecular 
system and the particles. The emission spectra were collected using a Varian Cary 
Fluorimeter, with an excitation and emission slit width of 10 nm. The lifetimes were 
collected using time correlated single photon counting (TCSPC). 
 
4.2.4 RuBODIPY particle preparation for cell uptake 
Cetyltrimethylammonium bromide (CTAB) from Sigma Aldrich, was used to induce a 
cationic surface charge on the particles for cell uptake. A 0.1 mM CTAB solution in 
PBS was added to the particles in a 3:2 ratio CTAB: particles, resulting in a final 
concentration of 150 μM, and was left to sonicate overnight to ensure sufficient particle 
coating. 
 
4.2.5 Real-time confocal luminescent imaging 
 4.2.5.1 [Ru(bpy)2-phen-BODIPY-Br2] Complex 
 
CHO cells were seeded at 2.5 x 105 cells in 2 mL media on 35 mm glass-bottom culture 
dishes. Cells were grown for 24 h at 37 °C at 5 % CO2. The growth media was removed 
and 15 μM of [Ru(bpy)2-phen-BODIPY-Br2] complex in phenol red-free media was 
added and left to incubate for 24 h at 37 °C at 5 % CO2 in the dark. The dye/media 
solution was removed and the cells were washed with PBS supplemented with 1.1 mM 
MgCl2 and 0.9 mM CaCl2. Cells were imaged using a Zeiss LSM 510 Meta confocal 
microscope using a 63X oil immersion objective lens. A 458 nm argon ion laser was 
used to excite the complex. The BODIPY emission was collected using a band-pass 505-
550 nm filter. The ruthenium complex emission was collected using a long pass 560 nm 
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filter. The excitation/λ scan was carried out using a 458 nm argon ion laser and the 
emission was collected between 497 nm and 754 nm with a step size of 10 nm. 
 
 4.2.5.2 RuBODIPY particle uptake 
CHO and HeLa cells were seeded at 1.5 × 105 cells in 2 mL media on 35 mm glass-
bottom culture dishes. Cells were grown for 48 h at 37 °C at 5 % CO2. The growth media 
was removed, and replaced with 2 mL Lebovitz media for 2 h. 5 % v/v nanoparticles in 
Lebovitz media were added to the cells and incubated for 5 minutes in the absence of 
light at 37 °C and 5 % CO2. The nanoparticles/media solution was removed and replaced 
with Lebovitz media. Cells were left to incubate for 2, 4, and 6 h at 37 °C in the dark. 
Cells were washed twice with PBS supplemented with 1.1 mM MgCl2 and 0.9 mM 
CaCl2 and imaged immediately. Cells were imaged using a Leica TSP DMi8 confocal 
microscope, using a 100 X oil immersion objective lens. The nanoparticles were excited 
using a 470 nm white light laser. The BODIPY emission was collected using a band pass 
505-550 nm filter, and the ruthenium emission was collected using a long pass 605 nm 
filter. DRAQ 7 (Biostatus, UK), which stains the nucleus of dead cells, was added to the 
culture dish (1:100 final concentration) to monitor cell viability. DRAQ 7 was excited 
using a 633 nm white light laser and emission was collected using a long pass 650 nm 
filter.  
4.2.6 Phosphorescent lifetime imaging microscopy (PLIM) of RuBODIPY particles 
CHO cells were seeded at 1.5 x 105 cells in 2 mL media on 35 mm glass-bottom culture 
dishes. Cells were grown for 48 h at 37 °C at 5 % CO2. The growth media was removed, 
and replaced with 2 mL Lebovitz media for 2 h. 5 % v/v nanoparticles in Lebovitx media 
were added to CHO cells and incubated for 5 minutes in the absence of light at 37 °C 
and 5 % CO2. The nanoparticles/media solution was removed and replaced with 
Lebovitz media. Cells were left to incubate for 4 h at 37 °C in the dark. CHO cells were 
washed twice with PBS supplemented with 1.1 mM MgCl2 and 0.9 mM CaCl2. Live 
PLIM images were acquired using MicroTime System attached to a Leica TSP Dmi8 
confocal microscope using a 100X oil immersion objective. Each PLIM image was 
acquired for 20 minutes at 512 x 512 resolution. A 405 nm laser was used to excite the 
sample. The BODIPY emission was collected using a 515-580 nm band pass filter at 8 
ps resolution, and the [Ru(bpy)2-Phen-Ar-COOH]
2+ was collected using a 570-700 nm 
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band pass filter at 256 ps resolution. The data was analysed using the PicoQuant 
Symphotime Software. Lifetimes were fit to a mono exponential decay until an X2 value 
of 0.9-1.1 was achieved. The average lifetime was taken from 2 separate experiments. 
 
4.2.7 Cytotoxicity assay 
CHO cells were seeded in a 96-well plate in 100 μL media at 1 x 104 cells per well for 
24 h at 37 °C with 5 % CO2. For [Ru(bpy)2-phen-BODIPY-Br2], the complex was added 
to the cells to give final concentrations of 150, 100, 50, 15, 1, 0.1 µM. Cells were 
incubated for 24 h at 37 ºC at 5% CO2 in the absence of light. For RuBODIPY, the 
particles were added to give final concentrations of 1, 2, 5, 10, 25, and 50 % v/v in CHO 
media. The cells were incubated for 5 minutes. The particles were removed and replaced 
with CHO media and left to incubate in the absence of light for 24 h at 37 °C at 5 % 
CO2. In both cases, 10 μL of Resazurin (Alamar Blue) reagent was added to each well 
and incubated for a further 7 h in the absence of light at 37 °C. The resazurin was 
converted to resorufin in viable cells and its absorbance was measured at 570 nm, with 
background measured at 600 nm using a Tecan 96-plate reader. 
 
4.3 Photophysical properties and Characterisation of The Molecular 
System; [Ru(bpy)2-phen-BODIPY-Br2] 
Scheme 4.1 illustrates the structure of [Ru(bpy)2-phen-BODIPY-Br2]. The ruthenium 
centre has two bipyridine (bpy) ligands with phenyl carboxylic acids. The 
phenanthroline-BODIPY moiety is brominated at the 2 and 6 positions. 
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Scheme 4.1 Structure of [Ru(bpy)2-phen-BODIPY-Br2] complex.26 
 
Figure 4.2 shows the absorbance and emission spectra of [Ru(bpy)2-phen-BODIPY-Br2] 
in non-aqueous methanol solution (__), acetonitrile (__) and in aqueous PBS solution (__). 
In methanol the complex exhibits a shoulder at 466 nm which is attributed to the 
ruthenium moiety. A sharp, intense absorbance feature is observed at 526 nm, which is 
typical of BODIPY. The strong absorbance is due to the dipyrromethane based S0  S1 
π – π* transition.28 When excited into the absorbance shoulder at 458 nm, a dual-emission 
is observed, with an intense emission peak at 552 nm attributed to the BODIPY and a 
peak centred at 610 nm assigned to the ruthenium 1MLCT absorbance. However, 
interestingly, in aqueous solution, the BODIPY emission switches off. In PBS solution, 
the ruthenium absorbance appears to be slightly more intense than in non-aqueous 
solution, when measured at 50 μM. The excitation of the BODIPY absorbance peak at 
525 nm decreases by almost 50 %. When excited at 458 nm, the BODIPY emission 
disappears and the ruthenium, now centred at 623 nm, remains. 
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Figure 4.2 Absorbance and emission spectra of [Ru(bpy)2-phen-BODIPY-Br2] complex at 50 μM in 
methanol solution (__), acetonitrile solution (__) and aqueous PBS solution (__). The emission was 
collected by exciting at 458 nm, slit width 5nm. 
 
The emission of [Ru(bpy)2-phen-BODIPY-Br2] was also assessed in the aprotic solvent 
acetonitrile, to compare to the emission spectra of [Ru(bpy)2-phen-BODIPY-Br2] with  
the protic solvent methanol. As shown in Figure 4.2, the relative luminescent emission 
intensity between the ruthenium and BODIPY is slightly greater when in methanol (__) 
solution compared to acetonitrile (__), but importantly both units of the dyad remain 
emissive in both acetonitrile and methanol To assess if this switch was reversible and 
due to environmental sensitivity and not a chemical reaction such as decomposition, a 
solution of [Ru(bpy)2-phen-BODIPY-Br2] was made up in methanol and its emission 
was recorded (—), as described in Figure 4.3.  
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Figure 4.3 Normalised emission intensity of [Ru(bpy)2-phen-BODIPY-Br2] illustrating the initial 
dual emission in methanol (—), the switching off of the BODIPY moiety in water (—), and its 
recovery upon changing back to methanol (—). 
 
Water was added and the emission spectrum showed no contribution from the BODIPY 
as expected (—). 100 μL of the aqueous solution was remixed with methanol, and the 
BODIPY emission was recovered (—). The intensity of the recovered spectrum is lower 
in Figure 4.3 because of this dilution. This water sensitivity was rather unexpected, 
particularly given that the BODIPY emits in methanol, which is a protic solvent.  
Subsequent work in our lab on the isolated BODIPY has shown that it is this component 
alone that is water sensitive and work is ongoing to understand the origin of the 
switching mechanism (to be published). However in the context of imaging it may be 
useful as recovery of the BODIPY can be used as a ‘switch’ reference complex for 
imaging non-aqueous environments. The shift in the emission spectra of [Ru(bpy)2-
phen-BODIPY-Br2] when introduced to water is attributed to the influence of solvent as 
some methanol solution still present. 
The emission lifetimes of the two components of the complex were measured in 
methanol, acetonitrile, and PBS using time correlated single photon counting (TCSPC), 
as outlined in Table 4.1. 
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Table 4.1 Luminescent spectra of [Ru(bpy)2-phen-BODIPY-Br2] in PBS a, methanol b, and 
acetonitrile c solution. Solutions were degassed with nitrogen for 15 minutes before reading the de-
aerated values. Emissions were collected when excited at 458 nm, slit width = 10 nm. (Amp = 
amplitude) 
 
Compound λ
abs
/λ
ex  
(nm) 
λ
em
 
(nm) 
τ
f
/ns 
aerated 
Ampaer 
 (%) 
τ
f
/ns 
de-aerated 
Ampde-aer 
(%) 
Ru(II) 
 
 
 
BODIPY 
468  a 
466  b 
466  c 
 
525  a 
526  b 
526  c 
623  a 
610  b 
617  c 
 
_____  a 
552  b 
548  c 
587 ± 13 a   
306 ± 28 b 
131 ± 13  c 
 
     _____  a 
24 ± 2  b 
1.14 ± 0.15 c 
 
 
100  
40.81 b 
 
 
 _____  a 
59.19 b 
 
 
1.08 μs ± 15 a 
825 ± 28 b  
319 ± 31 c 
 
     _____  a 
24 ± 2 b 
1.22 μs ± 0.12 c 
100  a 
33.2  b 
 
 
   _____  a 
66.8  b 
 
 
 
The lifetime data, collected by TCSPC, gave best fit in organic solvent and the particle 
to a dual exponential decay which allowed for identification of the lifetime of each 
component in the dyad. The molecular complex, in methanol or PBS, were purged with 
nitrogen for 15 minutes prior to measurement to obtain the de-aerated lifetime. 
Consistent with the emission spectra, in methanol, the lifetime fit a bi-exponential decay, 
while in PBS it fit to only a single exponential decay which corresponded to the lifetime 
of the ruthenium moiety. As expected, ruthenium displayed excellent oxygen sensitivity. 
When fully de-aerated, the lifetime of the ruthenium component increased from 306 ± 
28 ns to 825 ± 28 ns in methanol, and from 587 ± 23 ns to 1.082 μs ± 15 ns in PBS. 
However, the ruthenium component exhibits a much shorter lifetime of 131 ± 13 ns 
when in aerated acetonitrile, which increased to 319 ± 31 ns when de-aerated. 
Acetonitrile is more polar. In multi-exponential lifetime decays, the lifetimes are 
extracted from the decay, as well the fractional amplitudes of each lifetime component. 
The amplitude is given as % value. The amplitude of the ruthenium and BODIPY 
components in methanol solution are shown in Table 4.1. When in aerated methanol 
173 
 
solution, the fractional amplitudes contributing to the lifetime of [Ru(bpy)2-phen-
BODIPY-Br2] are almost equal, with ruthenium amplitude slightly smaller. When de-
aerated, the fractional amplitude of ruthenium decreases further, making up only a third 
of the overall lifetime consistent with the reduction in emission intensity observed. The 
longer lifetime in PBS is surprising but consistent with intensity studies of other related 
complexes where ruthenium emission is more intense in water.29 On the other hand, the 
BODIPY showed no change in intensity or lifetime in response to oxygen concentration. 
Its relatively short lifetime renders the BODIPY component insensitive to oxygen, 
making it an ideal reference probe in and oxygen ratiometric sensor. Figure 4.4 shows 
an example of the emission lifetime decays of [Ru(bpy)2-phen-BODIPY-Br2] in 
methanol when aerated (A) and de-aerated (B). In both cases, τ1 is attributed to the 
ruthenium lifetime contribution, and τ2 to the BODIPY. 
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Figure 4.4 TCSPC emission lifetime traces of [Ru(bpy)2-phen-BODIPY-Br2]  under aerated (A) and 
de-aerated (B) condiotions in methanol. [Ru(bpy)2-phen-BODIPY-Br2] was de-aerated for 15 
minutes with nitrogen. The complex was excited using the 450 nm laser, and the data was acquired 
using the PicoQuant Nano Harp system. The lifetime traces (___) were fit to give a χ2 value between 
0.9 and 1.1 and visual inspection of residuals (•) also confirmed goodness of fit. 
 
4.4 [Ru(bpy)2-phen-BODIPY-Br2] oxygen dependent studies  
The luminescent lifetime and emission intensity data indicated that [Ru(bpy)2-phen-
BODIPY-Br2] displays excellent response to oxygen concentration and this was 
investigated further as an oxygen sensing probe. The initial emission and lifetime of the 
probe in methanol were recorded as a function of oxygen concentration. When aerated, 
the maximum oxygen concentration in the solution was determined to be 256 μmol/L, 
measured using a commercial optical sensor – Presens O2 probe. The complex was 
purged for 15 minutes, and the emission and lifetime recorded. The minimum dissolved 
oxygen concentration following de-aeration was found to be 30 μmol/L. The emission 
of the BODIPY remained unaffected by oxygen concentration, whereas the ruthenium 
emission increased by 50 %, as demonstrated by the emission profile in Figure 4.5. 
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Figure 4.5 Luminescent emission spectra of [Ru(bpy)2-phen-BODIPY-Br2] in methanol as a 
function of oxygen concentration (50 μM, 18 °C). The complex was excited at 458 nm, slit width 5 
nm. 
 
Oxygen was gradually reintroduced to the solution by allowing it to re-aerate through 
slow re-equilibration with ambient air, and the emission and lifetimes were measured at 
varying oxygen concentrations over time as the oxygen concentration recovered. The 
resulting spectra are shown in Figure 4.5. Over the course of re-aeration, the BODIPY 
emission profile remained constant throughout, and its lifetimes were unaffected. 
However, the emission from the ruthenium centre decreased linearly with increasing 
oxygen concentration, and this behaviour was mirrored in the lifetime data.  
  
To obtain quantitative insights into O2 quenching, the lifetime as a function of oxygen 
was plotted using the Stern-Volmer equation shown in Equation 4.1: 
 
𝐼0
𝐼
=
τ0
𝜏
= 1 + 𝐾𝑆𝑉  . [𝑂2]     ……… Equation 4.1 
 
Figure 4.6 describes the Stern Volmer plots of the luminescent lifetime (___), and 
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relationship between the lifetime and oxygen concentration is linear, suggesting, as 
expected, that there is only one type of quenching occurring, dynamic quenching.  
 
 
Figure 4.6 Stern-Volmer plot of [Ru(bpy)2-phen-BODIPY-Br2] luminescent lifetime (___) and 
luminescent emission intensity (___) as a function of oxygen concentration in methanol (25 μM) at 18 
°C. The complex was excited at 450 nm over a range of oxygen concentrations. Calibration 
ratiometric plot intensities of the BODIPY and ruthenium centred emissions as a function of oxygen 
concentration in methanol (___). The complex was excited at 458 nm and the ratio of the two emission 
centres was plot. 
 
The Stern-Volmer constant, Ksv, can be obtained from the slope of the plot in Figure 4.6 
(__), in this case Ksv = 0.0078. The rate of quenching, kq, for [Ru(bpy)2-phen-BODIPY-
Br2] in methanol can be determined using Equation 4.2: 
 
KSV = kq. τ0 … Equation 4.2 
 
Where kq is the quenching rate, KSV is the slope of the Stern Volmer plot, and τ0 is the 
luminescent lifetime in the absence of oxygen. In methanol solution, [Ru(bpy)2-phen-
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BODIPY-Br2] has a quenching rate, kq, of 9.45 x 10
9 M-1 s-1. Figure 4.6 also shows the 
ratiometric luminescence response of the BODIPY and ruthenium centred emissions as 
a function of oxygen concentration in methanol (__).  
The probes response to oxygen in PBS was then explored under the same conditions. 
Figure 4.7 shows the emission intensities of the complex over a range of oxygen 
concentrations, with the Stern Volmer plot of τ0/τ versus oxygen concentration in the 
inset (•). 
 
 
  
Figure 4.7 Luminescent emission spectra of [Ru(bpy)2-phen-BODIPY-Br2] in PBS solution (25 μM) 
as a function of oxygen concentration. The corresponding Stern Volmer plot of the luminescent 
lifetimes (___) and emission intensity (___) over the range of oxygen concentrations. The complex was 
excited at 458 nm, slit width 5 nm. 
 
Here, it was observed that the BODIPY component has switched off, while the 
ruthenium emission displayed a similar, linear response to oxygen, unaffected in 
aqueous solution. The rate of quenching for [Ru(bpy)2-phen-BODIPY-Br2] PBS was 
determined to be 2.87 x 109 M-1 s-1, which is slightly slower than when it is methanol 
solution, which was measured to be kq, of 9.45 x 10
9 M-1 s-1. This is as a result of the 
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longer luminescent lifetime of ruthenium in aqueous solution. Demas et al obtained a 
quenching rate of 3.2 x 109 M-1 s-1 for [Ru(bpy)3]
2+ in water.30 Pellegrin et al reported 
on a Ru(II) polypyridyl complex with a kq value of 6.7 x 10
9 M-1 s-1 in water, which is 
of the same order, but slightly faster as the luminescent lifetime of their complex was 
much longer at 973 ± 3 ns compared to 587 ± 13 ns in PBS for our [Ru(bpy)2-phen-
BODIPY-Br2] complex.
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4.5 Introduction of [Ru(bpy)2-phen-BODIPY-Br2] to cells 
As demonstrated in section 4.4, [Ru(bpy)2-phen-BODIPY-Br2] showed promising self-
referenced oxygen sensing capabilities in non-aqueous solution. Although the BODIPY 
reference switches off in aqueous solution, this could be used as a contrast reference for 
imaging non-aqueous regions in a cell, for example, lipid membranes. 
In order to explore the uptake, distribution and sensing abilities in cells, Chinese hamster 
ovarian (CHO) cells, an adherent mammalian cell line, were used. CHO cells were 
seeded at 2.5 x 105 cells in 2 mL culture media on 35 mm glass-bottom culture dishes, 
and were grown for 24 h at 37 °C with 5 % CO2.  
All images were acquired using a Zeiss LSM 510 confocal microscope with a 63 x oil 
immersion objective lens. A 458 nm argon ion laser was used to excite the complex. The 
BODIPY emission was collected using a band-pass 505 – 550 nm filter. The ruthenium 
emission was collected using a long pass 560 nm filter. 
 
4.5.1 Cell Uptake of [Ru(bpy)2-phen-BODIPY-Br2] 
A range of working concentrations and incubation times were assessed. 1 % DMSO was 
used to solubilise the complex and concentrations were made up in PBS. Initially, uptake 
dynamics were studied using 15 μM of [Ru(bpy)2-phen-BODIPY-Br2] in cell media and 
was added to live CHO cells where its uptake was monitored. Uptake was initially slow, 
with emission seen in some cells after 10 minutes exposure, shown in Figure 4.8 A. The 
cells were imaged every 5 minutes. After 15 minutes the complex has appeared to have 
crossed the membrane of all the cells (B), and dispersed throughout the cytoplasm by 25 
minutes (C), with a plateau observed in uptake after 35 minutes (D). 
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Figure 4.8 Confocal microscopy of the live uptake of [Ru(bpy)2-phen-BODIPY-Br2] in CHO cells. 
15 μM in cell culture media was added to CHO cells and uptake was observed after 10 minutes (A). 
Uptake was monitored at 15 (B), 25 (C), and 35 minutes (D). The sample was excited using a 458 
nm argon laser. The BOPDIPY emission was collected using a 505-550 nm band-pass filter, and the 
ruthenium emission was collected using a long pass 560 nm filter. 
 
To study distribution following uptake, the cells were incubated with [Ru(bpy)2-phen-
BODIPY-Br2] (15 μM) for 24 h in the absence of light at 37 °C with 5 % CO2. The 
solution was removed and the cells were washed with PBS supplemented with 0.9 mM 
CaCl2 and 1.1 mM MgCl2. Figure 4.9 shows representative images of the probe in CHO 
cells. 
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Figure 4.9 Live CHO cells incubated with 15 μM [Ru(bpy)2-phen-BODIPY-Br2] complex for 24 h 
in the absence of light. Distribution can be seen in the cytoplasm (A) and in the nucleoli (B) of CHO 
cells. The sample was excited using a 458 nm argon laser. The BOPDIPY emission was collected 
using a 505-550 nm band-pass filter, and the ruthenium emission was collected using a long pass 560 
nm filter. 
 
As shown in the images, uptake is excellent with high contrast images achieved at low 
concentrations. [Ru(bpy)2-phen-BODIPY-Br2] permeated the cell membrane and 
appeared to be essentially non-selective in its localisation, distributing throughout the 
cytoplasm, although it also appears to permeate the nuclear envelope with evidence for 
localization of the probe in the nucleoli. Barton et al reported on a 
[Ru(phen)(bpy’)(dppz)]2+ complex conjugated to an octa-arginine sequence (Ru-D-R8), 
and to an octa-arginine-fluorescein sequence (Ru-D-R8-fluor). When incubated with 
Ru-D-R8, the complex localised in the cytoplasm of HeLa cells. However, it was found 
that Ru-D-R8-fluor located in the nucleoli of the cells. The greater lipophilicity of the 
fluorescein redirected the complex to the nucleus. The BODIPY, which is lipophilic, 
may be exerting the same influence here.31 The concentration of 15 μM was determined 
to be ideal for imaging [Ru(bpy)2-phen-BODIPY-Br2], given the good images at 
relatively low concentrations, and low cytotoxicity. Working concentrations of 50 μM 
and greater appeared to be toxic towards the cells, demonstrated in Figure 4.10. Large 
vacuoles can be seen throughout the sample, which are indicative of apoptosis occurring 
at higher dye concentrations. 
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Figure 4.10 Live CHO cells incubated with 50 μM [Ru(bpy)2-phen-BODIPY-Br2] for 24 h in the 
absence of light. Large vacuoles that have formed in the cells are indicative of apoptosis. The sample 
was excited using a 458 nm argon laser. The BOPDIPY emission was collected using a 505-550 nm 
band-pass filter, and the ruthenium emission was collected using a long pass 560 nm filter. 
 
When incubated with the optimum concentration of 15 μM of [Ru(bpy)2-phen-BODIPY-
Br2] the complex displayed strong luminescence from within the cell when excited at 
458 nm. To determine if the BODPIY emission was present, an excitation scan was 
carried using the 458 nm argon laser line, and the emission was collected between 497 
and 754 nm with a step size of 10 nm. Figure 4.11 A shows the results of the excitation 
scan. There is no emission seen in the range of 524 – 566 nm where the BODPIY would 
be expected to be. A slight emission can be seen in these windows, but it is attributed to 
contributions from the auto fluorescence of the cell.  
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Figure 4.11 Excitation scan of [Ru(bpy)2-phen-BODIPY-Br2] (15 μM) in a live CHO cell. Complex 
was excited at 458 nm and the emission was collected between 497-754 nm at 10 nm slit widths (A). 
Selected regions of interest (ROIs) were analysed further (B and C) to give an emission plot profile 
(D), demonstrating no BODIPY emission in the cell compared to when in aerated methanol solution. 
(Scale bars = 5 μM) 
 
A range of regions of interest (ROIs) were selected and analysed to obtain a profile of 
the emission wavelengths present in different parts of the cell (Figure 4.11 B and C) and 
compared to the complex in aerated methanol. As demonstrated by the plot in Figure 
4.11 D, there appears to be very little contribution from the BODIPY emission and 
certainly what is evident is below the calibration range used for referenced O2 detection,. 
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The BODIPY emission intensity is greatest in ROI 5, which represents the nucleolus. It 
was measured to be 52.4 a.u. However, the ruthenium intensity is several orders of 
magnitude greater at 1212.6 a.u. Therefore, although there is some contribution 
measured from the emission of the BODIPY, it is too small compared to the ruthenium 
intensity to give accurate ratiometric measurements from within the cell compared to 
when in aerated methanol solution. We can therefore conclude that the complex is 
primarily in aqueous locations within the cell, and has not appeared to bind to a target. 
 On the other hand, the ruthenium emission intensity fluctuates depending on where it is 
located in the cell, which can be attributed to variations oxygen concentrations and the 
cellular environment. ROI 2 and 6 show the highest emission intensities, while the 
nuclear region represented by ROI 1 displays a lower emission intensity. ROI 3 
represents the general cytoplasmic region of the cell, where ROI 4 represents the cell as 
a whole. Each ROI exhibits emission from the ruthenium moiety, but not from the 
BODIPY.  
 
4.5.2 [Ru(bpy)2-phen-BODIPY-Br2] localisation studies 
To determine more precisely where [Ru(bpy)2-phen-BODIPY-Br2] localised within the 
cells, CHO cells were prepared with 15 μM for 24 h. Before imaging, DiOC6, a 
commercial probe that emits in the green at 501 nm and stains the endoplasmic reticulum 
(ER), was introduced to the cells. 5 μM was added to the cell media and this was left at 
room temperature for 20 minutes. The solution was removed and the cells were washed 
with supplemented PBS. Figure 4.12 shows representative images of CHO cells 
incubated with [Ru(bpy)2-phen-BODIPY-Br2] represented in red (A), DiOC6 
represented in green (B), and their co-localisation represented in yellow (C).  
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Figure 4.12 Co-localisation of [Ru(bpy)2-phen-BODIPY-Br2] (15 μM) in live CHO cells. The cells 
were incubated with the complex for 24 h, and DiOC6 was added for 30 minutes at 5 μM. [Ru(bpy)2-
phen-BODIPY-Br2] represented in red (A), DiOC6 in green (B), and their co-localisation in yellow 
(C). [Ru(bpy)2-phen-BODIPY-Br2] was excited at 458 nm and emission was collected using a long 
pass 560 nm filter. DiOC6 was excited at 488 nm and the emission was collected using a band pass 
505 – 530 nm filter. 
 
To confirm that the complexes are coincident in the ER, an X-Y cross section of a single 
CHO cell and its corresponding fluorescent intensity profile was examined (Figure 
4.13). This confirms that they are both localising within the same cellular components. 
However, [Ru(bpy)2-phen-BODIPY-Br2] appears to be non-selective in entering the ER 
alone as it can be seen throughout the cytoplasm as described earlier was shown to enter 
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the nucleoli too. Localisation in the ER suggests that uptake was by endocytosis. 
However further studies would have to be carried out to establish more conclusively the 
mechanism of uptake. 
 
 
Figure 4.13 Co-localisation of [Ru(bpy)2-phen-BODIPY-Br2] (15 μM, 24 h) and DiOC6 (5 μM, 30 
minutes) in a live CHO cell, and its corresponding X-Y plot of intensity demonstrating their co-
localisation. [Ru(bpy)2-phen-BODIPY-Br2] was excited at 458 nm and emission was collected using 
a long pass 560 nm filter. DiOC6 was excited at 488 nm and the emission was collected using a band 
pass 505 – 530 nm filter. 
 
 
4.6 Cytotoxicity  
The effect of [Ru(bpy)2-phen-BODIPY-Br2] on cell viability was determined in CHO 
cells, using the Alamar Blue (Resazurin) cytotoxicity assay, as explained in section 
4.2.7. Figure 4.14 outlines the results of the assay. Remarkably, the probe proved to be 
highly toxic towards the cells 
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Figure 4.14 Cell viability studies of [Ru(bpy)2-phen-BODIPY-Br2] in live CHO cells. Cells were 
incubated with the complex in the absence of light for 24 h. Viability was measured using the 
Resazurin (Alamar Blue) assay. (n = 3)  
 
At concentrations greater than 50 μM, there were no viable cells remaining (0 ± 1.5 %) 
after 24 hours. At the working concentration of 15 μM, 75.2 ± 3.8 % of CHO cells were 
viable after 24 h exposure, while still giving excellent luminescence for cell imaging as 
demonstrated previously in section 4.5. For comparison with another O2 sensing 
compound, Papkovsky et al reported on a platinum-porphyrin, PtCP-NH2, for 
intracellular oxygen sensing. Following 24 h exposure to the complex, 95 – 100 % of 
cells remained viable. Although this complex demonstrated virtually no toxic effects on 
the cells, it was not readily taken up without the use of reagents.32  The superior uptake 
of [Ru(bpy)2-phen-BODIPY-Br2]  may be related to the relative lipophilicity of this 
compound, but this lipophilicity may also contribute to cytotoxicity.  
It has been demonstrated previously that the ligand combination ‘bpy-phen’ is highly 
toxic towards cells at high concentrations.6 From the work carried out in Chapters 2 and 
3, it is likely to be the phenanthroline ligand causing the high toxic affect towards the 
cells, as a ‘bpy-pic’ ligand combination described in Chapter 2 was not toxic towards 
CHO cells, and BODIPY complexes alone have demonstrated low toxic effects towards 
cells.33,34 Chen et al reported on a bis-methoxyphenyl-BODIPY fluorescent probe for 
nitric oxide detection. The complex was introduced to macrophages for 24 h, and the 
viability was assessed using the MTT assay. The MTT assay is a reduction reaction by 
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viable cells. Following 24 h incubation with the probe, 55 % of cells remained viable at 
100 μM of the complex.35 Zhang et al reported on similar results where by 84 % of cells 
remained viable at concentrations as high as 100 μM of their BODIPY fluorescent 
probe.33 
The [Ru(bpy)2-phen-BODIPY-Br2] dual emitting dyad discussed in the first half of this 
chapter has shown excellent, reversible oxygen sensing abilities in non-aqueous 
solution. It was readily taken up by CHO cells with a bright emission from the ruthenium 
moiety at low concentrations of 15 μM from inside the cytoplasm and nucleoli. Although 
the BODIPY emission switches off in aqueous solutions, this ratiometric oxygen probe 
would be ideal in imaging non-aqueous environments such as the lipid bilayer. 
 
4.7 Core-shell RuBODIPY particles 
In section 4.4 it was demonstrated that the combination of oxygen-sensitive ruthenium 
and oxygen-insensitive BODIPY in non-aqueous solution displayed excellent oxygen 
sensing capabilities. However, the switching off of the BODIPY moiety means that it 
can only be used as an oxygen sensor in non-aqueous solutions, or as a reference for 
imaging non-aqueous environments, although alone it may ultimately prove to be a 
useful membrane sensor. To avoid this switching off effect and any cross talk between 
the oxygen sensor ruthenium and the BODIPY reference, the complexes were 
introduced in to a novel core shell structure. It was anticipated that this would allow 
oxygen sensing in aqueous environments. Furthermore, it was hoped that by introducing 
the complexes to a particle that the toxicity would be reduced.  Figure 4.15 describes the 
structure of the poly(styrene) core shell particle. The poly(styrene) core particles were 
synthesised via a mini-emulsion polymerization by Dr. Jaco Jacobs. 36 The BODIPY 
moiety, which is composed of oxygen insensitive phen-Ar-BODIPY-Br2 complex, is 
encased in the poly(styrene) core to protect it from an aqueous environment and avoid 
switching off. It also limits any cross talk with the oxygen sensitive probe. It is hoped 
that the encasement in a poly(styrene) core will avoid any leaching from the particle, 
which will give accurate ratiometric measurements in vivo. The oxygen sensor, 
composed of [Ru-(bpy)2-phen-Ar-COOH], is conjugated to a poly(L-lysine) shell 
surface. 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochloride (EDC)/N-
hydroxysuccinimide (NHS) coupling chemistry was employed to attach [Ru-(bpy)2-
phen-Ar-COOH] to the lysine residues. The carboxylate (COO-) of [Ru-(bpy)2-phen-
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Ar-COOH], with NHS, in the presence of EDC, forms a semi-stable NHS active ester 
which can then bind with the NH2 of the lysine residue. This forms an amide crosslink 
between the [Ru-(bpy)2-phen-Ar-COOH] and the lysine residues. Selective deprotection 
of the triblock ensured that the Ru (II) complex would be situated at the outer periphery 
of the formed NPs.  This allows the ruthenium to access environmental oxygen for 
optimum sensing, and avoids contact with the reference probe in the core.  
 
 
Figure 4.15 Poly(styrene) core shell nano particle. The BODIPY moiety is encased in the 
poly(styrene) core while the ruthenium component [Ru-(bpy)2-phen-Ar-COOH] is bound to the 
poly(l-lysine) shell. The particle was measured to be 105 nm in diameter with a PDI = 0.08. 
 
The advantages of choosing poly(styrene) for the core shell particles is that they have 
been shown to be stable over long periods and their relatively low porosity reduces 
leaching of materials contained within which is idea for in vivo cell imaging.37  
Poly(styrene) (PS) has good optical properties, and is permeable to oxygen, allowing the 
probe access to dissolved oxygen.38 Polymerization of styrene allows for the size of the 
particle to be adjusted during the process, and the resulting particles can be readily 
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prepared with high monodispersity. Surface charge and chemical modifications can be 
altered to improve live cell uptake.36,39 In this case, the surface of the PS core was 
functionalised with a poly(L-lysine) shell. Lysine is a positively charged amino acid. As 
discussed in Chapter 1, peptide sequences that are rich in lysine residues are more likely 
to cross the cell membrane which is negatively charged. The size of the nanoparticles, 
the PS core and poly(L-lysine) shell, were measured by DLS to be an average of 105 
nm.40 It is hoped that the hydrophobic nature of PS nanoparticles will prevent any dye 
leakage. The polydispersity index (PDI) of the particles measures the width of the 
polymer molecular weight distribution.41 The ideal PDI value is less than 0.2. In this 
case, the RuBODIPY particles have a PDI = 0.08.40  
The core-shell particles were made by Dr. Jaco Jacobs from the group of Dr. Andreas 
Heise, DCU. The dyes were prepared by Christopher Burke (DCU). The encasement of 
the BODIPY and ruthenium conjugation, and the loading concentrations were varied in 
a number of particle batches in order to give optimum ratio emission intensities. The 
photophysical properties of these batches were then investigated, and the batch that gave 
optimum response to oxygen was then studied in depth described herein.  
 
4.8 Photophysical properties of the RuBODIPY particles  
The relative loading of the two chromophores was varied between batches by varying 
the amount of BODIPY in the core in order to achieve optimum relative luminescent 
emission intensities of probe and reference the particles chromophores. As BODIPY 
complexes have a much higher quantum yield than ruthenium complexes, it was 
important to ensure that the BODIPY emission intensity did not swamp the ruthenium 
emission intensity signals upon dual excitation. The emission profiles and response to 
oxygen concentration were analysed in PBS solution (pH 7.4) at 18 °C. Figure 4.16 
shows the emission profile of the particles made in Batch 1. The PS core encapsulating 
the BODIPY in Batch 1 was synthesised using emulsion polymerization. The ratio of 
intensity between the emissions of two complexes was good. The ruthenium exhibited 
high emission intensity without being swamped by the high BODIPY emission signal. 
However, upon de-aeration with nitrogen for 15 minutes, the magnitude of the changes 
in intensities was comparatively small, and the BODIPY signal was found to decrease 
with decreasing oxygen concentration. This is not ideal as the BODPIY is the reference 
probe and should exhibit no emission intensity changes in response to changing oxygen. 
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The emission recovery over a range of oxygen concentrations shown in Figure 4.16 
found that the BODIPY stabilised and the ruthenium decreased with increasing oxygen 
concentration. However, the oxygen stability and calibration of this batch was non-
linear, so these particles could not be used as a reliable oxygen sensing probe. The reason 
for this behaviour is believed to be poor stability of the polystyrene core due to high 
porosity which lead to leaching of the reference over time. 
A 
 
B 
 
Figure 4.16 Emission spectra of Batch 1 when excited at 458 nm in aerated (—) and deaerated (---) 
aqueous PBS solution. O2 concentration dependent calibration data from RuBODIPY particles in 
PBS solution (pH 7.4). Particles were purged for with N2 for 10 minutes and allowed to slowly re-
aerate, measuring the emission spectra at varying oxygen concentrations (μmol/L) using a PreSens 
Oxygen probe. 
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Figure A4.2 in the appendix illustrates the oxygen dependence profile of Batch 1 after 1 
month of storage in the dark. Again, the oxygen profile was found to be non-linear, and 
the emission profile of the BODIPY reference did not remain constant, further evidence 
that reference leaching had occurred over time.  
The structure of the particle composition was re-examined. In this case, mini-emulsion 
polymerization was used, which meant that the BODIPY was encapsulated chemically 
during synthesis rather than diffused into the PS sphere which was the case for Batch 1. 
The core of the particle was  reinforced for Batch 2 and 3 by increasing cross-linking in 
the core to ensuring no leaching of the BODIPY could occur improving stability of the 
dye loaded particle.40 Figure 4.17 shows the emission profile of Batch 2 when aerated 
and de-aerated. In the case of Batch 2, the ruthenium emission intensity did not increase 
by much upon de-aeration, suggesting that this would not give a wide range of oxygen 
sensing. Comparing this to Batch 3 in Figure 4.18, the ruthenium gave a bigger range 
for oxygen sensing, while the BODIPY emission remained sufficiently intense to allow 
for ratiometric referencing without surpassing the ruthenium. The profiles of each batch 
varies due to variation in the ratio of the concentration of the chromophores in the 
particles. Oxygen dependence studies indicated that the ruthenium–BODIPY ratio in 
Batch 3 gave optimum referenced oxygen sensitivity while the BODIPY signal was 
highly stable. The final ratio of BODIPY: Ru of Batch 3 is 1:125. Batch 3, known as 
RuBODIPY particles from here on, were examined in more detail as a ratiometric 
oxygen sensing probe as this composition and synthetic method gave the best stability 
and most reproducible analytical response.  
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Figure 4.17 Luminescent emission spectra of Batch 2 when excited at 458 nm in aerated (—) and 
deaerated (---) aqueous PBS solution. Slit width = 10 nm. 
 
As demonstrated previously in section 4.4, the BODIPY reference of the dyad 
[Ru(bpy)2-phen-BODIPY-Br2] switched off in aqueous solutions and aqueous 
environments of the cell. Although this can be used in imaging and sensing in lipid 
membranes and non-aqueous environments, now as part of a core-shell it can ultimately 
be used as a reference probe in aqueous solutions as isolating the BODPY in the PS core 
prevents its quenching in aqueous media. 
Figure 4.18 illustrates the excitation and emission profiles of the RuBODIPY particles 
in PBS solution. The excitation spectra showed two peaks at 460 nm and 510 nm, 
corresponding to the ruthenium and BODIPY moieties respectively. When excited at 
458 nm in aqueous media the particles exhibited dual emission with peak maxima 
observed at 547 nm attributed to the BODIPY and at 601 nm for the ruthenium centred 
emission. 
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Figure 4.18 Excitation (—) and emission spectra of RuBODIPY particles when aerated (—) and 
deaerated (---) in PBS solution. Solution was degassed with nitrogen for 10 minutes. The complex 
was excited at 458 nm at a slit width of 10 nm. 
 
The lifetimes of the two components were measured using TCSPC in PBS solution (pH 
7.4). The data was fit to a bi-exponential decay. The BODIPY lifetime was recorded to 
be 4.45 ± 0.3 ns (12.8 % amplitude) and the ruthenium lifetime was found to be 836 ± 
12 ns (87.2 % amplitude). The lifetime for the ruthenium component is relatively higher 
than previously reported for the [Ru-(bpy)2-phen-Ar-COOH] complex (698 ± 6 ns). This 
is likely attributed to the influence of the poly(L-lysine) coating to which the ruthenium 
is conjugated on the shell of the particle. Increased emission intensity has been reported 
before for ruthenium complexes on conjugation to protein for example on BSA binding 
reported by Vos et al.42 
 
4.9 Oxygen calibration of RuBODIPY particles 
The luminescent emission and lifetime of the RuBODIPY particles as a function of 
oxygen concentration were investigated to assess their suitability for oxygen sensing. 
Under air saturated conditions, the oxygen concentration in PBS solution was found to 
be 268 μmol/L using a PreSens fibre optic oxygen probe. The luminescent emission 
intensity and lifetime of the probe was measured under these conditions and the sample 
was de-aerated under nitrogen for 10 minutes. The emission intensity at 8 μmol/L of 
oxygen was recorded, and the ruthenium emission was observed to increase while the 
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BODIPY remained unaffected. The lifetime of the ruthenium component increased from 
836 ns to 1.064 μs. The solution was gradually re-aerated over time and the spectra were 
measured over a range of oxygen concentrations. Figure 4.19 A illustrates the gradual 
decrease in emission with increasing oxygen concentration of the ruthenium centre with 
concomitant stability of the BODIPY emission signal. Figure 4.19 B demonstrates the 
luminescent lifetime plots of BODIPY and ruthenium as a function of oxygen 
concentration. Importantly, the BODIPY lifetime did not change while the ruthenium 
lifetime decreased with increasing oxygen concentration. Both the emission and 
lifetimes show a linear correlation with oxygen, and the response was reversible. The 
luminescent emission intensity in (A) returned to its original value when the oxygen 
concentration returned to saturation again, showing that the response to oxygen is 
reversible and this observation also confirms the stability of the BODOPY/PS core to 
leaching or other degradation.  
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Figure 4.19 RuBODIPY response to oxygen concentrations. Oxygen dependent emission spectra in 
PBS at 18 °C (A), n = 2. The ruthenium emission centre decreases with increasing [O2] whilst the 
BODIPY is unaffected. Oxygen dependent lifetime plot under the same conditions (B) illustrates that 
the ruthenium lifetime (—) decreased with increasing [O2] and the BODIPY lifetime (—) remained 
constant (n = 2). 
 
The luminescent emission and lifetime data were plotted according to the Stern-Volmer 
equation (equation 4.1) to measure oxygen as a function of lifetime (τ) and emission 
intensity (I) described in Figure 4.20. 
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Figure 4.20 Stern-Volmer plot of ruthenium luminescent lifetime as a function of [O2] (•). Stern-
Volmer plot of emission intensity as a function of [O2] (•). Oxygen studies were carried out in PBS 
buffer solution (pH 7.4) at 18 °C. (n=2).  
 
The Stern-Volmer constant, KSV, can be obtained from the slope of each plot, and 
determines the limit of detection of a sensor. In this case, KSV for A and B are the same, 
suggesting that the oxygen response is due to dynamic quenching, which is typical for 
that of oxygen and transition metal complexes such as ruthenium.15  The rate of 
quenching, kq can be determined from equation 4.2 in section 4.4. The rate of quenching 
by the RuBODIPY particles was found to be 7.52 x 108 M-1 s-1. This is an order of 
magnitude less than the quenching rate of the [Ru(bpy)2-phen-BODIPY-Br2] dyad 
which was measured to be 9.45 x 109 M-1 s-1 in methanol solution. This quenching rate 
is unexpectedly slow. Interestingly, even though the ruthenium component of the 
particles has a longer luminescent lifetime in aerated PBS (836 ns) compared to the 
molecular dyad (587 ns), the particles have a slower quenching constant. Hartmann et 
al observed similar results of their two Ru(II) complexes dissolved in polystyrene.43 This 
may be due to environmental protection of the ruthenium oxygen sensor by the poly-L-
lysine. Longer lifetimes of ruthenium on protein conjugation has been ascribed 
previously to this affect.44 Overall, this result indicates that the RuBODIPY particles are 
less responsive to changing oxygen than the molecular system. 
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The sensitivity of both ratiometric sensors can be expressed by the overall quenching 
response to dissolved oxygen.45 This can be done by obtaining a ratio of the luminescent 
emission intensity of the ruthenium sensor to that of the BODIPY reference. This is 
defined by equation 4.3: 
 
Q = R(N2) – R(O2)   x 100 …… Equation 4.3 
R(N2) 
 
Where Q is the quenching response, R(N2) is the ratio of the emission intensity of probe 
and reference in de-aerated solution, and R(O2) is the ratio of the emission intensity of 
the probe and reference in aerated solution. The ratiometric molecular system [Ru(bpy)2-
phen-BODIPY-Br2] was measured to have a quenching response of 55 % in methanol 
solution. However, the RuBODIPY particles have a much lower quenching response of 
18 %. Philbert et al employed Equation 4.3 to obtain a quenching response for their 
PEBBLEs composed of silicate, which incorporated an oxygen-sensitive Pt(II) 
porphyrin dye. They measured the quenching response of their polymer oxygen sensor 
to be 97 %.46 They obtained a linear Stern-Volmer plot, with a KSV value of 0.787, 
indicating a faster quenching rate than our RuBODIPY particles, discussed in this 
section. In an earlier report, Philbert et al obtained a quenching response of a 
[Ru(dpp)3]
2+ complex in a silica nanoparticle to be 80 %,45 while MacCraith et al 
reported on the quenching response of the Ru(II) complex [Ru(Ph2phen3]
2+ in a silica 
film to be 30 %.47 In order to obtain an improved quenching response from the 
RuBODIPY particles, the concentration of the ruthenium component on the particle 
surface should be increased to increase its sensitivity. As shown by the Stern Volmer 
plots in Figure 4.19, the particles display an excellent linear response to oxygen, 
however have a relatively slow quenching rate constant (kq). Therefore, increasing the 
concentration of ruthenium residues on the particle surface may improve the quenching 
rate while retaining the same linear response to oxygen. 
 
Importantly, the luminescent intensity from the BODIPY remains constant while the 
emission from the ruthenium centre decreases linearly with increasing O2 concentration. 
Figure 4.21 illustrates the ratiometric plot of the intensities, where I601/I547 ratios were 
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plot as a function of oxygen concentration. The data was plotted by determining the ratio 
between the emission intensity values at 547 nm for BODIPY and 601 nm for ruthenium, 
as a function of oxygen concentration. 
 
 
 
Figure 4.21 Ratiometric plot intensities of the BODIPY centre at 547 nm and ruthenium centred 
emission at 601 nm as a function of [O2] in PBS (18 °C). The complex was excited at 458 nm, sit 
width 10 nm. 
 
4.10 Introduction of RuBODIPY particles to cells 
The ability of the RuBODIPY particles to cross the cell membrane was assessed in CHO 
cells. The CHO cells were incubated with the particles in cell culture media over a range 
of particle concentrations of percentage of particles in the cell media (%). Confocal 
microscopy showed that after incubating over a range of times up to 24 h at 37 °C, the 
particles did not enter the cells. Surprisingly, treating the cells with 0.1 % Triton X for 
permeabilisation before the addition of particles did not enhance uptake, shown in Figure 
4.22. After exposure to Triton X, the solution was removed and 1:10 dilution of 
RuBODIPY particles were added to the cells for 4 h at 37 °C, 5 % CO2 in the absence 
of light. The particles were removed and the cells were imaged. No emission from either 
the ruthenium or BODIPY channel was observed. 
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Figure 4.22 Confocal image of CHO cells. The cells were pre-treated with 0.1 % Triton X, then 
incubated with 1:10 RuBODIPY particles for 4 h at 37 °C in the absence of light. The particles were 
excited using a 458 nm laser, and the emission was collected using a 505-550 nm band pass filter for 
the BODIPY emission, and a 560 nm long pass filter for the ruthenium emission. The image 
represents an overlay of reflectance with the ruthenium and BODIPY emission channels. 
 
Cetyltrimethylammonium bromide (CTAB), a cationic detergent was chosen to enhance 
uptake. CTAB has be shown previously to be effective in coating nanoparticles and 
promoting their uptake.48,49 RuBODIPY particles were sonicated overnight in 150 μM 
CTAB solution. The emission spectra of the particles in the 150 μM CTAB solution is 
presented in Figure 4.23. This demonstrates that the dual emission of the particles is 
unaffected by using this reagent for cell uptake. 
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Figure 4.23 Emission spectra of the RuBODIPY particles after sonicating with 150 μM CTAB/PBS 
solution overnight at 18 °C. The particles were excited at 458 nm, at a slit width of 10 nm. 
 
The CTAB-treated RuBODIPY particles were added to CHO cells at varying 
concentrations to investigate their uptake. The overall total volume of CTAB added to 
the cells with the particles was 2 % 150 μM. Interestingly, it was found that at 
concentrations greater than a 1:10 dilution of particles: media added to the cells that the 
cells would not take up the particles. Thus, a 1:20 dilution of RuBODIPY particles in 
Leibovitz media were added to CHO cells. Figure 4.24 shows the live uptake of the 
particles using confocal microscopy.  
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Figure 4.24 Live uptake confocal imaging of RuBODIPY particles in CHO cells. Particles were pre-
treated with 150 μM CTAB prior to exposure to CHO cell membrane. Cells were imaged before 
addition of particles (A).  1:20 dilution of particles/media were added to live CHO cells and imaged 
after 2 minutes of addition (B). Particles were removed after 5 minutes NP exposure and washed and 
re-introduced to fresh supplemented PBS (C). The particles were excited using a 458 nm white light 
laser, and the emission was collected using a long pass 520 nm filter. 
 
The cells were imaged for emission at the probe wavelength before any particles were 
added (A), then after 2 minutes of addition (B). After 5 minutes of exposure to the 
particles, the solution was removed and the cells were washed with supplemented PBS. 
Figure 4.24 C shows that the particles bound to the cell membrane, and remained bound 
after washing. The cells were incubated for a further 2, 4, and 6 h in the absence of light 
at 37 °C with 5 % CO2 in fresh Lebovitz media. Figure 4.25 examines the uptake, 
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focusing closely on a small area of cells, representative of the uptake across the sample. 
After 2 h, the particles appear to have crossed the cell membrane, and are distributed 
throughout the cytoplasm. After 4 h, the particles appear to have become more localised 
in specific regions, that appear to be the lysosomes and possibly endoplasmic reticulum 
(ER) region, but they remain nuclear excluding. After a further 6 h, the particles remain 
in what appears to be the lysosomes. 
 
Figure 4.25 Confocal images of live CHO cells incubated with a 1:20 dilution of RuBODIPY 
particles in Lebovitz media for 2 h, 4 h, and 6 h at 37 °C. CHO cells were incubated for 4 h at 4 °C 
to assess mode of uptake. The particles were excited using a 458 nm white light laser. The BODIPY 
emission was collected between 505 and 550 nm, and the ruthenium emission was collected using a 
long pass 605 nm filter. 
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From the images shown in Figure 4.25, the particles appear to localise throughout the 
cytoplasm and do not enter the nucleus.  The luminescence from the ruthenium and the 
BODDIPY can be seen separately in the cells, the red channel for ruthenium (A), and 
the green channel for BODIPY (B). The overlap of the two channels, shown in (C), is 
represented in yellow. The varying intensities of the two chromophores can be seen in 
the images, in some cases more ruthenium than BODIPY emission coming through, and 
vice versa, possibly attributed to the varying oxygen concentrations throughout the cells 
as the particles migrate through the cytoplasm. To assess the mechanism of uptake, HeLa 
cells were incubated with the CTAB treated particles at 4 °C for 4 h. Figure 4.25 shows 
that the uptake was the same as when incubated at 37 °C. The particles were able to 
cross the membrane. However, their localisation appears to be more disperse in the 
cytoplasm as well as in the lysosomal region. This indicates that uptake occurs through 
passive diffusion, i.e. an energy independent mechanism. Nanoparticles of up to 200 nm 
in size have been reported to cross the cell membrane via endocytosis, which is an energy 
dependent mechanism.50,51 In this case, passive diffusion is likely be as a result of using 
CTAB, permeablising the cell membrane and promoting uptake. CTAB is a cationic 
surfactant that dissociates aggregates and unfolds proteins. It interacts with the 
hydrophilic and lipophilic groups in the cell membrane, solubilising the membrane 
proteins. The more widely used detergent is Triton X-100, a non-ionic surfactant which 
is a mild detergent as it does not break protein-protein interactions, but as described this 
was ineffective in promoting particle uptake. CTAB is considered more toxic towards 
cells, however as demonstrated in this chapter, at small concentrations of 100 μM, it is 
not toxic towards cells while slightly permeabilizing the membrane enough for the 
particles to enter. Interestingly, at 37 °C, ruthenium emission intensity is 17 ± 0.1 a.u. 
while at 4 °C it has an emission intensity of 2.75 ± 0.3 a.u. while the BODIPY emission 
remains. This suggests that the particles have entered the cells and are present at both 
temperatures, but the ruthenium emission has decreased at 4 °C. Figure 4.26 shows a 
chart summarising the emission intensities of ruthenium at two regions of interest during 
live uptake of the particles, when incubated at 37 °C, and at 4 °C, and the corresponding 
images from where the ROIs were chosen. 
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Figure 4.26 Relative emission intensities of ruthenium during live uptake with CHO cells at (A) 37 
°C (▄). (B) CHO cells were incubated with 1:20 dilution RuBODIPY particles for 4 h at 37 °C (▄), 
and (C) at 4 °C (▄). The emission intensities from two regions of interest were measured using Image 
J. 
 
At low temperatures, cellular metabolism slows down.52 Therefore, oxygen 
consumption slows down as the cells cannot use it to produce ATP. This build-up of 
oxygen could be quenching the ruthenium emission, while the BODIPY remains the 
same as it is unaffected by oxygen concentration. As discussed in section 4.11, the 
particles have a luminescent lifetime of 603 ± 10 ns when bound to the exterior of the 
cell membrane which decreases to 435 ns when they localise in the lysosomes. This 
reduction in lifetime further suggests quenching by oxygen. Furthermore, cell membrane 
stability has been shown occur in an attempt to maintain homeostasis within the cell 
when exposed to low temperatures.53 This could also be contributing to the build-up of 
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oxygen. The increased membrane stability may also confirm permeabilization caused by 
the CTAB as the particles are still able to cross the membrane. 
Figure 4.27 shows a Z-stack of a CHO cell that was incubated with 1:20 dilution of 
RuBODIPY nanoparticles for 4 h.  The Z-stack scanned through a single CHO cell, 
which was representative of the sample, starting at the top of the cell (A) to the bottom 
of the cell (D). B and C represent two of the slices from the scan at the centre of the cell, 
confirming that the particles are in fact inside the cell and not just localised at the plasma 
membrane, highlighted in white.  
 
Figure 4.27 Confocal Z-stack scan of a single CHO cell that was incubated with 1:20 dilution of 
RuBODIPY particles for 4 h at 37 °C in the absence of light. The sample was excited at 458 nm. The 
BODIPY emission was collected between 505 and 550 nm, and the ruthenium emission was collected 
using a long pass 605 nm filter. Each z-stack was collected every 0.2 μm. A-D represent slices at 
different depths through the cell. 
 
Localisation of the particles was investigated to determine where in the cytoplasm they 
reside. Here, HeLa cells were incubated with the RuBODIPY particles for 4 h as 
described in section 4.2.5.2. Before imaging, cells were co-stained with commercial 
dyes; ER Tracker Blue (1 μM), LysoTracker Green (100 nM), and MitoTracker Deep 
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Red (500 nM).  The commercial dyes were added to the cells for 30 minutes in PBS. 
Figure 4.28 shows the co-localisation of the particles with the commercial probes. 
 
 
 
 
 
Figure 4.28 Co-localisation of RuBODIPY particles in HeLa cells across the cytoplasm (A) and the 
nucleus (B). The corresponding profile demonstrates the ruthenium (—) and BODIPY (—) channels 
of the particles, MitoTracker Deep Red (500 nM) represented in pink (—), ER Tracker Blue (1 μM) 
in blue (—) and LysoTracker Green (100 nM) in yellow (—).  
 
The ruthenium channel is represented in red, BODIPY in green, ER Tracker in blue, 
LysoTracker in yellow and MitoTracker Deep Red in pink. The X-Y line profile through 
the cytoplasm of a single HeLa cell and its corresponding plot profile describe the 
localisation of the complexes (A). The X-Y line profile through the nucleus of a second 
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HeLa cell and its corresponding plot profile confirm that the particles are nuclear 
excluding (B). In both cases, there is no evidence for co-localisation of particles with 
the mitochondria or endoplasmic reticulum (ER) localising probes. However, the plot 
profile of RuBODIPY particles with LystoTracker appeared to be coincident in all but 
one region in both A and B. Figure 4.29 examines a single HeLa cell incubated with the 
RuBODIPY particles and LysoTracker only. 
 
 
Figure 4.29 Co-localisation studies of RuBODIPY particles in HeLa cells. Particle uptake was 
carried out as described previously, and cells were incubated with commercial probe LysoTracker 
Green (100 nM) for 20 minutes. Confocal image shows co-localisation of the particles with 
LysoTracker, with cross section of the cell and the corresponding distribution plot demonstrating 
their co-localisation. 
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Lysosomes are found throughout in the cytoplasm, which coincides with the confocal 
images. The corresponding plot profile further demonstrates that the RuBODIPY 
particles are localised within the lysosomes. In a similar report, Pieber et al 
demonstrated lysosomal localisation after 4 h incubation with their polystyrene 
nanoparticles that were also 100 nm in diameter.54 Localisation in the lysosomes could 
be as a result of the mode of uptake. The role of lysosomes in the cell is to engulf/digest 
food and foreign objects upon entering the cell. As suggested previously, the particles 
cross the membrane via passive diffusion as result of permeabilisation. With no 
recognition peptides on the particle surface, the lysosomes may engulf the particles as a 
method of removing them from the cell. Similarly, cationic polystyrene particles at 100 
nm in diameter have also been found to localise in the lysosomes.55 Xia et al also 
reported on cationic polystyrene particles localising in the lysosomes, however, their 
particles were slightly smaller at 60 nm in diameter.56 Entry of nanoparticles into other 
organelles has been shown to be size dependent. For example, Chang et al showed that 
their gold nanoparticles 13 nm in diameter localised in the endoplasmic reticulum and 
Golgi apparatus of murine melanoma cells.57 In another report, Salnikov et al showed 
that gold particles that were 6 nm could not enter the mitochondria, however, 3 nm 
particles could enter the mitochondria intermembrane space of ventricular myocytes 
(cardiac cells),58 while gold particles of 39 nm in diameter have been reported to cross 
the nuclear pore complex (NPC).59 Taking all of these reports into account, it appears, 
for the most part, that particles with a diameter greater than 40 nm localise in the 
lysosomes. This suggests that particle size is just as important as surface modification 
for targeting cell organelles. As lysosomes have an acidic environment with a pH 
ranging from 3-4, 60 the emission spectra of the particles was assessed at pH 3.8. 
RuBODIPY particles in PBS solution (pH 7.4) were acidified using 1 mM HCl until a 
pH of 3.8 was obtained. Figure 4.30 compares the emission spectra at pH 7.4, and pH 
3.8 which demonstrated no changes. The particles were left in the acidic solution for 1 
week and the emission spectra were recorded. A slight decrease in the emission was 
observed, but the dual emission and ratio of the chromophores were unaffected. 
Likewise, the luminescent lifetime of the particles is also unaffected as the ruthenium 
component has a lifetime of 838 ns, and the BODIPY component is 4.45 ns, within 
experimental error. This result indicates that these RuBODIPY core shell particles are 
suitable for use as a ratiometric probe in the acidic environment of the lysosomes. 
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B 
 
Figure 4.30 Luminescent emission spectra of RuBODIPY particles in PBS whose pH was adjusted 
to pH 3.8 using 0.1 M HCl, and compared to pH 7.4 (A). The particles were left at pH 3.8 for 1 week 
to assess any changes to the emission. They were excited at 458 nm, slit width 10 nm. The 
luminescent lifetime was measured using TCSPC by exciting at 405 nm (B). 
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4.11 Phosphorescent Lifetime Imaging Microscopy (PLIM) of RuBODIPY 
particles in cells 
To assess the lifetime of the chromophores within the cells, PLIM was used. Firstly, the 
luminescent lifetimes of an aqueous drop containing the particles was measured in 
PBS/CTAB solution. 50 μL of the particle/PBS/CTAB solution was deposited on a glass 
slide, and the PLIM image was acquired for 20 minutes to ensure high counts were 
achieved. The ruthenium and BODIPY components were imaged separately. The long-
lived component of the lifetime attributed to the ruthenium was determined as 628 ± 18 
ns.  
Next, CHO cells were prepared as described in section 4.2.6.2. Each short and long 
components were measured separately. Figure 4.31 A demonstrates the false-colour 
PLIM image of the lifetime distributions of the RuBODIPY particles when bound to the 
membrane of a single CHO cell after 5 minutes exposure. The highlighted area of the 
cell was examined closely to determine the luminescent lifetimes of the two components. 
When bound to the exterior of the cell membrane surface, the particles exhibit a lifetime 
of 4.49 ± 0.018 ns for the BODIPY component (B), and 603 ± 10 ns for the ruthenium 
component (C). The lifetime of the ruthenium decreased slightly when bound to the cell 
membrane, suggesting quenching is occurring. This would be expected at the cell 
membrane as it contains a higher concentration of dissolved oxygen due to the 
lipophilicity of the membrane compared to solution. 61 
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Figure 4.31 PLIM false-colour images of the BODIPY (A), and ruthenium (B) components of the 
particles bound to the cell membrane. The image was acquired by focusing on a selection of particles 
bound to the cell membrane. Both the ruthenium and BODIPY were excited using a 405 nm laser. 
The BODIPY emission was collected using a 515-580 nm band pass filter at 8 ps resolution, and the 
[Ru(bpy)2-Phen-Ar-COOH]2+ was collected using a 570-700 nm band pass filter at 256 ps resolution. 
 
Figure 4.32 illustrates the emission lifetime distributions of the particles when incubated 
with CHO cells for 4 h. Here, a single CHO, representative of the sample, was measured 
under the BODIPY settings first, then under the ruthenium settings. The lifetime of each 
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component was measured at the lysosomes as confirmed from co-localization studies 
described above. 
 
 
Figure 4.32 Fluorescence lifetime images of the RuBODIPY particles in a live CHO cell. Cells were 
prepared as described in section 4.2.6.2. The false-colour images show that the BODIPY component 
exhibits a lifetime of 4.62 ns (A), and ruthenium has a lifetime of 435 ns (B) from within the cell. 
The BODIPY emission was collected using a 515-580 nm band pass filter at 8 ps resolution, and the 
[Ru(bpy)2-Phen-Ar-COOH]2+ was collected using a 570-700 nm band pass filter at 256 ps resolution. 
 
The lifetime of the BODIPY component was found to be 4.26 ns (A). As expected, as it 
is isolated in the core, the luminescent lifetime did not deviate from the lifetime recorded 
for this component of the emission decay in solution, which was measured to be 4.45 ns. 
On the other hand, the lifetime of the ruthenium component for the nanoparticles 
localised within the lysosomes was found to be 435 ns (B). In solution, the ruthenium 
component of the probe decay exhibited a lifetime of 836 ns using TCSPC, and 628 ns 
on the PLIM. Even though the particles were prepared in the same manner at the same 
concentration, different luminescent lifetimes were measured. This is possibly a result 
of focus drift during PLIM as PLIM is acquired in conjunction with confocal, and the 
particles are set up on the confocal stage for imaging. Another possible reason is that 
during TCSPC, the sample is in a dark, sealed container. During PLIM, the particles are 
set up on the confocal stage. Although the experiment was carried out in a dark room, 
some photons may be lost during imaging. The decrease in lifetime from within the 
lysosomes suggests that it is being quenched. As discussed in section 4.10, the pH of the 
particles does not affect the luminescent emission or lifetime (Figure 4.30). Therefore, 
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the quenching of the lifetime is attributed to either oxygen or possible ROS 
concentration in the lysosome. By extrapolating the values from the calibration plot 
generated in section 4.9 described by Figure 4.21, the oxygen concentration from within 
the lysosome is measured to be 600 μmol/L. This value exceeds saturation, as the 
concentration was measured to be 268 μmol/L in PBS solution. This suggests that the 
probe is being quenched further by another method.  
One possible mechanism of quenching could be as a result of reactive oxygen species 
(ROS) production in the cell. The generation of ROS upon exposure to nanoparticles is 
a common observation as a reaction to the particles which are seen as a foreign object 
by the cell.62 Nanoparticles can generate ROS by different mechanisms in the cell such 
as by their interaction with organelles like mitochondria, interaction with cell surface 
receptors, and interaction with redox proteins in the cell. In this case it is possibly as a 
result of a redox reaction in the lysosomes. Lysosomes possess a high iron pool.63 Iron 
is known to play an important role as a redox-active metal producing ROS by acting as 
an electron donar.64 It catalyses H2O2 to ROS species via Fenton reactions.
65 The acidic 
pH of the lysosomes favours ROS production via an iron redox reaction.63 It is this redox 
reaction, as well as the production of ROS, that could possibly be quenching the 
ruthenium lifetime, as was shown in the mitochondria in Chapter 3 that ruthenium seems 
to be responsive to ROS. 
 
 
4.12 Ratiometric oxygen sensing in the cell using RuBODIPY particles 
As the RuBODIPY particles demonstrated good ratiometric oxygen sensitivity in vitro, 
their ability to sense oxygen concentrations from within the cell was assessed using 
intensity measurements. Confocal microscopy was used to measure the emission 
intensities of the two chromophores in the cell, and to monitor the intensities over the 
course of the oxygen experiments. A range of methods to alter the oxygen concentration 
in the cell and in the cells environment were investigated. HeLa cells were prepared as 
described in section 4.2.5.2 and after 4 h incubation, the particles were examined for 
oxygen sensing. 
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4.12.1 Nitrogen and argon 
In order to create a hypoxic environment for the cells, nitrogen and argon were explored. 
Tobita et al reported on a ratiometric oxygen probe which consisted of an Ir(III) oxygen 
sensitive complex conjugated to coumarin 343 as the fluorescent reference. They 
introduced their probe to HeLa cells and incubated them under 20 % and 2.5 % oxygen 
levels. They found that at 20 % oxygen, the Ir(III) emission intensity was very low, 
which increased significantly at 2.5 % oxygen.66 In an attempt to measure oxygen 
concentrations using the RuBODIPY particles from within the cell, de-gasses PBS was 
used. PBS, containing air-saturated levels of oxygen (20 %), was added to the prepared 
cells and left to equilibrate for 30 minutes. The cells were imaged to measure the 
ruthenium and BODIPY emissions separately at oxygen saturation. PBS was degassed 
with nitrogen for 1 h. The air-saturated PBS was removed from the cells, and was 
replaced with the de-aerated PBS. The cells were imaged every 2 minutes, but no change 
to either the BODIPY or the ruthenium emission intensities was recorded over 20 
minutes.  
The same process was carried out using argon. As argon is denser than oxygen it might 
be expected that the argon would form a layer over the cells, creating a hypoxic 
environment. Figure 4.33 shows a group of CHO cells that were incubated with 1:20 
RuBODIPY particles for 4 h at 37 °C in the absence of light. Here, the cells were imaged 
with aerated PBS solution on them, representing 21 % oxygen. PBS solution was de-
gassed using argon for 1 h, then added to the cells to create a hypoxic environment. The 
cells were imaged every 1 minute for 35 minutes, but no changes to the BODIPY or 
ruthenium emissions were seen.  
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Figure 4.33 CHO cells incubate with 1:20 RuBODIPY particles for 4 h at 37 °C in the absence of 
light. Aerated PBS was added to the cells to image the particles at a 21 % oxygen environment. The 
particles were excited at 458 nm. The BODIPY emission was collected between collected between 
505 and 550 nm (A), and the ruthenium emission was collected using a long pass 605 nm filter (B). 
An overlay of the two channels is shown in (C), and with the background channel (D). 
 
Figure 4.34 shows the emission of the BODIPY and ruthenium channels before the de-
aerated PBS was added (A), after 10 minute’s addition of the argon/PBS solution, and 
after 35 minutes. Four regions of interest (ROIs) were selected to measure any changes 
in emission intensities over the course of the experiment. However, no changes were 
seen at the ROIs. A possibility for this may be that this method is not suitable for altering 
the cells environment enough for the RuBODIPY particles to measure any changes.  
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Figure 4.34 RuBODIPY particles (1:20 dilution) in CHO cells when fully aerated in aerated PBS 
(A). PBS purged with argon gas for 1 h was added to the cells, and the emission intensity was 
recorded at 10 minutes (B), and at 35 minutes (C). The images show both the ruthenium and BODIPY 
channels overlayed, with the regions of interest highlighted for monitoring the emission changes. 
The particles were excited at 458 nm. The BODIPY emission was collected between collected 
between 505 and 550 nm (A), and the ruthenium emission was collected using a long pass 605 nm 
filter. 
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4.12.2 Chemical method 
Instead of changing the cell’s external environment, the cells internal oxygen 
concentrations were altered by stimulating with chemicals. There have been many 
reports of oxygen sensing using valinomycin23 and Antimycin A.6,13 Antimycin and 
H2O2 were used to alter the internal environment of the cell. Antimycin A is an inhibitor 
of electron transfer at complex III in mitochondria. It blocks the mitochondria from 
consuming oxygen in the cell. Therefore, there is a build up of oxygen in the cell, altering 
the natural concentration.67 100 mg/mL Antimycin A in PBS was added to the cells. 
Over 2 h, the ruthenium emission was monitored via confocal imaging. Figure 4.35 
shows a CHO cell, representative of the sample, before Antimycin A was added (A) and 
after 2 h exposure (B). The cell was imaged very 1 minute to measure any changes in 
the particles emission intensity. The average intensity of ruthenium remained at 87.23 
a.u. over the course of the experiment, suggesting that Antimycin A did not affect the 
oxygen concentration of the cells. However, we know from experiments in Chapter 4 
that Antimycin effectively alters O2 conc. 
 
 
Figure 4.35 A single CHO cell before the addition of Antimycin A (A) and after 2 h exposure to 100 
μg/mL Antimycin A in PBS. CHO cells were incubated with 1:20 RuBODIPY particles for 4 h at 37 
°C in the absence of light prior to imaging. The particles were excited at 458 nm. The BODIPY 
emission was collected between collected between 505 and 550 nm (A), and the ruthenium emission 
was collected using a long pass 605 nm filter. 
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Likewise, in a separate experiment, H2O2 was added to cells to introduce oxidative 
stress. 30 μM H2O2 in PBS solution to yield a final volume of 1 mL was added to the 
cells. The cells were imaged every 2 minutes and the emission was monitored. After 30 
minutes, the concentration was increased to give a final concentration of 60 μM. After 
1 h, no change to the ruthenium emission was seen across a number of cells.   
After investigating a multiple of methods to alter the cell’s external and internal oxygen 
concentration, and therefore measure the oxygen concentration using the ratiometric 
RuBODIPY particles, it was found to be unsuccessful. Although the particles showed 
excellent and reproducible oxygen sensitivity in PBS solution, their location within the 
lysosomes may be preventing the change in emission to be recorded. Alternatively, the 
particles are measuring changing oxygen but the method of detection via confocal 
microscopy may not be sensitive enough to monitor the changes to these particles.  
  
4.13 Cytotoxicity 
The effect of the RuBODIPY particles on the viability of the cells was examined using 
CHO cells. Cells were prepared as described in section 4.2.7. CTAB treated particles 
were added to CHO cells to yield final dilutions of 1:5, 1:10, 1:20, 1:50, and 1:100 
particles: media in each well. The cells were incubated for 5 minutes to allow the 
particles to bind to the cell membrane. The solution was removed and the cells were 
washed with supplemented PBS. The cells were replaced with fresh cell culture media 
and incubated for 24 h at 37 °C with 5 % CO2. Resazurin (Alamar Blue) Reagent was 
added to the cells for 7 hand the viability was measured. 
Figure 4.36 describes the results of the assay. It was found that the particles were 
moderately toxic towards CHO cells. At concentrations as high as 1:5, 50 % of cells 
remained viable (as a percentage of cells with no particles added). 
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Figure 4.36 Cytotoxicity of RuBODIPY nanoparticles. Particles were added to CHO cells to yield 
final dilution concentrations of particles to media and incubated for 24 h in the dark at 37 ºC at 5 % 
CO2. CHO viability was assessed using the Resazurin (Alamar Blue) assay (n=3). 
 
 
From this result, we reason that the particles remain in the lysosomes and do not affect 
cell viability. Images taken after incubation with the particles for 24 h demonstrate that 
the particles are still in the cells, ruling out removal or degradation by the acidic 
environment of the lysosome. Another suggestion for the viability could be that only a 
certain number of particles can bind to the cell membrane, irrespective of the 
concentration added to begin with. Therefore, the same amount of particles are crossing 
the membrane and localising in the cell, and the same number of cells remain viable 
after 24 h. PS particles are, generally, not cytotoxic towards cells. Pieber and co-workers 
reported on PS particles 100 nm in diameter, which after 24 h incubation localised in the 
lysosomes of endothelial cells and were non-toxic. 68 The group of Fecondo et al 
reported on 13 nm gold nanoparticles conjugated to a lysosomal CPP sequence. 
Similarly, their particles localised in the lysosomes and did not induce any toxic effects 
on CHO cells.69 Weiss et al reported on a series of SiO2 particles which were labelled 
with FITC, and monitored three different sizes in HeLa cells; 70 nm, 200 nm, and 500 
nm. They found that all sizes localised in lysosomal compartments of the cells following 
24 h incubation, and induced no toxic effects.70 
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However, the toxicity induced in the 50 % of cells that do not survive the incubation 
may be due to ROS production in the lysosomes as discussed previously in section 4.11, 
where the cells undergo apoptosis as a result. Strongly cationic PS particles can induce 
oxidative stress. Simmet et al demonstrated that PS-NH(2) particles of ~100 nm in 
diameter induced proton accumulation in the lysosomes of macrophages which is 
associated with lysosomal destabilisation. This destabilisation, in turn, caused damage 
to the mitochondrial membrane, triggering ROS.71 Similarly, Wang et al showed that 
their cationic NH2-PS particles (61 nm) generated ROS and induced ER stress after 6 h 
of treatment. The ROS production increased with increasing particle concentration in 
macrophages and human bronchial epithelial cells.72 Another possibility is that the 
particles localising in the lysosomes are affecting the acidifying proton pump, effecting 
homeostasis. In this case, it is thought that the cationic charge of the particles neutralises 
the lysosomes, causing osmotic swelling and resulting in the lysosomes rupturing. Such 
outcomes was reported by Xia et al. Their cationic NH2-PS particles (~60 nm) induced 
cytotoxic effects on macrophages. They attribute the toxicity to lysosomal degradation 
by a loss of proton pump activity, and thus osmotic swelling and rupture of the 
lysosomes occurred. 56 Lysosomal rupture releases lysosomal enzymes which can trigger 
pro-apoptotic signals such as Bid and Bax. The enzymes can also interfere with the 
mitochondrial, causing an increase in ROS productions. 
The specific cause or source of the particle toxicity is unknown. One possible reason is 
that the [Ru(bpy)2-phen-COOH]
+2 complex located on the particle surface may be 
inducing toxic effects on the cells. This complex was shown in Chapter 3 to be toxic 
when it localised in the mitochondria and throughout the cytoplasm. The cationic nature 
of the CTAB may be another cause of the toxicity of the RuBODIPY particles. The final 
concentration of CTAB (150 μM) was the same for each concentration of particles added 
to the cells during the assay. The fact that the percentage of cells remained the same over 
the range of particle concentrations strongly does it suggest it is CTAB rather than the 
particles which is inducing toxicity. In order to assess the true cause of toxicity, another 
method of encouraging cell uptake would have to be explored rather than using a 
detergent like CTAB such as functionalising the surface with polyethylene glycol 
residues (PEG),73-75 or a poly-arginine peptide sequence. Using PEG as a cross-linking 
system during the preparation of the particles may also help to maintain particle stability 
and protect from enzymatic degradation once inside the cells.76 
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4.14 Conclusions 
Chapter 4 examined two approaches to ratiometric sensing of O2 in the cellular 
environment. One probe was [Ru(bpy)2-phen-BODIPY-Br2], a molecular dyad, and the 
other consisted of a core-shell poly(styrene) nanoparticle with BODIPY at the core  and 
[Ru(bpy)2-phen-COOH]
+2 on the particle surface. Both probes contained the same 
molecular components, the non-oxygen sensitive reference complex consisted of a 
BODIPY complex. BODIPYs are not environmentally sensitive because of their short 
fluorescent lifetimes. The oxygen-sensitive complex was a Ru(II) polypyridyl complex, 
whose long luminescent lifetime renders it sensitive to oxygen concentration. A key 
reason for choosing these components for dyad and particle is that their emission spectra 
do not overlap so they could be ratio metrically assessed and monitored based on the 
relative emission intensities.  
For the molecule dyad, [Ru(bpy)2-phen-BODIPY-Br2] challenges associated with such 
probes is that there can be cross-talk and self-quenching between the two moieties. In 
this case, the probe was excited at a single wavelength, 458 nm, which resulted in dual-
emission without any crosstalk. The BODIPY emission centred around 552 nm, while 
the ruthenium emission centred at 607 nm. However, it was found that the BODOPY 
component of the dyad was sensitive to aqueous media wherein, the BODIPY emission 
switched off in PBS solution, leaving just the ruthenium emission present. Applying the 
same material to a nanoparticle core-shell probe, 100 nm in diameter. The BODIPY 
probe was located in a poly(styrene) core to avoid contact with aqueous solutions. The 
oxygen sensitive ruthenium was located on the poly(L-lysine) coating on the outside off 
the shell, to allow it to come in contact with oxygen. The RuBODIPY particles exhibited 
dual-emitting properties in aqueous PBS solution when excited at 458 nm, with the 
BODIPY emission centred at 547 nm and the ruthenium emission centred at 601 nm. 
The photophysical properties of both probes were examined in aqueous and non-aqueous 
solutions. Their oxygen sensing abilities were assessed by de-aerating with nitrogen, and 
measuring the luminescent emission intensity and lifetime as a function of oxygen 
concentration. The ruthenium exhibited excellent oxygen sensitivity, while the BODIPY 
reference remained unaffected. 
Both probes were introduced to CHO cells. Confocal microscopy showed that 
[Ru(bpy)2-phen-BODIPY-Br2] entered the cytoplasm and nucleoli of the cells following 
24 h incubation. On the other hand, the RuBODIPY particles localised in the lysosomes, 
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which is typical of particles of ~100 nm in diameter. The ruthenium luminescent lifetime 
was quenched beyond the lifetime of oxygen quenching. The reason for this is possibly 
due to ROS production as a result of lysosomal degradation, but this requires further 
exploration. 
Cytotoxicity studies found that [Ru(bpy)2-phen-BODIPY-Br2] was highly toxic towards 
CHO cells following 24 h incubation, with concentrations above 15 μM killing all the 
cells. In contrast, 50 % of cells remained viable after exposure to high concentrations of 
RuBODIPY particles. The difference in toxic effects was attributed to where the probes 
localise in the cell. [Ru(bpy)2-phen-BODIPY-Br2] resided in the cytoplasm and nucleoli. 
As it enters the nucleus, it was expected to be toxic when coming in contact with nuclear 
DNA. As RuBODIPY particles located in the lysosomes, it may require longer exposure 
times to see the same level of toxicity. This is something that would need to be explored 
further. 
Finally, RuBODIPY particles ability to report on oxygen concentrations from within the 
cell was explored in PBS solution which was de-gassed with nitrogen and argon, 
separately, and was added to live cells. The emission intensities were measured over 
time as a result of the changing oxygen concentration in the cells environment. However, 
no changes were observed. Chemical methods were also assessed. Rotenone and H2O2 
were added to live cells in order to alter the oxygen levels from within the cells. Again, 
no changes in emission intensity was observed. It was thought that this was as a result 
of the RuBODIPY particles residing in the lysosomes as the lysosomes may not respond 
to changing oxygen levels in the same manner in which other cellular organelles such as 
the mitochondria would respond. 
Both ratiometric methods showed excellent oxygen sensing abilities in vitro, but were 
unable to transfer to live cells. One possible use for [Ru(bpy)2-phen-BODIPY-Br2]  
would be to introduce it to liposomes to see how the BODIPY moiety behaves in the 
lipid bilayer. As for the RuBODIPY particles, future work may include conjugating or 
functionalising the ruthenium complex on the particle shell in order to direct the particles 
away from the lysosomes to assess if they are capable of measuring oxygen in vivo. 
Functionalising the surface with polyethylene glycol residues or poly-peptide sequences 
would also ensure the particles are membrane permeable, and therefore, CTAB would 
not need to be used to assist in the particles crossing the cell membrane.    
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Chapter 5: Application of Ru(II) probes to Stimulated 
Emission Depletion (STED) microscopy 
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5.1 Introduction 
Optical microscopy has played a crucial role in developments in cell biology permitting 
imaging of live cells, tissues and other biological structures.1-5 However, the spatial 
resolution of classical microscopes is limited due to the diffraction limit, which hinders 
the imaging of more detailed biological performances. STimulated Emission Depletion 
(STED) microscopy has been shown to greatly increase the resolving power of light 
microscopes and so is an attractive proposition for imaging live cell organelles which 
are often smaller than 1 µm. For example, the mitochondria in mammalian cells, such 
as HeLa and CHO cells, range from 1 – 2 μM long and 0.2 – 0.7 μM wide. While the 
lowest resolution achievable using confocal microscopy is 150 – 200 nm, detail in their 
structure such as the mitochondrial cristae cannot be imaged in high resolution. 
Likewise, the nucleus is ~10 μm in diameter. While the nucleus is visible using confocal 
microscopy, structural detail such as nuclear pores cannot be resolved as they are ~ 80 
nm long. The development of STED makes it possible to non-invasively image and 
resolve organelle structures and molecular dynamics at the nano-scale.6 There have been 
many reports of STED imaging of cellular processes using fluorescent-based probes for 
example in non-invasively imaging nerve and synaptic tissues in neuronal cultures 7 and 
dendritic spine synaptic signals.8 As discussed in section 1.12 in Chapter 1, STED 
microscopy uses separate laser beams for fluorescence excitation and quenching the 
fluorophore. It works by depleting a zone around the edge of the focal region of emitting 
fluorophore which is achieved by switching the fluorophore in the depletion zone to a 
dark state by stimulating its emission with a high intensity laser that matches the 
emission wavelength (usually the red edge of the emission) of the fluorophore.  This 
effectively reduces the spot size of the incident laser to below the diffraction limit.  The 
greater the intensity of the STED depletion laser, the more efficient the depletion process 
and the better the resolution.9 As a result, the fluorophore must be stable under 
continuous irradiation. All of these conditions put significant demands on the stability 
and photophysics of the STED fluorophore. Therefore, there is a need for much 
improved imaging probes to meet these demands.  
The ideal properties of a good STED probe  include 1) a high quantum yield, 2) good 
photostability, 3) possess a long lived emissive state, and 4) their emission spectrum 
must overlap with the STED depletion laser. The probe should also permeate the cell 
membrane and target with high precision for specific and detailed imaging. Many 
fluorescent dyes used for labelling STED samples are organic dyes which have short-
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lived emissive states, are prone to quenching at high concentrations, and tend to easily 
photo-bleach.10 Photo-stable dyes typically used for STED imaging such as Alexa Fluor, 
Atto and Chromeo exhibit good stability and quantum yields but show modest 
permeability and no selectivity in their distribution in cells so stain non-specifically 
leading to large backgrounds .11-14  
The photophysical properties associated with transition metal complex luminophores 
such as a large stokes shift, long lived emission states, excellent photostability and high 
quantum yields makes them potentially ideal candidates as STED imaging probes. To 
date, the properties of Ru(II) have been exploited in conventional imaging and as sensor 
probes.15-17 With its unique optical properties and proven cell compatibility, Ru(II) 
complexes are explored here as probes for STED microscopy.14,18 As discussed in 
Chapter 1, cell penetrating peptides (CPPs) have been used in recent years to direct such 
complexes to image and sense at the organelle level.19-22 By combining transition metal 
complexes with CPP or signal peptides, super resolution imaging enabled by the 
localisation of the probe at specific sub-cellular sites can be achieved to yield high 
contrast images compared to conventional imaging 
The aim of this chapter is to explore the application of Ru(II) polypyridyl complexes as 
imaging probes in STED microscopy as potential STED. As shown previously in 
Chapter 3, cell penetrating and signal peptides (CPPs) have outstanding targeting 
abilities, capable of directing peptide conjugate probes to specific cell organelles. This 
chapter exploits the power of signal peptides by using two novel organelle targeted 
ruthenium polypyridyl complex peptide conjugates that target the endoplasmic 
reticulum (ER), and the nucleus, in order to achieve high-resolution STED images of 
these organelles. The endoplasmic reticulum (ER) plays a key role in the cell in protein 
assembly, lipid biosynthesis, and vesicular trafficking.23 There are four separate sub-
compartments in the ER; rough ER, smooth ER, transitional ER, and nuclear envelope, 
making it a complicating organelle.24 The ER has recently become implicated as a key 
determinant in many disease states such as cancer, diabetes, neurodegeneration, and 
heart disease.25-27 Therefore, optical imaging protocols which enable the details of the 
ER specifically to be examine e.g. in diseased states is becoming important in the field 
of diagnostics.  The ER is a complicated organelle, and so the size varies. ER tubules 
can range from 30 to 100 nm in diameter, and the cisternae can be as tightly packed as 
16 nm.23,28 Therefore confocal microscopy cannot achieve such resolutions needed to 
image the structure of the ER in great detail. The ER-directing peptide 
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RQIKIWFQNRRMKWKK will be examined in directing [Ru(bpy)2phen-Ar-COOH]
2+ 
complex to the ER. 
Likewise, developing DNA-targeted probes for imaging in live cells is of great 
importance in theranostis given the significant role DNA has and its role in diseases. A 
key focus of targeted metal luminophore DNA probes is to intercalate with the DNA 
either in order to kill the cell. Whereas there has been extensive research on solution 
phase studies between the metal complexes particular of ruthenium and DNA, to date, 
there have been very few applied to targeting DNA in vivo and particularly for the 
purpose of imaging.29-32 Puckett et al successfully directed [Ru(phen)(bpy’)(dppz)]2+ 
complex conjugated to the nuclear targeting signal RrRk to the nucleus of HeLa cells.33 
Gottschaldt et al used D-glucose sugar moiety conjugated to a ruthenium polypyridyl 
complex to direct the complex to the nucleus of HepG2 cells.34 In both cases, the groups 
directed ruthenium to the nucleus, but showed no DNA binding. Gill et al are one of the 
few groups who have successfully shown nuclear localisation of a dinuclear Ru(II) 
probe.15,35 Here they demonstrated cell uptake and DNA staining in MCF-7 cells, and 
captured four phases of chromosomal aggregation in mitosis, the process of cell division. 
Combining Ru(II) complexes with a nuclear localising sequence to target the nucleus 
can only enhance the precision of complex localising there. The NLS sequence 
VQRKRQKLMP, known as NF-κB originates from the NF-κB transcription factor. 
Nuclear factor-κB (NF-κB) is a family of transcription factors that plays a role in the 
transcription of DNA, as well as inflammation and cell proliferation.36 This sequence 
will be explored further in directing Ru(II) complex to the nucleus. 
This chapter details the ER targeting complex [(Ru(bpy)2phen-Ar)2-ER]
9+, and 
[Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ nuclear targeting complex as novel STED imaging 
probes. Detailed cell studies were carried out including uptake and localisation of the 
complexes in HeLa cells, as well as cytotoxicity studies. [(Ru(bpy)2phen-Ar)2-ER]
9+ , 
[(Ru(bpy)2phen-Ar)2-Arg8]
7+ and [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ were investigated 
as STED imaging probes, and were compared to the commercial dye Alexa Fluor 
Phalloidin 532. Results from confocal fluorescence and STED imaging studies were 
compared out to assess the performance of Ru(II) polypyridyl complexes as a STED 
probes. Complex stability under the 660 nm STED depletion was also assessed and 
compared to the highly stable Alexa probe. STED images of the endoplasmic reticulum 
(ER) in HeLa cells were collected, which demonstrated a much improved resolution 
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compared to the confocal equivalent. Finally, images of nuclear DNA chromosomes at 
the different stages of mitosis were captured using STED microscopy. 
 
5.2 Materials and Methods 
 
5.2.1 Materials 
  
[Ru(bpy)2phen-Ar-COOH]
2+ parent complex was synthesised by Christopher S. Burke 
(DCU).37 [Ru(dppz)(bpy)(bpyArCOOH)](PF6)2 parent complex and its NLS conjugate 
[Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ (Scheme 5.2) were synthesised by Christopher S. 
Burke (DCU). Polypeptides (> 95 %) were purchased from Celtek Peptides (TN, USA) 
and used without further purification. All chemicals and solvents used in experimental 
procedures were purchased from Sigma Aldrich (Ireland). All solutions were made using 
deionised water, which was purified by a Milli-Q plus 18.5 Millipore purifying system. 
HeLa cells were purchase from ATCC Cell Biology Collecetion (UK). Resazurin 
reagents were acquired from Promokine. Cell culture media, serum and penicillin / 
streptomycin were purchased from Sigma Aldrich. Cell culture flasks were purchased 
from Corning Incorporated and VWR. Alexa Fluor Phalloidin 532 and ProLong Gold 
Antifade Mountant were purchased from Life Technologies. 
 
 
5.2.2 Synthesis of the [Ru(bpy)2-Phen-Ar-COOH]2+ conjugate 
 
A solution of [Ru(bpy)2-Phen-Ar-COOH]
2+ (8 mg, 0.009 mmol) in DMF (1 ml) with (2-
(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexaﬂuorophosphate, HBTU (13.0 
mg, 0.039 mmol) was stirred for 10 min at room temperature. Added to this was the 
peptide (sequence RQIKIWFQNRRMKWKK) (10 mg) in DMF (0.5 ml) with DIPEA 
(15 μL) and stirred for 21 h. The solution was placed on ice and a saturated aqueous 
solution of potassium hexafluorophosphate was added to induce precipitation. After 
stirring for 10 min, the orange suspension was then filtered using 0.5 μm filter paper and 
the product was washed with diethylether. The product was dissolved in minimum 
acetone, and DCM was added dropwise to the product/acetone solution to induce 
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precipitation. The suspension was filtered and left under N2 for 24 h to yield pure 
conjugate, [(Ru(bpy)2phen-Ar)2-ER]
9+ (Scheme 5.1). An indication of reaction progress 
and purity was easily followed by TLC. 
 
5.2.3 Spectroscopic Measurements 
 
The UV/Vis spectra were recorded on a Jasco V-679 UV/Vis/NIR spectrometer. 
Fluorescence emission and excitation were measured using a Cary Eclipse Fluorescence 
Spectrometer, both at a slit width of 5 nm. Solution measurements were carried out in 
1% DMSO with PBS, and neat PBS in a Hellma quartz cuvette of 1 cm optical path 
length. 
       
5.2.4 Luminescent Lifetime Measurements 
 
The lifetimes were collected using a FluoTime 100 Time-Correlated Single Photon 
Counting (TCSPC) instrument. The 405 nm laser was used for parent and conjugate 
complexes, provided from a Picoquant ‘PDL 800B’ pulsed diode laser. 10,000 counts 
were collected for each lifetime measurement. The measurements were carried out using 
Nanoharp software. The luminescent lifetimes were calculated using the PicoQuant 
FluoFit software by fitting an exponential decay function to each plot. The data was then 
fitted to a mono-exponential decay to the background decay curve, using a tail fit with 
a χ2 value between 0.9-1.1. 
 
5.2.5 Real-time confocal luminescent imaging  
HeLa cells were seeded at 1.5 x 105 cells in 2 mL media on 35 mm glass-bottom culture 
dishes. Cells were grown for 48 h at 37 ºC at 5 % CO2. The growth medium was removed 
and 70 µM of  [Ru(bpy)2-Phen-Ar-Arg8]
10+ or [(Ru(bpy)2phen-Ar)2-ER]
9+ in phenol red-
free media was added and left to incubate  for 4 h at 37 ºC at 5 % CO2 in the dark. In the 
case of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+, 40 μM was added to the cells for 24 h.  The 
dye/media solution was removed and cells were washed with PBS supplemented with 
1.1 mM MgCl2 and 0.9 mM CaCl2. For live cell imaging, cells were imaged immediately 
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using a Leica TSP DMi8 confocal microscope using a 100X oil immersion objective 
lens. A 488 nm white light laser was used to excite [(Ru(bpy)2phen-Ar)2-ER]
9+ , and its 
emission was collected using a band pass 590-700 nm filter set. [Ru(dppz)(bpy)(bpy-
Ar-NFkB)]6+ was excited using a 470 nm white light laser and the emission was 
collected using a band pass filter 565 – 700 nm. Nuclear stain DAPI was added to the 
cells (300 nM) for 1 h prior to imaging. DAPI was excited using a 633 nm laser and the 
emission was collected between 637 – 730 nm. 
 
5.2.6 Cytotoxicity   
HeLa cells were seeded in a 96-well plate in 100 µL of media at 1 x 104 cells per well 
for 24 h at 37 ºC with 5 % CO2. [(Ru(bpy)2-phen-Ar)-ER]
9+ or [Ru(dppz)(bpy)(bpy-Ar-
NFkB)]6+  was added to give final concentrations of 200, 150, 100, 50, 20, 10, 1, 0.1 µM 
of the complex. The cells were incubated with the complex for 24 h at 37 ºC at 5 % CO2. 
10 µL of Resazurin (Alamar Blue) reagent was added to each well, and incubated for a 
further 7 h in the dark at 37 ºC. The resazurin was converted to resorufin in viable cells 
and its absorbance was measured at 570 nm, with background measured at 600 nm using 
a Tecan 96-well plate reader.   
 
5.2.7 Phosphorescent lifetime imaging microscopy 
HeLa cells were seeded on a 35 mm glass bottom dish at 1.5 x 105 in 2 mL for 24 h at 
37 °C at 5 % CO2. [Ru(dppz)(bpy)(bpy-Ar-NFkB)]
6+ (40 μM) was added to the cells and 
incubated for 24 h in the absence of light. The complex was removed and the cells were 
washed twice with supplemented PBS. Live PLIM images were acquired usung 
MicroTime 200, PicoQuant, attached to a Zeiss LSM510 confocal microscope using a 
63 x oil immersion objective.  Each PLIM image was acquired for 5 minutes with 
256×256 resolution. 405 nm laser was used to excite the sample, and emission collected 
using a long pass 530 nm filter. The data was analysed using PicoQuant Symphotime 
software. Lifetimes were fit to a mono-exponential decay until a χ2 value of 0.9 - 1.1 
was achieved. The average lifetime was taken from 2 separate experiments (n = 2). 
 
237 
 
5.2.8 STED microscopy of fixed cells 
For fixed samples, HeLa cells were seeded at 1.5 x 105 cells on 35 mm glass slides 
treated with poly-L-lysine for 30 minutes. 70 µM of  [Ru(bpy)2-Phen-Ar-Arg8]
10+ or 
[(Ru(bpy)2phen-Ar)2-ER]
9+  for 4 h, or 40 μM of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ for 
24 h was added in cell media and left to incubate  at 37 ºC at 5 % CO2 in the dark. The 
dye/media solution was removed and cells were washed with PBS supplemented with 
1.1 mM MgCl2 and 0.9 mM CaCl2. HeLa cells were fixed using 3.8 % paraformaldehyde 
after washing with supplemented PBS for 15 minutes in the dark. The solution was 
removed and slides were washed twice with PBS. For Alexa 532 staining, 1:40 dilution 
of Alexa Fluor 532 with PBS was added to fixed HeLa cells for 30 minutes, removed, 
and washed three times with PBS. Fixed cells were mounted using Prolong Gold 
Antifade Mountant (ThermoFisher Scientific). To acquire STED images, a Leica DMI8 
confocal system with STED lasers was used. For [(Ru(bpy)2phen-Ar)2-ER]
9+ , a 488 nm 
white light laser was used to excite the complex collecting the emission  between 590 -
700 nm, and a 528 nm white light laser was used to excite Alexa 532 collecting the 
emission between 534 – 675 nm with a 100X oil immersion objective. For 
[Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ the 470 nm confocal laser line and a 660 nm STED 
depletion laser. Images were scanned at 1024 x 1024 resolutions using a scan speed of 
0.01/s. A line accumulation of 6x was used, where the laser scanned each line 6 times to 
collect enough photons. A frame accumulation of 2x was used to eliminate as much 
background as possible and to collect a high number of photons. A time gating system 
was used to separate the two complexes. Alexa 532 was set to 0 - 3.5 ns, and ruthenium 
set to 5 – 12 ns. A 660 nm depletion laser was used to acquire the STED images, and 
images were accumulated twice for best signal. Images were deconvolved using 
Huygens Professional software. All data and FWHM analysis were carried out on raw 
images before deconvolution process using OriginPro.  
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5.2.9 Photostability Studies 
HeLa cells were seeded on poly-L-lysine coated 35 mm glass slides  at 1.5 x 105 for 48 
h. [(Ru(bpy)2phen-Ar)2-ER]
9+ (70 μM) was added to the cells for 4 h at 37 °C and 5 % 
CO2 in the absence of light. The cells were washed twice with supplemented PBS. The 
cells were fixed with 3.8 % paraformaldehyde for 15 minutes and washed with PBS. For 
Alexa 532 staining, 1:40 dilution of Alexa Fluor 532 with PBS was added to fixed HeLa 
cells for 30 minutes, removed and washed three times with PBS. Fixed cells were 
mounted using Prolong Gold. The samples were imaged using the optimised STED 
settings described in section 5.2.7. A 488 nm white light laser was used to excite 
[(Ru(bpy)2phen-Ar)2-ER]
9+ , collecting the emission  between 590 -700 nm, and a 528 
nm white light laser was used to excite Alexa 532 collecting the emission between 534 
– 675 nm with a 100X oil immersion objective. The STED depletion line at 660 nm at 
0.05 W was used for both samples. The images were acquired at 1024 x 1024 resolution 
every 1 minutes over a 30 minute window at a pixel dwell time of 2.43 μs. The emission 
intensity of a selected area in both samples was measured at each time interval over the 
30 minutes and the intensity data was plotted to show stability over time. 
 
 
5.3 Photophysical properties and Characterisation  
 
5.3.1 [(Ru(bpy)2-phen-Ar)-ER]9+ 
Scheme 5.1 illustrates the structure of [(Ru(bpy)2phen-Ar-COOH)], in this instance, 
conjugated to endoplasmic reticulum directing peptide sequence 
RQIKIWFQNRRMKWKK, described in section 5.2.2, to yield [(Ru(bpy)2phen-Ar)2-
ER]9+. The sequence comes from the Drosophila transcription factor Antennepedia, 
which is made up of 60 amino acids.38 It is this particular 16 amino acid peptide 
sequence, also known as Penetratin 39 that is responsible for internalisation by all 
cells.40,41 The sequence corresponds to the 3rd helix of the DNA binding domain of 
Antennepedia. Although the sequence is long, it is rich in arginine (R) and lysine (K) 
residues, which are well known to promote cell uptake due to their positive charge.42,43  
 
239 
 
 
 
 
Scheme 5.1 Chemical structure of [(Ru(bpy)2-phen-Ar)-ER]9+  
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Figure 5.1 shows the spectroscopic properties of [(Ru(bpy)2phen-Ar)2-ER]
9+ in aqueous 
solution. The parent complex [Ru(bpy)2phen-Ar-COOH]
2+, which was discussed in 
Chapter 3, exhibits an electronic absorption maximum at 460 nm. Upon conjugation to 
the endoplasmic reticulum (ER) directing peptide sequence RQIKIWFQNRRMKWKK, 
the absorption shows a slight blue shift in peak maximum to 454 nm, which is assigned 
to the metal dπ to ligand π* charge transfer (MLCT) transition. The strong absorbance 
band observed at 284 nm arises from a π-π* transition of the polypyridyl ligands. 
 
 
Figure 5.1 Spectroscopic data of [(Ru(bpy)2-phen-Ar)-ER]9+ in PBS (50 μM). The absorbance (—), 
and the emission under aerated (—) and de-aerated (- - -) conditions when excited at 454 nm. Slit 
width = 5 nm.  
 
When excited into the MLCT transition at 454 nm, an intense emission peak is observed, 
which is centred at λmax 602 nm. When de-aerated with nitrogen for 15 minutes, 
[(Ru(bpy)2-phen-Ar)-ER]
9+ emission intensity increases as expected, as oxygen 
quenching is reduced. The lifetime of [(Ru(bpy)2-phen-Ar)-ER]
9+ was measured using 
TCSPC, and was found to be 683 ± 8 ns in aerated PBS solution (pH 7.4). Upon de-
aeration with nitrogen, the lifetime increased from 683 ± 8 ns to 1.064 μs ± 14 ns. This 
is considerably higher than the parent complex, but similar to pervious peptide 
conjugates discussed in Chapter 3. [Ru(bpy)2phen-Ar-COOH]
2+, the parent complex has 
a quantum yield (φ) of 0.046 ± 0.003. Upon conjugation to the ER peptide sequence, 
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surprisingly, the quantum yield decreases to 0.032 ± 0.0015, possibly as a result of the 
large peptide sequence.  
 
5.3.2 [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ 
Scheme 5.2 describes the structure of [Ru(dppz)(bpy)(bpyArCOOH)]2+ parent complex 
conjugated to the nuclear localising sequence (NLS) VQRKRQKLMP–NH2, to yield the 
complex [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+, where dppz = dipyrido[3,2–a:2’,3’-
]phenazine). The peptide sequence VQRKRQKLMP is known as NF-κB. The sequence 
originates from the NF-κB transcription factor. Its function is to internalise NF-κB to 
the nucleus.44,45 
 
 
Scheme 5.2 Chemical structure of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ 
 
Figure 5.2 shows the spectroscopic properties of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+. In 
both acetonitrile and water, the absorbance exhibits similar peak features. The band at 
282 nm is assigned to the bpy-centered π-π* transitions, in comparison with 
[Ru(bpy)3]
2+. The band at 354 nm can be ascribed to the dppz intraligand π-π* 
transitions.46 A peak maximum at 454 nm is assigned to the metal centre π to the 
phenazine ligand π* charge transfer (MLCT) transition.47 In non-aqueous media, when 
excited into the MLCT at 454 nm, a strong emission peak is observed, centred at 620 
nm. However, in aqueous solution, [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ does not emit. 
This confirms that [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ behaves, as described for related 
DPPZ containing complexes as a ‘light switch’. The ‘light switch’ effect is as a result of 
the phenazine moiety coming in contact with the nitrogen atoms in water.31  
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Figure 5.2 Absorbance and emission spectra of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ in MeCN (—) and 
water (—) at 10 μM. Slit width 5 nm. 
 
The luminescent lifetime of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ was found to be 241 ± 1 
ns in aerated acetonitrile solution, which increased to 408 ± 20 ns when de-aerated with 
nitrogen. There was no luminescent lifetime in aqueous PBS solution as 
[Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ does not emit in water. Table 5.1 summarises the 
photophysical data of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+and [(Ru(bpy)2-phen-Ar)-ER]
9+ 
for comparison. 
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Table 5.1 Photophysical properties of the [Ru(bpy)2phen-Ar-COOH]2+ parent complex and  
[(Ru(bpy)2-phen-Ar)-ER]9+ in PBS solution, and [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ in MeCN. 
* ER = peptide sequence RQIKIWFQNRRMKWKK 
§ NFκB = peptide sequence VQRKRQKLMP 
Complex Φ  
(%) 
UV-Vis  
Absmax 
(nm) 
Emmax 
(nm) 
τ (ns) 
aerated 
(18 °C) 
τ (ns) 
deaerated 
(18 °C) 
[Ru(bpy)2phen-Ar-
COOH]2+ 
0.046 ± 
0.003 
460  604 455 ± 11  780 ± 9  
[(Ru(bpy)2phen-
Ar)2-ER]9+ * 
0.032 ± 
0.0015 
454  602 683 ± 8  1.064 μs ± 
14 ns 
[Ru(dppz)(bpy)(bpy-
Ar-NFkB)]6+ § 
 454 620 241 ± 1  408 ± 20  
 
 
 
5.4 Cell uptake and Endoplasmic reticulum co-localisation of [(Ru(bpy)2-
phen-Ar)-ER]9+ 
In order to assess the ability of [(Ru(bpy)2-phen-Ar)-ER]
9+ to cross the cell membrane 
and localise in the endoplasmic reticulum (ER), HeLa cells were used. HeLa cells were 
prepared as described in section 5.2.5. All images were acquired using a Leica TSP 
DMi8 confocal microscope with a 100X oil immersion objective lens. Ru(II) was excited 
using a 488 nm white light laser line and its emission was collected between 590 – 700 
nm. 
 
244 
 
5.4.1 Cell uptake studies of [(Ru(bpy)2-phen-Ar)-ER]9+ 
Uptake studies of [(Ru(bpy)2-phen-Ar)-ER]
9+ were carried out in live HeLa cells. In 
Chapter 3, it was demonstrated that [Ru(bpy)2phen-Ar-COOH]
2+ parent complex did not 
cross the cell membrane. [(Ru(bpy)2-phen-Ar)-ER]
9+ (70 μM) was incubated with HeLa 
cells at 37 °C in the absence of light and its uptake was assessed.  
Uptake was found to be instantaneous using confocal microscopy upon incubation with 
[(Ru(bpy)2-phen-Ar)-ER]
9+ in phenol red-free media. After 2 hr, the complex was found 
to distribute throughout the cytoplasm, localising around but not entering, the nuclear 
envelope, as illustrated in Figure 5.3. A and B expand a selection of HeLa cells, 
demonstrating that the uptake is the same throughout the sample. C and D focus on a 
single HeLa cell for a more detailed view on the uptake. 
 
Figure 5.3 Confocal microscopy of HeLa cells incubated with [(Ru(bpy)2-phen-Ar)-ER]9+  (70 μm) 
in phenol red-free media for 2 h at 37 °C in the absence of light. A and C show [(Ru(bpy)2-phen-Ar)-
ER]9+  emission channel, and B and D show the overlay with the background channel.  The complex 
was excited using a 488 nm white light laser, and its emission was collected between 590 - 700 nm. 
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After 4 hr, [(Ru(bpy)2-phen-Ar)-ER]
9+ appeared to have become selectively localised in 
the cell. Figure 5.4 illustrates the uptake in HeLa cells after 4 hr exposure. A and B 
describe a selected area of HeLa cells, are representative of the broader sample. The 
distribution within the cells was consistent throughout the selected area, and the whole 
sample. [(Ru(bpy)2-phen-Ar)-ER]
9+ appeared to have localised in a punctate manner in 
the cells, around the nuclear envelope. 
 
Figure 5.4 Confocal microscopy of [(Ru(bpy)2-phen-Ar)-ER]9+ HeLa cells. The cells were incubated 
with 70 μM of [(Ru(bpy)2-phen-Ar)-ER]9+ in phenol red-free media for 4 h at 37 °C. [(Ru(bpy)2-
phen-Ar)-ER]9+ was excited at 488 nm and its emission collected between 590 - 700 nm. 
 
Figure 5.4 C and D describes a single HeLa cell, illustrating that [(Ru(bpy)2-phen-Ar)-
ER]9+ is nuclear excluding. Its localisation around the nuclear envelope suggests that it 
could be residing in the endoplasmic reticulum (ER). The peptide sequence 
RQIKIWFQNRRMKWKK has been shown previously to be taken up by 
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endocytosis.48,49 The punctate manner may suggest that the complex was taken up by 
endocytosis, and resides in tiny vesicles in the ER. 
 
5.4.2 Endoplasmic reticulum localisation studies 
To assess if the ER peptide sequence RQIKIWFQNRRMKWKK was successful in 
directing a ruthenium polypyridyl complex to the ER, co-localisation studies were 
carried out. HeLa ells were prepared as described in section 5.2.5. After 4 hr incubation 
with [(Ru(bpy)2-phen-Ar)-ER]
9+  (70 μM), HeLa cells were dual-stained with the 
commercial probe ER-Tracker Blue (1 μM) for a further 30 minutes before imaging. 
Figure 5.5 shows the accumulation of the complexes in HeLa cells, where [(Ru(bpy)2-
phen-Ar)-ER]9+ is represented in red, ER-Tracker Blue in blue, and their co-localisation 
in purple. To confirm that [(Ru(bpy)2-phen-Ar)-ER]
9+ and ER-Tracker Blue were 
coincident in the ER, a line section across a random location on a HeLa cell was selected 
and its corresponding fluorescent intensity profile was plot. The distribution intensities 
coincide exactly, confirming that the two complexes reside in the ER, and both probes 
are nuclear excluding.  
 
 
 
Figure 5.5 Co-localisation of [(Ru(bpy)2-phen-Ar)-ER]9+ (red) and ER-Tracker Blue (blue) in HeLa 
cells. The corresponding intensity distribution plot confirms that [(Ru(bpy)2-phen-Ar)-ER]9+  (red) 
and ER-Tracker Blue (black) are coincident in the ER. [(Ru(bpy)2-phen-Ar)-ER]9+  was excited at 
488 nm and its emission was collected at 590 – 700 nm. ER-Tracker Blue was excited at 405 nm and 
its emission was collected at 450 – 550 nm.  
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Upon closer examination of the STED image, discussed later in section 5.10 the mosaic 
manner in which [(Ru(bpy)2-phen-Ar)-ER]
9+ is localising in the ER could suggest the 
complex is within the smooth ER of the cell. The smooth ER consists of a double 
membrane that makes up sacs called cisternae. Compared to the rough ER, the smooth 
ER has no ribosomes attached to it, and appears more dilated and convoluted. 50 
This result demonstrates that the peptide sequence RQIKIWFQNRRMKWKK is highly 
effective in directing ruthenium complexes across the cell membrane and selectively to 
the ER of a cell. 
 
5.5 Cell uptake and nuclear localisation of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ 
In order to assess the ability of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ to cross the cell 
membrane and nuclear envelope to localise in the nucleus, HeLa cells were again used. 
Cells were prepared as described in section 6.2.5. All images were acquired using a 
Leica TSP DMi8 confocal microscope with a 100X oil immersion objective lens. Ru(II) 
was excited using a 470 nm white light laser line and its emission was collected between 
570 – 700 nm. 
 
5.5.1 Live uptake of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ 
Live uptake studies were carried out to assess the efficiency of uptake. 
[Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ (40 μM) was added to the cells in HeLa media, and 
the uptake was monitored every 3 minutes by confocal microscopy. Figure 5.6 describes 
the uptake every 15 minutes over a 60 minute time period. As expected, no emission is 
observed in the aqueous media. After 45 minutes, a slight emission can be observed from 
the cell membrane, which reflects the less aqueous conditions found in a lipid 
membrane. No emission wold be expected from the cytoplasm of the cell due to the 
aqueous environment. 
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Figure 5.6 Live uptake of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ in HeLa cells. Uptake was monitored 
and confocal image was collected every 15 minutes. [Ru(dppz)(bpy)(bpy-Ar-NLS)]6+ was excited 
using a 470 nm white light laser and the emission was collected between 565-700 nm. 
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The cells were incubated with [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ over 24 h and imaged 
to monitor uptake. Figure 5.7 describes a group of HeLa cells after 6 h incubation with 
the complex. Emission can be observed from the cell membrane, and now from the 
cytoplasm.  
 
 
Figure 5.7 Confocal microscopy of live HeLa cells incubated with [Ru(dppz)(bpy)(bpy-Ar-
NFkB)]6+ for 6 h  in cell media at 37 °C in the absence of light. [Ru(dppz)(bpy)(bpy-Ar-NLS)]6+ was 
excited using a 470 nm white light laser and the emission was collected between 565-700 nm. 
 
It is possible that [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ is binding to RNA that is present in 
the cytoplasm. Ragin et al have previously demonstrated that the NLS sequence NF-κB 
locates in the cytosol and nucleus.44 When bound to RNA, [Ru(bpy)2(dppz)]
2+ has been 
shown to luminesce, although not as brightly as when bound to nuclear DNA.51 As no 
luminescence was observed in the nucleus, the cells were left to incubate further.  
Figure 5.8 shows confocal fluorescence images of HeLa cells following their incubation  
with [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ for 24 h, focusing on three different HeLa cells 
in the sample where the complex has not bound to nuclear DNA (A), and when it has 
bound (B and C). The uptake across the sample varied. No luminescence in the nucleus 
was observed in some cells, represented in (A). However, [Ru(dppz)(bpy)(bpy-Ar-
NFkB)]6+ did enter and bind to nuclear DNA in the majority of cells. The luminescence 
in (B) confirms that the complex has been ‘switched on’ as a result of binding. Under 
the same imaging conditions, the luminescence in (C) is brighter than that of (B) 
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suggesting that intercalation with the DNA has occurred. The [Ru(bpy)2(dppz)]
2+ 
complex has been demonstrated to bind to DNA, displaying intense luminescence, but 
can also intercalate with the double helix, further enhancing the luminescence.47 The 
uptake and binding in the nucleus does not appear to be uniform across all the cells in 
the sample – this may be a consequence of the different stages in the cell life cycle, or 
due to variation in the rate at which binding is occurring.  
 
 
Figure 5.8 HeLa cells incubated with 40 μM [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ for 24 h. No 
luminescence was observed in the nucleus in a couple of cells across the sample (A). When bound, 
[Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ luminescence is observed (B), and emits more intensely wen 
intercalated with the DNA (C). [Ru(dppz)(bpy)(bpy-Ar-NLS)]6+ was excited using a 470 nm white 
light laser and the emission was collected between 565-700 nm. 
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5.5.2 Nuclear localisation of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ 
To confirm that [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ had entered the nuclear envelope, 
HeLa cells were incubated with the commercial probe DAPI (300 nM). HeLa cells were 
prepared as described in section 5.2.5. Prior to imaging, DAPI was introduced to the 
cells for 1 h at 37 °C in the absence of light. The cells were washed and imaged. Figure 
5.9 describes the nucleus of a HeLa cell, dual stained with [Ru(dppz)(bpy)(bpy-Ar-
NFkB)]6+ represented in red, DAPI in blue, and their co-localisation in pink/purple. 
From the image, both complexes appear to reside in the nucleus in a similar manner.  
 
 
Figure 5.9 Co-localisation of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ (40 μM) (red) and DAPI (300 nM) 
(blue) in the nucleus of a single HeLa cell. [Ru(dppz)(bpy)(bpy-Ar-NLS)]6+ was excited using a 470 
nm white light laser and the emission was collected between 565-700 nm. DAPI was excited at 633 
nm and the emission was collected between 637-730 nm. The corresponding plot profile indicating 
both compounds co-localize within the nucleus, where (—) represents [Ru(dppz)(bpy)(bpy-Ar-
NLS)]6+  and (—) DAPI. 
 
To prove that the two complexes were coincident in the nucleus, a line section across 
the sample was selected and its corresponding fluorescent intensity profile was plotted, 
show in in Figure 5.9. The distribution plot confirms that the two complexes both reside 
in the nucleus.  Similar results have been reported from Blackmore et al using the NF-
κB sequence.45 They successfully directed two Ru(II) complexes, [Ru(bpy)2PIC-βAla-
NFkB]6+  and [Ru(dpp)2PIC-βAla-NFkB]6+ to the nucleus of CHO cells. This result 
indicates the high selectivity of the NF-κB peptide sequence in directing transition metal 
complexes, of different ligand compositions, to the nucleus. 
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5.6 Phosphorescent lifetime imaging (PLIM) of [Ru(dppz)(bpy)(bpy-Ar-
NFkB)]6+ in the nucleus 
As discussed earlier in section 5.3.2, there is no luminescence observed from 
[Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ in aqueous solution, but is switched on when in a non-
aqueous environment, such as when it is bound to DNA. PLIM can be applied to measure 
the luminescent lifetime of the complex when it begins to bind with nuclear, and monitor 
the intercalation process with DNA from within the nucleus. 
As illustrated by Figure 5.8 A, [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ luminescence was not 
observed in the nucleus of all cells in the sample when they had been incubated with the 
complex for 24 h at 37 °C in the absence of light. However, absence of luminescence 
does not necessarily mean the complex has not entered the nucleus as it may be present 
but not bound to DNA, and therefore is incapable of emitting. Phosphorescence lifetime 
imaging microscopy (PLIM) was carried out to assess if the complex had entered the 
nucleus but had not yet intercalated with DNA. Figure 5.10 shows the confocal imaging 
and the corresponding false-colour PLIM image of the lifetime distributions in the cell. 
The cells were prepared as described in section 5.2.7. Figure 5.10 (A) shows a live single 
HeLa cell incubated with [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ for 24 h. A slight emission 
from [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ can be observed around the nuclear envelope, 
but there is no indication it has intercalated with DNA. The PLIM image shows that the 
ruthenium complex localised in the nucleus, which exhibits a different luminescent 
lifetime distribution than the dye in the cytoplasm. Using SymphoTime Software it was 
found that the lifetime of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ in the nucleus was 189 ns, 
compared to 398 ns when bound to membrane structures in the nucleus (B), further 
protecting [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ from an aqueous environment. This is a 
significant increase from the lifetime in non-aqueous solution, which was found to be 
241 ns. As there is no emission when [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ is in an aqueous 
environment, the emission lifetime from (A) suggests that [Ru(dppz)(bpy)(bpy-Ar-
NFkB)]6+ has entered the nucleus and has bound to some DNA proteins present, but has 
not yet intercalated with the DNA.  
On the other hand, the complex emission from the cytoplasmic region exhibited a shorter 
luminescent lifetime than the lifetime when in the nucleus, ranging between 36 and 67 
ns compared to 398 ns, indicating that the complex is not bound to DNA but is shielded 
from the water molecules. Examining the structural distribution of the dye in the cell, 
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indicates that the emission is coming from the membrane structures in the nucleus of the 
cell. Such emission on DPPZ binding to lipid membrane structures has been reported 
before and is attributed to weak intercalation of this ligand into the membrane. Cosgrave 
et al observed similar binding membrane structures with [Ru(dppz)2PIC-Arg8]
10+ 
complex in Sp2 mouse myeloma cells. 52  The longer nuclear lifetimes compared to the 
cytoplasm indicates that protection from the surrounding water molecules is more 
effective when [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+  is bound to DNA compared to 
membrane structures. Similar results were reported by Baggaley et al. They reported on 
a dinuclear ruthenium polypyridyl complex that when bound to nuclear DNA, and 
demonstrated a decrease in luminescent lifetime in the cytoplasm (124 ns) compared to 
the nucleus (200 ns) using PLIM.35 
 
 
Figure 5.10 Confocal and luminescent lifetime images of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ (40 μM) 
in the nucleus of HeLa cells comparing when unbound (A) and bound (B) to nuclear proteins and 
membrane structures. [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ was excited at 488 nm and the emission was 
collected using a long pass 560 nm filter. The PLIM image was acquired by exciting at 405 nm, and 
emission was collected using a long pass 530 nm filter. 
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5.7 Cytotoxicity  
The toxicity of [(Ru(bpy)2-phen-Ar)-ER]
9+ was evaluated in HeLa cells, as described in 
section 5.2.6, and compared to the toxicity of [(Ru(bpy)2phen-Ar)2-Arg8]
10+. As 
discussed in Chapter 3, it was found that [(Ru(bpy)2phen-Ar)2-Arg8]
10+ was highly toxic 
towards HeLa cells, where only 40 % of cells remained viable at 50 μM after 24 h 
exposure to the complex. Figure 5.11 demonstrates that, in contrast to [(Ru(bpy)2phen-
Ar)2-Arg8]
10+, [(Ru(bpy)2-phen-Ar)-ER]
9+ displayed little to no toxicity towards HeLa 
cells over 24 hours incubation. 
 
Figure 5.11 Cytotoxicity studies of [(Ru(bpy)2-phen-Ar)-ER]9+ (♦) and (■) [(Ru(bpy)2phen-Ar)2-
Arg8]10+  in HeLa cells over 24 h at 37 °C in the absence of light. The Resazurin (Alamar Blue) assay 
was used to determine the percentage (%) of viable cells remaining. (n = 3) 
 
After 24 h exposure, it was found that 72 % of cells were still viable at high 
concentrations of 200 μM [(Ru(bpy)2-phen-Ar)-ER]9+, where 0 % were viable at 200 
μM [(Ru(bpy)2phen-Ar)2-Arg8]10+.  As the metal complex in each probe is identical the 
distinction in terms of toxicity must be attributable to the identity of the peptide. This 
may be because the octa-arginine is fundamentally cytotoxic which we can exclude on 
the basis that other Ru(II) complexes bound to this peptide (e.g. Chapter 2) were not 
cytotoxic or it may be a result of the variation in location of the metal complex as a 
consequence of peptide targeting.   The octa-arginine peptide sequence distributes the 
complex throughout the entire cell, with no organelle specificity, whereas the ER peptide 
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leads to precise targeting and localisation of the metal complex to within the smooth ER. 
The smooth ER is involved in the production and storage of lipids, regulation of 
intracellular Ca2+, and detoxification.53 Whereas on the other hand, [(Ru(bpy)2phen-
Ar)2-Arg8]
10+ enters many cellular organelles including the mitochondria. As the 
mitochondria are involved in the production of the cell energy in the form of ATP, and 
in respiration, any interference here would expect to have toxic effects towards the cell. 
Therefore, the [(Ru(bpy)2-phen-Ar)-ER]
9+ complex localising in the smooth ER alone 
may prevent toxic effects on the cell over the 24 h exposure period of this experiment. 
Similarly, the toxicity of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+  was evaluated in HeLa cells 
as described previously in section 5.2.6. It was compared to the parent complex 
[Ru(dppz)(bpy)(bpyArCOOH)]2+, and to the octa-arginine conjugate, 
[Ru(dppz)(bpy)(bpy-Ar-Arg8]
10+, to assess if location was a factor in the toxicity of the 
complex. Figure 5.12 shows the results. As expected, the parent complex did not induce 
toxicity as it is not taken up by the cells.  
 
 
Figure 5.12 Cell viability studies in HeLa cells. [Ru(dppz)(bpy)(bpyArCOOH)]2+ parent complex 
(•), [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ (▄), and [Ru(dppz)(bpy)(bpy-Ar-Arg8]10+  (▲) were added to 
HeLa cells at various concentrations and left to incubate for 24 h at 37 °C in the absence of light. 
The resazurin (Alamar Blue) assay was used to determine the percentage (%) of viable cells 
remaining. (n = 2). 
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Whereas [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ was found to be moderately toxic towards 
the cells, with 55 % still viable after exposure to 200 μM for 24 h. At 50 μM, 73 % 
remained viable.  This reflects the results from the uptake studies, where the cells were 
still viable after incubation with 40 μM for 24 h. This result is somewhat surprising as 
the complex is localised in the nucleus and intercalating with the nuclear DNA, where it 
might be expected to impeded cell division. Interestingly in contrast to the very high 
toxicity of [(Ru(bpy)2phen-Ar)2-Arg8]
10+ when incubated with [Ru(dppz)(bpy)(bpy-Ar-
Arg8]
10+ , 83 % of cells were still  viable at 200 μM and 88 % and 50 μM. This result 
indicates that, as indicated in Chapter 3, it is indeed the [(Ru(bpy)2phen-Ar)]
2+ complex 
that is toxic, but that its ability to exert a toxic effect depends on its location, it would 
appear to be toxic when it enters the mitochondria. Many reported metal complexes used 
as a DNA stain possess anti-proliferative effects on the cells over long exposure times 
as a result of localising in the nucleus, interfering with processes involving DNA. For 
example, Gill et al reported on [Ru(phen)2(tpphz)]
2+ metallo-intercalator, which 
exhibited high toxic effects towards human cancer cells.54 In other work, Barton et al 
reported on a highly toxic rhodium complex, whose toxicity was a result of it binding to 
DNA.55 Following 24 h exposure to the complex, less than 10 % of cells remained viable 
at low concentrations of 25 μM. Such complexes are useful as anti-proliferative, anti-
cancer drugs. However, their high toxicity is not ideal for cell imaging of nuclear DNA. 
On the other hand, the low toxicity of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ allows for the 
complex to be applied as a DNA imaging agent to image chromosomal DNA in live 
cells. However, photocytotoxicity may become an issue over extended imaging 
windows. 
 
5.8 Application of Ru(II) complexes to super resolution microscopy 
As discussed previously, ruthenium complexes possess the properties for stimulated 
emission depletion (STED) microscopy. Their large Stokes shift, high quantum yields, 
long lived emissive state are among the desired properties of a STED imaging probe. 
Both [(Ru(bpy)2-phen-Ar)-ER]
9+ and [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+  displayed 
many of these important properties, when evaluated in section 5.3.  
Alexa Fluor Phalloidin 532 is a commercial prove that stains the actin filaments in a cell. 
Alexa Fluor dyes are known for their high quantum yields and photostability, which 
have been applied to super resolution microscopy.14,18,56 
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Figure 5.13 shows the fluorescence spectra of [(Ru(bpy)2-phen-Ar)-ER]
9+ excited at 470 
nm and emission detection at 611 nm, and Alexa 532 excited at 528 nm and emission 
detected at 552 nm. The excitation and emission of [(Ru(bpy)2-phen-Ar)-ER]
9+ (red) 
demonstrate its large Stokes shift. The absorbance and emission spectra of Alexa 532 
confirms that there is no spectral overlap with [(Ru(bpy)2-phen-Ar)-ER]
9+. Therefore, 
they can be introduced into a single sample for comparison to asses if they are suitable 
for STED imaging of cells. 
 
Figure 5.13 Spectral rationale of confocal and STED setup. Ruthenium excitation and emission (—
), and Alexa Fluor 532 excitation and emission spectra (—), in aerated PBS solution. 
 
Figure 5.13 also shows the STED depletion laser at 660 nm. Both [(Ru(bpy)2-phen-Ar)-
ER]9+ and Alexa 532 emission profiles overlap with the 660 nm depletion laser, 
indicating that they are well suited for this laser line without re-absorption by the ground 
state of the dye. 
In order to achieve emission depletion through STED and avoid re-excitation, the STED 
laser line must overlap with the tail of the emission spectra. In the case of [(Ru(bpy)2-
phen-Ar)-ER]9+ , it has an Emmax at 611 nm. Therefore, the 660 nm STED depletion 
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laser coincides with the red tail of the emission spectra, to give sufficient depletion 
without re-excitation. In the case of Alexa 532, it has an Emmax at 552 nm. From Figure 
5.13, the 660 nm STED depletion laser overlaps slightly with the tail of the emission 
spectra. As it only slightly overlaps, it might be expected that the 592 nm STED 
depletion laser would result in better emission depletion than the 660 nm laser as 592 
nm overlaps more with the emission tail. Therefore, the performance of the complex was 
assessed comparing depletion separately by both 592 nm and 660 nm depletion laser 
lines. HeLa cells were prepared as described in section 5.2.8. HeLa cells were fixed with 
3.8 % paraformaldehyde, then stained with Alexa 532 (1: 40) for 30 minutes, and washed 
three times with PBS. Cells were mounted using ProLong Gold Antifade Mountant for 
24 h. This ensures the sample has a refractive index (RI) = 1.47, which is closely 
matched to the index of the immersion oil used (1.518). Figure 5.14 shows STED images 
of a single HeLa cell. The images were acquired using the 592 nm (A) and 660 nm (B) 
depletion lasers. It might be expected that the 592 nm laser would be better suited to 
Alexa 532 depletion due to closer overlap of with its emission spectrum. However, it is 
evident from the images that the overall resolution and clarity is much improved 
following excitation with the 660 nm laser.  
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Figure 5.14 STED imaging of Alexa Fluor Phalloidin 532 in HeLa cells fixed with 3.8 % 
paraformaldehyde and mounted with Prolong Gold. The STED images were collected following 
excitation with the 592 nm (A) and 660 nm (B) depletion lasers. The following X-Y plot confirms 
the improved resolution and elimination of background noise upon exciting with the 660 nm laser 
(—) compared to the 592 nm laser (—). 
 
This is confirmed by the X-Y plot of the selected line profile through the region of 
interest. The plot from the 660 nm image (—) displays much improved resolution 
compared to the plot at 592 nm (—). For example, between 1000 nm and 1500 nm across 
the X-Y profile in Figure 5.14, the actin filaments are resolved when excited with the 
660 nm depletion laser, resulting in more detail observed in the peaks in the X-Y plot 
compared to the wider, more intense peaks when the 592 nm laser was used. An 
improvement in structural detail of the actin filaments is obtained  exciting at 660 nm, 
because it reduces the background noise which was observed when the 592 nm laser 
which is attributed to re-excitation of the Alexa under this wavelength. This results in 
an overall sharper, clearer image. This confirms that the 660 nm depletion laser is best 
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suited towards Alexa 532, and can be used as a comparison to assess the performance of 
[(Ru(bpy)2-phen-Ar)-ER]
9+ as a STED imaging probe. 
 
5.9 Confocal microscopy versus STED microscopy of dual-stained HeLa cells 
Single-colour staining means that only one molecular species can be observed in a cell 
at a given time. Dual-staining allows for multiple organelles to be imaged during the 
course of a single experiment. Such experiments can enable one to study and monitor 
multiple sites, particularly dynamics at multiple sites within a single cell at once. For 
dual colour experiments the chosen luminophores must not spectrally overlap, but at the 
same time must be depletable using a single STED depletion laser. As discussed in 
section 5.6, the ruthenium (II) poplypyridyl complex and Alexa 532 emission spectra do 
not overlap but both species emission can be stimulated for each with the 660 nm STED 
depletion laser. To evaluate [(Ru(bpy)2-phen-Ar)-ER]
9+ and [(Ru(bpy)2phen-Ar)2-
Arg8]
10+ as STED probes, HeLa cells were prepared with either [(Ru(bpy)2-phen-Ar)-
ER]9+  or [(Ru(bpy)2phen-Ar)2-Arg8]
10+ (70uM) as described in section 5.2.8 and were 
dual-stained with Alexa 532. Samples were mounted with ProLong Gold Antifade 
Mountant for 24 h, and were imaged by both confocal and STED microscopy using a 
Leica TSP DMi8 instrument. 
Figure 5.15 shows a single HeLa cell using a 100X objective lens, where the image was 
collected from the edge of the cell, showing the actin filaments in the cell. Here, the 
confocal image was compared to the super-resolution image. Figure 5.15 A compares a 
confocal and continuous wave STED (CW-STED) image at the region of interest. The 
confocal image was obtained by exciting at 528 nm and collecting the emission between 
534 – 675 nm. Figure 5.15 B shows [(Ru(bpy)2phen-Ar)2-Arg8]10+, which was excited 
at 488 nm, and the emission was collected between 590 – 700 nm. 
Upon dual staining, it is evident that Alexa 532 has forced some [Ru(bpy)2phen-Ar)2-
Arg8]
10+ complex to enter the actin filaments. Alexa 532 has an overall negative charge, 
and the phalloidin has a very strong affinity for the actin filaments in a cell. As the cells 
require fixing with 3.8 % paraformaldehyde in order to stain with Alexa 532, the 
negative charge of the probe may cause association of the positively charged 
[Ru(bpy)2phen-Ar)2-Arg8]
10+ drawing it with it as it stains the actin filaments.  As will 
be discussed in section 5.10, when stained and fixed by itself, [Ru(bpy)2phen-Ar)2-
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Arg8]
10+ does not stain the actin filaments, indicating it is phalloidin that drives 
[Ru(bpy)2phen-Ar)2-Arg8]
10+ to the actin filaments on fixing. The overall resolution of 
the CW-STED images has improved compared to the confocal images. To further 
evaluate the improvement of using CW-STED versus confocal imaging, the full width 
half maxima (FWHM) of a selected filament of each complex was assessed. The full 
width half maxima of the point spread function is used to evaluate the relative quality of 
the confocal and CW-STED images. The fluorescence intensity of the X-Y plots are 
fitted to a Gaussian distribution in order to measure the FWHM.  In the case of 
[(Ru(bpy)2phen-Ar)2-Arg8]
10+, the FWHM was greatly improved from 226.66 nm in the 
confocal image, to 86.8 nm after acquiring a CW-STED image. In comparison, the 
FWHM of Alexa 532 reduced just slightly from 363.8 nm to 315.4 nm. After using CW-
STED, [(Ru(bpy)2phen-Ar)2-Arg8]
10+ exhibited more than a 60 % improvement 
compared to only 10 % for Alexa 532. Urban et al reported on STED imaging of the 
actin filaments in a neuronal cell57 where they used Lifeact YFP to label the actin of the 
live cells. They excited the sample at 490 nm and used a 595 nm STED depletion laser 
to image to actin filaments inside synapses of up to 120 μm below the tissue surface. 
They were able to achieve spatial resolutions of between 60 to 80 nm of the actin 
filaments. These results are similar to the resolution achieved using [(Ru(bpy)2phen-
Ar)2-Arg8]
10+ to inadvertently image the actin of HeLa cells.  
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Figure 5.15 Alexa 532 (A) and [(Ru(bpy)2phen-Ar)2-Arg8]10+  (B) in a fixed single HeLa cell. The 
confocal image and CW-STED image of each complex is compared, with their corresponding 
intensity plot profiles describing the full width half maxima (FWHM) improvements in resolution. 
The FWHM was obtained by fitting fluorescence-intensity to Gaussian distributions (OriginPro). 
Alexa 532 was excited at 528 nm and the emission was collected between 534 and 675 nm. 
[Ru(bpy)2phen-Ar)2-ER]9+ was excited using a 488 nm white light laser and 660 nm depletion laser. 
The 660 nm STED depletion laser was used for both probes. 
 
5.10 Evaluation of time-gated STED microscopy 
Up until now, all of the STED images acquired in this chapter were carried out using 
continuous wave STED (CW-STED). Time-gated detection in super resolution serves 
as a spatial filter that reduces background noise and any auto-fluorescence from the 
sample, improving the resolution of the image quality.58,59 Time-gated STED is also very 
useful in resolving two dyes with different excited emissive lifetimes.60,61  Time-gate 
detection is used in fluorescence microscopy to suppress background from an image 
such as auto-fluorescence. Time-gate imaging exploits the luminescent lifetime of the 
probe by eliminating the detection of arriving excited photons based on their arrival 
times. Auto-fluorescence and background noise typically have fluorescent lifetimes of 
~3 ns. Using time-gate imaging can eliminate such interferences based on the lifetime 
of the detected photons to improve spatial resolution. For this reason, probes that possess 
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long luminescent lifetimes are ideal for imaging using this technique. Time-gate 
detection limits the detected fluorescence of each channel and suppresses the detection 
signals in the first nanosecond after the excitation pulse, which results in a reduced 
detected fluorescence signal. The loss of signal, however, is compensated by the 
increased resolution achieved.62 Using continuous-wave (CW) laser in STED reduces 
the complexity and increases the versatility of the system. However, CW lasers result in 
a lower peak intensity compared to a pulsed laser, which reduces the overall resolution 
of CW-STED system as it continuously excites the fluorophores all at the same time. 
Therefore, using time-gating detection improves on the resolution by discarding the 
early photons and recording the photons located at the donut centre of the STED beam 
where the higher effective spatial resolution is.63 
To evaluate the power of using time-gated STED (gCW-STED) over no gating applied 
(CW-STED), HeLa cells were prepared as described in section 2.5.8. Figure 5.16 
compares gCW-STED and CW-STED of a single HeLa cell dual-stained with Alexa 532 
(A) and [(Ru(bpy)2phen-Ar)2-ER]
9+ (B). In section 5.3, is was found that 
[(Ru(bpy)2phen-Ar)2-ER]
9+  has a luminescent lifetime of 683 ± 8 ns in aqueous media. 
Therefore, the two complexes can be readily resolved by exploiting the large difference 
in their luminescent lifetimes using the time-gating system. The time-gating system 
allows for time windows, Tg, to be selected. In this case, Alexa 532 was imaged at time 
window Tg between 0 – 3.5 ns, and the window for [(Ru(bpy)2phen-Ar)2-ER]9+ was set 
to Tg between 3.5 – 12 ns. 
Alexa Fluor Phalloidin 532 showed no improvement in image resolution or quality as a 
result of using gCW-STED (A). This was further demonstrated by the X-Y distribution 
plot, where no change in the resolution was seen. This was reflected in the FWHM 
values, where it actually increased from 218.9 nm at CW-STED to 225.5 nm when the 
gating system was applied. This is possibly as a result of a reduction in the signal to 
noise ratio at the shorter lifetimes as some of the emission intensity is gated out for the 
short lived probe as some emission intensity is excluded from the image. On the other 
hand, [(Ru(bpy)2phen-Ar)2-ER]
9+ exhibited a much improved image resolution upon 
imaging with gCW-STED. From Figure 5.16 (B) it is evident that the overall resolution 
of the gCW-STED image is much clearer than with CW-STED, which is reflected in the 
resolution of the three spots compared with CW STED.  
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Figure 5.16 CW-STED and gCW-STED images of a fixed HeLa cell dual stained with Alexa 532 
(A) and [(Ru(bpy)2-phen-Ar)-ER]9 (B). The X-Y line traces through a fixed HeLa cell highlighting 
the improvement of using gating (—) and (—) versus no gating (—)   shown by the line traces and 
plot profiles. Alexa 532 was excited at 528 nm and the emission was collected between 534 and 675 
nm. [Ru(bpy)2phen-Ar)2-ER]9+ was excited using a 488 nm white light laser and 660 nm depletion 
laser. The 660 nm STED depletion laser was used for both probes. The time-gating system was set 
to a window of Tg = 0 – 3 ns for Alexa 532, and a window of Tg = 3.5 -12 ns for [Ru(bpy)2phen-Ar)2-
ER]9+. 
 
Even though gCW-STED is a relatively new concept, there have been a few reports on 
the improvements in resolution using this technique.58,61 Vicidomini et al have reported 
on high spatial resolution images using a time-gated system with a continuous wave 
STED laser.59 Figure 5.17 shows an example from their work. They used Atto647N to 
immuno-stain the microtubules of fixed PtK2 mammalian cells. Here they compare the 
confocal image in the inset of (A), with the CW-STED (A), and the resolved image 
following gCW-STED (B). The corresponding intensity plot reflects the improvements 
in the resolving power of using time-gated detection systems. They were able to resolve 
single microtubules to a resolution of 89 nm. Interestingly, they also compared time-
gated windows, varying the size of the window used. In Figure 5.17 B, the window was 
set to Tg = 1.5 ns, while in Figure 5.17 D the window was set to Tg = 6 ns. The fluorescent 
lifetime of Atto647 is ~ 3 ns. The dis-improvement in using a larger time window is due 
to the uncorrelated background induced by the scattering of the STED beam which 
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dominates over the shorter lifetime signal. These results demonstrate that the long-lived 
lifetimes of transition metals are highly suited to the gCW-STED system to improve 
image resolution.  
 
 
Figure 5.16 Comparison of using CW-STED (A) with tCW-STED (B) of Atto647N stained 
microtubules of fixed PtK2 cells. The corresponding intensity plot if the arrows in (B) demonstrates 
the resolution following confocal (__), CW-STED (__), and gCW-STED (__). The time-gated window 
for (B) was set to Tg = 1.5 ns. The time-gated window for (C) was set to Tg = 6 ns.59 
 
The only practical limitation of using gCW-STED is the loss of some ‘good’ signal that 
is lost as it is gated out, depending on the luminescent lifetime of the luminophore. 
Applying the gate acts as a spatial frequency filter, and therefore a decrease in signal 
can occur. However, time-gated detection greatly improves the resolution in CW-STED, 
and the chosen imaging parameters can help overcome the loss in signal. 
 
5.11 Photostability of [(Ru(bpy)2phen-Ar)2-ER]9+  under gCW-STED 
imaging 
Photostability is one of the key issues for new STED imaging probe. Alexa probes, in 
general, are highly photostable, which is one of the reasons why they are so widely used 
in STED microscopy in spite of their poor Stokes shift. We were interested in evaluating 
the relative photostability of the Alexa probe with the ruthenium complexes used here.  
The photostability of [(Ru(bpy)2phen-Ar)2-ER]
9+  was assessed in fixed HeLa cells and 
compared to Alexa 532 under the same conditions. Samples were prepared and mounted 
as described in section 5.2.9. The samples were imaged continuously for 30 minutes 
(every 60 seconds) at a STED laser power of 0.5 W. Each frame was acquired at 1024 x 
1024 resolution to mimic imaging conditions for each complex.  
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Figure 5.17 shows the photobleaching of Alexa 532 (top row) and [(Ru(bpy)2phen-Ar)2-
ER]9+  (bottom row) in a HeLa cell (A) following 1 minute, 15 minutes, and 30 minutes 
of continuous STED imaging. Figure 5.10 (B) is the corresponding plot of the emission 
intensities over time. Their values were taken from a selected area at each frame for 
[(Ru(bpy)2phen-Ar)2-ER]
9+ and Alexa 532. As expected, the emission intensity of each 
probe decreased over time with each frame accumulation using the 660 nm depletion 
laser. From the plots in Figure 5.17 B, the decay rate of [(Ru(bpy)2phen-Ar)2-ER]
9+ was 
measured to be 7.66 x 10-4 s-1, while Alexa 532 has a decay rate of 5.27 x 10-4 s-1 under 
the same STED imaging conditions. Therefore two complexes both exhibit emission 
intensity decays at very similar rates of the order of 10-4 s-1. Although the decay rate for 
of [(Ru(bpy)2phen-Ar)2-ER]
9+ is very slightly faster, under the conditions used here it is 
important to remember that the STED source is a much closer match to the  
[(Ru(bpy)2phen-Ar)2-ER]
9+ emission indicating that the photostability is at least  as good 
as that of the highly photostable Alexa 532. 
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Figure 5.17 Photostability of Alexa 532 (top) and [(Ru(bpy)2phen-Ar)2-ER]9+  (bottom) in a fixed 
HeLa cell at 1, 15, and 30 minutes of continuous imaging (A). A plot of the emission intensities over 
time shows the gradual decrease in emission over time for Alexa 532 (—) and [(Ru(bpy)2phen-Ar)2-
ER]9+ (—). The 660 nm laser (0.5 W) was used to collect the images of each probe. 
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5.12 STED imaging of the endoplasmic reticulum 
In section 5.4.2, [(Ru(bpy)2phen-Ar)2-ER]
9+ was shown to localise within the 
endoplasmic reticulum (ER) of HeLa cells. In order to improve the image resolution of 
the ER, STED microscopy was applied, but without the dual-staining with Alexa 532. 
HeLa cells were prepared as described in section 5.2.8, without the addition of Alexa 
532. The cells were stained with [(Ru(bpy)2phen-Ar)2-ER]
9+ for 4 h, fixed, and mounted. 
Figure 5.18 shows the confocal image of [(Ru(bpy)2phen-Ar)2-ER]
9+ in the ER of a HeLa 
cell. The inset image shows the corresponding STED image. In Figure 5.18 (A), the 
confocal image shows [(Ru(bpy)2phen-Ar)2-ER]
9+ in the ER, and appears to be 
distributed in a punctate manner. A gCW-STED image was acquired using the 660 nm 
STED depletion laser, and the image was deconvolved using Huygens Professional 
software. The result shows that the spatial resolution of the selected area has been greatly 
improved. The detailed structure of the ER can be clearly seen on [(Ru(bpy)2phen-Ar)2-
ER]9+ labelling where it  has a tube-like structure. Figure 5.18 (B) shows a different 
HeLa cell of the same sample. Similarly, the gCW-STED image shows the same well-
resolved structure of the ER with tubular structures compared to the confocal image 
which indicates only that whole spots with no evidence for the central hole in the ER 
tubing. The precise labelling of the ER combined with gCW-STED results in 
background free images, with no auto-fluorescence from the surrounding cell. 
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Figure 5.18 gCW-STED image of [(Ru(bpy)2phen-Ar)2-ER]9+ in the endoplasmic reticulum of fixed 
HeLa cells mounted with ProLong Gold (A and B). [(Ru(bpy)2phen-Ar)2-ER]9+ was excited using a 
488 nm white light laser and the emission was collected between 590 and 700 nm. The 660 nm STED 
depletion laser was used to acquire a STED image. The time-gating system was set to Tg = 3.5 -12 
ns. 
 
Water-soluble proteins found in the cytosol of the cell are captured by the ER, and they 
are released into the lumen of the ER.64 These STED images appear to capture 
[(Ru(bpy)2phen-Ar)2-ER]
9+ in the lumen of the smooth ER, evident, as mentioned as 
tubular like structures. Figure 5.19 shows an electron micrograph image of the smooth 
ER of a hormone-secreting leydig cell. The shape and structure of these features is 
similar to that of the STED images presented in Figure 5.18.  
 
 
Figure 5.19 Electron micrograph of the smooth ER of a hormone-secreting leydig cell.64 
 
Schneider et al reported on the 3D structure of the ER, and other cellular organelles, of 
mouse adenocarcinoma cells using an X-ray microscope developed by their group. 65 
Figure 5.20 illustrates the 3D data complied together from a series of X-ray tomograms 
taken through a cell. The 3D image of the ER, represented in green, exhibits small, 
tubular like structures, which are quite similar to the structures of [(Ru(bpy)2phen-Ar)2-
ER]9+ imaged using STED. 
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Figure 5.20 3D imaging of cellular organelles. X-ray tomograms of the cytosol of a mouse 
adenocarcinoma cell (A). The 3D compilation data of a series of x-ray images to give a representative 
image of the organelles in the cytosol (B and C). Image taken from reference 65 
 
Moreover, many studies have examined the changing shape of the ER structure during 
mitosis. 66,67 The group of Lu et al have shown, using conventional fluorescence 
microscopy, that the ER structure is mostly tubular during metaphase of the cell cycle, 
which from Figure 5.18 the cell appears to be at, further confirming the tubular structure 
of the ER via STED microscopy. Figure 5.21 shows Z-stack images of the organisation 
of the ER in a HeLa cell. The 3D reconstruction images of the tubules of the ER highly 
resemble the tubule structures captured during STED in Figure 5.18. 
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Figure 5.21 Confocal Z-stack of the tubules and cisternae of the ER of a HeLa cell during metaphase. 
The Z-stack images were compiled to give 3D images of the ER structures.67 
 
Upon closer inspection of Figure 5.18 A, an X-Y line trace through the ER was plot to 
evaluate the improvement in resolution between the confocal and STED images, shown 
in Figure 5.22. Under confocal imaging each tubule is resolved as a single spherical 
point, which was fitted to a Gaussian plot. The FWHM of the two spots was found to 
532.4 nm and 527.6 nm. On the other hand, the X-Y plot of the STED image reveals the 
walls of the tubules, and the hollow nature of the tubule, possibly the lumen, which is 
clearly resolved in the Gaussian distribution plot. The FWHM of the first spot was found 
to be 309.3 nm and 183.25 nm across the now resolved ER. The second spot was found 
to be 279 nm and 388.18 nm. 
 
275 
 
 
Figure 5.22 gCW-STED image of [(Ru(bpy)2phen-Ar)2-ER]9+ in the endoplasmic reticulum of fixed 
HeLa cells mounted with ProLong Gold. [(Ru(bpy)2phen-Ar)2-ER]9+ was excited using a 488 nm 
white light laser and 660 nm depletion laser. The time-gating system was set to Tg = 3.5 -12 ns. The 
x-y line trace through a selected area of the ER stained with [(Ru(bpy)2phen-Ar)2-ER]9+. The 
corresponding plot profile compares confocal (—) with STED (—). The fluorescence-intensity was 
fit to a Gaussian distribution (OriginPro) to obtain the separated distributions for the STED profile 
fitting, indicated by grey dashed lines. 
 
Hell et al reported on resolutions of 65 nm of the ER of live PtK2 cells, expressing 
fluorescent protein Citrine.14 The most recent report of super resolution imaging of the 
ER employed dual-staining of the organelle to carry out two-photon STED microscopy. 
Bottanelli et al were able to achieve 50 nm resolutions of the ER.68 Figure 5.23 A shows 
the ER dual-stained, and the close up in B. Here they used SNAP-KDEL590 to stain the 
lumen, and Halo-S-C61β to stain the ER membrane. Although the two dual-stained 
structures can be seen in Figure 5.23 B, the image quality and structure detail is not clear.  
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Figure 5.23 Two-photon STED images of the ER of COS-7 cells (A) and the magnified region from 
the white box shown in (B).  The ER were dual-stained with SNAP-KDEL590 to stain the lumen 
(green), and Halo-S-C61β to stain the ER membrane (pink). Scale bar A = 2 μM. Scale bar B = 200 
nm.68 
 
In both cases, they appear to be measuring across the tubules of the ER, while in our 
images [(Ru(bpy)2phen-Ar)2-ER]
9+ appears to be localising in the lumen which may 
account for the difference in resolution achieved. Furthermore, in the reports from Hell 
et al and Bottanelli et al the ER was stained with fluorescent organic dyes. To our 
knowledge, there has been no reports of STED imaging of the ER using transition metal 
complexes, nor using signal peptides for targeted staining and imaging. The 
improvement in image resolution achieved using [(Ru(bpy)2phen-Ar)2-ER]
9+ allows the 
ER to be imaged in great detail. Using such optical methods in live cells may offer 
opportunity to monitor changes to the ER in real time. It also demonstrates the power of 
using ruthenium polypyridyl complexes with site-targeted peptide sequences to image 
specific organelles in great detail.  
 
5.13 Stimulated emission depletion (STED) microscopy of nuclear DNA 
As [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ has been successfully directed to the nucleus and 
shown to bind to DNA given the ‘switching on’ of the luminescence, time-gated, 
continuous wave STED (gCW-STED) was employed in an attempt to image the 
chromosomes when [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ has bound. To date, to our 
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knowledge, there have been no reports on STED images of nuclear DNA in the cell. 
HeLa cells were prepared as described in section 5.2.8. The cells were fixed and 
mounted prior to imaging. 
Figure 5.24 describes the confocal image of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ bound to 
chromosomal DNA in the nucleus of a HeLa cell. The chromosomes appear to be 
aligning down the middle of the nucleus preparing for cell division. This stage in mitosis 
is called Metaphase. Figure 5.24 compares the confocal image with the gCW-STED 
image. The images were acquired sequentially using a Leica TSP DMi8 system. The 
gCW-STED image was acquired using the 660 nm depletion laser. It is evident from the 
tow images that applying gCW-STED has greatly improved the resolution of the image. 
Chromosomes are made up of two chromatin, and are joined in the middle at the 
centromere, giving the chromosomes their well-known shape. The chromosome shape 
can be observed in greater detail as they align along the metaplate after employing gCW-
STED imaging. 
 
Figure 5.24 Confocal and gCW-STED images of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ bound to the 
chromosomes in the nucleus of a HeLa cell. Cells were incubated with 40 μM complex for 24 h at 
37 °C in the absence of light. The cells were fixed and mounted using ProLong Gold prior to imaging. 
[Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ was excited using a 470 nm white light laser and the emission was 
collected using a band pass filter 565 – 700 nm. STED was acquired using the 660 nm depletion 
laser. 
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Figure 5.25 shows a new HeLa cell in the same sample. Again, the chromosomes have 
aligned along the metaplate, preparing for cell division. In this case, it is evident from 
the gCW-STED acquired image that the chromosomes are still in their pairs, suggesting 
that the cell is in early metaphase. Individual sister chromatids are distinguishable, as 
are the grooves in the chromosome structures where the chromatids join at the 
centromere sites. The improvement in the resolution is reflected in the X-Y line profile 
through a single chromosome. The Gaussian distribution of the STED image can clearly 
resolve and distinguish the chromatids of the chromosome, which is not seen in the 
confocal image. 
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Figure 5.25 Confocal and gCW-STED images of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ in a fixed HeLa 
cell. The line plot of a single chromosome and its corresponding distribution confirms an 
improvement in using STED (—) compared to confocal (—).The fluorescence-intensity was fit to a 
Gaussian distribution (OriginPro) to obtain the separated distributions for the STED profile fitting, 
indicated by grey dashed lines. [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ was excited using a 470 nm white 
light laser and the emission was collected using a band pass filter 565 – 700 nm. STED was acquired 
using the 660 nm depletion laser. 
 
Figure 5.26 illustrates the different stages in mitosis using [Ru(dppz)(bpy)(bpy-Ar-
NFkB)]6+ as an imaging agent. When bound to nuclear DNA, mitosis, the process of cell 
division, can be observed. Figure 5.24 describes HeLa cells at the different stages of 
mitosis. During interphase the chromatin are dividing, and are in a relaxed state in the 
nucleus, shown in A. The fibres then begin to condense into chromosomes in Prophase 
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(B), where each chromosome containing two chromatin. From B the chromosomes are 
migrating towards the centre of the nucleus. The micro tubules, which are responsible 
for eventually pulling the chromosomes apart, begin to bind to the chromosomes in 
Prometaphase, shown in C. From C the chromosomes are now in the centre of the 
nucleus, ready to align for the next phase. The chromosomes then align along the middle 
of the nucleus in Metaphase, along the metaplate, shown in D. From this image, the 
shape of the sister chromatids of some of the chromosomes can be resolved. Figure E 
shows the single sister chromatids of the chromosomes being pulled apart in Anaphase, 
and the shape of the nucleus elongates to get ready for separation. Finally, in telophase, 
the new nuclear envelopes form around the daughter chromosomes, forming two new 
cells, shown in F. Here, the chromosomes become relaxed in the cell again as the two 
new cells are formed. These stages can all be clearly seen from DNA staining with 
[Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+. 
 
Figure 5.26 gCW-STED imaging of the stages in mitosis using 40 μM [Ru(dppz)(bpy)(bpy-Ar-
NFkB)]6+ to stain the nuclear DNA of HeLa cells. [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ was excited 
using a 470 nm white light laser and the emission was collected using a band pass filter 565 – 700 
nm. STED was acquired using the 660 nm depletion laser. 
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As discussed previously in Chapter 5, there have been few reports of nuclear localising 
complexes for the purpose of imaging. Those that have directed such complexes to the 
nucleus did not target or bind to DNA. However, Gill et al managed to inadvertently 
direct a ruthenium complex to the nucleus of MCF-7 cells without the use of CPP 
sequences or sugar moieties.15 They successfully imaged the chromosomes in the 
nucleus at the different stages of mitosis, shown in Figure 5.27.  
 
 
 
Figure 5.27 Confocal images of [(phen)2Ru(tpphz)Ru(phen)2]4+ in the nucleus of MCF-7 cells. The 
complex bound to nuclear DNA and the stages in cell division were captured.15 
 
While the chromosomal DNA can be made out in the phases of mitosis in Figure 5.27, 
the gCW-STED images acquired in this work, shown in Figure 5.26 show a dramatic 
improvement in resolution in comparison, where much more detail in the structure of 
individual sister chromatids can be resolved, as well as where they join at the 
centromeres. These improvements highlight the improvement in spatial resolution in the 
focal plane of STED over diffraction-limited approaches like confocal microscopy. 
 
5.14 Conclusions 
Chapter 5 discussed the application of Ru(II) complexes to STED microscopy. Cell-
penetrating peptide sequences were used to specifically target the endoplasmic reticulum 
using the sequence RQIKIWFQNRRMKWKK, and the nucleus using the sequence 
VQRKRQKLMP, for more precise imaging using STED microscopy, and compared to 
a commercial probe. 
The photophysical properties of both [(Ru(bpy)2phen-Ar)2-ER]
9+ and 
[Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ were examined. [(Ru(bpy)2phen-Ar)2-ER]
9+  
exhibited a strong absorbance band at 454 nm and an emission maximum of 602 nm. Its 
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long lived emissive lifetime of 683 ns in aerated aqueous solution showed excellent 
oxygen sensitivity, increasing dramatically to 1.064 μs when de-aerated. On the other 
hand, the properties of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ were investigated in both 
aqueous and non-aqueous solutions. In PBS solution the complex exhibited no emission, 
while an intense luminescent emission was observed in acetonitrile, successfully 
demonstrating the ‘light switch’ effect when in non-aqueous acetonitrile solution. In 
acetonitrile it exhibited a luminescent lifetime of 241 ± 1 ns. These photophysical 
properties- large Stokes shift, long lived emissive state, and high quantum yield 
suggested that these Ru(II) complexes would be well suited for super resolution 
microscopy. 
Confocal microscopy demonstrated that [(Ru(bpy)2phen-Ar)2-ER]
9+ (75 μM) exhibited 
efficient uptake in HeLa cells, distributing throughout the cytoplasm after 2 h, and 
finally localising within the ER after 4 h. Co-localisation studies confirmed that the 
complex was in the ER, illustrating the high selectivity of the chosen CPP sequence 
RQIKIWFQNRRMKWKK. On the other hand, [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ 
exhibited no luminescence in HeLa cells after 1 h exposure to the complex. After 4 h, a 
slight luminescence was seen in the cytoplasm, possibly as a result of the complex 
binding to RNA or proteins there. After 24 h, the complex was found to localise in the 
nucleus, confirmed by dual-staining with DAPI nuclear localising dye. The emission 
intensity of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+  varied in the nucleus compared to when 
bound and intercalated with nuclear DNA. 
As a result of the promising photophysical properties of [(Ru(bpy)2phen-Ar)2-ER]
9+, it 
was compared to Alexa Fluor Phalloidin 532 in HeLa cells for continuous wave STED 
(CW-STED) microscopy. It was found that the resolution using CW-STED was greatly 
improved when the 660 nm depletion laser was applied. The full width half maxima 
values confirmed that [(Ru(bpy)2phen-Ar)2-ER]
9+ resolution improved more so than that 
of Alex 532. Time-gating was employed as a method to resolve the two complexes in a 
dual-stained sample based on their emission lifetimes. Due to its long lifetime, using 
time-gating CW-STED (gCW-STED) with [(Ru(bpy)2phen-Ar)2-ER]
9+ improved the 
resolution further compared to using CW-STED, as any background noise or auto-
fluorescence was eliminated at the shorter lifetimes. [(Ru(bpy)2phen-Ar)2-ER]
9+ also 
demonstrated excellent photostability over a time course experiment, and diminished at 
a similar rate to that of the highly photostable Alexa 532. 
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gCW-STED was carried out to acquire high resolution images of the ER stained solely 
with [(Ru(bpy)2phen-Ar)2-ER]
9+ and of the nucleus stained with [Ru(dppz)(bpy)(bpy-
Ar-NFkB)]6+ . The resolution of the acquired images were greatly enhanced compare to 
the confocal images. Detailed structural resolution of the ER was seen, where they were 
observed as tubular-like structures.  The same structures appeared as closed spots in 
confocal fluorescence the cell without resolution of the open porous nature of the ER. 
Likewise, the resolution was improved and the background noise was reduced upon 
applying gCW-STED to image the chromosomal aggregation in six phases in cell 
division in fixed HeLa cells stained with [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ using gCW-
STED microscopy. 
Finally, the long luminescent lifetimes of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ in non-
aqueous solution meant [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ was well suited to PLIM 
imaging. It was found that the lifetime of [Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ increased 
significantly when bound to DNA (398 ns) compared to when in solution (241 ns). The 
cytoplasmic region gave a shorter lifetime, indicating its presence there. As 
[Ru(dppz)(bpy)(bpy-Ar-NFkB)]6+ does not luminescence in aqueous environments, the 
luminescent lifetimes were attributed to it binding to membrane structures in the 
cytoplasm. 
Ruthenium polypyridyl complexes demonstrated excellent suitability and compatibility 
with both CW- and gCW-STED. Their large Stokes shift, long lifetimes, and impeccable 
photostability gave an improvement in image resolution compared to the conventional 
confocal images. Furthermore, they have proven to be reliable in reporting from various 
cell organelles when combined with CPPs. The ability of [Ru(dppz)(bpy)(bpy-Ar-
NFkB)]6+ to report on  lifetime differences between the different phases in mitosis will 
allow for further investigation of the chromatin environment under a variety of 
physiological changes, for example, proliferation. Combining this lifetime data with 
gCW-STED microscopy may give a correlation between changes in lifetime and the 
visualisation of the DNA environment for in-depth monitoring on structural changes to 
DNA in different states. This means Ru(II) complexes are a valuable new class of 
imaging probes for super resolution microscopy. 
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This thesis focused on the application of novel Ruthenium and Osmium (II) polypyridyl 
complexes as contrast agents and sensing probes in live cell imaging applications.  There 
has been a dramatic upsurge in interest in metal complexes as imaging agents over the 
past decade, driven in part by increased understanding of targeting and cell permeation 
of molecules which has come from developments in pharmaceutical and therapeutic 
sciences. And, also in part by increased acceptance that metal complexes with the right 
ligand combinations can be rendered very stable and thus have low toxicity toward cells.   
The work presented here advances our understanding of both the cytotoxicity of Ru and 
Os complexes, indeed Chapter 2 detailed the first example of an Os (II) complex applied 
to cell imaging and explored the high precision with which peptides can target such 
metal complexes within the cell.  We also explored the applications of these luminescent 
probes in quantitatively measuring oxygen concentrations in vivo and their performance 
in the latest development in super resolution microscopy, STimulated Emission 
Depletion (STED). 
Chapter 2 detailed the first application of an Os(II) polypyridyl complex conjugated to 
an octa-arginine peptide sequence for cell imaging. Up until now, Os(II) had only been 
employed in therapeutic applications as anti-cancer agents because of their high 
cytotoxicity when coordination to arene or similar ligands. Here we demonstrated that 
Os(II) is a suitable probe for cell imaging, with an Emmax of 710 nm. Uptake studies in 
live CHO cells showed that Os(II) gave bright, high contrast images at low 
concentrations. It was also found to be non-toxic towards both CHO and Sp2 cells, a 
perhaps surprising attribute which is important for a cell imaging probe. Its outstanding 
photostability even compared to its Ru(II) analogue means it can undergo long 
exposures under confocal laser scanning without photobleaching during imaging  
experiments. The only drawback of the Os(II) explored noted is it relatively short 
luminescent lifetime, which rendered it insensitive to oxygen. However, this could 
possibly be used to study reactive oxygen species (ROS) in live cells, as Os(II) 
luminescent lifetime can be quenched in the presence of ROS. This is something that 
will be explored in the future. 
Chapter 3 focused on a dinuclear Ru(II) probe conjugated to the MPP sequence 
FrFKFrFK to not only direct the probe to the mitochondria of live cells, but to also 
quantitatively measure oxygen and ROS from within the mitochondria. This was 
successfully demonstrated phosphorescent lifetime imaging microscopy (PLIM) which 
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allowed us to draw dynamic maps of the metabolic response of live cells to Antymycin 
A. 
Chapter 4 examined the use of ratiometric probes for oxygen sensing in vivo, which 
consisted of the oxygen-sensitive Ru(II) complex and the oxygen-insensitive BODIPY 
reference probe. A single molecule ratiometric probe proved unsuccessful as when in 
aqueous solution the BODIPY reference switched off, meaning quantitative ratiometric 
oxygen sensing in cells could not be done. A core-shell ratiometric probe consisting of 
the BODIPY reference in a poly(styrene) core and the Ru(II) probe located on the 
outside of a poly-L-lysine shell overcame this problem as the BODIPY was now 
protected from aqueous solutions. At 100 nm in diameter, the particles crossed the cell 
membrane via passive diffusion with the help of the detergent CTAB, and localised in 
the lysosomes. However, ratiometric sensing from within the cells was unsuccessful. It 
was concluded that this was as a result of the particles locating in the lysosomes and the 
confocal was unable to successfully detect any changes in the luminescent emission 
intensity. One approach to try overcome this is to functionalise the outside of the 
particles in order to direct them away from the lysosomes when inside the cell. 
Increasing the concentrations of the probes used in the particles is also another factor 
that will be investigated to improve the particles. 
Finally, Chapter 5 explored the application of Ru(II) polypyridyl probes to STED 
microscopy, where the high precision targeting, large Stokes shifts and ability to switch 
on/off upon binding to DNA might offer key advantages over conventional and rather 
limited range of probes applied to these methods. Targeting specific organelles is 
challenging, but is potentially very useful as it allows for precise imaging and sensing at 
these sites. Using signal peptide sequences enable the complex to be recognised by the 
cells for uptake, and once inside the cell to be directed to their target organelle. In this 
case, two Ru(II) complexes were used, both conjugated to two different signal peptides. 
The peptide sequence RQIKIWFQNRRMKWKK from the Drosophila transcription 
factor Antennepedia was used to target the endoplasmic reticulum (ER). On the other 
hand, VQRKRQKLMP peptide sequence, known as NF-κB, a nuclear transcription 
factor, was used to target the nucleus. The probes were directed to the endoplasmic 
reticulum and nucleus of live HeLa cells, confirmed using confocal microscopy. The 
Ru(II) complexes proved to highly photostable when compared to Alexa Fluor 
532commercial probe which is widely used as a STED probe because of its 
photostability. Combining precise targeting probes with super resolution STED 
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microscopy allows for detailed, high resolution imaging specific organelles. Upon 
applying STED, high spatial resolution images of the ER were achieved, resolving single 
spots in the confocal image to the tube-like structure of the ER in the equivalent STED 
images. The ‘light switch’ effect of [Ru(dppz)]2+ complex was successful, as the 
complex emitted when bound to nuclear DNA, brought to the nucleus by the targeting 
peptide sequence. STED images of nuclear DNA during the different stages of cell 
division were captured, with very little background noise. Resolution as low as 86 nm 
were achieved. 
The future work to emerge from this thesis will focus on new transition metal complexes 
as suitable STED probes for live STED imaging. Os(II) complexes would make 
excellent STED probes because of their incredible photostability. There is currently a 
huge interest in the use of live STED imaging at the moment because of the improved 
resolutions as low as 20 nm. Dual-staining of samples also allows for live multi-photon 
STED images to capture interactions and complex dynamics between the different 
cellular organelles in real time. However, the increased resolutions achieved using 
STED needs to be exploited to capture live biological occurrences in order to study and 
understand at a sub-cellular level, something which is missing from the field at the 
moment. As demonstrated in this thesis, transition metal complexes are nearly ideal as 
STED imaging probes. Their multi-modal uses can combine STED imaging with 
intracellular sensing which is why the focus of future STED probes should be centred in 
developing transition metal complexes as suitable STED probes. 
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Appendix 
Chapter 4 Dual-emission Ruthenium-BODIPY ratiometric 
complex for Oxygen Sensing 
 
 
 
Figure A4.1 O2 calibration repeat of Compound 376 in PBS solution (pH 7.4) one month after Figure 
A1. Particles were stored in the dark before being used again.  Particles were purged for with N2 for 
10 minutes and allowed to slowly re-aerate, measuring the emission spectra at varying oxygen 
concentrations (μmol/L) using a PreSens Oxygen probe. 
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